id	sid	tid	token	lemma	pos
cord-342372-2g9sq36w	1	1	key	key	JJ
cord-342372-2g9sq36w	1	2	:	:	:
cord-342372-2g9sq36w	1	3	cord-342372	cord-342372	NN
cord-342372-2g9sq36w	1	4	-	-	HYPH
cord-342372-2g9sq36w	1	5	2g9sq36w	2g9sq36w	CD
cord-342372-2g9sq36w	1	6	authors	author	NNS
cord-342372-2g9sq36w	1	7	:	:	:
cord-342372-2g9sq36w	1	8	Zhu	Zhu	NNP
cord-342372-2g9sq36w	1	9	,	,	,
cord-342372-2g9sq36w	1	10	Frank	Frank	NNP
cord-342372-2g9sq36w	1	11	H.	H.	NNP
cord-342372-2g9sq36w	1	12	;	;	:
cord-342372-2g9sq36w	1	13	Ang	Ang	NNP
cord-342372-2g9sq36w	1	14	,	,	,
cord-342372-2g9sq36w	1	15	Jocelyn	Jocelyn	NNP
cord-342372-2g9sq36w	1	16	Y.	Y.	NNP
cord-342372-2g9sq36w	1	17	title	title	NN
cord-342372-2g9sq36w	1	18	:	:	:
cord-342372-2g9sq36w	1	19	The	the	DT
cord-342372-2g9sq36w	1	20	Clinical	Clinical	NNP
cord-342372-2g9sq36w	1	21	Diagnosis	Diagnosis	NNP
cord-342372-2g9sq36w	1	22	and	and	CC
cord-342372-2g9sq36w	1	23	Management	Management	NNP
cord-342372-2g9sq36w	1	24	of	of	IN
cord-342372-2g9sq36w	1	25	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	1	26	Disease	Disease	NNP
cord-342372-2g9sq36w	1	27	:	:	:
cord-342372-2g9sq36w	1	28	a	a	DT
cord-342372-2g9sq36w	1	29	Review	Review	NNP
cord-342372-2g9sq36w	1	30	and	and	CC
cord-342372-2g9sq36w	1	31	Update	update	NN
cord-342372-2g9sq36w	1	32	date	date	NN
cord-342372-2g9sq36w	1	33	:	:	:
cord-342372-2g9sq36w	1	34	2016	2016	CD
cord-342372-2g9sq36w	1	35	-	-	HYPH
cord-342372-2g9sq36w	1	36	09	09	CD
cord-342372-2g9sq36w	1	37	-	-	HYPH
cord-342372-2g9sq36w	1	38	28	28	CD
cord-342372-2g9sq36w	1	39	journal	journal	NN
cord-342372-2g9sq36w	1	40	:	:	:
cord-342372-2g9sq36w	2	1	Curr	Curr	NNP
cord-342372-2g9sq36w	2	2	Infect	infect	VBP
cord-342372-2g9sq36w	2	3	Dis	Dis	NNP
cord-342372-2g9sq36w	2	4	Rep	Rep	NNP
cord-342372-2g9sq36w	2	5	DOI	doi	NN
cord-342372-2g9sq36w	2	6	:	:	:
cord-342372-2g9sq36w	3	1	10.1007	10.1007	CD
cord-342372-2g9sq36w	3	2	/	/	SYM
cord-342372-2g9sq36w	3	3	s11908	s11908	NN
cord-342372-2g9sq36w	3	4	-	-	HYPH
cord-342372-2g9sq36w	3	5	016	016	CD
cord-342372-2g9sq36w	3	6	-	-	HYPH
cord-342372-2g9sq36w	3	7	0538	0538	CD
cord-342372-2g9sq36w	3	8	-	-	SYM
cord-342372-2g9sq36w	3	9	5	5	CD
cord-342372-2g9sq36w	3	10	sha	sha	NNP
cord-342372-2g9sq36w	3	11	:	:	:
cord-342372-2g9sq36w	4	1	3bf4c88f9a172e085886d6344e9d32dbac9be864	3bf4c88f9a172e085886d6344e9d32dbac9be864	NNP
cord-342372-2g9sq36w	4	2	doc_id	doc_id	CD
cord-342372-2g9sq36w	4	3	:	:	:
cord-342372-2g9sq36w	4	4	342372	342372	CD
cord-342372-2g9sq36w	4	5	cord_uid	cord_uid	NN
cord-342372-2g9sq36w	4	6	:	:	:
cord-342372-2g9sq36w	5	1	2g9sq36w	2g9sq36w	CD
cord-342372-2g9sq36w	6	1	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	6	2	disease	disease	NN
cord-342372-2g9sq36w	6	3	is	be	VBZ
cord-342372-2g9sq36w	6	4	an	an	DT
cord-342372-2g9sq36w	6	5	acute	acute	JJ
cord-342372-2g9sq36w	6	6	,	,	,
cord-342372-2g9sq36w	6	7	self	self	NN
cord-342372-2g9sq36w	6	8	-	-	HYPH
cord-342372-2g9sq36w	6	9	limited	limit	VBN
cord-342372-2g9sq36w	6	10	vasculitis	vasculitis	NN
cord-342372-2g9sq36w	6	11	of	of	IN
cord-342372-2g9sq36w	6	12	childhood	childhood	NN
cord-342372-2g9sq36w	6	13	and	and	CC
cord-342372-2g9sq36w	6	14	has	have	VBZ
cord-342372-2g9sq36w	6	15	become	become	VBN
cord-342372-2g9sq36w	6	16	the	the	DT
cord-342372-2g9sq36w	6	17	leading	leading	JJ
cord-342372-2g9sq36w	6	18	cause	cause	NN
cord-342372-2g9sq36w	6	19	of	of	IN
cord-342372-2g9sq36w	6	20	acquired	acquire	VBN
cord-342372-2g9sq36w	6	21	pediatric	pediatric	JJ
cord-342372-2g9sq36w	6	22	heart	heart	NN
cord-342372-2g9sq36w	6	23	disease	disease	NN
cord-342372-2g9sq36w	6	24	in	in	IN
cord-342372-2g9sq36w	6	25	the	the	DT
cord-342372-2g9sq36w	6	26	USA	USA	NNP
cord-342372-2g9sq36w	6	27	.	.	.
cord-342372-2g9sq36w	7	1	Prompt	prompt	JJ
cord-342372-2g9sq36w	7	2	treatment	treatment	NN
cord-342372-2g9sq36w	7	3	is	be	VBZ
cord-342372-2g9sq36w	7	4	essential	essential	JJ
cord-342372-2g9sq36w	7	5	in	in	IN
cord-342372-2g9sq36w	7	6	reducing	reduce	VBG
cord-342372-2g9sq36w	7	7	cardiac	cardiac	NN
cord-342372-2g9sq36w	7	8	-	-	HYPH
cord-342372-2g9sq36w	7	9	related	relate	VBN
cord-342372-2g9sq36w	7	10	morbidity	morbidity	NN
cord-342372-2g9sq36w	7	11	and	and	CC
cord-342372-2g9sq36w	7	12	mortality	mortality	NN
cord-342372-2g9sq36w	7	13	.	.	.
cord-342372-2g9sq36w	8	1	The	the	DT
cord-342372-2g9sq36w	8	2	underlying	underlying	JJ
cord-342372-2g9sq36w	8	3	etiology	etiology	NN
cord-342372-2g9sq36w	8	4	remains	remain	VBZ
cord-342372-2g9sq36w	8	5	unknown	unknown	JJ
cord-342372-2g9sq36w	8	6	.	.	.
cord-342372-2g9sq36w	9	1	The	the	DT
cord-342372-2g9sq36w	9	2	disease	disease	NN
cord-342372-2g9sq36w	9	3	itself	-PRON-	PRP
cord-342372-2g9sq36w	9	4	may	may	MD
cord-342372-2g9sq36w	9	5	be	be	VB
cord-342372-2g9sq36w	9	6	the	the	DT
cord-342372-2g9sq36w	9	7	characteristic	characteristic	JJ
cord-342372-2g9sq36w	9	8	manifestation	manifestation	NN
cord-342372-2g9sq36w	9	9	of	of	IN
cord-342372-2g9sq36w	9	10	a	a	DT
cord-342372-2g9sq36w	9	11	common	common	JJ
cord-342372-2g9sq36w	9	12	pathway	pathway	NN
cord-342372-2g9sq36w	9	13	of	of	IN
cord-342372-2g9sq36w	9	14	immune	immune	NN
cord-342372-2g9sq36w	9	15	-	-	HYPH
cord-342372-2g9sq36w	9	16	mediated	mediate	VBN
cord-342372-2g9sq36w	9	17	vascular	vascular	JJ
cord-342372-2g9sq36w	9	18	inflammation	inflammation	NN
cord-342372-2g9sq36w	9	19	in	in	IN
cord-342372-2g9sq36w	9	20	susceptible	susceptible	JJ
cord-342372-2g9sq36w	9	21	hosts	host	NNS
cord-342372-2g9sq36w	9	22	.	.	.
cord-342372-2g9sq36w	10	1	The	the	DT
cord-342372-2g9sq36w	10	2	characteristic	characteristic	JJ
cord-342372-2g9sq36w	10	3	clinical	clinical	JJ
cord-342372-2g9sq36w	10	4	features	feature	NNS
cord-342372-2g9sq36w	10	5	of	of	IN
cord-342372-2g9sq36w	10	6	fever	fever	NN
cord-342372-2g9sq36w	10	7	for	for	IN
cord-342372-2g9sq36w	10	8	at	at	RB
cord-342372-2g9sq36w	10	9	least	least	JJS
cord-342372-2g9sq36w	10	10	5	5	CD
cord-342372-2g9sq36w	10	11	days	day	NNS
cord-342372-2g9sq36w	10	12	with	with	IN
cord-342372-2g9sq36w	10	13	bilateral	bilateral	JJ
cord-342372-2g9sq36w	10	14	nonpurulent	nonpurulent	NN
cord-342372-2g9sq36w	10	15	conjunctivitis	conjunctivitis	NN
cord-342372-2g9sq36w	10	16	,	,	,
cord-342372-2g9sq36w	10	17	rash	rash	JJ
cord-342372-2g9sq36w	10	18	,	,	,
cord-342372-2g9sq36w	10	19	changes	change	NNS
cord-342372-2g9sq36w	10	20	in	in	IN
cord-342372-2g9sq36w	10	21	lips	lip	NNS
cord-342372-2g9sq36w	10	22	and	and	CC
cord-342372-2g9sq36w	10	23	oral	oral	JJ
cord-342372-2g9sq36w	10	24	cavity	cavity	NN
cord-342372-2g9sq36w	10	25	,	,	,
cord-342372-2g9sq36w	10	26	changes	change	NNS
cord-342372-2g9sq36w	10	27	in	in	IN
cord-342372-2g9sq36w	10	28	peripheral	peripheral	JJ
cord-342372-2g9sq36w	10	29	extremities	extremity	NNS
cord-342372-2g9sq36w	10	30	,	,	,
cord-342372-2g9sq36w	10	31	and	and	CC
cord-342372-2g9sq36w	10	32	cervical	cervical	JJ
cord-342372-2g9sq36w	10	33	lymphadenopathy	lymphadenopathy	NNS
cord-342372-2g9sq36w	10	34	remain	remain	VBP
cord-342372-2g9sq36w	10	35	the	the	DT
cord-342372-2g9sq36w	10	36	mainstay	mainstay	NN
cord-342372-2g9sq36w	10	37	of	of	IN
cord-342372-2g9sq36w	10	38	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	10	39	.	.	.
cord-342372-2g9sq36w	11	1	Supplementary	supplementary	JJ
cord-342372-2g9sq36w	11	2	laboratory	laboratory	NN
cord-342372-2g9sq36w	11	3	criteria	criterion	NNS
cord-342372-2g9sq36w	11	4	can	can	MD
cord-342372-2g9sq36w	11	5	aid	aid	VB
cord-342372-2g9sq36w	11	6	in	in	IN
cord-342372-2g9sq36w	11	7	the	the	DT
cord-342372-2g9sq36w	11	8	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	11	9	,	,	,
cord-342372-2g9sq36w	11	10	particularly	particularly	RB
cord-342372-2g9sq36w	11	11	in	in	IN
cord-342372-2g9sq36w	11	12	cases	case	NNS
cord-342372-2g9sq36w	11	13	of	of	IN
cord-342372-2g9sq36w	11	14	incomplete	incomplete	JJ
cord-342372-2g9sq36w	11	15	clinical	clinical	JJ
cord-342372-2g9sq36w	11	16	presentation	presentation	NN
cord-342372-2g9sq36w	11	17	.	.	.
cord-342372-2g9sq36w	12	1	Diagnosis	diagnosis	NN
cord-342372-2g9sq36w	12	2	of	of	IN
cord-342372-2g9sq36w	12	3	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	12	4	disease	disease	NN
cord-342372-2g9sq36w	12	5	can	can	MD
cord-342372-2g9sq36w	12	6	be	be	VB
cord-342372-2g9sq36w	12	7	challenging	challenging	JJ
cord-342372-2g9sq36w	12	8	as	as	IN
cord-342372-2g9sq36w	12	9	the	the	DT
cord-342372-2g9sq36w	12	10	clinical	clinical	JJ
cord-342372-2g9sq36w	12	11	presentation	presentation	NN
cord-342372-2g9sq36w	12	12	can	can	MD
cord-342372-2g9sq36w	12	13	be	be	VB
cord-342372-2g9sq36w	12	14	mistaken	mistake	VBN
cord-342372-2g9sq36w	12	15	for	for	IN
cord-342372-2g9sq36w	12	16	a	a	DT
cord-342372-2g9sq36w	12	17	variety	variety	NN
cord-342372-2g9sq36w	12	18	of	of	IN
cord-342372-2g9sq36w	12	19	other	other	JJ
cord-342372-2g9sq36w	12	20	pediatric	pediatric	JJ
cord-342372-2g9sq36w	12	21	illnesses	illness	NNS
cord-342372-2g9sq36w	12	22	.	.	.
cord-342372-2g9sq36w	13	1	Standard	standard	NN
cord-342372-2g9sq36w	13	2	of	of	IN
cord-342372-2g9sq36w	13	3	care	care	NN
cord-342372-2g9sq36w	13	4	consists	consist	NNS
cord-342372-2g9sq36w	13	5	of	of	IN
cord-342372-2g9sq36w	13	6	intravenous	intravenous	JJ
cord-342372-2g9sq36w	13	7	immune	immune	JJ
cord-342372-2g9sq36w	13	8	globulin	globulin	NN
cord-342372-2g9sq36w	13	9	and	and	CC
cord-342372-2g9sq36w	13	10	aspirin	aspirin	NN
cord-342372-2g9sq36w	13	11	.	.	.
cord-342372-2g9sq36w	14	1	Corticosteroids	corticosteroid	NNS
cord-342372-2g9sq36w	14	2	,	,	,
cord-342372-2g9sq36w	14	3	infliximab	infliximab	VBD
cord-342372-2g9sq36w	14	4	,	,	,
cord-342372-2g9sq36w	14	5	and	and	CC
cord-342372-2g9sq36w	14	6	cyclosporine	cyclosporine	NN
cord-342372-2g9sq36w	14	7	A	a	DT
cord-342372-2g9sq36w	14	8	have	have	VBP
cord-342372-2g9sq36w	14	9	been	be	VBN
cord-342372-2g9sq36w	14	10	used	use	VBN
cord-342372-2g9sq36w	14	11	as	as	IN
cord-342372-2g9sq36w	14	12	adjunct	adjunct	JJ
cord-342372-2g9sq36w	14	13	therapy	therapy	NN
cord-342372-2g9sq36w	14	14	for	for	IN
cord-342372-2g9sq36w	14	15	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	14	16	disease	disease	NN
cord-342372-2g9sq36w	14	17	refractory	refractory	JJ
cord-342372-2g9sq36w	14	18	to	to	IN
cord-342372-2g9sq36w	14	19	initial	initial	JJ
cord-342372-2g9sq36w	14	20	treatment	treatment	NN
cord-342372-2g9sq36w	14	21	.	.	.
cord-342372-2g9sq36w	15	1	There	there	EX
cord-342372-2g9sq36w	15	2	is	be	VBZ
cord-342372-2g9sq36w	15	3	ongoing	ongoing	JJ
cord-342372-2g9sq36w	15	4	research	research	NN
cord-342372-2g9sq36w	15	5	into	into	IN
cord-342372-2g9sq36w	15	6	the	the	DT
cord-342372-2g9sq36w	15	7	use	use	NN
cord-342372-2g9sq36w	15	8	of	of	IN
cord-342372-2g9sq36w	15	9	these	these	DT
cord-342372-2g9sq36w	15	10	agents	agent	NNS
cord-342372-2g9sq36w	15	11	in	in	IN
cord-342372-2g9sq36w	15	12	the	the	DT
cord-342372-2g9sq36w	15	13	initial	initial	JJ
cord-342372-2g9sq36w	15	14	therapy	therapy	NN
cord-342372-2g9sq36w	15	15	of	of	IN
cord-342372-2g9sq36w	15	16	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	15	17	disease	disease	NN
cord-342372-2g9sq36w	15	18	.	.	.
cord-342372-2g9sq36w	16	1	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	16	2	disease	disease	NN
cord-342372-2g9sq36w	16	3	(	(	-LRB-
cord-342372-2g9sq36w	16	4	KD	KD	NNP
cord-342372-2g9sq36w	16	5	)	)	-RRB-
cord-342372-2g9sq36w	16	6	is	be	VBZ
cord-342372-2g9sq36w	16	7	an	an	DT
cord-342372-2g9sq36w	16	8	acute	acute	JJ
cord-342372-2g9sq36w	16	9	self	self	NN
cord-342372-2g9sq36w	16	10	-	-	HYPH
cord-342372-2g9sq36w	16	11	limited	limit	VBN
cord-342372-2g9sq36w	16	12	vasculitis	vasculitis	NN
cord-342372-2g9sq36w	16	13	which	which	WDT
cord-342372-2g9sq36w	16	14	presents	present	VBZ
cord-342372-2g9sq36w	16	15	with	with	IN
cord-342372-2g9sq36w	16	16	characteristic	characteristic	JJ
cord-342372-2g9sq36w	16	17	clinical	clinical	JJ
cord-342372-2g9sq36w	16	18	features	feature	NNS
cord-342372-2g9sq36w	16	19	first	first	RB
cord-342372-2g9sq36w	16	20	described	describe	VBN
cord-342372-2g9sq36w	16	21	in	in	IN
cord-342372-2g9sq36w	16	22	1967	1967	CD
cord-342372-2g9sq36w	16	23	[	[	-LRB-
cord-342372-2g9sq36w	16	24	1	1	CD
cord-342372-2g9sq36w	16	25	]	]	-RRB-
cord-342372-2g9sq36w	16	26	.	.	.
cord-342372-2g9sq36w	17	1	The	the	DT
cord-342372-2g9sq36w	17	2	high	high	JJ
cord-342372-2g9sq36w	17	3	prevalence	prevalence	NN
cord-342372-2g9sq36w	17	4	of	of	IN
cord-342372-2g9sq36w	17	5	coronary	coronary	JJ
cord-342372-2g9sq36w	17	6	artery	artery	NN
cord-342372-2g9sq36w	17	7	aneurysm	aneurysm	NN
cord-342372-2g9sq36w	17	8	/	/	SYM
cord-342372-2g9sq36w	17	9	ectasia	ectasia	NNS
cord-342372-2g9sq36w	17	10	and	and	CC
cord-342372-2g9sq36w	17	11	its	-PRON-	PRP$
cord-342372-2g9sq36w	17	12	associated	associate	VBN
cord-342372-2g9sq36w	17	13	cardiovascular	cardiovascular	JJ
cord-342372-2g9sq36w	17	14	morbidity	morbidity	NN
cord-342372-2g9sq36w	17	15	in	in	IN
cord-342372-2g9sq36w	17	16	untreated	untreated	JJ
cord-342372-2g9sq36w	17	17	children	child	NNS
cord-342372-2g9sq36w	17	18	is	be	VBZ
cord-342372-2g9sq36w	17	19	well	well	RB
cord-342372-2g9sq36w	17	20	characterized	characterize	VBN
cord-342372-2g9sq36w	17	21	[	[	-LRB-
cord-342372-2g9sq36w	17	22	2	2	CD
cord-342372-2g9sq36w	17	23	]	]	-RRB-
cord-342372-2g9sq36w	17	24	.	.	.
cord-342372-2g9sq36w	18	1	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	18	2	disease	disease	NN
cord-342372-2g9sq36w	18	3	is	be	VBZ
cord-342372-2g9sq36w	18	4	now	now	RB
cord-342372-2g9sq36w	18	5	the	the	DT
cord-342372-2g9sq36w	18	6	leading	leading	JJ
cord-342372-2g9sq36w	18	7	cause	cause	NN
cord-342372-2g9sq36w	18	8	of	of	IN
cord-342372-2g9sq36w	18	9	pediatric	pediatric	JJ
cord-342372-2g9sq36w	18	10	acquired	acquire	VBN
cord-342372-2g9sq36w	18	11	heart	heart	NN
cord-342372-2g9sq36w	18	12	disease	disease	NN
cord-342372-2g9sq36w	18	13	in	in	IN
cord-342372-2g9sq36w	18	14	the	the	DT
cord-342372-2g9sq36w	18	15	USA	USA	NNP
cord-342372-2g9sq36w	18	16	[	[	-LRB-
cord-342372-2g9sq36w	18	17	3	3	CD
cord-342372-2g9sq36w	18	18	]	]	-RRB-
cord-342372-2g9sq36w	18	19	.	.	.
cord-342372-2g9sq36w	19	1	Prompt	prompt	JJ
cord-342372-2g9sq36w	19	2	treatment	treatment	NN
cord-342372-2g9sq36w	19	3	with	with	IN
cord-342372-2g9sq36w	19	4	high	high	JJ
cord-342372-2g9sq36w	19	5	-	-	HYPH
cord-342372-2g9sq36w	19	6	dose	dose	NN
cord-342372-2g9sq36w	19	7	intravenous	intravenous	JJ
cord-342372-2g9sq36w	19	8	immune	immune	NN
cord-342372-2g9sq36w	19	9	globulin	globulin	NN
cord-342372-2g9sq36w	19	10	(	(	-LRB-
cord-342372-2g9sq36w	19	11	IVIG	IVIG	NNP
cord-342372-2g9sq36w	19	12	)	)	-RRB-
cord-342372-2g9sq36w	19	13	reduces	reduce	VBZ
cord-342372-2g9sq36w	19	14	the	the	DT
cord-342372-2g9sq36w	19	15	incidence	incidence	NN
cord-342372-2g9sq36w	19	16	of	of	IN
cord-342372-2g9sq36w	19	17	coronary	coronary	JJ
cord-342372-2g9sq36w	19	18	artery	artery	NN
cord-342372-2g9sq36w	19	19	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	19	20	from	from	IN
cord-342372-2g9sq36w	19	21	18	18	CD
cord-342372-2g9sq36w	19	22	to	to	TO
cord-342372-2g9sq36w	19	23	4	4	CD
cord-342372-2g9sq36w	19	24	%	%	NN
cord-342372-2g9sq36w	19	25	[	[	-LRB-
cord-342372-2g9sq36w	19	26	4	4	CD
cord-342372-2g9sq36w	19	27	]	]	-RRB-
cord-342372-2g9sq36w	19	28	.	.	.
cord-342372-2g9sq36w	20	1	However	however	RB
cord-342372-2g9sq36w	20	2	,	,	,
cord-342372-2g9sq36w	20	3	significant	significant	JJ
cord-342372-2g9sq36w	20	4	gaps	gap	NNS
cord-342372-2g9sq36w	20	5	remain	remain	VBP
cord-342372-2g9sq36w	20	6	in	in	IN
cord-342372-2g9sq36w	20	7	our	-PRON-	PRP$
cord-342372-2g9sq36w	20	8	understanding	understanding	NN
cord-342372-2g9sq36w	20	9	of	of	IN
cord-342372-2g9sq36w	20	10	KD	KD	NNP
cord-342372-2g9sq36w	20	11	.	.	.
cord-342372-2g9sq36w	21	1	The	the	DT
cord-342372-2g9sq36w	21	2	underlying	underlying	JJ
cord-342372-2g9sq36w	21	3	etiology	etiology	NN
cord-342372-2g9sq36w	21	4	remains	remain	VBZ
cord-342372-2g9sq36w	21	5	unknown	unknown	JJ
cord-342372-2g9sq36w	21	6	.	.	.
cord-342372-2g9sq36w	22	1	Epidemiological	epidemiological	JJ
cord-342372-2g9sq36w	22	2	studies	study	NNS
cord-342372-2g9sq36w	22	3	have	have	VBP
cord-342372-2g9sq36w	22	4	recently	recently	RB
cord-342372-2g9sq36w	22	5	attributed	attribute	VBN
cord-342372-2g9sq36w	22	6	the	the	DT
cord-342372-2g9sq36w	22	7	possible	possible	JJ
cord-342372-2g9sq36w	22	8	source	source	NN
cord-342372-2g9sq36w	22	9	of	of	IN
cord-342372-2g9sq36w	22	10	the	the	DT
cord-342372-2g9sq36w	22	11	etiologic	etiologic	JJ
cord-342372-2g9sq36w	22	12	agent	agent	NN
cord-342372-2g9sq36w	22	13	of	of	IN
cord-342372-2g9sq36w	22	14	KD	KD	NNP
cord-342372-2g9sq36w	22	15	to	to	IN
cord-342372-2g9sq36w	22	16	northern	northern	JJ
cord-342372-2g9sq36w	22	17	China	China	NNP
cord-342372-2g9sq36w	22	18	with	with	IN
cord-342372-2g9sq36w	22	19	subsequent	subsequent	JJ
cord-342372-2g9sq36w	22	20	spread	spread	NN
cord-342372-2g9sq36w	22	21	to	to	IN
cord-342372-2g9sq36w	22	22	Japan	Japan	NNP
cord-342372-2g9sq36w	22	23	via	via	IN
cord-342372-2g9sq36w	22	24	tropospheric	tropospheric	JJ
cord-342372-2g9sq36w	22	25	winds	wind	NNS
cord-342372-2g9sq36w	22	26	[	[	-LRB-
cord-342372-2g9sq36w	22	27	5•	5•	CD
cord-342372-2g9sq36w	22	28	]	]	-RRB-
cord-342372-2g9sq36w	22	29	.	.	.
cord-342372-2g9sq36w	23	1	The	the	DT
cord-342372-2g9sq36w	23	2	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	23	3	of	of	IN
cord-342372-2g9sq36w	23	4	KD	KD	NNP
cord-342372-2g9sq36w	23	5	remains	remain	VBZ
cord-342372-2g9sq36w	23	6	primarily	primarily	RB
cord-342372-2g9sq36w	23	7	based	base	VBN
cord-342372-2g9sq36w	23	8	upon	upon	IN
cord-342372-2g9sq36w	23	9	the	the	DT
cord-342372-2g9sq36w	23	10	characteristic	characteristic	JJ
cord-342372-2g9sq36w	23	11	clinical	clinical	JJ
cord-342372-2g9sq36w	23	12	features	feature	NNS
cord-342372-2g9sq36w	23	13	of	of	IN
cord-342372-2g9sq36w	23	14	≥5	≥5	NN
cord-342372-2g9sq36w	23	15	days	day	NNS
cord-342372-2g9sq36w	23	16	of	of	IN
cord-342372-2g9sq36w	23	17	fever	fever	NN
cord-342372-2g9sq36w	23	18	,	,	,
cord-342372-2g9sq36w	23	19	bilateral	bilateral	JJ
cord-342372-2g9sq36w	23	20	nonpurulent	nonpurulent	NN
cord-342372-2g9sq36w	23	21	conjunctivitis	conjunctivitis	NN
cord-342372-2g9sq36w	23	22	,	,	,
cord-342372-2g9sq36w	23	23	rash	rash	JJ
cord-342372-2g9sq36w	23	24	,	,	,
cord-342372-2g9sq36w	23	25	cervical	cervical	JJ
cord-342372-2g9sq36w	23	26	lymphadenopathy	lymphadenopathy	NN
cord-342372-2g9sq36w	23	27	,	,	,
cord-342372-2g9sq36w	23	28	and	and	CC
cord-342372-2g9sq36w	23	29	mucocutaneous	mucocutaneous	JJ
cord-342372-2g9sq36w	23	30	changes	change	NNS
cord-342372-2g9sq36w	23	31	[	[	-LRB-
cord-342372-2g9sq36w	23	32	6••	6••	NN
cord-342372-2g9sq36w	23	33	]	]	-RRB-
cord-342372-2g9sq36w	23	34	.	.	.
cord-342372-2g9sq36w	24	1	However	however	RB
cord-342372-2g9sq36w	24	2	,	,	,
cord-342372-2g9sq36w	24	3	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	24	4	challenges	challenge	NNS
cord-342372-2g9sq36w	24	5	often	often	RB
cord-342372-2g9sq36w	24	6	arise	arise	VBP
cord-342372-2g9sq36w	24	7	given	give	VBN
cord-342372-2g9sq36w	24	8	the	the	DT
cord-342372-2g9sq36w	24	9	significant	significant	JJ
cord-342372-2g9sq36w	24	10	overlap	overlap	NN
cord-342372-2g9sq36w	24	11	in	in	IN
cord-342372-2g9sq36w	24	12	clinical	clinical	JJ
cord-342372-2g9sq36w	24	13	features	feature	NNS
cord-342372-2g9sq36w	24	14	of	of	IN
cord-342372-2g9sq36w	24	15	KD	KD	NNP
cord-342372-2g9sq36w	24	16	and	and	CC
cord-342372-2g9sq36w	24	17	other	other	JJ
cord-342372-2g9sq36w	24	18	pediatric	pediatric	JJ
cord-342372-2g9sq36w	24	19	illnesses	illness	NNS
cord-342372-2g9sq36w	24	20	.	.	.
cord-342372-2g9sq36w	25	1	Additionally	additionally	RB
cord-342372-2g9sq36w	25	2	,	,	,
cord-342372-2g9sq36w	25	3	KD	KD	NNP
cord-342372-2g9sq36w	25	4	can	can	MD
cord-342372-2g9sq36w	25	5	also	also	RB
cord-342372-2g9sq36w	25	6	present	present	VB
cord-342372-2g9sq36w	25	7	with	with	IN
cord-342372-2g9sq36w	25	8	incomplete	incomplete	JJ
cord-342372-2g9sq36w	25	9	clinical	clinical	JJ
cord-342372-2g9sq36w	25	10	features	feature	NNS
cord-342372-2g9sq36w	25	11	and	and	CC
cord-342372-2g9sq36w	25	12	a	a	DT
cord-342372-2g9sq36w	25	13	number	number	NN
cord-342372-2g9sq36w	25	14	of	of	IN
cord-342372-2g9sq36w	25	15	atypical	atypical	JJ
cord-342372-2g9sq36w	25	16	presentations	presentation	NNS
cord-342372-2g9sq36w	25	17	.	.	.
cord-342372-2g9sq36w	26	1	Yet	yet	RB
cord-342372-2g9sq36w	26	2	,	,	,
cord-342372-2g9sq36w	26	3	accurate	accurate	JJ
cord-342372-2g9sq36w	26	4	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	26	5	is	be	VBZ
cord-342372-2g9sq36w	26	6	integral	integral	JJ
cord-342372-2g9sq36w	26	7	in	in	IN
cord-342372-2g9sq36w	26	8	prevention	prevention	NN
cord-342372-2g9sq36w	26	9	of	of	IN
cord-342372-2g9sq36w	26	10	morbidity	morbidity	NN
cord-342372-2g9sq36w	26	11	and	and	CC
cord-342372-2g9sq36w	26	12	mortality	mortality	NN
cord-342372-2g9sq36w	26	13	of	of	IN
cord-342372-2g9sq36w	26	14	KD	KD	NNP
cord-342372-2g9sq36w	26	15	as	as	IN
cord-342372-2g9sq36w	26	16	prompt	prompt	JJ
cord-342372-2g9sq36w	26	17	treatment	treatment	NN
cord-342372-2g9sq36w	26	18	with	with	IN
cord-342372-2g9sq36w	26	19	IVIG	IVIG	NNP
cord-342372-2g9sq36w	26	20	significantly	significantly	RB
cord-342372-2g9sq36w	26	21	reduces	reduce	VBZ
cord-342372-2g9sq36w	26	22	the	the	DT
cord-342372-2g9sq36w	26	23	incidence	incidence	NN
cord-342372-2g9sq36w	26	24	of	of	IN
cord-342372-2g9sq36w	26	25	long	long	JJ
cord-342372-2g9sq36w	26	26	-	-	HYPH
cord-342372-2g9sq36w	26	27	term	term	NN
cord-342372-2g9sq36w	26	28	cardiac	cardiac	JJ
cord-342372-2g9sq36w	26	29	complications	complication	NNS
cord-342372-2g9sq36w	26	30	.	.	.
cord-342372-2g9sq36w	27	1	The	the	DT
cord-342372-2g9sq36w	27	2	most	most	RBS
cord-342372-2g9sq36w	27	3	recent	recent	JJ
cord-342372-2g9sq36w	27	4	epidemiological	epidemiological	JJ
cord-342372-2g9sq36w	27	5	data	datum	NNS
cord-342372-2g9sq36w	27	6	describes	describe	VBZ
cord-342372-2g9sq36w	27	7	a	a	DT
cord-342372-2g9sq36w	27	8	divergence	divergence	NN
cord-342372-2g9sq36w	27	9	in	in	IN
cord-342372-2g9sq36w	27	10	the	the	DT
cord-342372-2g9sq36w	27	11	incidence	incidence	NN
cord-342372-2g9sq36w	27	12	of	of	IN
cord-342372-2g9sq36w	27	13	KD	KD	NNP
cord-342372-2g9sq36w	27	14	between	between	IN
cord-342372-2g9sq36w	27	15	the	the	DT
cord-342372-2g9sq36w	27	16	West	West	NNP
cord-342372-2g9sq36w	27	17	(	(	-LRB-
cord-342372-2g9sq36w	27	18	North	North	NNP
cord-342372-2g9sq36w	27	19	America	America	NNP
cord-342372-2g9sq36w	27	20	,	,	,
cord-342372-2g9sq36w	27	21	Australia	Australia	NNP
cord-342372-2g9sq36w	27	22	,	,	,
cord-342372-2g9sq36w	27	23	Europe	Europe	NNP
cord-342372-2g9sq36w	27	24	)	)	-RRB-
cord-342372-2g9sq36w	27	25	and	and	CC
cord-342372-2g9sq36w	27	26	East	East	NNP
cord-342372-2g9sq36w	27	27	Asia	Asia	NNP
cord-342372-2g9sq36w	27	28	(	(	-LRB-
cord-342372-2g9sq36w	27	29	Japan	Japan	NNP
cord-342372-2g9sq36w	27	30	,	,	,
cord-342372-2g9sq36w	27	31	Taiwan	Taiwan	NNP
cord-342372-2g9sq36w	27	32	,	,	,
cord-342372-2g9sq36w	27	33	Korea	Korea	NNP
cord-342372-2g9sq36w	27	34	)	)	-RRB-
cord-342372-2g9sq36w	27	35	.	.	.
cord-342372-2g9sq36w	28	1	In	in	IN
cord-342372-2g9sq36w	28	2	the	the	DT
cord-342372-2g9sq36w	28	3	West	West	NNP
cord-342372-2g9sq36w	28	4	,	,	,
cord-342372-2g9sq36w	28	5	the	the	DT
cord-342372-2g9sq36w	28	6	current	current	JJ
cord-342372-2g9sq36w	28	7	incidence	incidence	NN
cord-342372-2g9sq36w	28	8	of	of	IN
cord-342372-2g9sq36w	28	9	KD	KD	NNP
cord-342372-2g9sq36w	28	10	is	be	VBZ
cord-342372-2g9sq36w	28	11	4	4	CD
cord-342372-2g9sq36w	28	12	-	-	SYM
cord-342372-2g9sq36w	28	13	25/100,000	25/100,000	CD
cord-342372-2g9sq36w	28	14	in	in	IN
cord-342372-2g9sq36w	28	15	children	child	NNS
cord-342372-2g9sq36w	28	16	<	<	XX
cord-342372-2g9sq36w	28	17	5	5	CD
cord-342372-2g9sq36w	28	18	years	year	NNS
cord-342372-2g9sq36w	28	19	.	.	.
cord-342372-2g9sq36w	29	1	In	in	IN
cord-342372-2g9sq36w	29	2	the	the	DT
cord-342372-2g9sq36w	29	3	last	last	JJ
cord-342372-2g9sq36w	29	4	decade	decade	NN
cord-342372-2g9sq36w	29	5	,	,	,
cord-342372-2g9sq36w	29	6	the	the	DT
cord-342372-2g9sq36w	29	7	overall	overall	JJ
cord-342372-2g9sq36w	29	8	incidence	incidence	NN
cord-342372-2g9sq36w	29	9	in	in	IN
cord-342372-2g9sq36w	29	10	the	the	DT
cord-342372-2g9sq36w	29	11	West	West	NNP
cord-342372-2g9sq36w	29	12	has	have	VBZ
cord-342372-2g9sq36w	29	13	plateaued	plateaue	VBN
cord-342372-2g9sq36w	29	14	following	follow	VBG
cord-342372-2g9sq36w	29	15	an	an	DT
cord-342372-2g9sq36w	29	16	initial	initial	JJ
cord-342372-2g9sq36w	29	17	increase	increase	NN
cord-342372-2g9sq36w	29	18	.	.	.
cord-342372-2g9sq36w	30	1	By	by	IN
cord-342372-2g9sq36w	30	2	comparison	comparison	NN
cord-342372-2g9sq36w	30	3	,	,	,
cord-342372-2g9sq36w	30	4	the	the	DT
cord-342372-2g9sq36w	30	5	incidence	incidence	NN
cord-342372-2g9sq36w	30	6	of	of	IN
cord-342372-2g9sq36w	30	7	KD	KD	NNP
cord-342372-2g9sq36w	30	8	in	in	IN
cord-342372-2g9sq36w	30	9	East	east	JJ
cord-342372-2g9sq36w	30	10	Asian	asian	JJ
cord-342372-2g9sq36w	30	11	countries	country	NNS
cord-342372-2g9sq36w	30	12	has	have	VBZ
cord-342372-2g9sq36w	30	13	continued	continue	VBN
cord-342372-2g9sq36w	30	14	to	to	TO
cord-342372-2g9sq36w	30	15	increase	increase	VB
cord-342372-2g9sq36w	30	16	and	and	CC
cord-342372-2g9sq36w	30	17	currently	currently	RB
cord-342372-2g9sq36w	30	18	report	report	VB
cord-342372-2g9sq36w	30	19	an	an	DT
cord-342372-2g9sq36w	30	20	incidence	incidence	NN
cord-342372-2g9sq36w	30	21	10	10	CD
cord-342372-2g9sq36w	30	22	-	-	SYM
cord-342372-2g9sq36w	30	23	20	20	CD
cord-342372-2g9sq36w	30	24	times	time	NNS
cord-342372-2g9sq36w	30	25	higher	high	JJR
cord-342372-2g9sq36w	30	26	than	than	IN
cord-342372-2g9sq36w	30	27	USA	USA	NNP
cord-342372-2g9sq36w	30	28	and	and	CC
cord-342372-2g9sq36w	30	29	Europe	Europe	NNP
cord-342372-2g9sq36w	30	30	.	.	.
cord-342372-2g9sq36w	31	1	Japan	Japan	NNP
cord-342372-2g9sq36w	31	2	has	have	VBZ
cord-342372-2g9sq36w	31	3	the	the	DT
cord-342372-2g9sq36w	31	4	highest	high	JJS
cord-342372-2g9sq36w	31	5	incidence	incidence	NN
cord-342372-2g9sq36w	31	6	of	of	IN
cord-342372-2g9sq36w	31	7	KD	KD	NNP
cord-342372-2g9sq36w	31	8	in	in	IN
cord-342372-2g9sq36w	31	9	children	child	NNS
cord-342372-2g9sq36w	31	10	<	<	XX
cord-342372-2g9sq36w	31	11	5	5	CD
cord-342372-2g9sq36w	31	12	years	year	NNS
cord-342372-2g9sq36w	31	13	of	of	IN
cord-342372-2g9sq36w	31	14	any	any	DT
cord-342372-2g9sq36w	31	15	country	country	NN
cord-342372-2g9sq36w	31	16	(	(	-LRB-
cord-342372-2g9sq36w	31	17	265/	265/	CD
cord-342372-2g9sq36w	31	18	100,000	100,000	CD
cord-342372-2g9sq36w	31	19	)	)	-RRB-
cord-342372-2g9sq36w	31	20	,	,	,
cord-342372-2g9sq36w	31	21	followed	follow	VBN
cord-342372-2g9sq36w	31	22	by	by	IN
cord-342372-2g9sq36w	31	23	Korea	Korea	NNP
cord-342372-2g9sq36w	31	24	(	(	-LRB-
cord-342372-2g9sq36w	31	25	134/100,000	134/100,000	CD
cord-342372-2g9sq36w	31	26	)	)	-RRB-
cord-342372-2g9sq36w	31	27	,	,	,
cord-342372-2g9sq36w	31	28	and	and	CC
cord-342372-2g9sq36w	31	29	Taiwan	Taiwan	NNP
cord-342372-2g9sq36w	31	30	(	(	-LRB-
cord-342372-2g9sq36w	31	31	83/100,000	83/100,000	CD
cord-342372-2g9sq36w	31	32	)	)	-RRB-
cord-342372-2g9sq36w	31	33	[	[	-LRB-
cord-342372-2g9sq36w	31	34	7•	7•	CD
cord-342372-2g9sq36w	31	35	]	]	-RRB-
cord-342372-2g9sq36w	31	36	.	.	.
cord-342372-2g9sq36w	32	1	Ethnic	ethnic	JJ
cord-342372-2g9sq36w	32	2	variation	variation	NN
cord-342372-2g9sq36w	32	3	in	in	IN
cord-342372-2g9sq36w	32	4	the	the	DT
cord-342372-2g9sq36w	32	5	incidence	incidence	NN
cord-342372-2g9sq36w	32	6	of	of	IN
cord-342372-2g9sq36w	32	7	KD	KD	NNP
cord-342372-2g9sq36w	32	8	suggests	suggest	VBZ
cord-342372-2g9sq36w	32	9	genetic	genetic	JJ
cord-342372-2g9sq36w	32	10	susceptibility	susceptibility	NN
cord-342372-2g9sq36w	32	11	as	as	IN
cord-342372-2g9sq36w	32	12	a	a	DT
cord-342372-2g9sq36w	32	13	significant	significant	JJ
cord-342372-2g9sq36w	32	14	factor	factor	NN
cord-342372-2g9sq36w	32	15	in	in	IN
cord-342372-2g9sq36w	32	16	the	the	DT
cord-342372-2g9sq36w	32	17	higher	high	JJR
cord-342372-2g9sq36w	32	18	prevalence	prevalence	NN
cord-342372-2g9sq36w	32	19	of	of	IN
cord-342372-2g9sq36w	32	20	KD	KD	NNP
cord-342372-2g9sq36w	32	21	in	in	IN
cord-342372-2g9sq36w	32	22	East	east	JJ
cord-342372-2g9sq36w	32	23	Asian	asian	JJ
cord-342372-2g9sq36w	32	24	countries	country	NNS
cord-342372-2g9sq36w	32	25	.	.	.
cord-342372-2g9sq36w	33	1	Within	within	IN
cord-342372-2g9sq36w	33	2	the	the	DT
cord-342372-2g9sq36w	33	3	USA	USA	NNP
cord-342372-2g9sq36w	33	4	,	,	,
cord-342372-2g9sq36w	33	5	the	the	DT
cord-342372-2g9sq36w	33	6	incidence	incidence	NN
cord-342372-2g9sq36w	33	7	of	of	IN
cord-342372-2g9sq36w	33	8	KD	KD	NNP
cord-342372-2g9sq36w	33	9	ranges	range	VBZ
cord-342372-2g9sq36w	33	10	from	from	IN
cord-342372-2g9sq36w	33	11	17.5	17.5	CD
cord-342372-2g9sq36w	33	12	to	to	IN
cord-342372-2g9sq36w	33	13	20.8/100,000	20.8/100,000	CD
cord-342372-2g9sq36w	33	14	in	in	IN
cord-342372-2g9sq36w	33	15	children	child	NNS
cord-342372-2g9sq36w	33	16	<	<	XX
cord-342372-2g9sq36w	33	17	5	5	CD
cord-342372-2g9sq36w	33	18	years	year	NNS
cord-342372-2g9sq36w	33	19	[	[	-LRB-
cord-342372-2g9sq36w	33	20	8	8	CD
cord-342372-2g9sq36w	33	21	]	]	-RRB-
cord-342372-2g9sq36w	33	22	.	.	.
cord-342372-2g9sq36w	34	1	However	however	RB
cord-342372-2g9sq36w	34	2	,	,	,
cord-342372-2g9sq36w	34	3	the	the	DT
cord-342372-2g9sq36w	34	4	incidence	incidence	NN
cord-342372-2g9sq36w	34	5	of	of	IN
cord-342372-2g9sq36w	34	6	KD	KD	NNP
cord-342372-2g9sq36w	34	7	is	be	VBZ
cord-342372-2g9sq36w	34	8	significantly	significantly	RB
cord-342372-2g9sq36w	34	9	higher	high	JJR
cord-342372-2g9sq36w	34	10	in	in	IN
cord-342372-2g9sq36w	34	11	Pacific	Pacific	NNP
cord-342372-2g9sq36w	34	12	Islanders	Islanders	NNPS
cord-342372-2g9sq36w	34	13	and	and	CC
cord-342372-2g9sq36w	34	14	African	African	NNPS
cord-342372-2g9sq36w	34	15	Americans	Americans	NNPS
cord-342372-2g9sq36w	34	16	.	.	.
cord-342372-2g9sq36w	35	1	In	in	IN
cord-342372-2g9sq36w	35	2	particular	particular	JJ
cord-342372-2g9sq36w	35	3	,	,	,
cord-342372-2g9sq36w	35	4	Americans	Americans	NNPS
cord-342372-2g9sq36w	35	5	of	of	IN
cord-342372-2g9sq36w	35	6	Japanese	japanese	JJ
cord-342372-2g9sq36w	35	7	ancestry	ancestry	NN
cord-342372-2g9sq36w	35	8	in	in	IN
cord-342372-2g9sq36w	35	9	Hawaii	Hawaii	NNP
cord-342372-2g9sq36w	35	10	exhibit	exhibit	VBP
cord-342372-2g9sq36w	35	11	a	a	DT
cord-342372-2g9sq36w	35	12	similar	similar	JJ
cord-342372-2g9sq36w	35	13	incidence	incidence	NN
cord-342372-2g9sq36w	35	14	of	of	IN
cord-342372-2g9sq36w	35	15	KD	KD	NNP
cord-342372-2g9sq36w	35	16	to	to	IN
cord-342372-2g9sq36w	35	17	that	that	DT
cord-342372-2g9sq36w	35	18	of	of	IN
cord-342372-2g9sq36w	35	19	the	the	DT
cord-342372-2g9sq36w	35	20	general	general	JJ
cord-342372-2g9sq36w	35	21	population	population	NN
cord-342372-2g9sq36w	35	22	of	of	IN
cord-342372-2g9sq36w	35	23	Japan	Japan	NNP
cord-342372-2g9sq36w	35	24	(	(	-LRB-
cord-342372-2g9sq36w	35	25	>	>	XX
cord-342372-2g9sq36w	36	1	200/100,000	200/100,000	CD
cord-342372-2g9sq36w	36	2	in	in	IN
cord-342372-2g9sq36w	36	3	children	child	NNS
cord-342372-2g9sq36w	36	4	<	<	XX
cord-342372-2g9sq36w	36	5	5	5	CD
cord-342372-2g9sq36w	36	6	years	year	NNS
cord-342372-2g9sq36w	36	7	)	)	-RRB-
cord-342372-2g9sq36w	37	1	[	[	-LRB-
cord-342372-2g9sq36w	37	2	9	9	CD
cord-342372-2g9sq36w	37	3	]	]	-RRB-
cord-342372-2g9sq36w	37	4	.	.	.
cord-342372-2g9sq36w	38	1	Many	many	JJ
cord-342372-2g9sq36w	38	2	infectious	infectious	JJ
cord-342372-2g9sq36w	38	3	etiologies	etiology	NNS
cord-342372-2g9sq36w	38	4	for	for	IN
cord-342372-2g9sq36w	38	5	KD	KD	NNP
cord-342372-2g9sq36w	38	6	have	have	VBP
cord-342372-2g9sq36w	38	7	been	be	VBN
cord-342372-2g9sq36w	38	8	proposed	propose	VBN
cord-342372-2g9sq36w	38	9	,	,	,
cord-342372-2g9sq36w	38	10	although	although	IN
cord-342372-2g9sq36w	38	11	a	a	DT
cord-342372-2g9sq36w	38	12	putative	putative	JJ
cord-342372-2g9sq36w	38	13	agent	agent	NN
cord-342372-2g9sq36w	38	14	has	have	VBZ
cord-342372-2g9sq36w	38	15	not	not	RB
cord-342372-2g9sq36w	38	16	been	be	VBN
cord-342372-2g9sq36w	38	17	isolated	isolate	VBN
cord-342372-2g9sq36w	38	18	.	.	.
cord-342372-2g9sq36w	39	1	The	the	DT
cord-342372-2g9sq36w	39	2	young	young	JJ
cord-342372-2g9sq36w	39	3	age	age	NN
cord-342372-2g9sq36w	39	4	of	of	IN
cord-342372-2g9sq36w	39	5	children	child	NNS
cord-342372-2g9sq36w	39	6	affected	affect	VBN
cord-342372-2g9sq36w	39	7	by	by	IN
cord-342372-2g9sq36w	39	8	KD	KD	NNP
cord-342372-2g9sq36w	39	9	suggests	suggest	VBZ
cord-342372-2g9sq36w	39	10	that	that	IN
cord-342372-2g9sq36w	39	11	KD	KD	NNP
cord-342372-2g9sq36w	39	12	is	be	VBZ
cord-342372-2g9sq36w	39	13	triggered	trigger	VBN
cord-342372-2g9sq36w	39	14	by	by	IN
cord-342372-2g9sq36w	39	15	an	an	DT
cord-342372-2g9sq36w	39	16	agent	agent	NN
cord-342372-2g9sq36w	39	17	to	to	TO
cord-342372-2g9sq36w	39	18	which	which	WDT
cord-342372-2g9sq36w	39	19	the	the	DT
cord-342372-2g9sq36w	39	20	population	population	NN
cord-342372-2g9sq36w	39	21	becomes	become	VBZ
cord-342372-2g9sq36w	39	22	immune	immune	JJ
cord-342372-2g9sq36w	39	23	to	to	IN
cord-342372-2g9sq36w	39	24	by	by	IN
cord-342372-2g9sq36w	39	25	late	late	JJ
cord-342372-2g9sq36w	39	26	childhood	childhood	NN
cord-342372-2g9sq36w	39	27	[	[	-LRB-
cord-342372-2g9sq36w	39	28	10	10	CD
cord-342372-2g9sq36w	39	29	]	]	-RRB-
cord-342372-2g9sq36w	39	30	.	.	.
cord-342372-2g9sq36w	40	1	A	a	DT
cord-342372-2g9sq36w	40	2	variety	variety	NN
cord-342372-2g9sq36w	40	3	of	of	IN
cord-342372-2g9sq36w	40	4	bacterial	bacterial	JJ
cord-342372-2g9sq36w	40	5	and	and	CC
cord-342372-2g9sq36w	40	6	viral	viral	JJ
cord-342372-2g9sq36w	40	7	pathogens	pathogen	NNS
cord-342372-2g9sq36w	40	8	have	have	VBP
cord-342372-2g9sq36w	40	9	been	be	VBN
cord-342372-2g9sq36w	40	10	isolated	isolate	VBN
cord-342372-2g9sq36w	40	11	from	from	IN
cord-342372-2g9sq36w	40	12	patients	patient	NNS
cord-342372-2g9sq36w	40	13	with	with	IN
cord-342372-2g9sq36w	40	14	KD	KD	NNP
cord-342372-2g9sq36w	40	15	.	.	.
cord-342372-2g9sq36w	41	1	These	these	DT
cord-342372-2g9sq36w	41	2	include	include	VBP
cord-342372-2g9sq36w	41	3	Staphylococcus	Staphylococcus	NNP
cord-342372-2g9sq36w	41	4	aureus	aureus	NN
cord-342372-2g9sq36w	41	5	,	,	,
cord-342372-2g9sq36w	41	6	Streptococcus	streptococcus	NN
cord-342372-2g9sq36w	41	7	pyogenes	pyogene	NNS
cord-342372-2g9sq36w	41	8	,	,	,
cord-342372-2g9sq36w	41	9	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	41	10	,	,	,
cord-342372-2g9sq36w	41	11	parvovirus	parvovirus	NN
cord-342372-2g9sq36w	41	12	B19	B19	NNP
cord-342372-2g9sq36w	41	13	,	,	,
cord-342372-2g9sq36w	41	14	human	human	JJ
cord-342372-2g9sq36w	41	15	herpes	herpes	NN
cord-342372-2g9sq36w	41	16	virus	virus	NN
cord-342372-2g9sq36w	41	17	6	6	CD
cord-342372-2g9sq36w	41	18	,	,	,
cord-342372-2g9sq36w	41	19	rotavirus	rotavirus	NN
cord-342372-2g9sq36w	41	20	,	,	,
cord-342372-2g9sq36w	41	21	human	human	JJ
cord-342372-2g9sq36w	41	22	coronavirus	coronavirus	NN
cord-342372-2g9sq36w	41	23	,	,	,
cord-342372-2g9sq36w	41	24	bocavirus	bocavirus	NNP
cord-342372-2g9sq36w	41	25	,	,	,
cord-342372-2g9sq36w	41	26	parainfluenza	parainfluenza	NNP
cord-342372-2g9sq36w	41	27	,	,	,
cord-342372-2g9sq36w	41	28	Epstein	Epstein	NNP
cord-342372-2g9sq36w	41	29	-	-	HYPH
cord-342372-2g9sq36w	41	30	Barr	Barr	NNP
cord-342372-2g9sq36w	41	31	,	,	,
cord-342372-2g9sq36w	41	32	dengue	dengue	NN
cord-342372-2g9sq36w	41	33	,	,	,
cord-342372-2g9sq36w	41	34	varicella	varicella	NN
cord-342372-2g9sq36w	41	35	-	-	HYPH
cord-342372-2g9sq36w	41	36	zoster	zoster	NN
cord-342372-2g9sq36w	41	37	,	,	,
cord-342372-2g9sq36w	41	38	measles	measle	NNS
cord-342372-2g9sq36w	41	39	,	,	,
cord-342372-2g9sq36w	41	40	and	and	CC
cord-342372-2g9sq36w	41	41	influenza	influenza	NN
cord-342372-2g9sq36w	41	42	viruses	virus	NNS
cord-342372-2g9sq36w	41	43	.	.	.
cord-342372-2g9sq36w	42	1	While	while	IN
cord-342372-2g9sq36w	42	2	intracytoplasmic	intracytoplasmic	JJ
cord-342372-2g9sq36w	42	3	inclusion	inclusion	NN
cord-342372-2g9sq36w	42	4	bodies	body	NNS
cord-342372-2g9sq36w	42	5	found	find	VBN
cord-342372-2g9sq36w	42	6	in	in	IN
cord-342372-2g9sq36w	42	7	the	the	DT
cord-342372-2g9sq36w	42	8	bronchial	bronchial	JJ
cord-342372-2g9sq36w	42	9	epithelium	epithelium	NN
cord-342372-2g9sq36w	42	10	on	on	IN
cord-342372-2g9sq36w	42	11	autopsy	autopsy	JJ
cord-342372-2g9sq36w	42	12	may	may	MD
cord-342372-2g9sq36w	42	13	support	support	VB
cord-342372-2g9sq36w	42	14	a	a	DT
cord-342372-2g9sq36w	42	15	viral	viral	JJ
cord-342372-2g9sq36w	42	16	etiology	etiology	NN
cord-342372-2g9sq36w	42	17	[	[	-LRB-
cord-342372-2g9sq36w	42	18	11	11	CD
cord-342372-2g9sq36w	42	19	]	]	-RRB-
cord-342372-2g9sq36w	42	20	,	,	.
cord-342372-2g9sq36w	43	1	the	the	DT
cord-342372-2g9sq36w	43	2	etiologic	etiologic	JJ
cord-342372-2g9sq36w	43	3	importance	importance	NN
cord-342372-2g9sq36w	43	4	of	of	IN
cord-342372-2g9sq36w	43	5	the	the	DT
cord-342372-2g9sq36w	43	6	concurrent	concurrent	JJ
cord-342372-2g9sq36w	43	7	infectious	infectious	JJ
cord-342372-2g9sq36w	43	8	pathogens	pathogen	NNS
cord-342372-2g9sq36w	43	9	seems	seem	VBZ
cord-342372-2g9sq36w	43	10	to	to	TO
cord-342372-2g9sq36w	43	11	be	be	VB
cord-342372-2g9sq36w	43	12	limited	limit	VBN
cord-342372-2g9sq36w	43	13	.	.	.
cord-342372-2g9sq36w	44	1	The	the	DT
cord-342372-2g9sq36w	44	2	possibility	possibility	NN
cord-342372-2g9sq36w	44	3	of	of	IN
cord-342372-2g9sq36w	44	4	a	a	DT
cord-342372-2g9sq36w	44	5	superantigen	superantigen	NN
cord-342372-2g9sq36w	44	6	/	/	SYM
cord-342372-2g9sq36w	44	7	bacterial	bacterial	JJ
cord-342372-2g9sq36w	44	8	toxin	toxin	NN
cord-342372-2g9sq36w	44	9	etiology	etiology	NN
cord-342372-2g9sq36w	44	10	has	have	VBZ
cord-342372-2g9sq36w	44	11	been	be	VBN
cord-342372-2g9sq36w	44	12	postulated	postulate	VBN
cord-342372-2g9sq36w	44	13	due	due	IN
cord-342372-2g9sq36w	44	14	to	to	IN
cord-342372-2g9sq36w	44	15	the	the	DT
cord-342372-2g9sq36w	44	16	similar	similar	JJ
cord-342372-2g9sq36w	44	17	desquamation	desquamation	NN
cord-342372-2g9sq36w	44	18	found	find	VBN
cord-342372-2g9sq36w	44	19	in	in	IN
cord-342372-2g9sq36w	44	20	scarlet	scarlet	JJ
cord-342372-2g9sq36w	44	21	fever	fever	NN
cord-342372-2g9sq36w	44	22	,	,	,
cord-342372-2g9sq36w	44	23	toxic	toxic	JJ
cord-342372-2g9sq36w	44	24	shock	shock	NN
cord-342372-2g9sq36w	44	25	syndrome	syndrome	NN
cord-342372-2g9sq36w	44	26	,	,	,
cord-342372-2g9sq36w	44	27	and	and	CC
cord-342372-2g9sq36w	44	28	KD	KD	NNP
cord-342372-2g9sq36w	44	29	.	.	.
cord-342372-2g9sq36w	45	1	However	however	RB
cord-342372-2g9sq36w	45	2	,	,	,
cord-342372-2g9sq36w	45	3	significant	significant	JJ
cord-342372-2g9sq36w	45	4	supportive	supportive	JJ
cord-342372-2g9sq36w	45	5	data	data	NN
cord-342372-2g9sq36w	45	6	is	be	VBZ
cord-342372-2g9sq36w	45	7	lacking	lack	VBG
cord-342372-2g9sq36w	45	8	.	.	.
cord-342372-2g9sq36w	46	1	Paralysis	paralysis	NN
cord-342372-2g9sq36w	46	2	of	of	IN
cord-342372-2g9sq36w	46	3	the	the	DT
cord-342372-2g9sq36w	46	4	adaptive	adaptive	JJ
cord-342372-2g9sq36w	46	5	immune	immune	JJ
cord-342372-2g9sq36w	46	6	system	system	NN
cord-342372-2g9sq36w	46	7	typically	typically	RB
cord-342372-2g9sq36w	46	8	seen	see	VBN
cord-342372-2g9sq36w	46	9	in	in	IN
cord-342372-2g9sq36w	46	10	superantigen	superantigen	NN
cord-342372-2g9sq36w	46	11	-	-	HYPH
cord-342372-2g9sq36w	46	12	mediated	mediate	VBN
cord-342372-2g9sq36w	46	13	illness	illness	NN
cord-342372-2g9sq36w	46	14	is	be	VBZ
cord-342372-2g9sq36w	46	15	not	not	RB
cord-342372-2g9sq36w	46	16	seen	see	VBN
cord-342372-2g9sq36w	46	17	in	in	IN
cord-342372-2g9sq36w	46	18	KD	KD	NNP
cord-342372-2g9sq36w	46	19	.	.	.
cord-342372-2g9sq36w	47	1	Additionally	additionally	RB
cord-342372-2g9sq36w	47	2	,	,	,
cord-342372-2g9sq36w	47	3	no	no	DT
cord-342372-2g9sq36w	47	4	bacterial	bacterial	JJ
cord-342372-2g9sq36w	47	5	toxin	toxin	NN
cord-342372-2g9sq36w	47	6	has	have	VBZ
cord-342372-2g9sq36w	47	7	been	be	VBN
cord-342372-2g9sq36w	47	8	detected	detect	VBN
cord-342372-2g9sq36w	47	9	in	in	IN
cord-342372-2g9sq36w	47	10	the	the	DT
cord-342372-2g9sq36w	47	11	peripheral	peripheral	JJ
cord-342372-2g9sq36w	47	12	blood	blood	NN
cord-342372-2g9sq36w	47	13	of	of	IN
cord-342372-2g9sq36w	47	14	KD	KD	NNP
cord-342372-2g9sq36w	47	15	patients	patient	NNS
cord-342372-2g9sq36w	47	16	making	make	VBG
cord-342372-2g9sq36w	47	17	such	such	PDT
cord-342372-2g9sq36w	47	18	a	a	DT
cord-342372-2g9sq36w	47	19	toxin	toxin	NN
cord-342372-2g9sq36w	47	20	unlikely	unlikely	JJ
cord-342372-2g9sq36w	47	21	to	to	TO
cord-342372-2g9sq36w	47	22	be	be	VB
cord-342372-2g9sq36w	47	23	responsible	responsible	JJ
cord-342372-2g9sq36w	47	24	for	for	IN
cord-342372-2g9sq36w	47	25	the	the	DT
cord-342372-2g9sq36w	47	26	diffuse	diffuse	JJ
cord-342372-2g9sq36w	47	27	inflammation	inflammation	NN
cord-342372-2g9sq36w	47	28	found	find	VBN
cord-342372-2g9sq36w	47	29	in	in	IN
cord-342372-2g9sq36w	47	30	acute	acute	JJ
cord-342372-2g9sq36w	47	31	KD	KD	NNP
cord-342372-2g9sq36w	47	32	[	[	-LRB-
cord-342372-2g9sq36w	47	33	11	11	CD
cord-342372-2g9sq36w	47	34	]	]	-RRB-
cord-342372-2g9sq36w	47	35	.	.	.
cord-342372-2g9sq36w	48	1	A	a	DT
cord-342372-2g9sq36w	48	2	primary	primary	JJ
cord-342372-2g9sq36w	48	3	autoimmune	autoimmune	JJ
cord-342372-2g9sq36w	48	4	etiology	etiology	NN
cord-342372-2g9sq36w	48	5	is	be	VBZ
cord-342372-2g9sq36w	48	6	unlikely	unlikely	JJ
cord-342372-2g9sq36w	48	7	due	due	IN
cord-342372-2g9sq36w	48	8	to	to	IN
cord-342372-2g9sq36w	48	9	the	the	DT
cord-342372-2g9sq36w	48	10	self	self	NN
cord-342372-2g9sq36w	48	11	-	-	HYPH
cord-342372-2g9sq36w	48	12	limited	limit	VBN
cord-342372-2g9sq36w	48	13	and	and	CC
cord-342372-2g9sq36w	48	14	nonrecurring	nonrecurring	JJ
cord-342372-2g9sq36w	48	15	nature	nature	NN
cord-342372-2g9sq36w	48	16	of	of	IN
cord-342372-2g9sq36w	48	17	KD	KD	NNP
cord-342372-2g9sq36w	48	18	.	.	.
cord-342372-2g9sq36w	49	1	The	the	DT
cord-342372-2g9sq36w	49	2	correlation	correlation	NN
cord-342372-2g9sq36w	49	3	of	of	IN
cord-342372-2g9sq36w	49	4	the	the	DT
cord-342372-2g9sq36w	49	5	seasonality	seasonality	NN
cord-342372-2g9sq36w	49	6	of	of	IN
cord-342372-2g9sq36w	49	7	KD	KD	NNP
cord-342372-2g9sq36w	49	8	with	with	IN
cord-342372-2g9sq36w	49	9	tropospheric	tropospheric	JJ
cord-342372-2g9sq36w	49	10	winds	wind	NNS
cord-342372-2g9sq36w	49	11	from	from	IN
cord-342372-2g9sq36w	49	12	densely	densely	RB
cord-342372-2g9sq36w	49	13	cultivated	cultivate	VBN
cord-342372-2g9sq36w	49	14	region	region	NN
cord-342372-2g9sq36w	49	15	of	of	IN
cord-342372-2g9sq36w	49	16	northeastern	northeastern	JJ
cord-342372-2g9sq36w	49	17	China	China	NNP
cord-342372-2g9sq36w	49	18	to	to	IN
cord-342372-2g9sq36w	49	19	Japan	Japan	NNP
cord-342372-2g9sq36w	49	20	suggests	suggest	VBZ
cord-342372-2g9sq36w	49	21	a	a	DT
cord-342372-2g9sq36w	49	22	possible	possible	JJ
cord-342372-2g9sq36w	49	23	windborne	windborne	NN
cord-342372-2g9sq36w	49	24	pathogen	pathogen	NN
cord-342372-2g9sq36w	49	25	as	as	IN
cord-342372-2g9sq36w	49	26	the	the	DT
cord-342372-2g9sq36w	49	27	underlying	underlie	VBG
cord-342372-2g9sq36w	49	28	etiology	etiology	NN
cord-342372-2g9sq36w	49	29	of	of	IN
cord-342372-2g9sq36w	49	30	KD	KD	NNP
cord-342372-2g9sq36w	49	31	[	[	-LRB-
cord-342372-2g9sq36w	49	32	5•	5•	CD
cord-342372-2g9sq36w	49	33	]	]	-RRB-
cord-342372-2g9sq36w	49	34	.	.	.
cord-342372-2g9sq36w	50	1	Nevertheless	nevertheless	RB
cord-342372-2g9sq36w	50	2	,	,	,
cord-342372-2g9sq36w	50	3	the	the	DT
cord-342372-2g9sq36w	50	4	clinical	clinical	JJ
cord-342372-2g9sq36w	50	5	features	feature	NNS
cord-342372-2g9sq36w	50	6	of	of	IN
cord-342372-2g9sq36w	50	7	KD	KD	NNP
cord-342372-2g9sq36w	50	8	may	may	MD
cord-342372-2g9sq36w	50	9	be	be	VB
cord-342372-2g9sq36w	50	10	the	the	DT
cord-342372-2g9sq36w	50	11	result	result	NN
cord-342372-2g9sq36w	50	12	of	of	IN
cord-342372-2g9sq36w	50	13	a	a	DT
cord-342372-2g9sq36w	50	14	common	common	JJ
cord-342372-2g9sq36w	50	15	pathway	pathway	NN
cord-342372-2g9sq36w	50	16	of	of	IN
cord-342372-2g9sq36w	50	17	immunemediated	immunemediated	JJ
cord-342372-2g9sq36w	50	18	vascular	vascular	JJ
cord-342372-2g9sq36w	50	19	inflammation	inflammation	NN
cord-342372-2g9sq36w	50	20	after	after	IN
cord-342372-2g9sq36w	50	21	a	a	DT
cord-342372-2g9sq36w	50	22	variety	variety	NN
cord-342372-2g9sq36w	50	23	of	of	IN
cord-342372-2g9sq36w	50	24	inciting	incite	VBG
cord-342372-2g9sq36w	50	25	infections	infection	NNS
cord-342372-2g9sq36w	50	26	rather	rather	RB
cord-342372-2g9sq36w	50	27	than	than	IN
cord-342372-2g9sq36w	50	28	infection	infection	NN
cord-342372-2g9sq36w	50	29	with	with	IN
cord-342372-2g9sq36w	50	30	a	a	DT
cord-342372-2g9sq36w	50	31	specific	specific	JJ
cord-342372-2g9sq36w	50	32	pathogen	pathogen	NN
cord-342372-2g9sq36w	50	33	[	[	-LRB-
cord-342372-2g9sq36w	50	34	12	12	CD
cord-342372-2g9sq36w	50	35	]	]	-RRB-
cord-342372-2g9sq36w	50	36	.	.	.
cord-342372-2g9sq36w	51	1	The	the	DT
cord-342372-2g9sq36w	51	2	fact	fact	NN
cord-342372-2g9sq36w	51	3	that	that	IN
cord-342372-2g9sq36w	51	4	a	a	DT
cord-342372-2g9sq36w	51	5	putative	putative	JJ
cord-342372-2g9sq36w	51	6	infectious	infectious	JJ
cord-342372-2g9sq36w	51	7	agent	agent	NN
cord-342372-2g9sq36w	51	8	has	have	VBZ
cord-342372-2g9sq36w	51	9	not	not	RB
cord-342372-2g9sq36w	51	10	been	be	VBN
cord-342372-2g9sq36w	51	11	isolated	isolate	VBN
cord-342372-2g9sq36w	51	12	despite	despite	IN
cord-342372-2g9sq36w	51	13	significant	significant	JJ
cord-342372-2g9sq36w	51	14	investigation	investigation	NN
cord-342372-2g9sq36w	51	15	supports	support	VBZ
cord-342372-2g9sq36w	51	16	this	this	DT
cord-342372-2g9sq36w	51	17	hypothesis	hypothesis	NN
cord-342372-2g9sq36w	51	18	.	.	.
cord-342372-2g9sq36w	52	1	Through	through	IN
cord-342372-2g9sq36w	52	2	exposure	exposure	NN
cord-342372-2g9sq36w	52	3	to	to	IN
cord-342372-2g9sq36w	52	4	a	a	DT
cord-342372-2g9sq36w	52	5	causative	causative	JJ
cord-342372-2g9sq36w	52	6	trigger(s	trigger(s	NN
cord-342372-2g9sq36w	52	7	)	)	-RRB-
cord-342372-2g9sq36w	52	8	,	,	,
cord-342372-2g9sq36w	52	9	systemic	systemic	JJ
cord-342372-2g9sq36w	52	10	inflammation	inflammation	NN
cord-342372-2g9sq36w	52	11	is	be	VBZ
cord-342372-2g9sq36w	52	12	induced	induce	VBN
cord-342372-2g9sq36w	52	13	in	in	IN
cord-342372-2g9sq36w	52	14	the	the	DT
cord-342372-2g9sq36w	52	15	host	host	NN
cord-342372-2g9sq36w	52	16	through	through	IN
cord-342372-2g9sq36w	52	17	an	an	DT
cord-342372-2g9sq36w	52	18	incompletely	incompletely	RB
cord-342372-2g9sq36w	52	19	understood	understand	VBN
cord-342372-2g9sq36w	52	20	cascade	cascade	NN
cord-342372-2g9sq36w	52	21	[	[	-LRB-
cord-342372-2g9sq36w	52	22	13	13	CD
cord-342372-2g9sq36w	52	23	]	]	-RRB-
cord-342372-2g9sq36w	52	24	.	.	.
cord-342372-2g9sq36w	53	1	The	the	DT
cord-342372-2g9sq36w	53	2	inflammation	inflammation	NN
cord-342372-2g9sq36w	53	3	primarily	primarily	RB
cord-342372-2g9sq36w	53	4	targets	target	VBZ
cord-342372-2g9sq36w	53	5	the	the	DT
cord-342372-2g9sq36w	53	6	medium	medium	JJ
cord-342372-2g9sq36w	53	7	-	-	HYPH
cord-342372-2g9sq36w	53	8	sized	sized	JJ
cord-342372-2g9sq36w	53	9	muscular	muscular	JJ
cord-342372-2g9sq36w	53	10	arteries	artery	NNS
cord-342372-2g9sq36w	53	11	,	,	,
cord-342372-2g9sq36w	53	12	most	most	RBS
cord-342372-2g9sq36w	53	13	notably	notably	RB
cord-342372-2g9sq36w	53	14	the	the	DT
cord-342372-2g9sq36w	53	15	coronary	coronary	JJ
cord-342372-2g9sq36w	53	16	arteries	artery	NNS
cord-342372-2g9sq36w	53	17	.	.	.
cord-342372-2g9sq36w	54	1	The	the	DT
cord-342372-2g9sq36w	54	2	initial	initial	JJ
cord-342372-2g9sq36w	54	3	infiltrate	infiltrate	NN
cord-342372-2g9sq36w	54	4	is	be	VBZ
cord-342372-2g9sq36w	54	5	primarily	primarily	RB
cord-342372-2g9sq36w	54	6	neutrophilic	neutrophilic	JJ
cord-342372-2g9sq36w	54	7	in	in	IN
cord-342372-2g9sq36w	54	8	the	the	DT
cord-342372-2g9sq36w	54	9	first	first	JJ
cord-342372-2g9sq36w	54	10	2	2	CD
cord-342372-2g9sq36w	54	11	weeks	week	NNS
cord-342372-2g9sq36w	54	12	.	.	.
cord-342372-2g9sq36w	55	1	This	this	DT
cord-342372-2g9sq36w	55	2	is	be	VBZ
cord-342372-2g9sq36w	55	3	followed	follow	VBN
cord-342372-2g9sq36w	55	4	by	by	IN
cord-342372-2g9sq36w	55	5	infiltration	infiltration	NN
cord-342372-2g9sq36w	55	6	of	of	IN
cord-342372-2g9sq36w	55	7	eosinophils	eosinophil	NNS
cord-342372-2g9sq36w	55	8	and	and	CC
cord-342372-2g9sq36w	55	9	CD8	CD8	NNP
cord-342372-2g9sq36w	55	10	T	T	NNP
cord-342372-2g9sq36w	55	11	cells	cell	NNS
cord-342372-2g9sq36w	55	12	>	>	NFP
cord-342372-2g9sq36w	55	13	2	2	CD
cord-342372-2g9sq36w	55	14	weeks	week	NNS
cord-342372-2g9sq36w	55	15	after	after	IN
cord-342372-2g9sq36w	55	16	disease	disease	NN
cord-342372-2g9sq36w	55	17	onset	onset	NN
cord-342372-2g9sq36w	55	18	[	[	-LRB-
cord-342372-2g9sq36w	55	19	10	10	CD
cord-342372-2g9sq36w	55	20	]	]	-RRB-
cord-342372-2g9sq36w	55	21	.	.	.
cord-342372-2g9sq36w	56	1	Investigation	investigation	NN
cord-342372-2g9sq36w	56	2	of	of	IN
cord-342372-2g9sq36w	56	3	coronary	coronary	JJ
cord-342372-2g9sq36w	56	4	arteries	artery	NNS
cord-342372-2g9sq36w	56	5	with	with	IN
cord-342372-2g9sq36w	56	6	light	light	NN
cord-342372-2g9sq36w	56	7	and	and	CC
cord-342372-2g9sq36w	56	8	transmission	transmission	NN
cord-342372-2g9sq36w	56	9	electron	electron	NN
cord-342372-2g9sq36w	56	10	microscopy	microscopy	NN
cord-342372-2g9sq36w	56	11	has	have	VBZ
cord-342372-2g9sq36w	56	12	identified	identify	VBN
cord-342372-2g9sq36w	56	13	three	three	CD
cord-342372-2g9sq36w	56	14	distinct	distinct	JJ
cord-342372-2g9sq36w	56	15	vascular	vascular	JJ
cord-342372-2g9sq36w	56	16	processes	process	NNS
cord-342372-2g9sq36w	56	17	:	:	:
cord-342372-2g9sq36w	56	18	necrotizing	necrotize	VBG
cord-342372-2g9sq36w	56	19	arteritis	arteritis	NN
cord-342372-2g9sq36w	56	20	(	(	-LRB-
cord-342372-2g9sq36w	56	21	NA	NA	NNP
cord-342372-2g9sq36w	56	22	)	)	-RRB-
cord-342372-2g9sq36w	56	23	,	,	,
cord-342372-2g9sq36w	56	24	subacute	subacute	JJ
cord-342372-2g9sq36w	56	25	/	/	SYM
cord-342372-2g9sq36w	56	26	chronic	chronic	JJ
cord-342372-2g9sq36w	56	27	(	(	-LRB-
cord-342372-2g9sq36w	56	28	SA	SA	NNP
cord-342372-2g9sq36w	56	29	/	/	SYM
cord-342372-2g9sq36w	56	30	C	C	NNP
cord-342372-2g9sq36w	56	31	)	)	-RRB-
cord-342372-2g9sq36w	56	32	vasculitis	vasculitis	NN
cord-342372-2g9sq36w	56	33	,	,	,
cord-342372-2g9sq36w	56	34	and	and	CC
cord-342372-2g9sq36w	56	35	luminal	luminal	JJ
cord-342372-2g9sq36w	56	36	myofibroblastic	myofibroblastic	JJ
cord-342372-2g9sq36w	56	37	proliferation	proliferation	NN
cord-342372-2g9sq36w	56	38	[	[	-LRB-
cord-342372-2g9sq36w	56	39	14	14	CD
cord-342372-2g9sq36w	56	40	]	]	-RRB-
cord-342372-2g9sq36w	56	41	.	.	.
cord-342372-2g9sq36w	57	1	The	the	DT
cord-342372-2g9sq36w	57	2	extent	extent	NN
cord-342372-2g9sq36w	57	3	and	and	CC
cord-342372-2g9sq36w	57	4	permanence	permanence	NN
cord-342372-2g9sq36w	57	5	of	of	IN
cord-342372-2g9sq36w	57	6	vascular	vascular	JJ
cord-342372-2g9sq36w	57	7	damage	damage	NN
cord-342372-2g9sq36w	57	8	depends	depend	VBZ
cord-342372-2g9sq36w	57	9	upon	upon	IN
cord-342372-2g9sq36w	57	10	the	the	DT
cord-342372-2g9sq36w	57	11	scope	scope	NN
cord-342372-2g9sq36w	57	12	of	of	IN
cord-342372-2g9sq36w	57	13	involvement	involvement	NN
cord-342372-2g9sq36w	57	14	of	of	IN
cord-342372-2g9sq36w	57	15	vascular	vascular	JJ
cord-342372-2g9sq36w	57	16	inflammation	inflammation	NN
cord-342372-2g9sq36w	57	17	.	.	.
cord-342372-2g9sq36w	58	1	Mild	mild	JJ
cord-342372-2g9sq36w	58	2	inflammation	inflammation	NN
cord-342372-2g9sq36w	58	3	and	and	CC
cord-342372-2g9sq36w	58	4	damage	damage	NN
cord-342372-2g9sq36w	58	5	generally	generally	RB
cord-342372-2g9sq36w	58	6	preserves	preserve	VBZ
cord-342372-2g9sq36w	58	7	the	the	DT
cord-342372-2g9sq36w	58	8	internal	internal	JJ
cord-342372-2g9sq36w	58	9	and	and	CC
cord-342372-2g9sq36w	58	10	external	external	JJ
cord-342372-2g9sq36w	58	11	elastic	elastic	JJ
cord-342372-2g9sq36w	58	12	lamina	lamina	NN
cord-342372-2g9sq36w	58	13	,	,	,
cord-342372-2g9sq36w	58	14	which	which	WDT
cord-342372-2g9sq36w	58	15	may	may	MD
cord-342372-2g9sq36w	58	16	cause	cause	VB
cord-342372-2g9sq36w	58	17	mild	mild	JJ
cord-342372-2g9sq36w	58	18	dilation	dilation	NN
cord-342372-2g9sq36w	58	19	but	but	CC
cord-342372-2g9sq36w	58	20	allows	allow	VBZ
cord-342372-2g9sq36w	58	21	the	the	DT
cord-342372-2g9sq36w	58	22	arteries	artery	NNS
cord-342372-2g9sq36w	58	23	to	to	TO
cord-342372-2g9sq36w	58	24	maintain	maintain	VB
cord-342372-2g9sq36w	58	25	its	-PRON-	PRP$
cord-342372-2g9sq36w	58	26	normal	normal	JJ
cord-342372-2g9sq36w	58	27	morphology	morphology	NN
cord-342372-2g9sq36w	58	28	.	.	.
cord-342372-2g9sq36w	59	1	As	as	IN
cord-342372-2g9sq36w	59	2	the	the	DT
cord-342372-2g9sq36w	59	3	severity	severity	NN
cord-342372-2g9sq36w	59	4	of	of	IN
cord-342372-2g9sq36w	59	5	the	the	DT
cord-342372-2g9sq36w	59	6	inflammation	inflammation	NN
cord-342372-2g9sq36w	59	7	increases	increase	NNS
cord-342372-2g9sq36w	59	8	,	,	,
cord-342372-2g9sq36w	59	9	the	the	DT
cord-342372-2g9sq36w	59	10	internal	internal	JJ
cord-342372-2g9sq36w	59	11	and	and	CC
cord-342372-2g9sq36w	59	12	external	external	JJ
cord-342372-2g9sq36w	59	13	elastic	elastic	JJ
cord-342372-2g9sq36w	59	14	lamina	lamina	NN
cord-342372-2g9sq36w	59	15	is	be	VBZ
cord-342372-2g9sq36w	59	16	destroyed	destroy	VBN
cord-342372-2g9sq36w	59	17	resulting	result	VBG
cord-342372-2g9sq36w	59	18	in	in	IN
cord-342372-2g9sq36w	59	19	progressively	progressively	RB
cord-342372-2g9sq36w	59	20	larger	large	JJR
cord-342372-2g9sq36w	59	21	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	59	22	.	.	.
cord-342372-2g9sq36w	60	1	These	these	DT
cord-342372-2g9sq36w	60	2	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	60	3	may	may	MD
cord-342372-2g9sq36w	60	4	be	be	VB
cord-342372-2g9sq36w	60	5	fusiform	fusiform	JJ
cord-342372-2g9sq36w	60	6	(	(	-LRB-
cord-342372-2g9sq36w	60	7	from	from	IN
cord-342372-2g9sq36w	60	8	mild	mild	JJ
cord-342372-2g9sq36w	60	9	SA	SA	NNP
cord-342372-2g9sq36w	60	10	/	/	SYM
cord-342372-2g9sq36w	60	11	C	C	NNP
cord-342372-2g9sq36w	60	12	vasculitis	vasculitis	NN
cord-342372-2g9sq36w	60	13	)	)	-RRB-
cord-342372-2g9sq36w	60	14	or	or	CC
cord-342372-2g9sq36w	60	15	saccular	saccular	NNP
cord-342372-2g9sq36w	60	16	(	(	-LRB-
cord-342372-2g9sq36w	60	17	from	from	IN
cord-342372-2g9sq36w	60	18	severe	severe	JJ
cord-342372-2g9sq36w	60	19	SA	SA	NNP
cord-342372-2g9sq36w	60	20	/	/	SYM
cord-342372-2g9sq36w	60	21	C	C	NNP
cord-342372-2g9sq36w	60	22	vasculitis	vasculitis	NN
cord-342372-2g9sq36w	60	23	or	or	CC
cord-342372-2g9sq36w	60	24	NA	NA	NNP
cord-342372-2g9sq36w	60	25	)	)	-RRB-
cord-342372-2g9sq36w	60	26	.	.	.
cord-342372-2g9sq36w	61	1	These	these	DT
cord-342372-2g9sq36w	61	2	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	61	3	are	be	VBP
cord-342372-2g9sq36w	61	4	at	at	IN
cord-342372-2g9sq36w	61	5	risk	risk	NN
cord-342372-2g9sq36w	61	6	for	for	IN
cord-342372-2g9sq36w	61	7	rupture	rupture	NN
cord-342372-2g9sq36w	61	8	or	or	CC
cord-342372-2g9sq36w	61	9	development	development	NN
cord-342372-2g9sq36w	61	10	of	of	IN
cord-342372-2g9sq36w	61	11	thrombosis	thrombosis	NN
cord-342372-2g9sq36w	61	12	.	.	.
cord-342372-2g9sq36w	62	1	Thrombosis	thrombosis	NN
cord-342372-2g9sq36w	62	2	may	may	MD
cord-342372-2g9sq36w	62	3	result	result	VB
cord-342372-2g9sq36w	62	4	in	in	IN
cord-342372-2g9sq36w	62	5	ischemia	ischemia	NN
cord-342372-2g9sq36w	62	6	/	/	SYM
cord-342372-2g9sq36w	62	7	myocardial	myocardial	JJ
cord-342372-2g9sq36w	62	8	infarction	infarction	NN
cord-342372-2g9sq36w	62	9	or	or	CC
cord-342372-2g9sq36w	62	10	can	can	MD
cord-342372-2g9sq36w	62	11	undergo	undergo	VB
cord-342372-2g9sq36w	62	12	organization	organization	NN
cord-342372-2g9sq36w	62	13	and	and	CC
cord-342372-2g9sq36w	62	14	ultimately	ultimately	RB
cord-342372-2g9sq36w	62	15	recanalization	recanalization	VBP
cord-342372-2g9sq36w	62	16	[	[	-LRB-
cord-342372-2g9sq36w	62	17	14	14	CD
cord-342372-2g9sq36w	62	18	]	]	-RRB-
cord-342372-2g9sq36w	62	19	.	.	.
cord-342372-2g9sq36w	63	1	Coronary	coronary	JJ
cord-342372-2g9sq36w	63	2	artery	artery	NN
cord-342372-2g9sq36w	63	3	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	63	4	have	have	VBP
cord-342372-2g9sq36w	63	5	also	also	RB
cord-342372-2g9sq36w	63	6	been	be	VBN
cord-342372-2g9sq36w	63	7	previously	previously	RB
cord-342372-2g9sq36w	63	8	described	describe	VBN
cord-342372-2g9sq36w	63	9	to	to	TO
cord-342372-2g9sq36w	63	10	remodel	remodel	VB
cord-342372-2g9sq36w	63	11	and	and	CC
cord-342372-2g9sq36w	63	12	regress	regress	VB
cord-342372-2g9sq36w	63	13	[	[	-LRB-
cord-342372-2g9sq36w	63	14	15	15	CD
cord-342372-2g9sq36w	63	15	]	]	-RRB-
cord-342372-2g9sq36w	63	16	[	[	-LRB-
cord-342372-2g9sq36w	63	17	16	16	CD
cord-342372-2g9sq36w	63	18	]	]	-RRB-
cord-342372-2g9sq36w	63	19	[	[	-LRB-
cord-342372-2g9sq36w	63	20	17	17	CD
cord-342372-2g9sq36w	63	21	]	]	-RRB-
cord-342372-2g9sq36w	63	22	.	.	.
cord-342372-2g9sq36w	64	1	There	there	EX
cord-342372-2g9sq36w	64	2	is	be	VBZ
cord-342372-2g9sq36w	64	3	no	no	DT
cord-342372-2g9sq36w	64	4	single	single	JJ
cord-342372-2g9sq36w	64	5	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	64	6	test	test	NN
cord-342372-2g9sq36w	64	7	or	or	CC
cord-342372-2g9sq36w	64	8	pathognomonic	pathognomonic	JJ
cord-342372-2g9sq36w	64	9	clinical	clinical	JJ
cord-342372-2g9sq36w	64	10	feature	feature	NN
cord-342372-2g9sq36w	64	11	of	of	IN
cord-342372-2g9sq36w	64	12	KD	KD	NNP
cord-342372-2g9sq36w	64	13	.	.	.
cord-342372-2g9sq36w	65	1	Therefore	therefore	RB
cord-342372-2g9sq36w	65	2	,	,	,
cord-342372-2g9sq36w	65	3	a	a	DT
cord-342372-2g9sq36w	65	4	thorough	thorough	JJ
cord-342372-2g9sq36w	65	5	history	history	NN
cord-342372-2g9sq36w	65	6	and	and	CC
cord-342372-2g9sq36w	65	7	physical	physical	JJ
cord-342372-2g9sq36w	65	8	examination	examination	NN
cord-342372-2g9sq36w	65	9	for	for	IN
cord-342372-2g9sq36w	65	10	the	the	DT
cord-342372-2g9sq36w	65	11	established	establish	VBN
cord-342372-2g9sq36w	65	12	clinical	clinical	JJ
cord-342372-2g9sq36w	65	13	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	65	14	criteria	criterion	NNS
cord-342372-2g9sq36w	65	15	is	be	VBZ
cord-342372-2g9sq36w	65	16	essential	essential	JJ
cord-342372-2g9sq36w	65	17	.	.	.
cord-342372-2g9sq36w	66	1	The	the	DT
cord-342372-2g9sq36w	66	2	classic	classic	JJ
cord-342372-2g9sq36w	66	3	clinical	clinical	JJ
cord-342372-2g9sq36w	66	4	criteria	criterion	NNS
cord-342372-2g9sq36w	66	5	for	for	IN
cord-342372-2g9sq36w	66	6	the	the	DT
cord-342372-2g9sq36w	66	7	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	66	8	of	of	IN
cord-342372-2g9sq36w	66	9	KD	KD	NNP
cord-342372-2g9sq36w	66	10	require	require	VB
cord-342372-2g9sq36w	66	11	the	the	DT
cord-342372-2g9sq36w	66	12	presence	presence	NN
cord-342372-2g9sq36w	66	13	of	of	IN
cord-342372-2g9sq36w	66	14	≥5	≥5	NNP
cord-342372-2g9sq36w	66	15	days	day	NNS
cord-342372-2g9sq36w	66	16	of	of	IN
cord-342372-2g9sq36w	66	17	fever	fever	NN
cord-342372-2g9sq36w	66	18	and	and	CC
cord-342372-2g9sq36w	66	19	≥4/5	≥4/5	NNP
cord-342372-2g9sq36w	66	20	clinical	clinical	JJ
cord-342372-2g9sq36w	66	21	features	feature	NNS
cord-342372-2g9sq36w	66	22	(	(	-LRB-
cord-342372-2g9sq36w	66	23	see	see	VB
cord-342372-2g9sq36w	66	24	Table	table	NN
cord-342372-2g9sq36w	66	25	1	1	CD
cord-342372-2g9sq36w	66	26	)	)	-RRB-
cord-342372-2g9sq36w	66	27	[	[	-LRB-
cord-342372-2g9sq36w	66	28	6••	6••	NN
cord-342372-2g9sq36w	66	29	]	]	-RRB-
cord-342372-2g9sq36w	66	30	.	.	.
cord-342372-2g9sq36w	67	1	The	the	DT
cord-342372-2g9sq36w	67	2	characteristic	characteristic	JJ
cord-342372-2g9sq36w	67	3	clinical	clinical	JJ
cord-342372-2g9sq36w	67	4	features	feature	NNS
cord-342372-2g9sq36w	67	5	are	be	VBP
cord-342372-2g9sq36w	67	6	typically	typically	RB
cord-342372-2g9sq36w	67	7	not	not	RB
cord-342372-2g9sq36w	67	8	present	present	JJ
cord-342372-2g9sq36w	67	9	all	all	RB
cord-342372-2g9sq36w	67	10	at	at	IN
cord-342372-2g9sq36w	67	11	the	the	DT
cord-342372-2g9sq36w	67	12	same	same	JJ
cord-342372-2g9sq36w	67	13	time	time	NN
cord-342372-2g9sq36w	67	14	,	,	,
cord-342372-2g9sq36w	67	15	and	and	CC
cord-342372-2g9sq36w	67	16	therefore	therefore	RB
cord-342372-2g9sq36w	67	17	continuous	continuous	JJ
cord-342372-2g9sq36w	67	18	close	close	JJ
cord-342372-2g9sq36w	67	19	observation	observation	NN
cord-342372-2g9sq36w	67	20	may	may	MD
cord-342372-2g9sq36w	67	21	be	be	VB
cord-342372-2g9sq36w	67	22	necessary	necessary	JJ
cord-342372-2g9sq36w	67	23	to	to	TO
cord-342372-2g9sq36w	67	24	make	make	VB
cord-342372-2g9sq36w	67	25	the	the	DT
cord-342372-2g9sq36w	67	26	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	67	27	.	.	.
cord-342372-2g9sq36w	68	1	The	the	DT
cord-342372-2g9sq36w	68	2	fever	fever	NN
cord-342372-2g9sq36w	68	3	of	of	IN
cord-342372-2g9sq36w	68	4	KD	KD	NNP
cord-342372-2g9sq36w	68	5	is	be	VBZ
cord-342372-2g9sq36w	68	6	high	high	RB
cord-342372-2g9sq36w	68	7	-	-	HYPH
cord-342372-2g9sq36w	68	8	spiking	spiking	NN
cord-342372-2g9sq36w	68	9	,	,	,
cord-342372-2g9sq36w	68	10	peaking	peak	VBG
cord-342372-2g9sq36w	68	11	>	>	XX
cord-342372-2g9sq36w	68	12	39	39	CD
cord-342372-2g9sq36w	68	13	-	-	SYM
cord-342372-2g9sq36w	68	14	40	40	CD
cord-342372-2g9sq36w	68	15	°	°	NN
cord-342372-2g9sq36w	68	16	C	c	NN
cord-342372-2g9sq36w	68	17	,	,	,
cord-342372-2g9sq36w	68	18	with	with	IN
cord-342372-2g9sq36w	68	19	a	a	DT
cord-342372-2g9sq36w	68	20	mean	mean	JJ
cord-342372-2g9sq36w	68	21	duration	duration	NN
cord-342372-2g9sq36w	68	22	of	of	IN
cord-342372-2g9sq36w	68	23	11	11	CD
cord-342372-2g9sq36w	68	24	days	day	NNS
cord-342372-2g9sq36w	68	25	,	,	,
cord-342372-2g9sq36w	68	26	although	although	IN
cord-342372-2g9sq36w	68	27	it	-PRON-	PRP
cord-342372-2g9sq36w	68	28	has	have	VBZ
cord-342372-2g9sq36w	68	29	been	be	VBN
cord-342372-2g9sq36w	68	30	reported	report	VBN
cord-342372-2g9sq36w	68	31	to	to	TO
cord-342372-2g9sq36w	68	32	last	last	VB
cord-342372-2g9sq36w	68	33	for	for	IN
cord-342372-2g9sq36w	68	34	up	up	IN
cord-342372-2g9sq36w	68	35	to	to	TO
cord-342372-2g9sq36w	68	36	3	3	CD
cord-342372-2g9sq36w	68	37	-	-	SYM
cord-342372-2g9sq36w	68	38	4	4	CD
cord-342372-2g9sq36w	68	39	weeks	week	NNS
cord-342372-2g9sq36w	68	40	in	in	IN
cord-342372-2g9sq36w	68	41	the	the	DT
cord-342372-2g9sq36w	68	42	absence	absence	NN
cord-342372-2g9sq36w	68	43	of	of	IN
cord-342372-2g9sq36w	68	44	treatment	treatment	NN
cord-342372-2g9sq36w	68	45	.	.	.
cord-342372-2g9sq36w	69	1	Upon	upon	IN
cord-342372-2g9sq36w	69	2	initiation	initiation	NN
cord-342372-2g9sq36w	69	3	of	of	IN
cord-342372-2g9sq36w	69	4	treatment	treatment	NN
cord-342372-2g9sq36w	69	5	,	,	,
cord-342372-2g9sq36w	69	6	the	the	DT
cord-342372-2g9sq36w	69	7	fever	fever	NN
cord-342372-2g9sq36w	69	8	typically	typically	RB
cord-342372-2g9sq36w	69	9	resolves	resolve	VBZ
cord-342372-2g9sq36w	69	10	within	within	IN
cord-342372-2g9sq36w	69	11	1	1	CD
cord-342372-2g9sq36w	69	12	-	-	SYM
cord-342372-2g9sq36w	69	13	2	2	CD
cord-342372-2g9sq36w	69	14	days	day	NNS
cord-342372-2g9sq36w	69	15	.	.	.
cord-342372-2g9sq36w	70	1	Extremity	extremity	NN
cord-342372-2g9sq36w	70	2	changes	change	NNS
cord-342372-2g9sq36w	70	3	initially	initially	RB
cord-342372-2g9sq36w	70	4	present	present	JJ
cord-342372-2g9sq36w	70	5	as	as	IN
cord-342372-2g9sq36w	70	6	erythema	erythema	NN
cord-342372-2g9sq36w	70	7	,	,	,
cord-342372-2g9sq36w	70	8	induration	induration	NN
cord-342372-2g9sq36w	70	9	,	,	,
cord-342372-2g9sq36w	70	10	and	and	CC
cord-342372-2g9sq36w	70	11	swelling	swelling	NN
cord-342372-2g9sq36w	70	12	of	of	IN
cord-342372-2g9sq36w	70	13	the	the	DT
cord-342372-2g9sq36w	70	14	hands	hand	NNS
cord-342372-2g9sq36w	70	15	and/or	and/or	CC
cord-342372-2g9sq36w	70	16	feet	foot	NNS
cord-342372-2g9sq36w	70	17	in	in	IN
cord-342372-2g9sq36w	70	18	the	the	DT
cord-342372-2g9sq36w	70	19	acute	acute	JJ
cord-342372-2g9sq36w	70	20	phase	phase	NN
cord-342372-2g9sq36w	70	21	of	of	IN
cord-342372-2g9sq36w	70	22	KD	KD	NNP
cord-342372-2g9sq36w	70	23	.	.	.
cord-342372-2g9sq36w	71	1	Desquamation	Desquamation	NNP
cord-342372-2g9sq36w	71	2	of	of	IN
cord-342372-2g9sq36w	71	3	the	the	DT
cord-342372-2g9sq36w	71	4	fingers	finger	NNS
cord-342372-2g9sq36w	71	5	and	and	CC
cord-342372-2g9sq36w	71	6	toes	toe	NNS
cord-342372-2g9sq36w	71	7	is	be	VBZ
cord-342372-2g9sq36w	71	8	typically	typically	RB
cord-342372-2g9sq36w	71	9	a	a	DT
cord-342372-2g9sq36w	71	10	late	late	JJ
cord-342372-2g9sq36w	71	11	finding	finding	NN
cord-342372-2g9sq36w	71	12	,	,	,
cord-342372-2g9sq36w	71	13	beginning	begin	VBG
cord-342372-2g9sq36w	71	14	2	2	CD
cord-342372-2g9sq36w	71	15	-	-	SYM
cord-342372-2g9sq36w	71	16	3	3	CD
cord-342372-2g9sq36w	71	17	weeks	week	NNS
cord-342372-2g9sq36w	71	18	after	after	IN
cord-342372-2g9sq36w	71	19	onset	onset	NN
cord-342372-2g9sq36w	71	20	of	of	IN
cord-342372-2g9sq36w	71	21	the	the	DT
cord-342372-2g9sq36w	71	22	fever	fever	NN
cord-342372-2g9sq36w	71	23	.	.	.
cord-342372-2g9sq36w	72	1	The	the	DT
cord-342372-2g9sq36w	72	2	polymorphous	polymorphous	JJ
cord-342372-2g9sq36w	72	3	exanthema	exanthema	NN
cord-342372-2g9sq36w	72	4	of	of	IN
cord-342372-2g9sq36w	72	5	KD	KD	NNP
cord-342372-2g9sq36w	72	6	may	may	MD
cord-342372-2g9sq36w	72	7	take	take	VB
cord-342372-2g9sq36w	72	8	various	various	JJ
cord-342372-2g9sq36w	72	9	forms	form	NNS
cord-342372-2g9sq36w	72	10	:	:	:
cord-342372-2g9sq36w	72	11	maculopapular	maculopapular	JJ
cord-342372-2g9sq36w	72	12	rash	rash	JJ
cord-342372-2g9sq36w	72	13	(	(	-LRB-
cord-342372-2g9sq36w	72	14	most	most	RBS
cord-342372-2g9sq36w	72	15	common	common	JJ
cord-342372-2g9sq36w	72	16	)	)	-RRB-
cord-342372-2g9sq36w	72	17	,	,	,
cord-342372-2g9sq36w	72	18	scarlatiniform	scarlatiniform	NN
cord-342372-2g9sq36w	72	19	rash	rash	NN
cord-342372-2g9sq36w	72	20	,	,	,
cord-342372-2g9sq36w	72	21	erythroderma	erythroderma	NNS
cord-342372-2g9sq36w	72	22	,	,	,
cord-342372-2g9sq36w	72	23	erythema	erythema	NN
cord-342372-2g9sq36w	72	24	-	-	HYPH
cord-342372-2g9sq36w	72	25	multiforme	multiforme	NN
cord-342372-2g9sq36w	72	26	,	,	,
cord-342372-2g9sq36w	72	27	or	or	CC
cord-342372-2g9sq36w	72	28	micropustular	micropustular	NNP
cord-342372-2g9sq36w	72	29	.	.	.
cord-342372-2g9sq36w	73	1	Bullous	Bullous	NNP
cord-342372-2g9sq36w	73	2	/	/	SYM
cord-342372-2g9sq36w	73	3	vesicular	vesicular	JJ
cord-342372-2g9sq36w	73	4	rashes	rash	NNS
cord-342372-2g9sq36w	73	5	have	have	VBP
cord-342372-2g9sq36w	73	6	not	not	RB
cord-342372-2g9sq36w	73	7	been	be	VBN
cord-342372-2g9sq36w	73	8	described	describe	VBN
cord-342372-2g9sq36w	73	9	.	.	.
cord-342372-2g9sq36w	74	1	The	the	DT
cord-342372-2g9sq36w	74	2	rash	rash	NN
cord-342372-2g9sq36w	74	3	typically	typically	RB
cord-342372-2g9sq36w	74	4	presents	present	VBZ
cord-342372-2g9sq36w	74	5	within	within	IN
cord-342372-2g9sq36w	74	6	the	the	DT
cord-342372-2g9sq36w	74	7	first	first	JJ
cord-342372-2g9sq36w	74	8	5	5	CD
cord-342372-2g9sq36w	74	9	days	day	NNS
cord-342372-2g9sq36w	74	10	of	of	IN
cord-342372-2g9sq36w	74	11	fever	fever	NN
cord-342372-2g9sq36w	74	12	as	as	IN
cord-342372-2g9sq36w	74	13	a	a	DT
cord-342372-2g9sq36w	74	14	generalized	generalized	JJ
cord-342372-2g9sq36w	74	15	eruption	eruption	NN
cord-342372-2g9sq36w	74	16	involving	involve	VBG
cord-342372-2g9sq36w	74	17	the	the	DT
cord-342372-2g9sq36w	74	18	trunk	trunk	NN
cord-342372-2g9sq36w	74	19	,	,	,
cord-342372-2g9sq36w	74	20	extremities	extremity	NNS
cord-342372-2g9sq36w	74	21	,	,	,
cord-342372-2g9sq36w	74	22	and	and	CC
cord-342372-2g9sq36w	74	23	perineal	perineal	NN
cord-342372-2g9sq36w	74	24	region	region	NN
cord-342372-2g9sq36w	74	25	.	.	.
cord-342372-2g9sq36w	75	1	Early	early	JJ
cord-342372-2g9sq36w	75	2	desquamation	desquamation	NN
cord-342372-2g9sq36w	75	3	may	may	MD
cord-342372-2g9sq36w	75	4	occur	occur	VB
cord-342372-2g9sq36w	75	5	in	in	IN
cord-342372-2g9sq36w	75	6	regions	region	NNS
cord-342372-2g9sq36w	75	7	of	of	IN
cord-342372-2g9sq36w	75	8	perineum	perineum	NN
cord-342372-2g9sq36w	75	9	and	and	CC
cord-342372-2g9sq36w	75	10	is	be	VBZ
cord-342372-2g9sq36w	75	11	a	a	DT
cord-342372-2g9sq36w	75	12	strong	strong	JJ
cord-342372-2g9sq36w	75	13	indicator	indicator	NN
cord-342372-2g9sq36w	75	14	of	of	IN
cord-342372-2g9sq36w	75	15	KD	KD	NNP
cord-342372-2g9sq36w	75	16	.	.	.
cord-342372-2g9sq36w	76	1	Bilateral	bilateral	JJ
cord-342372-2g9sq36w	76	2	conjunctival	conjunctival	NN
cord-342372-2g9sq36w	76	3	injection	injection	NN
cord-342372-2g9sq36w	76	4	in	in	IN
cord-342372-2g9sq36w	76	5	KD	KD	NNP
cord-342372-2g9sq36w	76	6	affects	affect	VBZ
cord-342372-2g9sq36w	76	7	the	the	DT
cord-342372-2g9sq36w	76	8	bulbar	bulbar	NN
cord-342372-2g9sq36w	76	9	conjunctivae	conjunctivae	NNP
cord-342372-2g9sq36w	76	10	and	and	CC
cord-342372-2g9sq36w	76	11	spares	spare	VBZ
cord-342372-2g9sq36w	76	12	the	the	DT
cord-342372-2g9sq36w	76	13	limbus	limbus	NN
cord-342372-2g9sq36w	76	14	.	.	.
cord-342372-2g9sq36w	77	1	The	the	DT
cord-342372-2g9sq36w	77	2	injection	injection	NN
cord-342372-2g9sq36w	77	3	is	be	VBZ
cord-342372-2g9sq36w	77	4	nonpurulent	nonpurulent	JJ
cord-342372-2g9sq36w	77	5	and	and	CC
cord-342372-2g9sq36w	77	6	painless	painless	JJ
cord-342372-2g9sq36w	77	7	,	,	,
cord-342372-2g9sq36w	77	8	presenting	present	VBG
cord-342372-2g9sq36w	77	9	shortly	shortly	RB
cord-342372-2g9sq36w	77	10	after	after	IN
cord-342372-2g9sq36w	77	11	onset	onset	NN
cord-342372-2g9sq36w	77	12	of	of	IN
cord-342372-2g9sq36w	77	13	fever	fever	NN
cord-342372-2g9sq36w	77	14	.	.	.
cord-342372-2g9sq36w	78	1	Mild	mild	JJ
cord-342372-2g9sq36w	78	2	anterior	anterior	JJ
cord-342372-2g9sq36w	78	3	uveitis	uveitis	NN
cord-342372-2g9sq36w	78	4	may	may	MD
cord-342372-2g9sq36w	78	5	be	be	VB
cord-342372-2g9sq36w	78	6	present	present	JJ
cord-342372-2g9sq36w	78	7	on	on	IN
cord-342372-2g9sq36w	78	8	slit	slit	JJ
cord-342372-2g9sq36w	78	9	lamp	lamp	NN
cord-342372-2g9sq36w	78	10	examination	examination	NN
cord-342372-2g9sq36w	78	11	.	.	.
cord-342372-2g9sq36w	79	1	Oral	oral	JJ
cord-342372-2g9sq36w	79	2	cavity	cavity	NN
cord-342372-2g9sq36w	79	3	and	and	CC
cord-342372-2g9sq36w	79	4	lip	lip	NN
cord-342372-2g9sq36w	79	5	changes	change	NNS
cord-342372-2g9sq36w	79	6	in	in	IN
cord-342372-2g9sq36w	79	7	KD	KD	NNP
cord-342372-2g9sq36w	79	8	present	present	NN
cord-342372-2g9sq36w	79	9	include	include	VBP
cord-342372-2g9sq36w	79	10	generalized	generalized	JJ
cord-342372-2g9sq36w	79	11	erythema	erythema	NN
cord-342372-2g9sq36w	79	12	of	of	IN
cord-342372-2g9sq36w	79	13	the	the	DT
cord-342372-2g9sq36w	79	14	lips	lip	NNS
cord-342372-2g9sq36w	79	15	and	and	CC
cord-342372-2g9sq36w	79	16	oropharyngeal	oropharyngeal	JJ
cord-342372-2g9sq36w	79	17	mucosa	mucosa	NN
cord-342372-2g9sq36w	79	18	,	,	,
cord-342372-2g9sq36w	79	19	peeling	peel	VBG
cord-342372-2g9sq36w	79	20	/	/	SYM
cord-342372-2g9sq36w	79	21	cracking	crack	VBG
cord-342372-2g9sq36w	79	22	/	/	SYM
cord-342372-2g9sq36w	79	23	fissuring	fissuring	NN
cord-342372-2g9sq36w	79	24	of	of	IN
cord-342372-2g9sq36w	79	25	the	the	DT
cord-342372-2g9sq36w	79	26	lips	lip	NNS
cord-342372-2g9sq36w	79	27	,	,	,
cord-342372-2g9sq36w	79	28	and	and	CC
cord-342372-2g9sq36w	79	29	erythema	erythema	NN
cord-342372-2g9sq36w	79	30	and	and	CC
cord-342372-2g9sq36w	79	31	prominent	prominent	JJ
cord-342372-2g9sq36w	79	32	fungiform	fungiform	JJ
cord-342372-2g9sq36w	79	33	papillae	papilla	NNS
cord-342372-2g9sq36w	79	34	on	on	IN
cord-342372-2g9sq36w	79	35	the	the	DT
cord-342372-2g9sq36w	79	36	tongue	tongue	NN
cord-342372-2g9sq36w	79	37	,	,	,
cord-342372-2g9sq36w	79	38	commonly	commonly	RB
cord-342372-2g9sq36w	79	39	referred	refer	VBD
cord-342372-2g9sq36w	79	40	to	to	IN
cord-342372-2g9sq36w	79	41	as	as	IN
cord-342372-2g9sq36w	79	42	a	a	DT
cord-342372-2g9sq36w	79	43	"	"	``
cord-342372-2g9sq36w	79	44	strawberry	strawberry	JJ
cord-342372-2g9sq36w	79	45	tongue	tongue	NN
cord-342372-2g9sq36w	79	46	.	.	.
cord-342372-2g9sq36w	80	1	"	"	``
cord-342372-2g9sq36w	80	2	Strawberry	strawberry	JJ
cord-342372-2g9sq36w	80	3	tongue	tongue	NN
cord-342372-2g9sq36w	80	4	is	be	VBZ
cord-342372-2g9sq36w	80	5	not	not	RB
cord-342372-2g9sq36w	80	6	unique	unique	JJ
cord-342372-2g9sq36w	80	7	to	to	IN
cord-342372-2g9sq36w	80	8	KD	KD	NNP
cord-342372-2g9sq36w	80	9	as	as	IN
cord-342372-2g9sq36w	80	10	it	-PRON-	PRP
cord-342372-2g9sq36w	80	11	is	be	VBZ
cord-342372-2g9sq36w	80	12	also	also	RB
cord-342372-2g9sq36w	80	13	associated	associate	VBN
cord-342372-2g9sq36w	80	14	with	with	IN
cord-342372-2g9sq36w	80	15	streptococcal	streptococcal	JJ
cord-342372-2g9sq36w	80	16	scarlet	scarlet	JJ
cord-342372-2g9sq36w	80	17	fever	fever	NN
cord-342372-2g9sq36w	80	18	.	.	.
cord-342372-2g9sq36w	81	1	Cervical	cervical	JJ
cord-342372-2g9sq36w	81	2	lymphadenopathy	lymphadenopathy	NN
cord-342372-2g9sq36w	81	3	in	in	IN
cord-342372-2g9sq36w	81	4	KD	KD	NNP
cord-342372-2g9sq36w	81	5	is	be	VBZ
cord-342372-2g9sq36w	81	6	usually	usually	RB
cord-342372-2g9sq36w	81	7	unilateral	unilateral	JJ
cord-342372-2g9sq36w	81	8	,	,	,
cord-342372-2g9sq36w	81	9	classically	classically	RB
cord-342372-2g9sq36w	81	10	presents	present	VBZ
cord-342372-2g9sq36w	81	11	in	in	IN
cord-342372-2g9sq36w	81	12	the	the	DT
cord-342372-2g9sq36w	81	13	anterior	anterior	JJ
cord-342372-2g9sq36w	81	14	cervical	cervical	JJ
cord-342372-2g9sq36w	81	15	triangle	triangle	NN
cord-342372-2g9sq36w	81	16	,	,	,
cord-342372-2g9sq36w	81	17	and	and	CC
cord-342372-2g9sq36w	81	18	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	81	19	criteria	criterion	NNS
cord-342372-2g9sq36w	81	20	require	require	VBP
cord-342372-2g9sq36w	81	21	≥1	≥1	IN
cord-342372-2g9sq36w	81	22	enlarged	enlarge	VBN
cord-342372-2g9sq36w	81	23	lymph	lymph	NN
cord-342372-2g9sq36w	81	24	node	node	NN
cord-342372-2g9sq36w	81	25	which	which	WDT
cord-342372-2g9sq36w	81	26	is	be	VBZ
cord-342372-2g9sq36w	81	27	≥1.5	≥1.5	NNP
cord-342372-2g9sq36w	81	28	cm	cm	NNS
cord-342372-2g9sq36w	81	29	in	in	IN
cord-342372-2g9sq36w	81	30	diameter	diameter	NN
cord-342372-2g9sq36w	81	31	.	.	.
cord-342372-2g9sq36w	82	1	Of	of	IN
cord-342372-2g9sq36w	82	2	the	the	DT
cord-342372-2g9sq36w	82	3	classic	classic	JJ
cord-342372-2g9sq36w	82	4	clinical	clinical	JJ
cord-342372-2g9sq36w	82	5	features	feature	NNS
cord-342372-2g9sq36w	82	6	,	,	,
cord-342372-2g9sq36w	82	7	cervical	cervical	JJ
cord-342372-2g9sq36w	82	8	lymphadenopathy	lymphadenopathy	NN
cord-342372-2g9sq36w	82	9	is	be	VBZ
cord-342372-2g9sq36w	82	10	the	the	DT
cord-342372-2g9sq36w	82	11	least	least	JJS
cord-342372-2g9sq36w	82	12	commonly	commonly	RB
cord-342372-2g9sq36w	82	13	observed	observe	VBN
cord-342372-2g9sq36w	82	14	.	.	.
cord-342372-2g9sq36w	83	1	The	the	DT
cord-342372-2g9sq36w	83	2	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	83	3	of	of	IN
cord-342372-2g9sq36w	83	4	incomplete	incomplete	JJ
cord-342372-2g9sq36w	83	5	KD	KD	NNP
cord-342372-2g9sq36w	83	6	is	be	VBZ
cord-342372-2g9sq36w	83	7	made	make	VBN
cord-342372-2g9sq36w	83	8	in	in	IN
cord-342372-2g9sq36w	83	9	patients	patient	NNS
cord-342372-2g9sq36w	83	10	who	who	WP
cord-342372-2g9sq36w	83	11	do	do	VBP
cord-342372-2g9sq36w	83	12	not	not	RB
cord-342372-2g9sq36w	83	13	fulfill	fulfill	VB
cord-342372-2g9sq36w	83	14	the	the	DT
cord-342372-2g9sq36w	83	15	classic	classic	JJ
cord-342372-2g9sq36w	83	16	clinical	clinical	JJ
cord-342372-2g9sq36w	83	17	criteria	criterion	NNS
cord-342372-2g9sq36w	83	18	(	(	-LRB-
cord-342372-2g9sq36w	83	19	see	see	VB
cord-342372-2g9sq36w	83	20	Fig	Fig	NNP
cord-342372-2g9sq36w	83	21	.	.	NNP
cord-342372-2g9sq36w	83	22	1	1	CD
cord-342372-2g9sq36w	83	23	)	)	-RRB-
cord-342372-2g9sq36w	83	24	.	.	.
cord-342372-2g9sq36w	84	1	Incomplete	incomplete	JJ
cord-342372-2g9sq36w	84	2	KD	KD	NNP
cord-342372-2g9sq36w	84	3	is	be	VBZ
cord-342372-2g9sq36w	84	4	a	a	DT
cord-342372-2g9sq36w	84	5	separate	separate	JJ
cord-342372-2g9sq36w	84	6	entity	entity	NN
cord-342372-2g9sq36w	84	7	from	from	IN
cord-342372-2g9sq36w	84	8	"	"	``
cord-342372-2g9sq36w	84	9	atypical	atypical	JJ
cord-342372-2g9sq36w	84	10	"	"	''
cord-342372-2g9sq36w	84	11	KD	KD	NNP
cord-342372-2g9sq36w	84	12	,	,	,
cord-342372-2g9sq36w	84	13	which	which	WDT
cord-342372-2g9sq36w	84	14	present	present	VBP
cord-342372-2g9sq36w	84	15	with	with	IN
cord-342372-2g9sq36w	84	16	symptoms	symptom	NNS
cord-342372-2g9sq36w	84	17	typically	typically	RB
cord-342372-2g9sq36w	84	18	not	not	RB
cord-342372-2g9sq36w	84	19	seen	see	VBN
cord-342372-2g9sq36w	84	20	in	in	IN
cord-342372-2g9sq36w	84	21	KD	KD	NNP
cord-342372-2g9sq36w	84	22	.	.	.
cord-342372-2g9sq36w	85	1	Incomplete	incomplete	JJ
cord-342372-2g9sq36w	85	2	KD	KD	NNP
cord-342372-2g9sq36w	85	3	should	should	MD
cord-342372-2g9sq36w	85	4	be	be	VB
cord-342372-2g9sq36w	85	5	considered	consider	VBN
cord-342372-2g9sq36w	85	6	in	in	IN
cord-342372-2g9sq36w	85	7	children	child	NNS
cord-342372-2g9sq36w	85	8	with	with	IN
cord-342372-2g9sq36w	85	9	unexplained	unexplained	JJ
cord-342372-2g9sq36w	85	10	fever	fever	NN
cord-342372-2g9sq36w	85	11	for	for	IN
cord-342372-2g9sq36w	85	12	≥5	≥5	NNP
cord-342372-2g9sq36w	85	13	days	day	NNS
cord-342372-2g9sq36w	85	14	in	in	IN
cord-342372-2g9sq36w	85	15	addition	addition	NN
cord-342372-2g9sq36w	85	16	to	to	IN
cord-342372-2g9sq36w	85	17	the	the	DT
cord-342372-2g9sq36w	85	18	presence	presence	NN
cord-342372-2g9sq36w	85	19	of	of	IN
cord-342372-2g9sq36w	85	20	2	2	CD
cord-342372-2g9sq36w	85	21	-	-	SYM
cord-342372-2g9sq36w	85	22	3	3	CD
cord-342372-2g9sq36w	85	23	principal	principal	JJ
cord-342372-2g9sq36w	85	24	clinical	clinical	JJ
cord-342372-2g9sq36w	85	25	features	feature	NNS
cord-342372-2g9sq36w	85	26	of	of	IN
cord-342372-2g9sq36w	85	27	KD	KD	NNP
cord-342372-2g9sq36w	85	28	.	.	.
cord-342372-2g9sq36w	86	1	There	there	EX
cord-342372-2g9sq36w	86	2	is	be	VBZ
cord-342372-2g9sq36w	86	3	a	a	DT
cord-342372-2g9sq36w	86	4	higher	high	JJR
cord-342372-2g9sq36w	86	5	prevalence	prevalence	NN
cord-342372-2g9sq36w	86	6	of	of	IN
cord-342372-2g9sq36w	86	7	"	"	``
cord-342372-2g9sq36w	86	8	incomplete	incomplete	JJ
cord-342372-2g9sq36w	86	9	"	"	''
cord-342372-2g9sq36w	86	10	presentation	presentation	NN
cord-342372-2g9sq36w	86	11	in	in	IN
cord-342372-2g9sq36w	86	12	younger	young	JJR
cord-342372-2g9sq36w	86	13	children	child	NNS
cord-342372-2g9sq36w	86	14	.	.	.
cord-342372-2g9sq36w	87	1	Therefore	therefore	RB
cord-342372-2g9sq36w	87	2	,	,	,
cord-342372-2g9sq36w	87	3	incomplete	incomplete	JJ
cord-342372-2g9sq36w	87	4	KD	KD	NNP
cord-342372-2g9sq36w	87	5	should	should	MD
cord-342372-2g9sq36w	87	6	be	be	VB
cord-342372-2g9sq36w	87	7	considered	consider	VBN
cord-342372-2g9sq36w	87	8	in	in	IN
cord-342372-2g9sq36w	87	9	young	young	JJ
cord-342372-2g9sq36w	87	10	children	child	NNS
cord-342372-2g9sq36w	87	11	(	(	-LRB-
cord-342372-2g9sq36w	87	12	<	<	NNP
cord-342372-2g9sq36w	87	13	12	12	CD
cord-342372-2g9sq36w	87	14	months	month	NNS
cord-342372-2g9sq36w	87	15	old	old	JJ
cord-342372-2g9sq36w	87	16	)	)	-RRB-
cord-342372-2g9sq36w	87	17	with	with	IN
cord-342372-2g9sq36w	87	18	unexplained	unexplained	JJ
cord-342372-2g9sq36w	87	19	fever	fever	NN
cord-342372-2g9sq36w	87	20	for	for	IN
cord-342372-2g9sq36w	87	21	≥5	≥5	NNP
cord-342372-2g9sq36w	87	22	days	day	NNS
cord-342372-2g9sq36w	87	23	associated	associate	VBN
cord-342372-2g9sq36w	87	24	with	with	IN
cord-342372-2g9sq36w	87	25	any	any	DT
cord-342372-2g9sq36w	87	26	of	of	IN
cord-342372-2g9sq36w	87	27	the	the	DT
cord-342372-2g9sq36w	87	28	clinical	clinical	JJ
cord-342372-2g9sq36w	87	29	features	feature	NNS
cord-342372-2g9sq36w	87	30	as	as	IN
cord-342372-2g9sq36w	87	31	KD	KD	NNP
cord-342372-2g9sq36w	87	32	[	[	-LRB-
cord-342372-2g9sq36w	87	33	6••	6••	NN
cord-342372-2g9sq36w	87	34	]	]	-RRB-
cord-342372-2g9sq36w	87	35	.	.	.
cord-342372-2g9sq36w	88	1	In	in	IN
cord-342372-2g9sq36w	88	2	the	the	DT
cord-342372-2g9sq36w	88	3	evaluation	evaluation	NN
cord-342372-2g9sq36w	88	4	for	for	IN
cord-342372-2g9sq36w	88	5	incomplete	incomplete	JJ
cord-342372-2g9sq36w	88	6	KD	KD	NNP
cord-342372-2g9sq36w	88	7	,	,	,
cord-342372-2g9sq36w	88	8	the	the	DT
cord-342372-2g9sq36w	88	9	presence	presence	NN
cord-342372-2g9sq36w	88	10	of	of	IN
cord-342372-2g9sq36w	88	11	supportive	supportive	JJ
cord-342372-2g9sq36w	88	12	laboratory	laboratory	NN
cord-342372-2g9sq36w	88	13	and	and	CC
cord-342372-2g9sq36w	88	14	echocardiogram	echocardiogram	NN
cord-342372-2g9sq36w	88	15	findings	finding	NNS
cord-342372-2g9sq36w	88	16	(	(	-LRB-
cord-342372-2g9sq36w	88	17	see	see	VB
cord-342372-2g9sq36w	88	18	Table	table	NN
cord-342372-2g9sq36w	88	19	1	1	CD
cord-342372-2g9sq36w	88	20	)	)	-RRB-
cord-342372-2g9sq36w	88	21	is	be	VBZ
cord-342372-2g9sq36w	88	22	useful	useful	JJ
cord-342372-2g9sq36w	88	23	in	in	IN
cord-342372-2g9sq36w	88	24	ultimately	ultimately	RB
cord-342372-2g9sq36w	88	25	confirming	confirm	VBG
cord-342372-2g9sq36w	88	26	the	the	DT
cord-342372-2g9sq36w	88	27	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	88	28	.	.	.
cord-342372-2g9sq36w	89	1	The	the	DT
cord-342372-2g9sq36w	89	2	term	term	NN
cord-342372-2g9sq36w	89	3	"	"	``
cord-342372-2g9sq36w	89	4	atypical	atypical	JJ
cord-342372-2g9sq36w	89	5	KD	kd	NN
cord-342372-2g9sq36w	89	6	"	"	''
cord-342372-2g9sq36w	89	7	has	have	VBZ
cord-342372-2g9sq36w	89	8	been	be	VBN
cord-342372-2g9sq36w	89	9	used	use	VBN
cord-342372-2g9sq36w	89	10	interchangeably	interchangeably	RB
cord-342372-2g9sq36w	89	11	with	with	IN
cord-342372-2g9sq36w	89	12	incomplete	incomplete	JJ
cord-342372-2g9sq36w	89	13	KD	KD	NNP
cord-342372-2g9sq36w	89	14	in	in	IN
cord-342372-2g9sq36w	89	15	the	the	DT
cord-342372-2g9sq36w	89	16	past	past	NN
cord-342372-2g9sq36w	89	17	,	,	,
cord-342372-2g9sq36w	89	18	but	but	CC
cord-342372-2g9sq36w	89	19	should	should	MD
cord-342372-2g9sq36w	89	20	be	be	VB
cord-342372-2g9sq36w	89	21	reserved	reserve	VBN
cord-342372-2g9sq36w	89	22	for	for	IN
cord-342372-2g9sq36w	89	23	cases	case	NNS
cord-342372-2g9sq36w	89	24	of	of	IN
cord-342372-2g9sq36w	89	25	KD	KD	NNP
cord-342372-2g9sq36w	89	26	which	which	WDT
cord-342372-2g9sq36w	89	27	present	present	JJ
cord-342372-2g9sq36w	89	28	with	with	IN
cord-342372-2g9sq36w	89	29	findings	finding	NNS
cord-342372-2g9sq36w	89	30	rarely	rarely	RB
cord-342372-2g9sq36w	89	31	associated	associate	VBN
cord-342372-2g9sq36w	89	32	with	with	IN
cord-342372-2g9sq36w	89	33	KD	KD	NNP
cord-342372-2g9sq36w	89	34	.	.	.
cord-342372-2g9sq36w	90	1	These	these	DT
cord-342372-2g9sq36w	90	2	features	feature	NNS
cord-342372-2g9sq36w	90	3	include	include	VBP
cord-342372-2g9sq36w	90	4	transient	transient	JJ
cord-342372-2g9sq36w	90	5	unilateral	unilateral	JJ
cord-342372-2g9sq36w	90	6	peripheral	peripheral	JJ
cord-342372-2g9sq36w	90	7	facial	facial	JJ
cord-342372-2g9sq36w	90	8	nerve	nerve	NN
cord-342372-2g9sq36w	90	9	palsy	palsy	NN
cord-342372-2g9sq36w	90	10	,	,	,
cord-342372-2g9sq36w	90	11	transient	transient	JJ
cord-342372-2g9sq36w	90	12	high	high	JJ
cord-342372-2g9sq36w	90	13	-	-	HYPH
cord-342372-2g9sq36w	90	14	frequency	frequency	NN
cord-342372-2g9sq36w	90	15	sensorineural	sensorineural	JJ
cord-342372-2g9sq36w	90	16	hearing	hearing	NN
cord-342372-2g9sq36w	90	17	loss	loss	NN
cord-342372-2g9sq36w	90	18	,	,	,
cord-342372-2g9sq36w	90	19	hepatic	hepatic	JJ
cord-342372-2g9sq36w	90	20	enlargement	enlargement	NN
cord-342372-2g9sq36w	90	21	with	with	IN
cord-342372-2g9sq36w	90	22	jaundice	jaundice	NN
cord-342372-2g9sq36w	90	23	,	,	,
cord-342372-2g9sq36w	90	24	and	and	CC
cord-342372-2g9sq36w	90	25	acalculous	acalculous	JJ
cord-342372-2g9sq36w	90	26	gallbladder	gallbladder	NN
cord-342372-2g9sq36w	90	27	distention	distention	NN
cord-342372-2g9sq36w	90	28	.	.	.
cord-342372-2g9sq36w	91	1	Testicular	testicular	JJ
cord-342372-2g9sq36w	91	2	swelling	swelling	NN
cord-342372-2g9sq36w	91	3	,	,	,
cord-342372-2g9sq36w	91	4	pulmonary	pulmonary	JJ
cord-342372-2g9sq36w	91	5	nodules	nodule	NNS
cord-342372-2g9sq36w	91	6	,	,	,
cord-342372-2g9sq36w	91	7	pleural	pleural	JJ
cord-342372-2g9sq36w	91	8	effusions	effusion	NNS
cord-342372-2g9sq36w	91	9	,	,	,
cord-342372-2g9sq36w	91	10	and	and	CC
cord-342372-2g9sq36w	91	11	hemophagocytic	hemophagocytic	JJ
cord-342372-2g9sq36w	91	12	syndrome	syndrome	NN
cord-342372-2g9sq36w	91	13	have	have	VBP
cord-342372-2g9sq36w	91	14	also	also	RB
cord-342372-2g9sq36w	91	15	been	be	VBN
cord-342372-2g9sq36w	91	16	reported	report	VBN
cord-342372-2g9sq36w	91	17	but	but	CC
cord-342372-2g9sq36w	91	18	are	be	VBP
cord-342372-2g9sq36w	91	19	less	less	RBR
cord-342372-2g9sq36w	91	20	common	common	JJ
cord-342372-2g9sq36w	91	21	.	.	.
cord-342372-2g9sq36w	92	1	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	92	2	shock	shock	NN
cord-342372-2g9sq36w	92	3	syndrome	syndrome	NN
cord-342372-2g9sq36w	92	4	,	,	,
cord-342372-2g9sq36w	92	5	the	the	DT
cord-342372-2g9sq36w	92	6	presentation	presentation	NN
cord-342372-2g9sq36w	92	7	of	of	IN
cord-342372-2g9sq36w	92	8	KD	KD	NNP
cord-342372-2g9sq36w	92	9	disease	disease	NN
cord-342372-2g9sq36w	92	10	with	with	IN
cord-342372-2g9sq36w	92	11	systolic	systolic	JJ
cord-342372-2g9sq36w	92	12	hypotension	hypotension	NN
cord-342372-2g9sq36w	92	13	or	or	CC
cord-342372-2g9sq36w	92	14	clinical	clinical	JJ
cord-342372-2g9sq36w	92	15	signs	sign	NNS
cord-342372-2g9sq36w	92	16	of	of	IN
cord-342372-2g9sq36w	92	17	poor	poor	JJ
cord-342372-2g9sq36w	92	18	perfusion	perfusion	NN
cord-342372-2g9sq36w	92	19	,	,	,
cord-342372-2g9sq36w	92	20	has	have	VBZ
cord-342372-2g9sq36w	92	21	also	also	RB
cord-342372-2g9sq36w	92	22	been	be	VBN
cord-342372-2g9sq36w	92	23	described	describe	VBN
cord-342372-2g9sq36w	92	24	as	as	IN
cord-342372-2g9sq36w	92	25	a	a	DT
cord-342372-2g9sq36w	92	26	rare	rare	JJ
cord-342372-2g9sq36w	92	27	presentation	presentation	NN
cord-342372-2g9sq36w	92	28	of	of	IN
cord-342372-2g9sq36w	92	29	KD	KD	NNP
cord-342372-2g9sq36w	92	30	[	[	-LRB-
cord-342372-2g9sq36w	92	31	18•	18•	CD
cord-342372-2g9sq36w	92	32	]	]	-RRB-
cord-342372-2g9sq36w	92	33	.	.	.
cord-342372-2g9sq36w	93	1	The	the	DT
cord-342372-2g9sq36w	93	2	major	major	JJ
cord-342372-2g9sq36w	93	3	cardiac	cardiac	JJ
cord-342372-2g9sq36w	93	4	sequelae	sequela	NNS
cord-342372-2g9sq36w	93	5	of	of	IN
cord-342372-2g9sq36w	93	6	KD	KD	NNP
cord-342372-2g9sq36w	93	7	affect	affect	VBP
cord-342372-2g9sq36w	93	8	the	the	DT
cord-342372-2g9sq36w	93	9	coronary	coronary	JJ
cord-342372-2g9sq36w	93	10	arterial	arterial	JJ
cord-342372-2g9sq36w	93	11	system	system	NN
cord-342372-2g9sq36w	93	12	.	.	.
cord-342372-2g9sq36w	94	1	The	the	DT
cord-342372-2g9sq36w	94	2	pericardium	pericardium	NN
cord-342372-2g9sq36w	94	3	,	,	,
cord-342372-2g9sq36w	94	4	myocardium	myocardium	NN
cord-342372-2g9sq36w	94	5	,	,	,
cord-342372-2g9sq36w	94	6	endocardium	endocardium	NN
cord-342372-2g9sq36w	94	7	,	,	,
cord-342372-2g9sq36w	94	8	valves	valve	NNS
cord-342372-2g9sq36w	94	9	,	,	,
cord-342372-2g9sq36w	94	10	and	and	CC
cord-342372-2g9sq36w	94	11	coronary	coronary	JJ
cord-342372-2g9sq36w	94	12	arteries	artery	NNS
cord-342372-2g9sq36w	94	13	may	may	MD
cord-342372-2g9sq36w	94	14	all	all	DT
cord-342372-2g9sq36w	94	15	be	be	VB
cord-342372-2g9sq36w	94	16	affected	affect	VBN
cord-342372-2g9sq36w	94	17	by	by	IN
cord-342372-2g9sq36w	94	18	the	the	DT
cord-342372-2g9sq36w	94	19	diffuse	diffuse	JJ
cord-342372-2g9sq36w	94	20	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	94	21	process	process	NN
cord-342372-2g9sq36w	94	22	of	of	IN
cord-342372-2g9sq36w	94	23	KD	KD	NNP
cord-342372-2g9sq36w	94	24	.	.	.
cord-342372-2g9sq36w	95	1	This	this	DT
cord-342372-2g9sq36w	95	2	may	may	MD
cord-342372-2g9sq36w	95	3	present	present	VB
cord-342372-2g9sq36w	95	4	as	as	IN
cord-342372-2g9sq36w	95	5	pericarditis	pericarditis	NN
cord-342372-2g9sq36w	95	6	,	,	,
cord-342372-2g9sq36w	95	7	myocarditis	myocarditis	NN
cord-342372-2g9sq36w	95	8	,	,	,
cord-342372-2g9sq36w	95	9	valvulitis	valvulitis	NN
cord-342372-2g9sq36w	95	10	,	,	,
cord-342372-2g9sq36w	95	11	and	and	CC
cord-342372-2g9sq36w	95	12	new	new	JJ
cord-342372-2g9sq36w	95	13	valvular	valvular	JJ
cord-342372-2g9sq36w	95	14	regurgitation	regurgitation	NN
cord-342372-2g9sq36w	95	15	.	.	.
cord-342372-2g9sq36w	96	1	A	a	DT
cord-342372-2g9sq36w	96	2	gallop	gallop	NN
cord-342372-2g9sq36w	96	3	rhythm	rhythm	NN
cord-342372-2g9sq36w	96	4	with	with	IN
cord-342372-2g9sq36w	96	5	innocent	innocent	JJ
cord-342372-2g9sq36w	96	6	flow	flow	NN
cord-342372-2g9sq36w	96	7	murmur	murmur	NN
cord-342372-2g9sq36w	96	8	may	may	MD
cord-342372-2g9sq36w	96	9	also	also	RB
cord-342372-2g9sq36w	96	10	be	be	VB
cord-342372-2g9sq36w	96	11	present	present	JJ
cord-342372-2g9sq36w	96	12	,	,	,
cord-342372-2g9sq36w	96	13	commonly	commonly	RB
cord-342372-2g9sq36w	96	14	in	in	IN
cord-342372-2g9sq36w	96	15	the	the	DT
cord-342372-2g9sq36w	96	16	setting	setting	NN
cord-342372-2g9sq36w	96	17	of	of	IN
cord-342372-2g9sq36w	96	18	anemia	anemia	NN
cord-342372-2g9sq36w	96	19	and	and	CC
cord-342372-2g9sq36w	96	20	fever	fever	NN
cord-342372-2g9sq36w	96	21	of	of	IN
cord-342372-2g9sq36w	96	22	acute	acute	JJ
cord-342372-2g9sq36w	96	23	KD	KD	NNP
cord-342372-2g9sq36w	96	24	.	.	.
cord-342372-2g9sq36w	97	1	Poor	poor	JJ
cord-342372-2g9sq36w	97	2	myocardial	myocardial	JJ
cord-342372-2g9sq36w	97	3	function	function	NN
cord-342372-2g9sq36w	97	4	can	can	MD
cord-342372-2g9sq36w	97	5	also	also	RB
cord-342372-2g9sq36w	97	6	result	result	VB
cord-342372-2g9sq36w	97	7	in	in	IN
cord-342372-2g9sq36w	97	8	cardiogenic	cardiogenic	JJ
cord-342372-2g9sq36w	97	9	shock	shock	NN
cord-342372-2g9sq36w	97	10	.	.	.
cord-342372-2g9sq36w	98	1	Arrhythmia	arrhythmia	NN
cord-342372-2g9sq36w	98	2	,	,	,
cord-342372-2g9sq36w	98	3	prolonged	prolonged	JJ
cord-342372-2g9sq36w	98	4	PR	PR	NNP
cord-342372-2g9sq36w	98	5	interval	interval	NN
cord-342372-2g9sq36w	98	6	,	,	,
cord-342372-2g9sq36w	98	7	and	and	CC
cord-342372-2g9sq36w	98	8	nonspecific	nonspecific	JJ
cord-342372-2g9sq36w	98	9	ST	ST	NNP
cord-342372-2g9sq36w	98	10	and	and	CC
cord-342372-2g9sq36w	98	11	T	T	NNP
cord-342372-2g9sq36w	98	12	wave	wave	NN
cord-342372-2g9sq36w	98	13	changes	change	NNS
cord-342372-2g9sq36w	98	14	may	may	MD
cord-342372-2g9sq36w	98	15	be	be	VB
cord-342372-2g9sq36w	98	16	present	present	JJ
cord-342372-2g9sq36w	98	17	on	on	IN
cord-342372-2g9sq36w	98	18	EKG	EKG	NNP
cord-342372-2g9sq36w	98	19	.	.	.
cord-342372-2g9sq36w	99	1	Supplementary	supplementary	JJ
cord-342372-2g9sq36w	99	2	laboratory	laboratory	NN
cord-342372-2g9sq36w	99	3	criteria	criterion	NNS
cord-342372-2g9sq36w	99	4	supporting	support	VBG
cord-342372-2g9sq36w	99	5	the	the	DT
cord-342372-2g9sq36w	99	6	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	99	7	of	of	IN
cord-342372-2g9sq36w	99	8	KD	KD	NNP
cord-342372-2g9sq36w	99	9	are	be	VBP
cord-342372-2g9sq36w	99	10	listed	list	VBN
cord-342372-2g9sq36w	99	11	in	in	IN
cord-342372-2g9sq36w	99	12	Table	Table	NNP
cord-342372-2g9sq36w	99	13	1	1	CD
cord-342372-2g9sq36w	99	14	and	and	CC
cord-342372-2g9sq36w	99	15	include	include	VBP
cord-342372-2g9sq36w	99	16	hypoalbuminemia	hypoalbuminemia	NN
cord-342372-2g9sq36w	99	17	,	,	,
cord-342372-2g9sq36w	99	18	anemia	anemia	NN
cord-342372-2g9sq36w	99	19	for	for	IN
cord-342372-2g9sq36w	99	20	age	age	NN
cord-342372-2g9sq36w	99	21	,	,	,
cord-342372-2g9sq36w	99	22	elevation	elevation	NN
cord-342372-2g9sq36w	99	23	of	of	IN
cord-342372-2g9sq36w	99	24	alanine	alanine	NNP
cord-342372-2g9sq36w	99	25	aminotransferase	aminotransferase	NN
cord-342372-2g9sq36w	99	26	(	(	-LRB-
cord-342372-2g9sq36w	99	27	ALT	alt	NN
cord-342372-2g9sq36w	99	28	)	)	-RRB-
cord-342372-2g9sq36w	100	1	,	,	,
cord-342372-2g9sq36w	100	2	thrombocytosis	thrombocytosis	NNP
cord-342372-2g9sq36w	100	3	after	after	IN
cord-342372-2g9sq36w	100	4	7	7	CD
cord-342372-2g9sq36w	100	5	days	day	NNS
cord-342372-2g9sq36w	100	6	,	,	,
cord-342372-2g9sq36w	100	7	leukocytosis	leukocytosis	NN
cord-342372-2g9sq36w	100	8	,	,	,
cord-342372-2g9sq36w	100	9	and	and	CC
cord-342372-2g9sq36w	100	10	sterile	sterile	JJ
cord-342372-2g9sq36w	100	11	pyuria	pyuria	NNS
cord-342372-2g9sq36w	100	12	.	.	.
cord-342372-2g9sq36w	101	1	Additional	additional	JJ
cord-342372-2g9sq36w	101	2	nonspecific	nonspecific	JJ
cord-342372-2g9sq36w	101	3	laboratory	laboratory	NN
cord-342372-2g9sq36w	101	4	findings	finding	NNS
cord-342372-2g9sq36w	101	5	are	be	VBP
cord-342372-2g9sq36w	101	6	elevated	elevated	JJ
cord-342372-2g9sq36w	101	7	markers	marker	NNS
cord-342372-2g9sq36w	101	8	of	of	IN
cord-342372-2g9sq36w	101	9	inflammation	inflammation	NN
cord-342372-2g9sq36w	101	10	(	(	-LRB-
cord-342372-2g9sq36w	101	11	erythrocyte	erythrocyte	NN
cord-342372-2g9sq36w	101	12	sedimentation	sedimentation	NN
cord-342372-2g9sq36w	101	13	rate	rate	NN
cord-342372-2g9sq36w	101	14	(	(	-LRB-
cord-342372-2g9sq36w	101	15	ESR	ESR	NNP
cord-342372-2g9sq36w	101	16	)	)	-RRB-
cord-342372-2g9sq36w	101	17	and	and	CC
cord-342372-2g9sq36w	101	18	C	C	NNP
cord-342372-2g9sq36w	101	19	-	-	HYPH
cord-342372-2g9sq36w	101	20	reactive	reactive	JJ
cord-342372-2g9sq36w	101	21	protein	protein	NN
cord-342372-2g9sq36w	101	22	(	(	-LRB-
cord-342372-2g9sq36w	101	23	CRP	CRP	NNP
cord-342372-2g9sq36w	101	24	)	)	-RRB-
cord-342372-2g9sq36w	101	25	)	)	-RRB-
cord-342372-2g9sq36w	101	26	.	.	.
cord-342372-2g9sq36w	102	1	Approximately	approximately	RB
cord-342372-2g9sq36w	102	2	50	50	CD
cord-342372-2g9sq36w	102	3	%	%	NN
cord-342372-2g9sq36w	102	4	of	of	IN
cord-342372-2g9sq36w	102	5	patients	patient	NNS
cord-342372-2g9sq36w	102	6	with	with	IN
cord-342372-2g9sq36w	102	7	KD	KD	NNP
cord-342372-2g9sq36w	102	8	have	have	VBP
cord-342372-2g9sq36w	102	9	WBC	WBC	NNP
cord-342372-2g9sq36w	103	1	>	>	XX
cord-342372-2g9sq36w	104	1	15,000	15,000	CD
cord-342372-2g9sq36w	104	2	/	/	SYM
cord-342372-2g9sq36w	104	3	mm	mm	NN
cord-342372-2g9sq36w	104	4	3	3	CD
cord-342372-2g9sq36w	104	5	.	.	.
cord-342372-2g9sq36w	105	1	Anemia	anemia	NN
cord-342372-2g9sq36w	105	2	may	may	MD
cord-342372-2g9sq36w	105	3	develop	develop	VB
cord-342372-2g9sq36w	105	4	in	in	IN
cord-342372-2g9sq36w	105	5	patients	patient	NNS
cord-342372-2g9sq36w	105	6	with	with	IN
cord-342372-2g9sq36w	105	7	prolonged	prolonged	JJ
cord-342372-2g9sq36w	105	8	duration	duration	NN
cord-342372-2g9sq36w	105	9	of	of	IN
cord-342372-2g9sq36w	105	10	active	active	JJ
cord-342372-2g9sq36w	105	11	inflammation	inflammation	NN
cord-342372-2g9sq36w	105	12	and	and	CC
cord-342372-2g9sq36w	105	13	is	be	VBZ
cord-342372-2g9sq36w	105	14	typically	typically	RB
cord-342372-2g9sq36w	105	15	present	present	JJ
cord-342372-2g9sq36w	105	16	with	with	IN
cord-342372-2g9sq36w	105	17	normal	normal	JJ
cord-342372-2g9sq36w	105	18	RBC	RBC	NNP
cord-342372-2g9sq36w	105	19	indexes	index	NNS
cord-342372-2g9sq36w	105	20	.	.	.
cord-342372-2g9sq36w	106	1	Acute	acute	JJ
cord-342372-2g9sq36w	106	2	phase	phase	NN
cord-342372-2g9sq36w	106	3	reactant	reactant	NN
cord-342372-2g9sq36w	106	4	elevation	elevation	NN
cord-342372-2g9sq36w	106	5	(	(	-LRB-
cord-342372-2g9sq36w	106	6	ESR	ESR	NNP
cord-342372-2g9sq36w	106	7	/	/	SYM
cord-342372-2g9sq36w	106	8	CRP	CRP	NNP
cord-342372-2g9sq36w	106	9	)	)	-RRB-
cord-342372-2g9sq36w	106	10	is	be	VBZ
cord-342372-2g9sq36w	106	11	nearly	nearly	RB
cord-342372-2g9sq36w	106	12	universally	universally	RB
cord-342372-2g9sq36w	106	13	present	present	JJ
cord-342372-2g9sq36w	106	14	,	,	,
cord-342372-2g9sq36w	106	15	although	although	IN
cord-342372-2g9sq36w	106	16	discordant	discordant	JJ
cord-342372-2g9sq36w	106	17	ESR	ESR	NNP
cord-342372-2g9sq36w	106	18	/	/	SYM
cord-342372-2g9sq36w	106	19	CRP	CRP	NNP
cord-342372-2g9sq36w	106	20	can	can	MD
cord-342372-2g9sq36w	106	21	be	be	VB
cord-342372-2g9sq36w	106	22	seen	see	VBN
cord-342372-2g9sq36w	106	23	in	in	IN
cord-342372-2g9sq36w	106	24	the	the	DT
cord-342372-2g9sq36w	106	25	acute	acute	JJ
cord-342372-2g9sq36w	106	26	presentation	presentation	NN
cord-342372-2g9sq36w	106	27	of	of	IN
cord-342372-2g9sq36w	106	28	KD	KD	NNP
cord-342372-2g9sq36w	106	29	.	.	.
cord-342372-2g9sq36w	107	1	Thrombocytosis	Thrombocytosis	NNP
cord-342372-2g9sq36w	107	2	,	,	,
cord-342372-2g9sq36w	107	3	with	with	IN
cord-342372-2g9sq36w	107	4	platelet	platelet	NN
cord-342372-2g9sq36w	107	5	counts	count	VBZ
cord-342372-2g9sq36w	107	6	from	from	IN
cord-342372-2g9sq36w	107	7	500,000	500,000	CD
cord-342372-2g9sq36w	107	8	to	to	IN
cord-342372-2g9sq36w	107	9	>	>	XX
cord-342372-2g9sq36w	107	10	1	1	CD
cord-342372-2g9sq36w	107	11	million	million	CD
cord-342372-2g9sq36w	107	12	/	/	SYM
cord-342372-2g9sq36w	107	13	mm	mm	NNP
cord-342372-2g9sq36w	107	14	3	3	CD
cord-342372-2g9sq36w	107	15	,	,	,
cord-342372-2g9sq36w	107	16	is	be	VBZ
cord-342372-2g9sq36w	107	17	a	a	DT
cord-342372-2g9sq36w	107	18	late	late	JJ
cord-342372-2g9sq36w	107	19	feature	feature	NN
cord-342372-2g9sq36w	107	20	of	of	IN
cord-342372-2g9sq36w	107	21	KD	KD	NNP
cord-342372-2g9sq36w	107	22	commonly	commonly	RB
cord-342372-2g9sq36w	107	23	occurring	occur	VBG
cord-342372-2g9sq36w	107	24	in	in	IN
cord-342372-2g9sq36w	107	25	the	the	DT
cord-342372-2g9sq36w	107	26	second	second	JJ
cord-342372-2g9sq36w	107	27	week	week	NN
cord-342372-2g9sq36w	107	28	of	of	IN
cord-342372-2g9sq36w	107	29	the	the	DT
cord-342372-2g9sq36w	107	30	disease	disease	NN
cord-342372-2g9sq36w	107	31	and	and	CC
cord-342372-2g9sq36w	107	32	slowly	slowly	RB
cord-342372-2g9sq36w	107	33	resolving	resolve	VBG
cord-342372-2g9sq36w	107	34	by	by	IN
cord-342372-2g9sq36w	107	35	weeks	week	NNS
cord-342372-2g9sq36w	107	36	4	4	CD
cord-342372-2g9sq36w	107	37	to	to	TO
cord-342372-2g9sq36w	107	38	8	8	CD
cord-342372-2g9sq36w	107	39	in	in	IN
cord-342372-2g9sq36w	107	40	uncomplicated	uncomplicated	JJ
cord-342372-2g9sq36w	107	41	KD	KD	NNP
cord-342372-2g9sq36w	107	42	.	.	.
cord-342372-2g9sq36w	108	1	Elevation	elevation	NN
cord-342372-2g9sq36w	108	2	of	of	IN
cord-342372-2g9sq36w	108	3	ALT	ALT	NNP
cord-342372-2g9sq36w	108	4	is	be	VBZ
cord-342372-2g9sq36w	108	5	typically	typically	RB
cord-342372-2g9sq36w	108	6	mild	mild	JJ
cord-342372-2g9sq36w	108	7	to	to	TO
cord-342372-2g9sq36w	108	8	moderate	moderate	VB
cord-342372-2g9sq36w	108	9	and	and	CC
cord-342372-2g9sq36w	108	10	occur	occur	VB
cord-342372-2g9sq36w	108	11	in	in	IN
cord-342372-2g9sq36w	108	12	≤40	≤40	CD
cord-342372-2g9sq36w	108	13	%	%	NN
cord-342372-2g9sq36w	108	14	of	of	IN
cord-342372-2g9sq36w	108	15	cases	case	NNS
cord-342372-2g9sq36w	108	16	.	.	.
cord-342372-2g9sq36w	109	1	Hypoalbuminemia	Hypoalbuminemia	NNP
cord-342372-2g9sq36w	109	2	(	(	-LRB-
cord-342372-2g9sq36w	109	3	albumin	albumin	NN
cord-342372-2g9sq36w	109	4	≤3.0	≤3.0	NN
cord-342372-2g9sq36w	109	5	)	)	-RRB-
cord-342372-2g9sq36w	109	6	is	be	VBZ
cord-342372-2g9sq36w	109	7	associated	associate	VBN
cord-342372-2g9sq36w	109	8	with	with	IN
cord-342372-2g9sq36w	109	9	more	more	RBR
cord-342372-2g9sq36w	109	10	severe	severe	JJ
cord-342372-2g9sq36w	109	11	and	and	CC
cord-342372-2g9sq36w	109	12	prolonged	prolonged	JJ
cord-342372-2g9sq36w	109	13	disease	disease	NN
cord-342372-2g9sq36w	109	14	.	.	.
cord-342372-2g9sq36w	110	1	Sterile	sterile	JJ
cord-342372-2g9sq36w	110	2	pyuria	pyuria	NNS
cord-342372-2g9sq36w	110	3	is	be	VBZ
cord-342372-2g9sq36w	110	4	present	present	JJ
cord-342372-2g9sq36w	110	5	in	in	IN
cord-342372-2g9sq36w	110	6	approximately	approximately	RB
cord-342372-2g9sq36w	110	7	one	one	CD
cord-342372-2g9sq36w	110	8	third	third	NN
cord-342372-2g9sq36w	110	9	of	of	IN
cord-342372-2g9sq36w	110	10	patients	patient	NNS
cord-342372-2g9sq36w	110	11	.	.	.
cord-342372-2g9sq36w	111	1	Sterile	sterile	JJ
cord-342372-2g9sq36w	111	2	pyuria	pyuria	NNS
cord-342372-2g9sq36w	111	3	is	be	VBZ
cord-342372-2g9sq36w	111	4	not	not	RB
cord-342372-2g9sq36w	111	5	found	find	VBN
cord-342372-2g9sq36w	111	6	in	in	IN
cord-342372-2g9sq36w	111	7	suprapubic	suprapubic	JJ
cord-342372-2g9sq36w	111	8	aspiration	aspiration	NN
cord-342372-2g9sq36w	111	9	of	of	IN
cord-342372-2g9sq36w	111	10	urine	urine	NN
cord-342372-2g9sq36w	111	11	as	as	IN
cord-342372-2g9sq36w	111	12	underlying	underlying	JJ
cord-342372-2g9sq36w	111	13	urethritis	urethritis	NN
cord-342372-2g9sq36w	111	14	is	be	VBZ
cord-342372-2g9sq36w	111	15	present	present	JJ
cord-342372-2g9sq36w	111	16	in	in	IN
cord-342372-2g9sq36w	111	17	KD	KD	NNP
cord-342372-2g9sq36w	111	18	.	.	.
cord-342372-2g9sq36w	112	1	The	the	DT
cord-342372-2g9sq36w	112	2	differential	differential	JJ
cord-342372-2g9sq36w	112	3	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	112	4	of	of	IN
cord-342372-2g9sq36w	112	5	patients	patient	NNS
cord-342372-2g9sq36w	112	6	presenting	present	VBG
cord-342372-2g9sq36w	112	7	with	with	IN
cord-342372-2g9sq36w	112	8	the	the	DT
cord-342372-2g9sq36w	112	9	clinical	clinical	JJ
cord-342372-2g9sq36w	112	10	features	feature	NNS
cord-342372-2g9sq36w	112	11	of	of	IN
cord-342372-2g9sq36w	112	12	KD	KD	NNP
cord-342372-2g9sq36w	112	13	is	be	VBZ
cord-342372-2g9sq36w	112	14	vast	vast	JJ
cord-342372-2g9sq36w	112	15	.	.	.
cord-342372-2g9sq36w	113	1	There	there	EX
cord-342372-2g9sq36w	113	2	is	be	VBZ
cord-342372-2g9sq36w	113	3	considerable	considerable	JJ
cord-342372-2g9sq36w	113	4	overlap	overlap	NN
cord-342372-2g9sq36w	113	5	in	in	IN
cord-342372-2g9sq36w	113	6	the	the	DT
cord-342372-2g9sq36w	113	7	clinical	clinical	JJ
cord-342372-2g9sq36w	113	8	features	feature	NNS
cord-342372-2g9sq36w	113	9	of	of	IN
cord-342372-2g9sq36w	113	10	KD	KD	NNP
cord-342372-2g9sq36w	113	11	with	with	IN
cord-342372-2g9sq36w	113	12	several	several	JJ
cord-342372-2g9sq36w	113	13	common	common	JJ
cord-342372-2g9sq36w	113	14	pediatric	pediatric	JJ
cord-342372-2g9sq36w	113	15	illnesses	illness	NNS
cord-342372-2g9sq36w	113	16	including	include	VBG
cord-342372-2g9sq36w	113	17	but	but	CC
cord-342372-2g9sq36w	113	18	not	not	RB
cord-342372-2g9sq36w	113	19	limited	limited	JJ
cord-342372-2g9sq36w	113	20	to	to	IN
cord-342372-2g9sq36w	113	21	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	113	22	infection	infection	NN
cord-342372-2g9sq36w	113	23	,	,	,
cord-342372-2g9sq36w	113	24	bacterial	bacterial	JJ
cord-342372-2g9sq36w	113	25	cervical	cervical	JJ
cord-342372-2g9sq36w	113	26	adenitis	adenitis	NN
cord-342372-2g9sq36w	113	27	,	,	,
cord-342372-2g9sq36w	113	28	retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	113	29	abscess	abscess	NN
cord-342372-2g9sq36w	113	30	,	,	,
cord-342372-2g9sq36w	113	31	systemic	systemic	JJ
cord-342372-2g9sq36w	113	32	onset	onset	NN
cord-342372-2g9sq36w	113	33	JRA	JRA	NNP
cord-342372-2g9sq36w	113	34	,	,	,
cord-342372-2g9sq36w	113	35	and	and	CC
cord-342372-2g9sq36w	113	36	toxic	toxic	JJ
cord-342372-2g9sq36w	113	37	shock	shock	NN
cord-342372-2g9sq36w	113	38	syndrome	syndrome	NN
cord-342372-2g9sq36w	113	39	.	.	.
cord-342372-2g9sq36w	114	1	Incomplete	incomplete	JJ
cord-342372-2g9sq36w	114	2	KD	KD	NNP
cord-342372-2g9sq36w	114	3	often	often	RB
cord-342372-2g9sq36w	114	4	presents	present	VBZ
cord-342372-2g9sq36w	114	5	the	the	DT
cord-342372-2g9sq36w	114	6	greatest	great	JJS
cord-342372-2g9sq36w	114	7	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	114	8	challenge	challenge	NN
cord-342372-2g9sq36w	114	9	as	as	IN
cord-342372-2g9sq36w	114	10	initial	initial	JJ
cord-342372-2g9sq36w	114	11	presentation	presentation	NN
cord-342372-2g9sq36w	114	12	may	may	MD
cord-342372-2g9sq36w	114	13	be	be	VB
cord-342372-2g9sq36w	114	14	consistent	consistent	JJ
cord-342372-2g9sq36w	114	15	with	with	IN
cord-342372-2g9sq36w	114	16	any	any	DT
cord-342372-2g9sq36w	114	17	of	of	IN
cord-342372-2g9sq36w	114	18	the	the	DT
cord-342372-2g9sq36w	114	19	previously	previously	RB
cord-342372-2g9sq36w	114	20	mentioned	mention	VBN
cord-342372-2g9sq36w	114	21	clinical	clinical	JJ
cord-342372-2g9sq36w	114	22	illnesses	illness	NNS
cord-342372-2g9sq36w	114	23	given	give	VBN
cord-342372-2g9sq36w	114	24	the	the	DT
cord-342372-2g9sq36w	114	25	limited	limited	JJ
cord-342372-2g9sq36w	114	26	clinical	clinical	JJ
cord-342372-2g9sq36w	114	27	manifestations	manifestation	NNS
cord-342372-2g9sq36w	114	28	.	.	.
cord-342372-2g9sq36w	115	1	Therefore	therefore	RB
cord-342372-2g9sq36w	115	2	,	,	,
cord-342372-2g9sq36w	115	3	it	-PRON-	PRP
cord-342372-2g9sq36w	115	4	is	be	VBZ
cord-342372-2g9sq36w	115	5	essential	essential	JJ
cord-342372-2g9sq36w	115	6	to	to	TO
cord-342372-2g9sq36w	115	7	consider	consider	VB
cord-342372-2g9sq36w	115	8	KD	KD	NNP
cord-342372-2g9sq36w	115	9	in	in	IN
cord-342372-2g9sq36w	115	10	the	the	DT
cord-342372-2g9sq36w	115	11	differential	differential	JJ
cord-342372-2g9sq36w	115	12	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	115	13	of	of	IN
cord-342372-2g9sq36w	115	14	these	these	DT
cord-342372-2g9sq36w	115	15	illnesses	illness	NNS
cord-342372-2g9sq36w	115	16	.	.	.
cord-342372-2g9sq36w	116	1	Adenovirus	Adenovirus	NNP
cord-342372-2g9sq36w	116	2	infection	infection	NN
cord-342372-2g9sq36w	116	3	is	be	VBZ
cord-342372-2g9sq36w	116	4	one	one	CD
cord-342372-2g9sq36w	116	5	of	of	IN
cord-342372-2g9sq36w	116	6	the	the	DT
cord-342372-2g9sq36w	116	7	most	most	RBS
cord-342372-2g9sq36w	116	8	common	common	JJ
cord-342372-2g9sq36w	116	9	pediatric	pediatric	JJ
cord-342372-2g9sq36w	116	10	infections	infection	NNS
cord-342372-2g9sq36w	116	11	,	,	,
cord-342372-2g9sq36w	116	12	comprising	comprise	VBG
cord-342372-2g9sq36w	116	13	7	7	CD
cord-342372-2g9sq36w	116	14	-	-	SYM
cord-342372-2g9sq36w	116	15	8	8	CD
cord-342372-2g9sq36w	116	16	%	%	NN
cord-342372-2g9sq36w	116	17	of	of	IN
cord-342372-2g9sq36w	116	18	all	all	DT
cord-342372-2g9sq36w	116	19	pediatric	pediatric	JJ
cord-342372-2g9sq36w	116	20	respiratory	respiratory	JJ
cord-342372-2g9sq36w	116	21	illnesses	illness	NNS
cord-342372-2g9sq36w	116	22	[	[	-LRB-
cord-342372-2g9sq36w	116	23	19	19	CD
cord-342372-2g9sq36w	116	24	]	]	-RRB-
cord-342372-2g9sq36w	116	25	.	.	.
cord-342372-2g9sq36w	117	1	The	the	DT
cord-342372-2g9sq36w	117	2	presence	presence	NN
cord-342372-2g9sq36w	117	3	of	of	IN
cord-342372-2g9sq36w	117	4	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	117	5	can	can	MD
cord-342372-2g9sq36w	117	6	be	be	VB
cord-342372-2g9sq36w	117	7	detected	detect	VBN
cord-342372-2g9sq36w	117	8	through	through	IN
cord-342372-2g9sq36w	117	9	polymerase	polymerase	NN
cord-342372-2g9sq36w	117	10	chain	chain	NN
cord-342372-2g9sq36w	117	11	reaction	reaction	NN
cord-342372-2g9sq36w	117	12	(	(	-LRB-
cord-342372-2g9sq36w	117	13	PCR	PCR	NNP
cord-342372-2g9sq36w	117	14	)	)	-RRB-
cord-342372-2g9sq36w	117	15	testing	testing	NN
cord-342372-2g9sq36w	117	16	of	of	IN
cord-342372-2g9sq36w	117	17	the	the	DT
cord-342372-2g9sq36w	117	18	nasopharynx	nasopharynx	NN
cord-342372-2g9sq36w	117	19	(	(	-LRB-
cord-342372-2g9sq36w	117	20	NP	NP	NNP
cord-342372-2g9sq36w	117	21	)	)	-RRB-
cord-342372-2g9sq36w	117	22	swab	swab	VBP
cord-342372-2g9sq36w	117	23	in	in	RP
cord-342372-2g9sq36w	117	24	up	up	IN
cord-342372-2g9sq36w	117	25	to	to	TO
cord-342372-2g9sq36w	117	26	11	11	CD
cord-342372-2g9sq36w	117	27	%	%	NN
cord-342372-2g9sq36w	117	28	of	of	IN
cord-342372-2g9sq36w	117	29	healthy	healthy	JJ
cord-342372-2g9sq36w	117	30	children	child	NNS
cord-342372-2g9sq36w	117	31	[	[	-LRB-
cord-342372-2g9sq36w	117	32	20	20	CD
cord-342372-2g9sq36w	117	33	]	]	-RRB-
cord-342372-2g9sq36w	117	34	.	.	.
cord-342372-2g9sq36w	118	1	In	in	IN
cord-342372-2g9sq36w	118	2	patients	patient	NNS
cord-342372-2g9sq36w	118	3	with	with	IN
cord-342372-2g9sq36w	118	4	KD	KD	NNP
cord-342372-2g9sq36w	118	5	with	with	IN
cord-342372-2g9sq36w	118	6	subsequent	subsequent	JJ
cord-342372-2g9sq36w	118	7	development	development	NN
cord-342372-2g9sq36w	118	8	of	of	IN
cord-342372-2g9sq36w	118	9	coronary	coronary	JJ
cord-342372-2g9sq36w	118	10	artery	artery	NN
cord-342372-2g9sq36w	118	11	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	118	12	,	,	,
cord-342372-2g9sq36w	118	13	incidental	incidental	JJ
cord-342372-2g9sq36w	118	14	detection	detection	NN
cord-342372-2g9sq36w	118	15	of	of	IN
cord-342372-2g9sq36w	118	16	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	118	17	by	by	IN
cord-342372-2g9sq36w	118	18	PCR	PCR	NNP
cord-342372-2g9sq36w	118	19	in	in	IN
cord-342372-2g9sq36w	118	20	NP	NP	NNP
cord-342372-2g9sq36w	118	21	swab	swab	NN
cord-342372-2g9sq36w	118	22	has	have	VBZ
cord-342372-2g9sq36w	118	23	been	be	VBN
cord-342372-2g9sq36w	118	24	described	describe	VBN
cord-342372-2g9sq36w	118	25	.	.	.
cord-342372-2g9sq36w	119	1	Therefore	therefore	RB
cord-342372-2g9sq36w	119	2	,	,	,
cord-342372-2g9sq36w	119	3	accurate	accurate	JJ
cord-342372-2g9sq36w	119	4	differentiation	differentiation	NN
cord-342372-2g9sq36w	119	5	between	between	IN
cord-342372-2g9sq36w	119	6	the	the	DT
cord-342372-2g9sq36w	119	7	incidental	incidental	JJ
cord-342372-2g9sq36w	119	8	detection	detection	NN
cord-342372-2g9sq36w	119	9	of	of	IN
cord-342372-2g9sq36w	119	10	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	119	11	in	in	IN
cord-342372-2g9sq36w	119	12	patients	patient	NNS
cord-342372-2g9sq36w	119	13	with	with	IN
cord-342372-2g9sq36w	119	14	KD	KD	NNP
cord-342372-2g9sq36w	119	15	and	and	CC
cord-342372-2g9sq36w	119	16	primary	primary	JJ
cord-342372-2g9sq36w	119	17	adenoviral	adenoviral	JJ
cord-342372-2g9sq36w	119	18	disease	disease	NN
cord-342372-2g9sq36w	119	19	is	be	VBZ
cord-342372-2g9sq36w	119	20	essential	essential	JJ
cord-342372-2g9sq36w	119	21	to	to	TO
cord-342372-2g9sq36w	119	22	avoid	avoid	VB
cord-342372-2g9sq36w	119	23	the	the	DT
cord-342372-2g9sq36w	119	24	subsequent	subsequent	JJ
cord-342372-2g9sq36w	119	25	mortality	mortality	NN
cord-342372-2g9sq36w	119	26	/	/	SYM
cord-342372-2g9sq36w	119	27	morbidity	morbidity	NN
cord-342372-2g9sq36w	119	28	associated	associate	VBN
cord-342372-2g9sq36w	119	29	with	with	IN
cord-342372-2g9sq36w	119	30	undiagnosed	undiagnosed	JJ
cord-342372-2g9sq36w	119	31	KD	kd	NN
cord-342372-2g9sq36w	119	32	.	.	.
cord-342372-2g9sq36w	120	1	Prolonged	prolonged	JJ
cord-342372-2g9sq36w	120	2	fever	fever	NN
cord-342372-2g9sq36w	120	3	and	and	CC
cord-342372-2g9sq36w	120	4	elevated	elevate	VBN
cord-342372-2g9sq36w	120	5	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	120	6	markers	marker	NNS
cord-342372-2g9sq36w	120	7	are	be	VBP
cord-342372-2g9sq36w	120	8	common	common	JJ
cord-342372-2g9sq36w	120	9	features	feature	NNS
cord-342372-2g9sq36w	120	10	of	of	IN
cord-342372-2g9sq36w	120	11	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	120	12	infection	infection	NN
cord-342372-2g9sq36w	120	13	and	and	CC
cord-342372-2g9sq36w	120	14	KD	KD	NNP
cord-342372-2g9sq36w	120	15	.	.	.
cord-342372-2g9sq36w	121	1	The	the	DT
cord-342372-2g9sq36w	121	2	most	most	RBS
cord-342372-2g9sq36w	121	3	commonly	commonly	RB
cord-342372-2g9sq36w	121	4	described	describe	VBN
cord-342372-2g9sq36w	121	5	clinical	clinical	JJ
cord-342372-2g9sq36w	121	6	feature	feature	NN
cord-342372-2g9sq36w	121	7	of	of	IN
cord-342372-2g9sq36w	121	8	KD	KD	NNP
cord-342372-2g9sq36w	121	9	compared	compare	VBN
cord-342372-2g9sq36w	121	10	to	to	IN
cord-342372-2g9sq36w	121	11	adenoviral	adenoviral	JJ
cord-342372-2g9sq36w	121	12	infection	infection	NN
cord-342372-2g9sq36w	121	13	reported	report	VBN
cord-342372-2g9sq36w	121	14	in	in	IN
cord-342372-2g9sq36w	121	15	a	a	DT
cord-342372-2g9sq36w	121	16	cohort	cohort	NN
cord-342372-2g9sq36w	121	17	study	study	NN
cord-342372-2g9sq36w	121	18	was	be	VBD
cord-342372-2g9sq36w	121	19	conjunctivitis	conjunctivitis	JJ
cord-342372-2g9sq36w	121	20	.	.	.
cord-342372-2g9sq36w	122	1	Features	feature	NNS
cord-342372-2g9sq36w	122	2	of	of	IN
cord-342372-2g9sq36w	122	3	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	122	4	conjunctivitis	conjunctivitis	NN
cord-342372-2g9sq36w	122	5	include	include	VBP
cord-342372-2g9sq36w	122	6	unilateral	unilateral	JJ
cord-342372-2g9sq36w	122	7	onset	onset	NN
cord-342372-2g9sq36w	122	8	,	,	,
cord-342372-2g9sq36w	122	9	prominence	prominence	NN
cord-342372-2g9sq36w	122	10	of	of	IN
cord-342372-2g9sq36w	122	11	tearing	tear	VBG
cord-342372-2g9sq36w	122	12	more	more	RBR
cord-342372-2g9sq36w	122	13	frequently	frequently	RB
cord-342372-2g9sq36w	122	14	than	than	IN
cord-342372-2g9sq36w	122	15	purulence	purulence	NN
cord-342372-2g9sq36w	122	16	,	,	,
cord-342372-2g9sq36w	122	17	and	and	CC
cord-342372-2g9sq36w	122	18	follicular	follicular	JJ
cord-342372-2g9sq36w	122	19	hyperplasia	hyperplasia	NN
cord-342372-2g9sq36w	122	20	.	.	.
cord-342372-2g9sq36w	123	1	Additionally	additionally	RB
cord-342372-2g9sq36w	123	2	,	,	,
cord-342372-2g9sq36w	123	3	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	123	4	often	often	RB
cord-342372-2g9sq36w	123	5	presents	present	VBZ
cord-342372-2g9sq36w	123	6	with	with	IN
cord-342372-2g9sq36w	123	7	pharyngoconjunctival	pharyngoconjunctival	NNP
cord-342372-2g9sq36w	123	8	fever	fever	NNP
cord-342372-2g9sq36w	123	9	,	,	,
cord-342372-2g9sq36w	123	10	characterized	characterize	VBN
cord-342372-2g9sq36w	123	11	by	by	IN
cord-342372-2g9sq36w	123	12	nonexudative	nonexudative	JJ
cord-342372-2g9sq36w	123	13	or	or	CC
cord-342372-2g9sq36w	123	14	exudative	exudative	JJ
cord-342372-2g9sq36w	123	15	pharyngitis	pharyngitis	NN
cord-342372-2g9sq36w	123	16	in	in	IN
cord-342372-2g9sq36w	123	17	addition	addition	NN
cord-342372-2g9sq36w	123	18	to	to	IN
cord-342372-2g9sq36w	123	19	conjunctivitis	conjunctivitis	NN
cord-342372-2g9sq36w	123	20	.	.	.
cord-342372-2g9sq36w	124	1	Extremity	extremity	NN
cord-342372-2g9sq36w	124	2	changes	change	NNS
cord-342372-2g9sq36w	124	3	and	and	CC
cord-342372-2g9sq36w	124	4	unilateral	unilateral	JJ
cord-342372-2g9sq36w	124	5	neck	neck	NN
cord-342372-2g9sq36w	124	6	swelling	swell	VBG
cord-342372-2g9sq36w	124	7	were	be	VBD
cord-342372-2g9sq36w	124	8	the	the	DT
cord-342372-2g9sq36w	124	9	least	least	JJS
cord-342372-2g9sq36w	124	10	common	common	JJ
cord-342372-2g9sq36w	124	11	clinical	clinical	JJ
cord-342372-2g9sq36w	124	12	features	feature	NNS
cord-342372-2g9sq36w	124	13	of	of	IN
cord-342372-2g9sq36w	124	14	KD	KD	NNP
cord-342372-2g9sq36w	124	15	seen	see	VBN
cord-342372-2g9sq36w	124	16	in	in	IN
cord-342372-2g9sq36w	124	17	patients	patient	NNS
cord-342372-2g9sq36w	124	18	with	with	IN
cord-342372-2g9sq36w	124	19	adenoviral	adenoviral	JJ
cord-342372-2g9sq36w	124	20	disease	disease	NN
cord-342372-2g9sq36w	124	21	[	[	-LRB-
cord-342372-2g9sq36w	124	22	21•	21•	CD
cord-342372-2g9sq36w	124	23	]	]	-RRB-
cord-342372-2g9sq36w	124	24	.	.	.
cord-342372-2g9sq36w	125	1	Node	node	NN
cord-342372-2g9sq36w	125	2	-	-	HYPH
cord-342372-2g9sq36w	125	3	first	first	JJ
cord-342372-2g9sq36w	125	4	presentation	presentation	NN
cord-342372-2g9sq36w	125	5	of	of	IN
cord-342372-2g9sq36w	125	6	KD	KD	NNP
cord-342372-2g9sq36w	125	7	(	(	-LRB-
cord-342372-2g9sq36w	125	8	NFKD	NFKD	NNP
cord-342372-2g9sq36w	125	9	)	)	-RRB-
cord-342372-2g9sq36w	125	10	is	be	VBZ
cord-342372-2g9sq36w	125	11	the	the	DT
cord-342372-2g9sq36w	125	12	manifestation	manifestation	NN
cord-342372-2g9sq36w	125	13	of	of	IN
cord-342372-2g9sq36w	125	14	KD	KD	NNP
cord-342372-2g9sq36w	125	15	with	with	IN
cord-342372-2g9sq36w	125	16	fever	fever	NN
cord-342372-2g9sq36w	125	17	and	and	CC
cord-342372-2g9sq36w	125	18	cervical	cervical	JJ
cord-342372-2g9sq36w	125	19	adenopathy	adenopathy	NN
cord-342372-2g9sq36w	125	20	prior	prior	RB
cord-342372-2g9sq36w	125	21	to	to	IN
cord-342372-2g9sq36w	125	22	the	the	DT
cord-342372-2g9sq36w	125	23	presentation	presentation	NN
cord-342372-2g9sq36w	125	24	of	of	IN
cord-342372-2g9sq36w	125	25	other	other	JJ
cord-342372-2g9sq36w	125	26	clinical	clinical	JJ
cord-342372-2g9sq36w	125	27	features	feature	NNS
cord-342372-2g9sq36w	125	28	of	of	IN
cord-342372-2g9sq36w	125	29	KD	KD	NNP
cord-342372-2g9sq36w	125	30	.	.	.
cord-342372-2g9sq36w	126	1	Compared	compare	VBN
cord-342372-2g9sq36w	126	2	to	to	IN
cord-342372-2g9sq36w	126	3	typical	typical	JJ
cord-342372-2g9sq36w	126	4	KD	KD	NNP
cord-342372-2g9sq36w	126	5	,	,	,
cord-342372-2g9sq36w	126	6	the	the	DT
cord-342372-2g9sq36w	126	7	patients	patient	NNS
cord-342372-2g9sq36w	126	8	of	of	IN
cord-342372-2g9sq36w	126	9	NFKD	NFKD	NNP
cord-342372-2g9sq36w	126	10	tend	tend	VBP
cord-342372-2g9sq36w	126	11	to	to	TO
cord-342372-2g9sq36w	126	12	be	be	VB
cord-342372-2g9sq36w	126	13	older	old	JJR
cord-342372-2g9sq36w	126	14	and	and	CC
cord-342372-2g9sq36w	126	15	have	have	VBP
cord-342372-2g9sq36w	126	16	higher	high	JJR
cord-342372-2g9sq36w	126	17	markers	marker	NNS
cord-342372-2g9sq36w	126	18	of	of	IN
cord-342372-2g9sq36w	126	19	inflammation	inflammation	NN
cord-342372-2g9sq36w	126	20	.	.	.
cord-342372-2g9sq36w	127	1	Node	node	NN
cord-342372-2g9sq36w	127	2	-	-	HYPH
cord-342372-2g9sq36w	127	3	first	first	JJ
cord-342372-2g9sq36w	127	4	presentation	presentation	NN
cord-342372-2g9sq36w	127	5	of	of	IN
cord-342372-2g9sq36w	127	6	KD	KD	NNP
cord-342372-2g9sq36w	127	7	may	may	MD
cord-342372-2g9sq36w	127	8	often	often	RB
cord-342372-2g9sq36w	127	9	be	be	VB
cord-342372-2g9sq36w	127	10	misdiagnosed	misdiagnose	VBN
cord-342372-2g9sq36w	127	11	as	as	IN
cord-342372-2g9sq36w	127	12	bacterial	bacterial	JJ
cord-342372-2g9sq36w	127	13	cervical	cervical	JJ
cord-342372-2g9sq36w	127	14	adenitis	adenitis	NN
cord-342372-2g9sq36w	127	15	as	as	IN
cord-342372-2g9sq36w	127	16	fever	fever	NN
cord-342372-2g9sq36w	127	17	and	and	CC
cord-342372-2g9sq36w	127	18	cervical	cervical	JJ
cord-342372-2g9sq36w	127	19	adenopathy	adenopathy	NN
cord-342372-2g9sq36w	127	20	are	be	VBP
cord-342372-2g9sq36w	127	21	characteristic	characteristic	JJ
cord-342372-2g9sq36w	127	22	clinical	clinical	JJ
cord-342372-2g9sq36w	127	23	findings	finding	NNS
cord-342372-2g9sq36w	127	24	in	in	IN
cord-342372-2g9sq36w	127	25	both	both	DT
cord-342372-2g9sq36w	127	26	diseases	disease	NNS
cord-342372-2g9sq36w	127	27	.	.	.
cord-342372-2g9sq36w	128	1	Laboratory	laboratory	NN
cord-342372-2g9sq36w	128	2	findings	finding	NNS
cord-342372-2g9sq36w	128	3	to	to	TO
cord-342372-2g9sq36w	128	4	aid	aid	VB
cord-342372-2g9sq36w	128	5	in	in	IN
cord-342372-2g9sq36w	128	6	differentiation	differentiation	NN
cord-342372-2g9sq36w	128	7	of	of	IN
cord-342372-2g9sq36w	128	8	these	these	DT
cord-342372-2g9sq36w	128	9	two	two	CD
cord-342372-2g9sq36w	128	10	entities	entity	NNS
cord-342372-2g9sq36w	128	11	include	include	VBP
cord-342372-2g9sq36w	128	12	lower	low	JJR
cord-342372-2g9sq36w	128	13	WBC	WBC	NNP
cord-342372-2g9sq36w	128	14	count	count	NN
cord-342372-2g9sq36w	128	15	,	,	,
cord-342372-2g9sq36w	128	16	hemoglobin	hemoglobin	NN
cord-342372-2g9sq36w	128	17	,	,	,
cord-342372-2g9sq36w	128	18	platelet	platelet	NN
cord-342372-2g9sq36w	128	19	counts	count	NNS
cord-342372-2g9sq36w	128	20	,	,	,
cord-342372-2g9sq36w	128	21	and	and	CC
cord-342372-2g9sq36w	128	22	higher	high	JJR
cord-342372-2g9sq36w	128	23	absolute	absolute	JJ
cord-342372-2g9sq36w	128	24	band	band	NN
cord-342372-2g9sq36w	128	25	count	count	NN
cord-342372-2g9sq36w	128	26	,	,	,
cord-342372-2g9sq36w	128	27	CRP	CRP	NNP
cord-342372-2g9sq36w	128	28	,	,	,
cord-342372-2g9sq36w	128	29	ESR	ESR	NNP
cord-342372-2g9sq36w	128	30	,	,	,
cord-342372-2g9sq36w	128	31	ALT	ALT	NNP
cord-342372-2g9sq36w	128	32	in	in	IN
cord-342372-2g9sq36w	128	33	NFKD	NFKD	NNP
cord-342372-2g9sq36w	128	34	.	.	.
cord-342372-2g9sq36w	129	1	Additionally	additionally	RB
cord-342372-2g9sq36w	129	2	,	,	,
cord-342372-2g9sq36w	129	3	radiographic	radiographic	JJ
cord-342372-2g9sq36w	129	4	findings	finding	NNS
cord-342372-2g9sq36w	129	5	in	in	IN
cord-342372-2g9sq36w	129	6	bacterial	bacterial	JJ
cord-342372-2g9sq36w	129	7	cervical	cervical	NN
cord-342372-2g9sq36w	129	8	adenitis	adenitis	NN
cord-342372-2g9sq36w	129	9	favor	favor	VBP
cord-342372-2g9sq36w	129	10	a	a	DT
cord-342372-2g9sq36w	129	11	single	single	JJ
cord-342372-2g9sq36w	129	12	dominant	dominant	JJ
cord-342372-2g9sq36w	129	13	node	node	NN
cord-342372-2g9sq36w	129	14	or	or	CC
cord-342372-2g9sq36w	129	15	conglomerations	conglomeration	NNS
cord-342372-2g9sq36w	129	16	and	and	CC
cord-342372-2g9sq36w	129	17	suppuration	suppuration	NN
cord-342372-2g9sq36w	129	18	of	of	IN
cord-342372-2g9sq36w	129	19	lymph	lymph	NN
cord-342372-2g9sq36w	129	20	nodes	node	NNS
cord-342372-2g9sq36w	129	21	.	.	.
cord-342372-2g9sq36w	130	1	Conversely	conversely	RB
cord-342372-2g9sq36w	130	2	,	,	,
cord-342372-2g9sq36w	130	3	radiographic	radiographic	JJ
cord-342372-2g9sq36w	130	4	findings	finding	NNS
cord-342372-2g9sq36w	130	5	in	in	IN
cord-342372-2g9sq36w	130	6	NFKD	NFKD	NNP
cord-342372-2g9sq36w	130	7	favor	favor	VBP
cord-342372-2g9sq36w	130	8	multiple	multiple	JJ
cord-342372-2g9sq36w	130	9	discrete	discrete	JJ
cord-342372-2g9sq36w	130	10	nodes	node	NNS
cord-342372-2g9sq36w	130	11	[	[	-LRB-
cord-342372-2g9sq36w	130	12	22•	22•	CD
cord-342372-2g9sq36w	130	13	]	]	-RRB-
cord-342372-2g9sq36w	130	14	.	.	.
cord-342372-2g9sq36w	131	1	Retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	131	2	edema	edema	NN
cord-342372-2g9sq36w	131	3	is	be	VBZ
cord-342372-2g9sq36w	131	4	a	a	DT
cord-342372-2g9sq36w	131	5	rare	rare	JJ
cord-342372-2g9sq36w	131	6	presentation	presentation	NN
cord-342372-2g9sq36w	131	7	of	of	IN
cord-342372-2g9sq36w	131	8	KD	KD	NNP
cord-342372-2g9sq36w	131	9	,	,	,
cord-342372-2g9sq36w	131	10	which	which	WDT
cord-342372-2g9sq36w	131	11	due	due	IN
cord-342372-2g9sq36w	131	12	to	to	IN
cord-342372-2g9sq36w	131	13	unfamiliarity	unfamiliarity	NN
cord-342372-2g9sq36w	131	14	with	with	IN
cord-342372-2g9sq36w	131	15	the	the	DT
cord-342372-2g9sq36w	131	16	presentation	presentation	NN
cord-342372-2g9sq36w	131	17	,	,	,
cord-342372-2g9sq36w	131	18	is	be	VBZ
cord-342372-2g9sq36w	131	19	often	often	RB
cord-342372-2g9sq36w	131	20	misdiagnosed	misdiagnose	VBN
cord-342372-2g9sq36w	131	21	as	as	IN
cord-342372-2g9sq36w	131	22	retropharyngeal	retropharyngeal	NN
cord-342372-2g9sq36w	131	23	abscess	abscess	NN
cord-342372-2g9sq36w	131	24	.	.	.
cord-342372-2g9sq36w	132	1	Many	many	JJ
cord-342372-2g9sq36w	132	2	of	of	IN
cord-342372-2g9sq36w	132	3	these	these	DT
cord-342372-2g9sq36w	132	4	patients	patient	NNS
cord-342372-2g9sq36w	132	5	have	have	VBP
cord-342372-2g9sq36w	132	6	underwent	undergo	VBN
cord-342372-2g9sq36w	132	7	pharyngeal	pharyngeal	JJ
cord-342372-2g9sq36w	132	8	needle	needle	NN
cord-342372-2g9sq36w	132	9	aspiration	aspiration	NN
cord-342372-2g9sq36w	132	10	and	and	CC
cord-342372-2g9sq36w	132	11	antibiotic	antibiotic	JJ
cord-342372-2g9sq36w	132	12	therapy	therapy	NN
cord-342372-2g9sq36w	132	13	due	due	IN
cord-342372-2g9sq36w	132	14	to	to	IN
cord-342372-2g9sq36w	132	15	misdiagnosis	misdiagnosis	NN
cord-342372-2g9sq36w	132	16	,	,	,
cord-342372-2g9sq36w	132	17	delaying	delay	VBG
cord-342372-2g9sq36w	132	18	treatment	treatment	NN
cord-342372-2g9sq36w	132	19	for	for	IN
cord-342372-2g9sq36w	132	20	KD	KD	NNP
cord-342372-2g9sq36w	132	21	and	and	CC
cord-342372-2g9sq36w	132	22	increasing	increase	VBG
cord-342372-2g9sq36w	132	23	the	the	DT
cord-342372-2g9sq36w	132	24	risk	risk	NN
cord-342372-2g9sq36w	132	25	of	of	IN
cord-342372-2g9sq36w	132	26	development	development	NN
cord-342372-2g9sq36w	132	27	of	of	IN
cord-342372-2g9sq36w	132	28	coronary	coronary	JJ
cord-342372-2g9sq36w	132	29	artery	artery	NN
cord-342372-2g9sq36w	132	30	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	132	31	[	[	-LRB-
cord-342372-2g9sq36w	132	32	23	23	CD
cord-342372-2g9sq36w	132	33	,	,	,
cord-342372-2g9sq36w	132	34	24	24	CD
cord-342372-2g9sq36w	132	35	]	]	-RRB-
cord-342372-2g9sq36w	132	36	.	.	.
cord-342372-2g9sq36w	133	1	The	the	DT
cord-342372-2g9sq36w	133	2	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	133	3	of	of	IN
cord-342372-2g9sq36w	133	4	KD	KD	NNP
cord-342372-2g9sq36w	133	5	with	with	IN
cord-342372-2g9sq36w	133	6	retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	133	7	edema	edema	NN
cord-342372-2g9sq36w	133	8	should	should	MD
cord-342372-2g9sq36w	133	9	be	be	VB
cord-342372-2g9sq36w	133	10	considered	consider	VBN
cord-342372-2g9sq36w	133	11	in	in	IN
cord-342372-2g9sq36w	133	12	patients	patient	NNS
cord-342372-2g9sq36w	133	13	diagnosed	diagnose	VBN
cord-342372-2g9sq36w	133	14	with	with	IN
cord-342372-2g9sq36w	133	15	retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	133	16	abscess	abscess	NN
cord-342372-2g9sq36w	133	17	subsequently	subsequently	RB
cord-342372-2g9sq36w	133	18	found	find	VBD
cord-342372-2g9sq36w	133	19	to	to	TO
cord-342372-2g9sq36w	133	20	have	have	VB
cord-342372-2g9sq36w	133	21	sterile	sterile	JJ
cord-342372-2g9sq36w	133	22	culture	culture	NN
cord-342372-2g9sq36w	133	23	results	result	NNS
cord-342372-2g9sq36w	133	24	from	from	IN
cord-342372-2g9sq36w	133	25	surgical	surgical	JJ
cord-342372-2g9sq36w	133	26	drainage	drainage	NN
cord-342372-2g9sq36w	133	27	.	.	.
cord-342372-2g9sq36w	134	1	There	there	EX
cord-342372-2g9sq36w	134	2	were	be	VBD
cord-342372-2g9sq36w	134	3	no	no	DT
cord-342372-2g9sq36w	134	4	significant	significant	JJ
cord-342372-2g9sq36w	134	5	differences	difference	NNS
cord-342372-2g9sq36w	134	6	in	in	IN
cord-342372-2g9sq36w	134	7	laboratory	laboratory	NN
cord-342372-2g9sq36w	134	8	findings	finding	NNS
cord-342372-2g9sq36w	134	9	between	between	IN
cord-342372-2g9sq36w	134	10	these	these	DT
cord-342372-2g9sq36w	134	11	two	two	CD
cord-342372-2g9sq36w	134	12	entities	entity	NNS
cord-342372-2g9sq36w	134	13	.	.	.
cord-342372-2g9sq36w	135	1	Clinical	clinical	JJ
cord-342372-2g9sq36w	135	2	symptoms	symptom	NNS
cord-342372-2g9sq36w	135	3	classically	classically	RB
cord-342372-2g9sq36w	135	4	associated	associate	VBN
cord-342372-2g9sq36w	135	5	with	with	IN
cord-342372-2g9sq36w	135	6	retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	135	7	abscess	abscess	NN
cord-342372-2g9sq36w	135	8	such	such	JJ
cord-342372-2g9sq36w	135	9	as	as	IN
cord-342372-2g9sq36w	135	10	stridor	stridor	NNP
cord-342372-2g9sq36w	135	11	,	,	,
cord-342372-2g9sq36w	135	12	neck	neck	NN
cord-342372-2g9sq36w	135	13	pain	pain	NN
cord-342372-2g9sq36w	135	14	,	,	,
cord-342372-2g9sq36w	135	15	and	and	CC
cord-342372-2g9sq36w	135	16	dysphagia	dysphagia	NN
cord-342372-2g9sq36w	135	17	are	be	VBP
cord-342372-2g9sq36w	135	18	less	less	RBR
cord-342372-2g9sq36w	135	19	common	common	JJ
cord-342372-2g9sq36w	135	20	in	in	IN
cord-342372-2g9sq36w	135	21	the	the	DT
cord-342372-2g9sq36w	135	22	retropharyngeal	retropharyngeal	NN
cord-342372-2g9sq36w	135	23	edema	edema	NN
cord-342372-2g9sq36w	135	24	of	of	IN
cord-342372-2g9sq36w	135	25	KD	KD	NNP
cord-342372-2g9sq36w	135	26	.	.	.
cord-342372-2g9sq36w	136	1	Radiological	radiological	JJ
cord-342372-2g9sq36w	136	2	findings	finding	NNS
cord-342372-2g9sq36w	136	3	of	of	IN
cord-342372-2g9sq36w	136	4	ring	ring	NN
cord-342372-2g9sq36w	136	5	enhancement	enhancement	NN
cord-342372-2g9sq36w	136	6	and	and	CC
cord-342372-2g9sq36w	136	7	mass	mass	NN
cord-342372-2g9sq36w	136	8	effect	effect	NN
cord-342372-2g9sq36w	136	9	on	on	IN
cord-342372-2g9sq36w	136	10	neck	neck	NN
cord-342372-2g9sq36w	136	11	CT	CT	NNP
cord-342372-2g9sq36w	136	12	were	be	VBD
cord-342372-2g9sq36w	136	13	more	more	RBR
cord-342372-2g9sq36w	136	14	commonly	commonly	RB
cord-342372-2g9sq36w	136	15	found	find	VBN
cord-342372-2g9sq36w	136	16	in	in	IN
cord-342372-2g9sq36w	136	17	patients	patient	NNS
cord-342372-2g9sq36w	136	18	with	with	IN
cord-342372-2g9sq36w	136	19	retropharyngeal	retropharyngeal	NN
cord-342372-2g9sq36w	136	20	abscess	abscess	NN
cord-342372-2g9sq36w	136	21	[	[	-LRB-
cord-342372-2g9sq36w	136	22	25•	25•	CD
cord-342372-2g9sq36w	136	23	]	]	-RRB-
cord-342372-2g9sq36w	136	24	.	.	.
cord-342372-2g9sq36w	137	1	Systemic	systemic	JJ
cord-342372-2g9sq36w	137	2	onset	onset	NN
cord-342372-2g9sq36w	137	3	juvenile	juvenile	JJ
cord-342372-2g9sq36w	137	4	idiopathic	idiopathic	JJ
cord-342372-2g9sq36w	137	5	arthritis	arthritis	NN
cord-342372-2g9sq36w	137	6	(	(	-LRB-
cord-342372-2g9sq36w	137	7	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	137	8	)	)	-RRB-
cord-342372-2g9sq36w	137	9	is	be	VBZ
cord-342372-2g9sq36w	137	10	an	an	DT
cord-342372-2g9sq36w	137	11	autoimmune	autoimmune	JJ
cord-342372-2g9sq36w	137	12	disease	disease	NN
cord-342372-2g9sq36w	137	13	characterized	characterize	VBN
cord-342372-2g9sq36w	137	14	by	by	IN
cord-342372-2g9sq36w	137	15	severe	severe	JJ
cord-342372-2g9sq36w	137	16	inflammation	inflammation	NN
cord-342372-2g9sq36w	137	17	of	of	IN
cord-342372-2g9sq36w	137	18	multiple	multiple	JJ
cord-342372-2g9sq36w	137	19	organ	organ	NN
cord-342372-2g9sq36w	137	20	systems	system	NNS
cord-342372-2g9sq36w	137	21	.	.	.
cord-342372-2g9sq36w	138	1	The	the	DT
cord-342372-2g9sq36w	138	2	clinical	clinical	JJ
cord-342372-2g9sq36w	138	3	features	feature	NNS
cord-342372-2g9sq36w	138	4	of	of	IN
cord-342372-2g9sq36w	138	5	early	early	JJ
cord-342372-2g9sq36w	138	6	stage	stage	NN
cord-342372-2g9sq36w	138	7	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	139	1	(	(	-LRB-
cord-342372-2g9sq36w	139	2	fever	fever	NN
cord-342372-2g9sq36w	139	3	,	,	,
cord-342372-2g9sq36w	139	4	rash	rash	JJ
cord-342372-2g9sq36w	139	5	,	,	,
cord-342372-2g9sq36w	139	6	thrombocytosis	thrombocytosis	NNP
cord-342372-2g9sq36w	139	7	,	,	,
cord-342372-2g9sq36w	139	8	increased	increase	VBN
cord-342372-2g9sq36w	139	9	markers	marker	NNS
cord-342372-2g9sq36w	139	10	of	of	IN
cord-342372-2g9sq36w	139	11	inflammation	inflammation	NN
cord-342372-2g9sq36w	139	12	,	,	,
cord-342372-2g9sq36w	139	13	and	and	CC
cord-342372-2g9sq36w	139	14	arthritis	arthritis	NN
cord-342372-2g9sq36w	139	15	)	)	-RRB-
cord-342372-2g9sq36w	139	16	may	may	MD
cord-342372-2g9sq36w	139	17	resemble	resemble	VB
cord-342372-2g9sq36w	139	18	KD	KD	NNP
cord-342372-2g9sq36w	139	19	.	.	.
cord-342372-2g9sq36w	140	1	Coronary	coronary	JJ
cord-342372-2g9sq36w	140	2	artery	artery	NN
cord-342372-2g9sq36w	140	3	dilation	dilation	NN
cord-342372-2g9sq36w	140	4	can	can	MD
cord-342372-2g9sq36w	140	5	be	be	VB
cord-342372-2g9sq36w	140	6	present	present	JJ
cord-342372-2g9sq36w	140	7	in	in	IN
cord-342372-2g9sq36w	140	8	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	140	9	,	,	,
cord-342372-2g9sq36w	140	10	but	but	CC
cord-342372-2g9sq36w	140	11	is	be	VBZ
cord-342372-2g9sq36w	140	12	less	less	RBR
cord-342372-2g9sq36w	140	13	common	common	JJ
cord-342372-2g9sq36w	140	14	.	.	.
cord-342372-2g9sq36w	141	1	Arthritis	arthritis	NN
cord-342372-2g9sq36w	141	2	is	be	VBZ
cord-342372-2g9sq36w	141	3	a	a	DT
cord-342372-2g9sq36w	141	4	feature	feature	NN
cord-342372-2g9sq36w	141	5	that	that	WDT
cord-342372-2g9sq36w	141	6	may	may	MD
cord-342372-2g9sq36w	141	7	be	be	VB
cord-342372-2g9sq36w	141	8	present	present	JJ
cord-342372-2g9sq36w	141	9	in	in	IN
cord-342372-2g9sq36w	141	10	both	both	DT
cord-342372-2g9sq36w	141	11	KD	KD	NNP
cord-342372-2g9sq36w	141	12	and	and	CC
cord-342372-2g9sq36w	141	13	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	141	14	.	.	.
cord-342372-2g9sq36w	142	1	It	-PRON-	PRP
cord-342372-2g9sq36w	142	2	is	be	VBZ
cord-342372-2g9sq36w	142	3	generally	generally	RB
cord-342372-2g9sq36w	142	4	mild	mild	JJ
cord-342372-2g9sq36w	142	5	and	and	CC
cord-342372-2g9sq36w	142	6	self	self	NN
cord-342372-2g9sq36w	142	7	-	-	HYPH
cord-342372-2g9sq36w	142	8	limited	limit	VBN
cord-342372-2g9sq36w	142	9	in	in	IN
cord-342372-2g9sq36w	142	10	KD	KD	NNP
cord-342372-2g9sq36w	142	11	,	,	,
cord-342372-2g9sq36w	142	12	as	as	IN
cord-342372-2g9sq36w	142	13	compared	compare	VBN
cord-342372-2g9sq36w	142	14	to	to	IN
cord-342372-2g9sq36w	142	15	the	the	DT
cord-342372-2g9sq36w	142	16	persistent	persistent	JJ
cord-342372-2g9sq36w	142	17	and	and	CC
cord-342372-2g9sq36w	142	18	severe	severe	JJ
cord-342372-2g9sq36w	142	19	arthritis	arthritis	NN
cord-342372-2g9sq36w	142	20	of	of	IN
cord-342372-2g9sq36w	142	21	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	142	22	which	which	WDT
cord-342372-2g9sq36w	142	23	often	often	RB
cord-342372-2g9sq36w	142	24	requires	require	VBZ
cord-342372-2g9sq36w	142	25	treatment	treatment	NN
cord-342372-2g9sq36w	142	26	with	with	IN
cord-342372-2g9sq36w	142	27	immunosuppressive	immunosuppressive	JJ
cord-342372-2g9sq36w	142	28	agents	agent	NNS
cord-342372-2g9sq36w	142	29	for	for	IN
cord-342372-2g9sq36w	142	30	resolution	resolution	NN
cord-342372-2g9sq36w	142	31	[	[	-LRB-
cord-342372-2g9sq36w	142	32	26	26	CD
cord-342372-2g9sq36w	142	33	]	]	-RRB-
cord-342372-2g9sq36w	142	34	.	.	.
cord-342372-2g9sq36w	143	1	The	the	DT
cord-342372-2g9sq36w	143	2	rash	rash	NN
cord-342372-2g9sq36w	143	3	of	of	IN
cord-342372-2g9sq36w	143	4	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	143	5	is	be	VBZ
cord-342372-2g9sq36w	143	6	typically	typically	RB
cord-342372-2g9sq36w	143	7	intermittent	intermittent	JJ
cord-342372-2g9sq36w	143	8	and	and	CC
cord-342372-2g9sq36w	143	9	coincides	coincide	VBZ
cord-342372-2g9sq36w	143	10	with	with	IN
cord-342372-2g9sq36w	143	11	fever	fever	NN
cord-342372-2g9sq36w	143	12	spikes	spike	NNS
cord-342372-2g9sq36w	143	13	as	as	IN
cord-342372-2g9sq36w	143	14	compared	compare	VBN
cord-342372-2g9sq36w	143	15	to	to	IN
cord-342372-2g9sq36w	143	16	the	the	DT
cord-342372-2g9sq36w	143	17	fixed	fix	VBN
cord-342372-2g9sq36w	143	18	rash	rash	NN
cord-342372-2g9sq36w	143	19	of	of	IN
cord-342372-2g9sq36w	143	20	KD	KD	NNP
cord-342372-2g9sq36w	143	21	.	.	.
cord-342372-2g9sq36w	144	1	The	the	DT
cord-342372-2g9sq36w	144	2	presence	presence	NN
cord-342372-2g9sq36w	144	3	of	of	IN
cord-342372-2g9sq36w	144	4	mucocutaneous	mucocutaneous	JJ
cord-342372-2g9sq36w	144	5	findings	finding	NNS
cord-342372-2g9sq36w	144	6	suggests	suggest	VBZ
cord-342372-2g9sq36w	144	7	KD	KD	NNP
cord-342372-2g9sq36w	144	8	as	as	IN
cord-342372-2g9sq36w	144	9	this	this	DT
cord-342372-2g9sq36w	144	10	finding	finding	NN
cord-342372-2g9sq36w	144	11	is	be	VBZ
cord-342372-2g9sq36w	144	12	absent	absent	JJ
cord-342372-2g9sq36w	144	13	in	in	IN
cord-342372-2g9sq36w	144	14	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	144	15	.	.	.
cord-342372-2g9sq36w	145	1	Additionally	additionally	RB
cord-342372-2g9sq36w	145	2	,	,	,
cord-342372-2g9sq36w	145	3	thrombocytosis	thrombocytosis	NNP
cord-342372-2g9sq36w	145	4	is	be	VBZ
cord-342372-2g9sq36w	145	5	typically	typically	RB
cord-342372-2g9sq36w	145	6	a	a	DT
cord-342372-2g9sq36w	145	7	late	late	JJ
cord-342372-2g9sq36w	145	8	finding	finding	NN
cord-342372-2g9sq36w	145	9	of	of	IN
cord-342372-2g9sq36w	145	10	KD	KD	NNP
cord-342372-2g9sq36w	145	11	(	(	-LRB-
cord-342372-2g9sq36w	145	12	occurring	occur	VBG
cord-342372-2g9sq36w	145	13	in	in	IN
cord-342372-2g9sq36w	145	14	the	the	DT
cord-342372-2g9sq36w	145	15	second	second	JJ
cord-342372-2g9sq36w	145	16	week	week	NN
cord-342372-2g9sq36w	145	17	of	of	IN
cord-342372-2g9sq36w	145	18	disease	disease	NN
cord-342372-2g9sq36w	145	19	)	)	-RRB-
cord-342372-2g9sq36w	145	20	as	as	IN
cord-342372-2g9sq36w	145	21	compared	compare	VBN
cord-342372-2g9sq36w	145	22	to	to	IN
cord-342372-2g9sq36w	145	23	the	the	DT
cord-342372-2g9sq36w	145	24	early	early	JJ
cord-342372-2g9sq36w	145	25	stages	stage	NNS
cord-342372-2g9sq36w	145	26	of	of	IN
cord-342372-2g9sq36w	145	27	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	145	28	.	.	.
cord-342372-2g9sq36w	146	1	As	as	IN
cord-342372-2g9sq36w	146	2	IVIG	IVIG	NNP
cord-342372-2g9sq36w	146	3	is	be	VBZ
cord-342372-2g9sq36w	146	4	an	an	DT
cord-342372-2g9sq36w	146	5	adjunctive	adjunctive	NN
cord-342372-2g9sq36w	146	6	rather	rather	RB
cord-342372-2g9sq36w	146	7	than	than	IN
cord-342372-2g9sq36w	146	8	primary	primary	JJ
cord-342372-2g9sq36w	146	9	modality	modality	NN
cord-342372-2g9sq36w	146	10	of	of	IN
cord-342372-2g9sq36w	146	11	therapy	therapy	NN
cord-342372-2g9sq36w	146	12	for	for	IN
cord-342372-2g9sq36w	146	13	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	146	14	,	,	,
cord-342372-2g9sq36w	146	15	the	the	DT
cord-342372-2g9sq36w	146	16	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	146	17	of	of	IN
cord-342372-2g9sq36w	146	18	SoJIA	SoJIA	NNP
cord-342372-2g9sq36w	146	19	should	should	MD
cord-342372-2g9sq36w	146	20	be	be	VB
cord-342372-2g9sq36w	146	21	considered	consider	VBN
cord-342372-2g9sq36w	146	22	in	in	IN
cord-342372-2g9sq36w	146	23	patients	patient	NNS
cord-342372-2g9sq36w	146	24	with	with	IN
cord-342372-2g9sq36w	146	25	KD	KD	NNP
cord-342372-2g9sq36w	146	26	which	which	WDT
cord-342372-2g9sq36w	146	27	do	do	VBP
cord-342372-2g9sq36w	146	28	not	not	RB
cord-342372-2g9sq36w	146	29	respond	respond	VB
cord-342372-2g9sq36w	146	30	to	to	IN
cord-342372-2g9sq36w	146	31	multiple	multiple	JJ
cord-342372-2g9sq36w	146	32	IVIG	IVIG	NNP
cord-342372-2g9sq36w	146	33	infusions	infusion	NNS
cord-342372-2g9sq36w	146	34	[	[	-LRB-
cord-342372-2g9sq36w	146	35	27	27	CD
cord-342372-2g9sq36w	146	36	]	]	-RRB-
cord-342372-2g9sq36w	146	37	.	.	.
cord-342372-2g9sq36w	147	1	Toxic	toxic	JJ
cord-342372-2g9sq36w	147	2	shock	shock	NN
cord-342372-2g9sq36w	147	3	syndrome	syndrome	NN
cord-342372-2g9sq36w	147	4	(	(	-LRB-
cord-342372-2g9sq36w	147	5	TSS	TSS	NNP
cord-342372-2g9sq36w	147	6	)	)	-RRB-
cord-342372-2g9sq36w	147	7	is	be	VBZ
cord-342372-2g9sq36w	147	8	a	a	DT
cord-342372-2g9sq36w	147	9	toxin	toxin	NN
cord-342372-2g9sq36w	147	10	-	-	HYPH
cord-342372-2g9sq36w	147	11	mediated	mediate	VBN
cord-342372-2g9sq36w	147	12	disease	disease	NN
cord-342372-2g9sq36w	147	13	which	which	WDT
cord-342372-2g9sq36w	147	14	presents	present	VBZ
cord-342372-2g9sq36w	147	15	with	with	IN
cord-342372-2g9sq36w	147	16	clinical	clinical	JJ
cord-342372-2g9sq36w	147	17	features	feature	NNS
cord-342372-2g9sq36w	147	18	of	of	IN
cord-342372-2g9sq36w	147	19	fever	fever	NN
cord-342372-2g9sq36w	147	20	,	,	,
cord-342372-2g9sq36w	147	21	hypotension	hypotension	NN
cord-342372-2g9sq36w	147	22	,	,	,
cord-342372-2g9sq36w	147	23	rash	rash	JJ
cord-342372-2g9sq36w	147	24	,	,	,
cord-342372-2g9sq36w	147	25	and	and	CC
cord-342372-2g9sq36w	147	26	subsequent	subsequent	JJ
cord-342372-2g9sq36w	147	27	desquamation	desquamation	NN
cord-342372-2g9sq36w	147	28	of	of	IN
cord-342372-2g9sq36w	147	29	the	the	DT
cord-342372-2g9sq36w	147	30	skin	skin	NN
cord-342372-2g9sq36w	147	31	with	with	IN
cord-342372-2g9sq36w	147	32	multi	multi	JJ
cord-342372-2g9sq36w	147	33	-	-	JJ
cord-342372-2g9sq36w	147	34	organ	organ	JJ
cord-342372-2g9sq36w	147	35	involvement	involvement	NN
cord-342372-2g9sq36w	147	36	and	and	CC
cord-342372-2g9sq36w	147	37	may	may	MD
cord-342372-2g9sq36w	147	38	be	be	VB
cord-342372-2g9sq36w	147	39	confused	confuse	VBN
cord-342372-2g9sq36w	147	40	with	with	IN
cord-342372-2g9sq36w	147	41	KD	KD	NNP
cord-342372-2g9sq36w	147	42	.	.	.
cord-342372-2g9sq36w	148	1	The	the	DT
cord-342372-2g9sq36w	148	2	most	most	RBS
cord-342372-2g9sq36w	148	3	common	common	JJ
cord-342372-2g9sq36w	148	4	causative	causative	JJ
cord-342372-2g9sq36w	148	5	organism	organism	NN
cord-342372-2g9sq36w	148	6	is	be	VBZ
cord-342372-2g9sq36w	148	7	S.	S.	NNP
cord-342372-2g9sq36w	148	8	aureus	aureus	NN
cord-342372-2g9sq36w	148	9	.	.	.
cord-342372-2g9sq36w	149	1	The	the	DT
cord-342372-2g9sq36w	149	2	condition	condition	NN
cord-342372-2g9sq36w	149	3	has	have	VBZ
cord-342372-2g9sq36w	149	4	been	be	VBN
cord-342372-2g9sq36w	149	5	misdiagnosed	misdiagnose	VBN
cord-342372-2g9sq36w	149	6	as	as	IN
cord-342372-2g9sq36w	149	7	KD	KD	NNP
cord-342372-2g9sq36w	149	8	due	due	IN
cord-342372-2g9sq36w	149	9	to	to	IN
cord-342372-2g9sq36w	149	10	similar	similar	JJ
cord-342372-2g9sq36w	149	11	clinical	clinical	JJ
cord-342372-2g9sq36w	149	12	features	feature	NNS
cord-342372-2g9sq36w	149	13	of	of	IN
cord-342372-2g9sq36w	149	14	rash	rash	NN
cord-342372-2g9sq36w	149	15	and	and	CC
cord-342372-2g9sq36w	149	16	fever	fever	NN
cord-342372-2g9sq36w	149	17	.	.	.
cord-342372-2g9sq36w	150	1	The	the	DT
cord-342372-2g9sq36w	150	2	hypotension	hypotension	NN
cord-342372-2g9sq36w	150	3	of	of	IN
cord-342372-2g9sq36w	150	4	TSS	TSS	NNP
cord-342372-2g9sq36w	150	5	can	can	MD
cord-342372-2g9sq36w	150	6	be	be	VB
cord-342372-2g9sq36w	150	7	misattributed	misattribute	VBN
cord-342372-2g9sq36w	150	8	to	to	IN
cord-342372-2g9sq36w	150	9	the	the	DT
cord-342372-2g9sq36w	150	10	shock	shock	NN
cord-342372-2g9sq36w	150	11	associated	associate	VBN
cord-342372-2g9sq36w	150	12	with	with	IN
cord-342372-2g9sq36w	150	13	KD	KD	NNP
cord-342372-2g9sq36w	150	14	.	.	.
cord-342372-2g9sq36w	151	1	Patients	patient	NNS
cord-342372-2g9sq36w	151	2	presenting	present	VBG
cord-342372-2g9sq36w	151	3	with	with	IN
cord-342372-2g9sq36w	151	4	TSS	TSS	NNP
cord-342372-2g9sq36w	151	5	are	be	VBP
cord-342372-2g9sq36w	151	6	on	on	IN
cord-342372-2g9sq36w	151	7	average	average	JJ
cord-342372-2g9sq36w	151	8	older	old	JJR
cord-342372-2g9sq36w	151	9	(	(	-LRB-
cord-342372-2g9sq36w	151	10	mean	mean	VB
cord-342372-2g9sq36w	151	11	age	age	NN
cord-342372-2g9sq36w	151	12	113	113	CD
cord-342372-2g9sq36w	151	13	±	±	CD
cord-342372-2g9sq36w	151	14	56	56	CD
cord-342372-2g9sq36w	151	15	months	month	NNS
cord-342372-2g9sq36w	151	16	)	)	-RRB-
cord-342372-2g9sq36w	151	17	than	than	IN
cord-342372-2g9sq36w	151	18	patients	patient	NNS
cord-342372-2g9sq36w	151	19	with	with	IN
cord-342372-2g9sq36w	151	20	KD	KD	NNP
cord-342372-2g9sq36w	151	21	(	(	-LRB-
cord-342372-2g9sq36w	151	22	37	37	CD
cord-342372-2g9sq36w	151	23	±	±	CD
cord-342372-2g9sq36w	151	24	41	41	CD
cord-342372-2g9sq36w	151	25	months	month	NNS
cord-342372-2g9sq36w	151	26	)	)	-RRB-
cord-342372-2g9sq36w	151	27	[	[	-LRB-
cord-342372-2g9sq36w	151	28	28•	28•	CD
cord-342372-2g9sq36w	151	29	]	]	-RRB-
cord-342372-2g9sq36w	151	30	.	.	.
cord-342372-2g9sq36w	152	1	Other	other	JJ
cord-342372-2g9sq36w	152	2	features	feature	NNS
cord-342372-2g9sq36w	152	3	suggestive	suggestive	JJ
cord-342372-2g9sq36w	152	4	of	of	IN
cord-342372-2g9sq36w	152	5	TSS	TSS	NNP
cord-342372-2g9sq36w	152	6	include	include	VBP
cord-342372-2g9sq36w	152	7	elevated	elevated	JJ
cord-342372-2g9sq36w	152	8	creatinine	creatinine	NN
cord-342372-2g9sq36w	152	9	and	and	CC
cord-342372-2g9sq36w	152	10	labile	labile	JJ
cord-342372-2g9sq36w	152	11	blood	blood	NN
cord-342372-2g9sq36w	152	12	pressures	pressure	NNS
cord-342372-2g9sq36w	152	13	requiring	require	VBG
cord-342372-2g9sq36w	152	14	higher	high	JJR
cord-342372-2g9sq36w	152	15	vasopressor	vasopressor	NN
cord-342372-2g9sq36w	152	16	support	support	NN
cord-342372-2g9sq36w	152	17	and	and	CC
cord-342372-2g9sq36w	152	18	increased	increase	VBN
cord-342372-2g9sq36w	152	19	fluid	fluid	JJ
cord-342372-2g9sq36w	152	20	resuscitation	resuscitation	NN
cord-342372-2g9sq36w	152	21	.	.	.
cord-342372-2g9sq36w	153	1	Features	feature	NNS
cord-342372-2g9sq36w	153	2	suggestive	suggestive	JJ
cord-342372-2g9sq36w	153	3	of	of	IN
cord-342372-2g9sq36w	153	4	KD	KD	NNP
cord-342372-2g9sq36w	153	5	include	include	VBP
cord-342372-2g9sq36w	153	6	anemia	anemia	NN
cord-342372-2g9sq36w	153	7	,	,	,
cord-342372-2g9sq36w	153	8	thrombocytosis	thrombocytosis	NN
cord-342372-2g9sq36w	153	9	,	,	,
cord-342372-2g9sq36w	153	10	and	and	CC
cord-342372-2g9sq36w	153	11	cardiac	cardiac	JJ
cord-342372-2g9sq36w	153	12	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	153	13	[	[	-LRB-
cord-342372-2g9sq36w	153	14	29	29	CD
cord-342372-2g9sq36w	153	15	]	]	-RRB-
cord-342372-2g9sq36w	153	16	[	[	-LRB-
cord-342372-2g9sq36w	153	17	30	30	CD
cord-342372-2g9sq36w	153	18	]	]	-RRB-
cord-342372-2g9sq36w	153	19	[	[	-LRB-
cord-342372-2g9sq36w	153	20	31	31	CD
cord-342372-2g9sq36w	153	21	]	]	-RRB-
cord-342372-2g9sq36w	153	22	.	.	.
cord-342372-2g9sq36w	154	1	The	the	DT
cord-342372-2g9sq36w	154	2	use	use	NN
cord-342372-2g9sq36w	154	3	of	of	IN
cord-342372-2g9sq36w	154	4	intravenous	intravenous	JJ
cord-342372-2g9sq36w	154	5	immune	immune	JJ
cord-342372-2g9sq36w	154	6	globulin	globulin	NN
cord-342372-2g9sq36w	154	7	(	(	-LRB-
cord-342372-2g9sq36w	154	8	IVIG	IVIG	NNP
cord-342372-2g9sq36w	154	9	)	)	-RRB-
cord-342372-2g9sq36w	154	10	in	in	IN
cord-342372-2g9sq36w	154	11	the	the	DT
cord-342372-2g9sq36w	154	12	acute	acute	JJ
cord-342372-2g9sq36w	154	13	phase	phase	NN
cord-342372-2g9sq36w	154	14	of	of	IN
cord-342372-2g9sq36w	154	15	KD	KD	NNP
cord-342372-2g9sq36w	154	16	to	to	TO
cord-342372-2g9sq36w	154	17	prevent	prevent	VB
cord-342372-2g9sq36w	154	18	the	the	DT
cord-342372-2g9sq36w	154	19	development	development	NN
cord-342372-2g9sq36w	154	20	of	of	IN
cord-342372-2g9sq36w	154	21	coronary	coronary	JJ
cord-342372-2g9sq36w	154	22	artery	artery	NN
cord-342372-2g9sq36w	154	23	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	154	24	is	be	VBZ
cord-342372-2g9sq36w	154	25	well	well	RB
cord-342372-2g9sq36w	154	26	defined	define	VBN
cord-342372-2g9sq36w	154	27	[	[	-LRB-
cord-342372-2g9sq36w	154	28	4	4	CD
cord-342372-2g9sq36w	154	29	,	,	,
cord-342372-2g9sq36w	154	30	32	32	CD
cord-342372-2g9sq36w	154	31	,	,	,
cord-342372-2g9sq36w	154	32	33	33	CD
cord-342372-2g9sq36w	154	33	]	]	-RRB-
cord-342372-2g9sq36w	154	34	.	.	.
cord-342372-2g9sq36w	155	1	Treatment	treatment	NN
cord-342372-2g9sq36w	155	2	with	with	IN
cord-342372-2g9sq36w	155	3	IVIG	IVIG	NNP
cord-342372-2g9sq36w	155	4	within	within	IN
cord-342372-2g9sq36w	155	5	the	the	DT
cord-342372-2g9sq36w	155	6	first	first	JJ
cord-342372-2g9sq36w	155	7	10	10	CD
cord-342372-2g9sq36w	155	8	days	day	NNS
cord-342372-2g9sq36w	155	9	of	of	IN
cord-342372-2g9sq36w	155	10	illness	illness	NN
cord-342372-2g9sq36w	155	11	reduces	reduce	VBZ
cord-342372-2g9sq36w	155	12	the	the	DT
cord-342372-2g9sq36w	155	13	risk	risk	NN
cord-342372-2g9sq36w	155	14	of	of	IN
cord-342372-2g9sq36w	155	15	development	development	NN
cord-342372-2g9sq36w	155	16	of	of	IN
cord-342372-2g9sq36w	155	17	coronary	coronary	JJ
cord-342372-2g9sq36w	155	18	artery	artery	NN
cord-342372-2g9sq36w	155	19	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	155	20	to	to	IN
cord-342372-2g9sq36w	155	21	approximately	approximately	RB
cord-342372-2g9sq36w	155	22	5	5	CD
cord-342372-2g9sq36w	155	23	%	%	NN
cord-342372-2g9sq36w	155	24	from	from	IN
cord-342372-2g9sq36w	155	25	25	25	CD
cord-342372-2g9sq36w	155	26	%	%	NN
cord-342372-2g9sq36w	155	27	[	[	-LRB-
cord-342372-2g9sq36w	155	28	32	32	CD
cord-342372-2g9sq36w	155	29	]	]	-RRB-
cord-342372-2g9sq36w	155	30	.	.	.
cord-342372-2g9sq36w	156	1	The	the	DT
cord-342372-2g9sq36w	156	2	mechanism	mechanism	NN
cord-342372-2g9sq36w	156	3	of	of	IN
cord-342372-2g9sq36w	156	4	action	action	NN
cord-342372-2g9sq36w	156	5	remains	remain	VBZ
cord-342372-2g9sq36w	156	6	unknown	unknown	JJ
cord-342372-2g9sq36w	156	7	,	,	,
cord-342372-2g9sq36w	156	8	but	but	CC
cord-342372-2g9sq36w	156	9	the	the	DT
cord-342372-2g9sq36w	156	10	generalized	generalized	JJ
cord-342372-2g9sq36w	156	11	anti	anti	JJ
cord-342372-2g9sq36w	156	12	-	-	JJ
cord-342372-2g9sq36w	156	13	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	156	14	effect	effect	NN
cord-342372-2g9sq36w	156	15	of	of	IN
cord-342372-2g9sq36w	156	16	IVIG	IVIG	NNP
cord-342372-2g9sq36w	156	17	likely	likely	RB
cord-342372-2g9sq36w	156	18	inhibits	inhibit	VBZ
cord-342372-2g9sq36w	156	19	progression	progression	NN
cord-342372-2g9sq36w	156	20	of	of	IN
cord-342372-2g9sq36w	156	21	KD	KD	NNP
cord-342372-2g9sq36w	156	22	,	,	,
cord-342372-2g9sq36w	156	23	ultimately	ultimately	RB
cord-342372-2g9sq36w	156	24	preventing	prevent	VBG
cord-342372-2g9sq36w	156	25	the	the	DT
cord-342372-2g9sq36w	156	26	development	development	NN
cord-342372-2g9sq36w	156	27	of	of	IN
cord-342372-2g9sq36w	156	28	coronary	coronary	JJ
cord-342372-2g9sq36w	156	29	artery	artery	NN
cord-342372-2g9sq36w	156	30	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	156	31	.	.	.
cord-342372-2g9sq36w	157	1	The	the	DT
cord-342372-2g9sq36w	157	2	use	use	NN
cord-342372-2g9sq36w	157	3	IVIG	IVIG	NNP
cord-342372-2g9sq36w	157	4	is	be	VBZ
cord-342372-2g9sq36w	157	5	recommended	recommend	VBN
cord-342372-2g9sq36w	157	6	for	for	IN
cord-342372-2g9sq36w	157	7	treatment	treatment	NN
cord-342372-2g9sq36w	157	8	of	of	IN
cord-342372-2g9sq36w	157	9	patients	patient	NNS
cord-342372-2g9sq36w	157	10	with	with	IN
cord-342372-2g9sq36w	157	11	KD	KD	NNP
cord-342372-2g9sq36w	157	12	[	[	-LRB-
cord-342372-2g9sq36w	157	13	6••	6••	NN
cord-342372-2g9sq36w	157	14	]	]	-RRB-
cord-342372-2g9sq36w	157	15	and	and	CC
cord-342372-2g9sq36w	157	16	has	have	VBZ
cord-342372-2g9sq36w	157	17	been	be	VBN
cord-342372-2g9sq36w	157	18	shown	show	VBN
cord-342372-2g9sq36w	157	19	to	to	TO
cord-342372-2g9sq36w	157	20	be	be	VB
cord-342372-2g9sq36w	157	21	cost	cost	VBN
cord-342372-2g9sq36w	157	22	effective	effective	JJ
cord-342372-2g9sq36w	157	23	[	[	-LRB-
cord-342372-2g9sq36w	157	24	34	34	CD
cord-342372-2g9sq36w	157	25	]	]	-RRB-
cord-342372-2g9sq36w	157	26	.	.	.
cord-342372-2g9sq36w	158	1	Dosed	dose	VBN
cord-342372-2g9sq36w	158	2	at	at	IN
cord-342372-2g9sq36w	158	3	2	2	CD
cord-342372-2g9sq36w	158	4	gm	gm	NNP
cord-342372-2g9sq36w	158	5	/	/	SYM
cord-342372-2g9sq36w	158	6	kg	kg	NNS
cord-342372-2g9sq36w	158	7	in	in	IN
cord-342372-2g9sq36w	158	8	a	a	DT
cord-342372-2g9sq36w	158	9	single	single	JJ
cord-342372-2g9sq36w	158	10	infusion	infusion	NN
cord-342372-2g9sq36w	158	11	,	,	,
cord-342372-2g9sq36w	158	12	IVIG	IVIG	NNP
cord-342372-2g9sq36w	158	13	should	should	MD
cord-342372-2g9sq36w	158	14	be	be	VB
cord-342372-2g9sq36w	158	15	given	give	VBN
cord-342372-2g9sq36w	158	16	as	as	IN
cord-342372-2g9sq36w	158	17	initial	initial	JJ
cord-342372-2g9sq36w	158	18	treatment	treatment	NN
cord-342372-2g9sq36w	158	19	for	for	IN
cord-342372-2g9sq36w	158	20	KD	KD	NNP
cord-342372-2g9sq36w	158	21	.	.	.
cord-342372-2g9sq36w	159	1	Treatment	treatment	NN
cord-342372-2g9sq36w	159	2	should	should	MD
cord-342372-2g9sq36w	159	3	be	be	VB
cord-342372-2g9sq36w	159	4	instituted	institute	VBN
cord-342372-2g9sq36w	159	5	within	within	IN
cord-342372-2g9sq36w	159	6	the	the	DT
cord-342372-2g9sq36w	159	7	first	first	JJ
cord-342372-2g9sq36w	159	8	10	10	CD
cord-342372-2g9sq36w	159	9	days	day	NNS
cord-342372-2g9sq36w	159	10	of	of	IN
cord-342372-2g9sq36w	159	11	illness	illness	NN
cord-342372-2g9sq36w	159	12	and	and	CC
cord-342372-2g9sq36w	159	13	should	should	MD
cord-342372-2g9sq36w	159	14	still	still	RB
cord-342372-2g9sq36w	159	15	be	be	VB
cord-342372-2g9sq36w	159	16	administered	administer	VBN
cord-342372-2g9sq36w	159	17	to	to	IN
cord-342372-2g9sq36w	159	18	children	child	NNS
cord-342372-2g9sq36w	159	19	after	after	IN
cord-342372-2g9sq36w	159	20	the	the	DT
cord-342372-2g9sq36w	159	21	tenth	tenth	JJ
cord-342372-2g9sq36w	159	22	day	day	NN
cord-342372-2g9sq36w	159	23	of	of	IN
cord-342372-2g9sq36w	159	24	illness	illness	NN
cord-342372-2g9sq36w	159	25	should	should	MD
cord-342372-2g9sq36w	159	26	fever	fever	NN
cord-342372-2g9sq36w	159	27	persists	persist	VBZ
cord-342372-2g9sq36w	159	28	,	,	,
cord-342372-2g9sq36w	159	29	or	or	CC
cord-342372-2g9sq36w	159	30	with	with	IN
cord-342372-2g9sq36w	159	31	ongoing	ongoing	JJ
cord-342372-2g9sq36w	159	32	systemic	systemic	JJ
cord-342372-2g9sq36w	159	33	inflammation	inflammation	NN
cord-342372-2g9sq36w	159	34	(	(	-LRB-
cord-342372-2g9sq36w	159	35	elevated	elevate	VBN
cord-342372-2g9sq36w	159	36	ESR	ESR	NNP
cord-342372-2g9sq36w	159	37	/	/	SYM
cord-342372-2g9sq36w	159	38	CRP	CRP	NNP
cord-342372-2g9sq36w	159	39	)	)	-RRB-
cord-342372-2g9sq36w	159	40	or	or	CC
cord-342372-2g9sq36w	159	41	the	the	DT
cord-342372-2g9sq36w	159	42	presence	presence	NN
cord-342372-2g9sq36w	159	43	of	of	IN
cord-342372-2g9sq36w	159	44	coronary	coronary	JJ
cord-342372-2g9sq36w	159	45	artery	artery	NN
cord-342372-2g9sq36w	159	46	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	159	47	[	[	-LRB-
cord-342372-2g9sq36w	159	48	6••	6••	CD
cord-342372-2g9sq36w	159	49	]	]	-RRB-
cord-342372-2g9sq36w	159	50	.	.	.
cord-342372-2g9sq36w	160	1	Treatment	treatment	NN
cord-342372-2g9sq36w	160	2	of	of	IN
cord-342372-2g9sq36w	160	3	KD	KD	NNP
cord-342372-2g9sq36w	160	4	prior	prior	RB
cord-342372-2g9sq36w	160	5	to	to	IN
cord-342372-2g9sq36w	160	6	day	day	NN
cord-342372-2g9sq36w	160	7	5	5	CD
cord-342372-2g9sq36w	160	8	of	of	IN
cord-342372-2g9sq36w	160	9	illness	illness	NN
cord-342372-2g9sq36w	160	10	may	may	MD
cord-342372-2g9sq36w	160	11	be	be	VB
cord-342372-2g9sq36w	160	12	associated	associate	VBN
cord-342372-2g9sq36w	160	13	with	with	IN
cord-342372-2g9sq36w	160	14	increased	increase	VBN
cord-342372-2g9sq36w	160	15	need	need	NN
cord-342372-2g9sq36w	160	16	for	for	IN
cord-342372-2g9sq36w	160	17	IVIG	IVIG	NNP
cord-342372-2g9sq36w	160	18	retreatment	retreatment	NN
cord-342372-2g9sq36w	160	19	[	[	-LRB-
cord-342372-2g9sq36w	160	20	35	35	CD
cord-342372-2g9sq36w	160	21	]	]	-RRB-
cord-342372-2g9sq36w	160	22	.	.	.
cord-342372-2g9sq36w	161	1	Live	live	JJ
cord-342372-2g9sq36w	161	2	vaccines	vaccine	NNS
cord-342372-2g9sq36w	161	3	,	,	,
cord-342372-2g9sq36w	161	4	particularly	particularly	RB
cord-342372-2g9sq36w	161	5	measles	measle	NNS
cord-342372-2g9sq36w	161	6	and	and	CC
cord-342372-2g9sq36w	161	7	varicella	varicella	NN
cord-342372-2g9sq36w	161	8	,	,	,
cord-342372-2g9sq36w	161	9	should	should	MD
cord-342372-2g9sq36w	161	10	be	be	VB
cord-342372-2g9sq36w	161	11	deferred	defer	VBN
cord-342372-2g9sq36w	161	12	for	for	IN
cord-342372-2g9sq36w	161	13	11	11	CD
cord-342372-2g9sq36w	161	14	months	month	NNS
cord-342372-2g9sq36w	161	15	after	after	IN
cord-342372-2g9sq36w	161	16	IVIG	IVIG	NNP
cord-342372-2g9sq36w	161	17	treatment	treatment	NN
cord-342372-2g9sq36w	161	18	.	.	.
cord-342372-2g9sq36w	162	1	Children	child	NNS
cord-342372-2g9sq36w	162	2	at	at	IN
cord-342372-2g9sq36w	162	3	high	high	JJ
cord-342372-2g9sq36w	162	4	risk	risk	NN
cord-342372-2g9sq36w	162	5	of	of	IN
cord-342372-2g9sq36w	162	6	measles	measle	NNS
cord-342372-2g9sq36w	162	7	exposure	exposure	NN
cord-342372-2g9sq36w	162	8	may	may	MD
cord-342372-2g9sq36w	162	9	be	be	VB
cord-342372-2g9sq36w	162	10	vaccinated	vaccinate	VBN
cord-342372-2g9sq36w	162	11	earlier	early	RBR
cord-342372-2g9sq36w	162	12	,	,	,
cord-342372-2g9sq36w	162	13	but	but	CC
cord-342372-2g9sq36w	162	14	will	will	MD
cord-342372-2g9sq36w	162	15	require	require	VB
cord-342372-2g9sq36w	162	16	re	re	NN
cord-342372-2g9sq36w	162	17	-	-	NN
cord-342372-2g9sq36w	162	18	immunization	immunization	NN
cord-342372-2g9sq36w	162	19	11	11	CD
cord-342372-2g9sq36w	162	20	months	month	NNS
cord-342372-2g9sq36w	162	21	after	after	IN
cord-342372-2g9sq36w	162	22	IVIG	IVIG	NNP
cord-342372-2g9sq36w	162	23	treatment	treatment	NN
cord-342372-2g9sq36w	162	24	.	.	.
cord-342372-2g9sq36w	163	1	Treatment	treatment	NN
cord-342372-2g9sq36w	163	2	with	with	IN
cord-342372-2g9sq36w	163	3	IVIG	IVIG	NNP
cord-342372-2g9sq36w	163	4	is	be	VBZ
cord-342372-2g9sq36w	163	5	given	give	VBN
cord-342372-2g9sq36w	163	6	concurrently	concurrently	RB
cord-342372-2g9sq36w	163	7	with	with	IN
cord-342372-2g9sq36w	163	8	aspirin	aspirin	NN
cord-342372-2g9sq36w	163	9	(	(	-LRB-
cord-342372-2g9sq36w	163	10	see	see	VB
cord-342372-2g9sq36w	163	11	below	below	RB
cord-342372-2g9sq36w	163	12	)	)	-RRB-
cord-342372-2g9sq36w	163	13	.	.	.
cord-342372-2g9sq36w	164	1	During	during	IN
cord-342372-2g9sq36w	164	2	the	the	DT
cord-342372-2g9sq36w	164	3	acute	acute	JJ
cord-342372-2g9sq36w	164	4	phase	phase	NN
cord-342372-2g9sq36w	164	5	of	of	IN
cord-342372-2g9sq36w	164	6	KD	KD	NNP
cord-342372-2g9sq36w	164	7	,	,	,
cord-342372-2g9sq36w	164	8	aspirin	aspirin	NN
cord-342372-2g9sq36w	164	9	(	(	-LRB-
cord-342372-2g9sq36w	164	10	ASA	ASA	NNP
cord-342372-2g9sq36w	164	11	)	)	-RRB-
cord-342372-2g9sq36w	164	12	is	be	VBZ
cord-342372-2g9sq36w	164	13	administered	administer	VBN
cord-342372-2g9sq36w	164	14	at	at	IN
cord-342372-2g9sq36w	164	15	high	high	JJ
cord-342372-2g9sq36w	164	16	dosages	dosage	NNS
cord-342372-2g9sq36w	164	17	(	(	-LRB-
cord-342372-2g9sq36w	164	18	80	80	CD
cord-342372-2g9sq36w	164	19	-	-	SYM
cord-342372-2g9sq36w	164	20	100	100	CD
cord-342372-2g9sq36w	164	21	mg	mg	NNP
cord-342372-2g9sq36w	164	22	/	/	SYM
cord-342372-2g9sq36w	164	23	kg	kg	NNP
cord-342372-2g9sq36w	164	24	/	/	SYM
cord-342372-2g9sq36w	164	25	day	day	NN
cord-342372-2g9sq36w	164	26	divided	divide	VBD
cord-342372-2g9sq36w	164	27	every	every	DT
cord-342372-2g9sq36w	164	28	6	6	CD
cord-342372-2g9sq36w	164	29	h	h	NN
cord-342372-2g9sq36w	164	30	)	)	-RRB-
cord-342372-2g9sq36w	164	31	.	.	.
cord-342372-2g9sq36w	165	1	Concurrent	concurrent	JJ
cord-342372-2g9sq36w	165	2	administration	administration	NN
cord-342372-2g9sq36w	165	3	of	of	IN
cord-342372-2g9sq36w	165	4	high	high	JJ
cord-342372-2g9sq36w	165	5	-	-	HYPH
cord-342372-2g9sq36w	165	6	dose	dose	NN
cord-342372-2g9sq36w	165	7	ASA	ASA	NNP
cord-342372-2g9sq36w	165	8	with	with	IN
cord-342372-2g9sq36w	165	9	IVIG	IVIG	NNP
cord-342372-2g9sq36w	165	10	during	during	IN
cord-342372-2g9sq36w	165	11	the	the	DT
cord-342372-2g9sq36w	165	12	acute	acute	JJ
cord-342372-2g9sq36w	165	13	phase	phase	NN
cord-342372-2g9sq36w	165	14	of	of	IN
cord-342372-2g9sq36w	165	15	KD	KD	NNP
cord-342372-2g9sq36w	165	16	seems	seem	VBZ
cord-342372-2g9sq36w	165	17	to	to	TO
cord-342372-2g9sq36w	165	18	provide	provide	VB
cord-342372-2g9sq36w	165	19	an	an	DT
cord-342372-2g9sq36w	165	20	additive	additive	NN
cord-342372-2g9sq36w	165	21	antiinflammatory	antiinflammatory	JJ
cord-342372-2g9sq36w	165	22	effect	effect	NN
cord-342372-2g9sq36w	165	23	.	.	.
cord-342372-2g9sq36w	166	1	High	high	JJ
cord-342372-2g9sq36w	166	2	-	-	HYPH
cord-342372-2g9sq36w	166	3	dose	dose	NN
cord-342372-2g9sq36w	166	4	aspirin	aspirin	NN
cord-342372-2g9sq36w	166	5	alone	alone	RB
cord-342372-2g9sq36w	166	6	does	do	VBZ
cord-342372-2g9sq36w	166	7	not	not	RB
cord-342372-2g9sq36w	166	8	lower	lower	VB
cord-342372-2g9sq36w	166	9	the	the	DT
cord-342372-2g9sq36w	166	10	frequency	frequency	NN
cord-342372-2g9sq36w	166	11	of	of	IN
cord-342372-2g9sq36w	166	12	development	development	NN
cord-342372-2g9sq36w	166	13	of	of	IN
cord-342372-2g9sq36w	166	14	coronary	coronary	JJ
cord-342372-2g9sq36w	166	15	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	166	16	despite	despite	IN
cord-342372-2g9sq36w	166	17	its	-PRON-	PRP$
cord-342372-2g9sq36w	166	18	anti	anti	JJ
cord-342372-2g9sq36w	166	19	-	-	JJ
cord-342372-2g9sq36w	166	20	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	166	21	effect	effect	NN
cord-342372-2g9sq36w	166	22	[	[	-LRB-
cord-342372-2g9sq36w	166	23	32	32	CD
cord-342372-2g9sq36w	166	24	]	]	-RRB-
cord-342372-2g9sq36w	166	25	.	.	.
cord-342372-2g9sq36w	167	1	The	the	DT
cord-342372-2g9sq36w	167	2	duration	duration	NN
cord-342372-2g9sq36w	167	3	of	of	IN
cord-342372-2g9sq36w	167	4	high	high	JJ
cord-342372-2g9sq36w	167	5	-	-	HYPH
cord-342372-2g9sq36w	167	6	dose	dose	NN
cord-342372-2g9sq36w	167	7	aspirin	aspirin	NN
cord-342372-2g9sq36w	167	8	therapy	therapy	NN
cord-342372-2g9sq36w	167	9	varies	vary	VBZ
cord-342372-2g9sq36w	167	10	with	with	IN
cord-342372-2g9sq36w	167	11	institution	institution	NN
cord-342372-2g9sq36w	167	12	.	.	.
cord-342372-2g9sq36w	168	1	All	all	DT
cord-342372-2g9sq36w	168	2	institutions	institution	NNS
cord-342372-2g9sq36w	168	3	require	require	VBP
cord-342372-2g9sq36w	168	4	resolution	resolution	NN
cord-342372-2g9sq36w	168	5	of	of	IN
cord-342372-2g9sq36w	168	6	fever	fever	NN
cord-342372-2g9sq36w	168	7	for	for	IN
cord-342372-2g9sq36w	168	8	48	48	CD
cord-342372-2g9sq36w	168	9	-	-	SYM
cord-342372-2g9sq36w	168	10	72	72	CD
cord-342372-2g9sq36w	168	11	h	h	NN
cord-342372-2g9sq36w	168	12	prior	prior	RB
cord-342372-2g9sq36w	168	13	to	to	IN
cord-342372-2g9sq36w	168	14	stopping	stop	VBG
cord-342372-2g9sq36w	168	15	high	high	JJ
cord-342372-2g9sq36w	168	16	-	-	HYPH
cord-342372-2g9sq36w	168	17	dose	dose	NN
cord-342372-2g9sq36w	168	18	ASA	ASA	NNP
cord-342372-2g9sq36w	168	19	therapy	therapy	NN
cord-342372-2g9sq36w	168	20	.	.	.
cord-342372-2g9sq36w	169	1	However	however	RB
cord-342372-2g9sq36w	169	2	,	,	,
cord-342372-2g9sq36w	169	3	some	some	DT
cord-342372-2g9sq36w	169	4	institutions	institution	NNS
cord-342372-2g9sq36w	169	5	will	will	MD
cord-342372-2g9sq36w	169	6	treat	treat	VB
cord-342372-2g9sq36w	169	7	with	with	IN
cord-342372-2g9sq36w	169	8	high	high	JJ
cord-342372-2g9sq36w	169	9	-	-	HYPH
cord-342372-2g9sq36w	169	10	dose	dose	NN
cord-342372-2g9sq36w	169	11	ASA	ASA	NNP
cord-342372-2g9sq36w	169	12	until	until	IN
cord-342372-2g9sq36w	169	13	day	day	NN
cord-342372-2g9sq36w	169	14	14	14	CD
cord-342372-2g9sq36w	169	15	of	of	IN
cord-342372-2g9sq36w	169	16	illness	illness	NN
cord-342372-2g9sq36w	169	17	regardless	regardless	RB
cord-342372-2g9sq36w	169	18	of	of	IN
cord-342372-2g9sq36w	169	19	fever	fever	NN
cord-342372-2g9sq36w	169	20	resolution	resolution	NN
cord-342372-2g9sq36w	169	21	.	.	.
cord-342372-2g9sq36w	170	1	Once	once	RB
cord-342372-2g9sq36w	170	2	high	high	JJ
cord-342372-2g9sq36w	170	3	-	-	HYPH
cord-342372-2g9sq36w	170	4	dose	dose	NN
cord-342372-2g9sq36w	170	5	ASA	ASA	NNP
cord-342372-2g9sq36w	170	6	is	be	VBZ
cord-342372-2g9sq36w	170	7	discontinued	discontinue	VBN
cord-342372-2g9sq36w	170	8	,	,	,
cord-342372-2g9sq36w	170	9	low	low	JJ
cord-342372-2g9sq36w	170	10	-	-	HYPH
cord-342372-2g9sq36w	170	11	dose	dose	NN
cord-342372-2g9sq36w	170	12	ASA	ASA	NNP
cord-342372-2g9sq36w	170	13	(	(	-LRB-
cord-342372-2g9sq36w	170	14	3	3	CD
cord-342372-2g9sq36w	170	15	-	-	SYM
cord-342372-2g9sq36w	170	16	5	5	CD
cord-342372-2g9sq36w	170	17	mg	mg	NNP
cord-342372-2g9sq36w	170	18	/	/	SYM
cord-342372-2g9sq36w	170	19	kg	kg	NNS
cord-342372-2g9sq36w	170	20	given	give	VBN
cord-342372-2g9sq36w	170	21	daily	daily	RB
cord-342372-2g9sq36w	170	22	)	)	-RRB-
cord-342372-2g9sq36w	170	23	is	be	VBZ
cord-342372-2g9sq36w	170	24	started	start	VBN
cord-342372-2g9sq36w	170	25	.	.	.
cord-342372-2g9sq36w	171	1	Low	low	JJ
cord-342372-2g9sq36w	171	2	-	-	HYPH
cord-342372-2g9sq36w	171	3	dose	dose	NN
cord-342372-2g9sq36w	171	4	ASA	ASA	NNP
cord-342372-2g9sq36w	171	5	is	be	VBZ
cord-342372-2g9sq36w	171	6	used	use	VBN
cord-342372-2g9sq36w	171	7	for	for	IN
cord-342372-2g9sq36w	171	8	its	-PRON-	PRP$
cord-342372-2g9sq36w	171	9	anti	anti	JJ
cord-342372-2g9sq36w	171	10	-	-	JJ
cord-342372-2g9sq36w	171	11	platelet	platelet	JJ
cord-342372-2g9sq36w	171	12	effect	effect	NN
cord-342372-2g9sq36w	171	13	to	to	TO
cord-342372-2g9sq36w	171	14	prevent	prevent	VB
cord-342372-2g9sq36w	171	15	possible	possible	JJ
cord-342372-2g9sq36w	171	16	complications	complication	NNS
cord-342372-2g9sq36w	171	17	from	from	IN
cord-342372-2g9sq36w	171	18	coronary	coronary	JJ
cord-342372-2g9sq36w	171	19	artery	artery	NN
cord-342372-2g9sq36w	171	20	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	171	21	associated	associate	VBN
cord-342372-2g9sq36w	171	22	with	with	IN
cord-342372-2g9sq36w	171	23	KD	KD	NNP
cord-342372-2g9sq36w	171	24	.	.	.
cord-342372-2g9sq36w	172	1	Evaluation	evaluation	NN
cord-342372-2g9sq36w	172	2	for	for	IN
cord-342372-2g9sq36w	172	3	coronary	coronary	JJ
cord-342372-2g9sq36w	172	4	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	172	5	should	should	MD
cord-342372-2g9sq36w	172	6	be	be	VB
cord-342372-2g9sq36w	172	7	done	do	VBN
cord-342372-2g9sq36w	172	8	at	at	IN
cord-342372-2g9sq36w	172	9	least	least	JJS
cord-342372-2g9sq36w	172	10	until	until	IN
cord-342372-2g9sq36w	172	11	6	6	CD
cord-342372-2g9sq36w	172	12	-	-	SYM
cord-342372-2g9sq36w	172	13	8	8	CD
cord-342372-2g9sq36w	172	14	weeks	week	NNS
cord-342372-2g9sq36w	172	15	after	after	IN
cord-342372-2g9sq36w	172	16	the	the	DT
cord-342372-2g9sq36w	172	17	onset	onset	NN
cord-342372-2g9sq36w	172	18	of	of	IN
cord-342372-2g9sq36w	172	19	KD	KD	NNP
cord-342372-2g9sq36w	172	20	.	.	.
cord-342372-2g9sq36w	173	1	Low	low	JJ
cord-342372-2g9sq36w	173	2	-	-	HYPH
cord-342372-2g9sq36w	173	3	dose	dose	NN
cord-342372-2g9sq36w	173	4	ASA	ASA	NNP
cord-342372-2g9sq36w	173	5	is	be	VBZ
cord-342372-2g9sq36w	173	6	discontinued	discontinue	VBN
cord-342372-2g9sq36w	173	7	if	if	IN
cord-342372-2g9sq36w	173	8	there	there	EX
cord-342372-2g9sq36w	173	9	is	be	VBZ
cord-342372-2g9sq36w	173	10	no	no	DT
cord-342372-2g9sq36w	173	11	evidence	evidence	NN
cord-342372-2g9sq36w	173	12	of	of	IN
cord-342372-2g9sq36w	173	13	coronary	coronary	JJ
cord-342372-2g9sq36w	173	14	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	173	15	and	and	CC
cord-342372-2g9sq36w	173	16	platelet	platelet	NN
cord-342372-2g9sq36w	173	17	count	count	NN
cord-342372-2g9sq36w	173	18	is	be	VBZ
cord-342372-2g9sq36w	173	19	normal	normal	JJ
cord-342372-2g9sq36w	173	20	at	at	IN
cord-342372-2g9sq36w	173	21	that	that	DT
cord-342372-2g9sq36w	173	22	time	time	NN
cord-342372-2g9sq36w	173	23	.	.	.
cord-342372-2g9sq36w	174	1	Should	Should	MD
cord-342372-2g9sq36w	174	2	evidence	evidence	NN
cord-342372-2g9sq36w	174	3	of	of	IN
cord-342372-2g9sq36w	174	4	coronary	coronary	JJ
cord-342372-2g9sq36w	174	5	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	174	6	develop	develop	VBP
cord-342372-2g9sq36w	174	7	or	or	CC
cord-342372-2g9sq36w	174	8	persist	persist	VBP
cord-342372-2g9sq36w	174	9	,	,	,
cord-342372-2g9sq36w	174	10	low	low	JJ
cord-342372-2g9sq36w	174	11	-	-	HYPH
cord-342372-2g9sq36w	174	12	dose	dose	NN
cord-342372-2g9sq36w	174	13	ASA	ASA	NNP
cord-342372-2g9sq36w	174	14	is	be	VBZ
cord-342372-2g9sq36w	174	15	continued	continue	VBN
cord-342372-2g9sq36w	174	16	indefinitely	indefinitely	RB
cord-342372-2g9sq36w	174	17	.	.	.
cord-342372-2g9sq36w	175	1	Ibuprofen	ibuprofen	NN
cord-342372-2g9sq36w	175	2	should	should	MD
cord-342372-2g9sq36w	175	3	be	be	VB
cord-342372-2g9sq36w	175	4	avoided	avoid	VBN
cord-342372-2g9sq36w	175	5	while	while	IN
cord-342372-2g9sq36w	175	6	the	the	DT
cord-342372-2g9sq36w	175	7	patient	patient	NN
cord-342372-2g9sq36w	175	8	is	be	VBZ
cord-342372-2g9sq36w	175	9	on	on	IN
cord-342372-2g9sq36w	175	10	ASA	ASA	NNP
cord-342372-2g9sq36w	175	11	as	as	IN
cord-342372-2g9sq36w	175	12	it	-PRON-	PRP
cord-342372-2g9sq36w	175	13	antagonizes	antagonize	VBZ
cord-342372-2g9sq36w	175	14	the	the	DT
cord-342372-2g9sq36w	175	15	platelet	platelet	NN
cord-342372-2g9sq36w	175	16	inhibition	inhibition	NN
cord-342372-2g9sq36w	175	17	of	of	IN
cord-342372-2g9sq36w	175	18	ASA	ASA	NNP
cord-342372-2g9sq36w	175	19	[	[	-LRB-
cord-342372-2g9sq36w	175	20	36	36	CD
cord-342372-2g9sq36w	175	21	]	]	-RRB-
cord-342372-2g9sq36w	175	22	.	.	.
cord-342372-2g9sq36w	176	1	Children	child	NNS
cord-342372-2g9sq36w	176	2	receiving	receive	VBG
cord-342372-2g9sq36w	176	3	ASA	ASA	NNP
cord-342372-2g9sq36w	176	4	therapy	therapy	NN
cord-342372-2g9sq36w	176	5	are	be	VBP
cord-342372-2g9sq36w	176	6	at	at	IN
cord-342372-2g9sq36w	176	7	risk	risk	NN
cord-342372-2g9sq36w	176	8	of	of	IN
cord-342372-2g9sq36w	176	9	development	development	NN
cord-342372-2g9sq36w	176	10	of	of	IN
cord-342372-2g9sq36w	176	11	Reye	Reye	NNP
cord-342372-2g9sq36w	176	12	syndrome	syndrome	NN
cord-342372-2g9sq36w	176	13	,	,	,
cord-342372-2g9sq36w	176	14	particularly	particularly	RB
cord-342372-2g9sq36w	176	15	during	during	IN
cord-342372-2g9sq36w	176	16	active	active	JJ
cord-342372-2g9sq36w	176	17	infections	infection	NNS
cord-342372-2g9sq36w	176	18	with	with	IN
cord-342372-2g9sq36w	176	19	varicella	varicella	NN
cord-342372-2g9sq36w	176	20	or	or	CC
cord-342372-2g9sq36w	176	21	influenza	influenza	NN
cord-342372-2g9sq36w	176	22	.	.	.
cord-342372-2g9sq36w	177	1	Reye	Reye	NNP
cord-342372-2g9sq36w	177	2	syndrome	syndrome	NN
cord-342372-2g9sq36w	177	3	has	have	VBZ
cord-342372-2g9sq36w	177	4	been	be	VBN
cord-342372-2g9sq36w	177	5	reported	report	VBN
cord-342372-2g9sq36w	177	6	in	in	IN
cord-342372-2g9sq36w	177	7	patients	patient	NNS
cord-342372-2g9sq36w	177	8	receiving	receive	VBG
cord-342372-2g9sq36w	177	9	prolonged	prolonged	JJ
cord-342372-2g9sq36w	177	10	high	high	JJ
cord-342372-2g9sq36w	177	11	-	-	HYPH
cord-342372-2g9sq36w	177	12	dose	dose	NN
cord-342372-2g9sq36w	177	13	ASA	ASA	NNP
cord-342372-2g9sq36w	177	14	therapy	therapy	NN
cord-342372-2g9sq36w	177	15	for	for	IN
cord-342372-2g9sq36w	177	16	KD	KD	NNP
cord-342372-2g9sq36w	177	17	[	[	-LRB-
cord-342372-2g9sq36w	177	18	37	37	CD
cord-342372-2g9sq36w	177	19	]	]	-RRB-
cord-342372-2g9sq36w	177	20	,	,	,
cord-342372-2g9sq36w	177	21	although	although	IN
cord-342372-2g9sq36w	177	22	it	-PRON-	PRP
cord-342372-2g9sq36w	177	23	is	be	VBZ
cord-342372-2g9sq36w	177	24	unclear	unclear	JJ
cord-342372-2g9sq36w	177	25	whether	whether	IN
cord-342372-2g9sq36w	177	26	low	low	JJ
cord-342372-2g9sq36w	177	27	-	-	HYPH
cord-342372-2g9sq36w	177	28	dose	dose	NN
cord-342372-2g9sq36w	177	29	ASA	ASA	NNP
cord-342372-2g9sq36w	177	30	increased	increase	VBD
cord-342372-2g9sq36w	177	31	the	the	DT
cord-342372-2g9sq36w	177	32	risk	risk	NN
cord-342372-2g9sq36w	177	33	of	of	IN
cord-342372-2g9sq36w	177	34	Reye	Reye	NNP
cord-342372-2g9sq36w	177	35	syndrome	syndrome	NN
cord-342372-2g9sq36w	177	36	.	.	.
cord-342372-2g9sq36w	178	1	Children	child	NNS
cord-342372-2g9sq36w	178	2	on	on	IN
cord-342372-2g9sq36w	178	3	long	long	JJ
cord-342372-2g9sq36w	178	4	-	-	HYPH
cord-342372-2g9sq36w	178	5	term	term	NN
cord-342372-2g9sq36w	178	6	ASA	ASA	NNP
cord-342372-2g9sq36w	178	7	therapy	therapy	NN
cord-342372-2g9sq36w	178	8	should	should	MD
cord-342372-2g9sq36w	178	9	receive	receive	VB
cord-342372-2g9sq36w	178	10	inactivated	inactivate	VBN
cord-342372-2g9sq36w	178	11	influenza	influenza	NN
cord-342372-2g9sq36w	178	12	vaccine	vaccine	NN
cord-342372-2g9sq36w	178	13	.	.	.
cord-342372-2g9sq36w	179	1	Physicians	physician	NNS
cord-342372-2g9sq36w	179	2	should	should	MD
cord-342372-2g9sq36w	179	3	evaluate	evaluate	VB
cord-342372-2g9sq36w	179	4	patients	patient	NNS
cord-342372-2g9sq36w	179	5	on	on	IN
cord-342372-2g9sq36w	179	6	ASA	ASA	NNP
cord-342372-2g9sq36w	179	7	who	who	WP
cord-342372-2g9sq36w	179	8	are	be	VBP
cord-342372-2g9sq36w	179	9	exposed	expose	VBN
cord-342372-2g9sq36w	179	10	to	to	IN
cord-342372-2g9sq36w	179	11	or	or	CC
cord-342372-2g9sq36w	179	12	develop	develop	VB
cord-342372-2g9sq36w	179	13	symptoms	symptom	NNS
cord-342372-2g9sq36w	179	14	of	of	IN
cord-342372-2g9sq36w	179	15	influenza	influenza	NN
cord-342372-2g9sq36w	179	16	and	and	CC
cord-342372-2g9sq36w	179	17	varicella	varicella	NN
cord-342372-2g9sq36w	179	18	.	.	.
cord-342372-2g9sq36w	180	1	Approximately	approximately	RB
cord-342372-2g9sq36w	180	2	13	13	CD
cord-342372-2g9sq36w	180	3	%	%	NN
cord-342372-2g9sq36w	180	4	of	of	IN
cord-342372-2g9sq36w	180	5	patients	patient	NNS
cord-342372-2g9sq36w	180	6	with	with	IN
cord-342372-2g9sq36w	180	7	KD	KD	NNP
cord-342372-2g9sq36w	180	8	fail	fail	VBP
cord-342372-2g9sq36w	180	9	to	to	TO
cord-342372-2g9sq36w	180	10	respond	respond	VB
cord-342372-2g9sq36w	180	11	to	to	IN
cord-342372-2g9sq36w	180	12	initial	initial	JJ
cord-342372-2g9sq36w	180	13	treatment	treatment	NN
cord-342372-2g9sq36w	180	14	with	with	IN
cord-342372-2g9sq36w	180	15	IVIG	IVIG	NNP
cord-342372-2g9sq36w	180	16	[	[	-LRB-
cord-342372-2g9sq36w	180	17	38	38	CD
cord-342372-2g9sq36w	180	18	]	]	-RRB-
cord-342372-2g9sq36w	180	19	.	.	.
cord-342372-2g9sq36w	181	1	Failure	failure	NN
cord-342372-2g9sq36w	181	2	to	to	TO
cord-342372-2g9sq36w	181	3	respond	respond	VB
cord-342372-2g9sq36w	181	4	is	be	VBZ
cord-342372-2g9sq36w	181	5	characterized	characterize	VBN
cord-342372-2g9sq36w	181	6	as	as	IN
cord-342372-2g9sq36w	181	7	persistent	persistent	JJ
cord-342372-2g9sq36w	181	8	fever	fever	NN
cord-342372-2g9sq36w	181	9	≥36	≥36	NN
cord-342372-2g9sq36w	181	10	-	-	:
cord-342372-2g9sq36w	181	11	48	48	CD
cord-342372-2g9sq36w	182	1	h	h	LS
cord-342372-2g9sq36w	182	2	following	follow	VBG
cord-342372-2g9sq36w	182	3	completion	completion	NN
cord-342372-2g9sq36w	182	4	of	of	IN
cord-342372-2g9sq36w	182	5	IVIG	IVIG	NNP
cord-342372-2g9sq36w	182	6	infusion	infusion	NN
cord-342372-2g9sq36w	182	7	.	.	.
cord-342372-2g9sq36w	183	1	The	the	DT
cord-342372-2g9sq36w	183	2	most	most	RBS
cord-342372-2g9sq36w	183	3	likely	likely	JJ
cord-342372-2g9sq36w	183	4	explanation	explanation	NN
cord-342372-2g9sq36w	183	5	for	for	IN
cord-342372-2g9sq36w	183	6	persistent	persistent	JJ
cord-342372-2g9sq36w	183	7	fever	fever	NN
cord-342372-2g9sq36w	183	8	in	in	IN
cord-342372-2g9sq36w	183	9	these	these	DT
cord-342372-2g9sq36w	183	10	patients	patient	NNS
cord-342372-2g9sq36w	183	11	is	be	VBZ
cord-342372-2g9sq36w	183	12	failure	failure	NN
cord-342372-2g9sq36w	183	13	of	of	IN
cord-342372-2g9sq36w	183	14	initial	initial	JJ
cord-342372-2g9sq36w	183	15	IVIG	IVIG	NNP
cord-342372-2g9sq36w	183	16	to	to	TO
cord-342372-2g9sq36w	183	17	abort	abort	VB
cord-342372-2g9sq36w	183	18	the	the	DT
cord-342372-2g9sq36w	183	19	disease	disease	NN
cord-342372-2g9sq36w	183	20	process	process	NN
cord-342372-2g9sq36w	183	21	of	of	IN
cord-342372-2g9sq36w	183	22	KD	KD	NNP
cord-342372-2g9sq36w	183	23	.	.	.
cord-342372-2g9sq36w	184	1	However	however	RB
cord-342372-2g9sq36w	184	2	,	,	,
cord-342372-2g9sq36w	184	3	KD	KD	NNP
cord-342372-2g9sq36w	184	4	can	can	MD
cord-342372-2g9sq36w	184	5	be	be	VB
cord-342372-2g9sq36w	184	6	misdiagnosed	misdiagnose	VBN
cord-342372-2g9sq36w	184	7	due	due	IN
cord-342372-2g9sq36w	184	8	to	to	IN
cord-342372-2g9sq36w	184	9	its	-PRON-	PRP$
cord-342372-2g9sq36w	184	10	shared	share	VBN
cord-342372-2g9sq36w	184	11	clinical	clinical	JJ
cord-342372-2g9sq36w	184	12	characteristics	characteristic	NNS
cord-342372-2g9sq36w	184	13	with	with	IN
cord-342372-2g9sq36w	184	14	a	a	DT
cord-342372-2g9sq36w	184	15	wide	wide	JJ
cord-342372-2g9sq36w	184	16	variety	variety	NN
cord-342372-2g9sq36w	184	17	of	of	IN
cord-342372-2g9sq36w	184	18	common	common	JJ
cord-342372-2g9sq36w	184	19	pediatric	pediatric	JJ
cord-342372-2g9sq36w	184	20	illnesses	illness	NNS
cord-342372-2g9sq36w	184	21	.	.	.
cord-342372-2g9sq36w	185	1	Therefore	therefore	RB
cord-342372-2g9sq36w	185	2	,	,	,
cord-342372-2g9sq36w	185	3	patients	patient	NNS
cord-342372-2g9sq36w	185	4	with	with	IN
cord-342372-2g9sq36w	185	5	refractory	refractory	JJ
cord-342372-2g9sq36w	185	6	KD	KD	NNP
cord-342372-2g9sq36w	185	7	should	should	MD
cord-342372-2g9sq36w	185	8	be	be	VB
cord-342372-2g9sq36w	185	9	assessed	assess	VBN
cord-342372-2g9sq36w	185	10	for	for	IN
cord-342372-2g9sq36w	185	11	possible	possible	JJ
cord-342372-2g9sq36w	185	12	misdiagnosis	misdiagnosis	NN
cord-342372-2g9sq36w	185	13	of	of	IN
cord-342372-2g9sq36w	185	14	KD	KD	NNP
cord-342372-2g9sq36w	185	15	as	as	RB
cord-342372-2g9sq36w	185	16	well	well	RB
cord-342372-2g9sq36w	185	17	(	(	-LRB-
cord-342372-2g9sq36w	185	18	see	see	VB
cord-342372-2g9sq36w	185	19	"	"	``
cord-342372-2g9sq36w	185	20	Diagnostic	Diagnostic	NNP
cord-342372-2g9sq36w	185	21	Challenges	challenge	NNS
cord-342372-2g9sq36w	185	22	"	"	''
cord-342372-2g9sq36w	185	23	section	section	NN
cord-342372-2g9sq36w	185	24	)	)	-RRB-
cord-342372-2g9sq36w	185	25	.	.	.
cord-342372-2g9sq36w	186	1	Patients	patient	NNS
cord-342372-2g9sq36w	186	2	with	with	IN
cord-342372-2g9sq36w	186	3	KD	KD	NNP
cord-342372-2g9sq36w	186	4	who	who	WP
cord-342372-2g9sq36w	186	5	fail	fail	VBP
cord-342372-2g9sq36w	186	6	to	to	TO
cord-342372-2g9sq36w	186	7	respond	respond	VB
cord-342372-2g9sq36w	186	8	to	to	IN
cord-342372-2g9sq36w	186	9	initial	initial	JJ
cord-342372-2g9sq36w	186	10	IVIG	IVIG	NNP
cord-342372-2g9sq36w	186	11	therapy	therapy	NN
cord-342372-2g9sq36w	186	12	should	should	MD
cord-342372-2g9sq36w	186	13	receive	receive	VB
cord-342372-2g9sq36w	186	14	a	a	DT
cord-342372-2g9sq36w	186	15	repeat	repeat	NN
cord-342372-2g9sq36w	186	16	infusion	infusion	NN
cord-342372-2g9sq36w	186	17	of	of	IN
cord-342372-2g9sq36w	186	18	IVIG	IVIG	NNP
cord-342372-2g9sq36w	186	19	at	at	IN
cord-342372-2g9sq36w	186	20	the	the	DT
cord-342372-2g9sq36w	186	21	same	same	JJ
cord-342372-2g9sq36w	186	22	dose	dose	NN
cord-342372-2g9sq36w	186	23	(	(	-LRB-
cord-342372-2g9sq36w	186	24	2	2	CD
cord-342372-2g9sq36w	186	25	gm	gm	NNP
cord-342372-2g9sq36w	186	26	/	/	SYM
cord-342372-2g9sq36w	186	27	kg	kg	NNP
cord-342372-2g9sq36w	186	28	as	as	IN
cord-342372-2g9sq36w	186	29	a	a	DT
cord-342372-2g9sq36w	186	30	single	single	JJ
cord-342372-2g9sq36w	186	31	infusion	infusion	NN
cord-342372-2g9sq36w	186	32	)	)	-RRB-
cord-342372-2g9sq36w	186	33	.	.	.
cord-342372-2g9sq36w	187	1	Retreatment	retreatment	NN
cord-342372-2g9sq36w	187	2	at	at	IN
cord-342372-2g9sq36w	187	3	lower	low	JJR
cord-342372-2g9sq36w	187	4	doses	dose	NNS
cord-342372-2g9sq36w	187	5	(	(	-LRB-
cord-342372-2g9sq36w	187	6	1	1	CD
cord-342372-2g9sq36w	187	7	gm	gm	NNP
cord-342372-2g9sq36w	187	8	/	/	SYM
cord-342372-2g9sq36w	187	9	kg	kg	NNP
cord-342372-2g9sq36w	187	10	)	)	-RRB-
cord-342372-2g9sq36w	187	11	has	have	VBZ
cord-342372-2g9sq36w	187	12	been	be	VBN
cord-342372-2g9sq36w	187	13	associated	associate	VBN
cord-342372-2g9sq36w	187	14	with	with	IN
cord-342372-2g9sq36w	187	15	increased	increase	VBN
cord-342372-2g9sq36w	187	16	risk	risk	NN
cord-342372-2g9sq36w	187	17	of	of	IN
cord-342372-2g9sq36w	187	18	developing	develop	VBG
cord-342372-2g9sq36w	187	19	coronary	coronary	JJ
cord-342372-2g9sq36w	187	20	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	187	21	[	[	-LRB-
cord-342372-2g9sq36w	187	22	38	38	CD
cord-342372-2g9sq36w	187	23	]	]	-RRB-
cord-342372-2g9sq36w	187	24	.	.	.
cord-342372-2g9sq36w	188	1	Pulse	pulse	NN
cord-342372-2g9sq36w	188	2	steroid	steroid	NN
cord-342372-2g9sq36w	188	3	therapy	therapy	NN
cord-342372-2g9sq36w	188	4	in	in	IN
cord-342372-2g9sq36w	188	5	patients	patient	NNS
cord-342372-2g9sq36w	188	6	with	with	IN
cord-342372-2g9sq36w	188	7	KD	KD	NNP
cord-342372-2g9sq36w	188	8	refractory	refractory	JJ
cord-342372-2g9sq36w	188	9	to	to	IN
cord-342372-2g9sq36w	188	10	two	two	CD
cord-342372-2g9sq36w	188	11	IVIG	IVIG	NNP
cord-342372-2g9sq36w	188	12	infusions	infusion	NNS
cord-342372-2g9sq36w	188	13	(	(	-LRB-
cord-342372-2g9sq36w	188	14	2	2	CD
cord-342372-2g9sq36w	188	15	gm	gm	NNP
cord-342372-2g9sq36w	188	16	/	/	SYM
cord-342372-2g9sq36w	188	17	kg	kg	NN
cord-342372-2g9sq36w	188	18	infusion	infusion	NN
cord-342372-2g9sq36w	188	19	followed	follow	VBN
cord-342372-2g9sq36w	188	20	by	by	IN
cord-342372-2g9sq36w	188	21	1	1	CD
cord-342372-2g9sq36w	188	22	gm	gm	NNP
cord-342372-2g9sq36w	188	23	/	/	SYM
cord-342372-2g9sq36w	188	24	kg	kg	NN
cord-342372-2g9sq36w	188	25	infusion	infusion	NN
cord-342372-2g9sq36w	188	26	)	)	-RRB-
cord-342372-2g9sq36w	188	27	has	have	VBZ
cord-342372-2g9sq36w	188	28	been	be	VBN
cord-342372-2g9sq36w	188	29	associated	associate	VBN
cord-342372-2g9sq36w	188	30	with	with	IN
cord-342372-2g9sq36w	188	31	shorter	short	JJR
cord-342372-2g9sq36w	188	32	duration	duration	NN
cord-342372-2g9sq36w	188	33	of	of	IN
cord-342372-2g9sq36w	188	34	fever	fever	NN
cord-342372-2g9sq36w	188	35	and	and	CC
cord-342372-2g9sq36w	188	36	hospital	hospital	NN
cord-342372-2g9sq36w	188	37	stay	stay	NN
cord-342372-2g9sq36w	188	38	when	when	WRB
cord-342372-2g9sq36w	188	39	compared	compare	VBN
cord-342372-2g9sq36w	188	40	to	to	TO
cord-342372-2g9sq36w	188	41	repeat	repeat	VB
cord-342372-2g9sq36w	188	42	1	1	CD
cord-342372-2g9sq36w	188	43	gm	gm	NNP
cord-342372-2g9sq36w	188	44	/	/	SYM
cord-342372-2g9sq36w	188	45	kg	kg	NN
cord-342372-2g9sq36w	188	46	IVIG	IVIG	NNP
cord-342372-2g9sq36w	188	47	infusion	infusion	NN
cord-342372-2g9sq36w	188	48	[	[	-LRB-
cord-342372-2g9sq36w	188	49	39	39	CD
cord-342372-2g9sq36w	188	50	]	]	-RRB-
cord-342372-2g9sq36w	188	51	.	.	.
cord-342372-2g9sq36w	189	1	The	the	DT
cord-342372-2g9sq36w	189	2	use	use	NN
cord-342372-2g9sq36w	189	3	of	of	IN
cord-342372-2g9sq36w	189	4	corticosteroids	corticosteroid	NNS
cord-342372-2g9sq36w	189	5	in	in	IN
cord-342372-2g9sq36w	189	6	patients	patient	NNS
cord-342372-2g9sq36w	189	7	with	with	IN
cord-342372-2g9sq36w	189	8	KD	KD	NNP
cord-342372-2g9sq36w	189	9	is	be	VBZ
cord-342372-2g9sq36w	189	10	currently	currently	RB
cord-342372-2g9sq36w	189	11	reserved	reserve	VBN
cord-342372-2g9sq36w	189	12	for	for	IN
cord-342372-2g9sq36w	189	13	children	child	NNS
cord-342372-2g9sq36w	189	14	who	who	WP
cord-342372-2g9sq36w	189	15	have	have	VBP
cord-342372-2g9sq36w	189	16	received	receive	VBN
cord-342372-2g9sq36w	189	17	≥2	≥2	NNP
cord-342372-2g9sq36w	189	18	infusions	infusion	NNS
cord-342372-2g9sq36w	189	19	of	of	IN
cord-342372-2g9sq36w	189	20	IVIG	IVIG	NNP
cord-342372-2g9sq36w	189	21	on	on	IN
cord-342372-2g9sq36w	189	22	the	the	DT
cord-342372-2g9sq36w	189	23	basis	basis	NN
cord-342372-2g9sq36w	189	24	that	that	IN
cord-342372-2g9sq36w	189	25	effects	effect	NNS
cord-342372-2g9sq36w	189	26	of	of	IN
cord-342372-2g9sq36w	189	27	steroid	steroid	NN
cord-342372-2g9sq36w	189	28	therapy	therapy	NN
cord-342372-2g9sq36w	189	29	on	on	IN
cord-342372-2g9sq36w	189	30	coronary	coronary	JJ
cord-342372-2g9sq36w	189	31	artery	artery	NN
cord-342372-2g9sq36w	189	32	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	189	33	were	be	VBD
cord-342372-2g9sq36w	189	34	uncertain	uncertain	JJ
cord-342372-2g9sq36w	189	35	at	at	IN
cord-342372-2g9sq36w	189	36	the	the	DT
cord-342372-2g9sq36w	189	37	time	time	NN
cord-342372-2g9sq36w	189	38	of	of	IN
cord-342372-2g9sq36w	189	39	publication	publication	NN
cord-342372-2g9sq36w	189	40	of	of	IN
cord-342372-2g9sq36w	189	41	KD	KD	NNP
cord-342372-2g9sq36w	189	42	treatment	treatment	NN
cord-342372-2g9sq36w	189	43	guidelines	guideline	NNS
cord-342372-2g9sq36w	189	44	in	in	IN
cord-342372-2g9sq36w	189	45	2004	2004	CD
cord-342372-2g9sq36w	189	46	.	.	.
cord-342372-2g9sq36w	190	1	The	the	DT
cord-342372-2g9sq36w	190	2	most	most	RBS
cord-342372-2g9sq36w	190	3	commonly	commonly	RB
cord-342372-2g9sq36w	190	4	used	use	VBN
cord-342372-2g9sq36w	190	5	steroid	steroid	NN
cord-342372-2g9sq36w	190	6	regimen	regimen	NN
cord-342372-2g9sq36w	190	7	is	be	VBZ
cord-342372-2g9sq36w	190	8	IV	IV	NNP
cord-342372-2g9sq36w	190	9	methylprednisolone	methylprednisolone	NNP
cord-342372-2g9sq36w	190	10	(	(	-LRB-
cord-342372-2g9sq36w	190	11	IVMP	IVMP	NNP
cord-342372-2g9sq36w	190	12	)	)	-RRB-
cord-342372-2g9sq36w	191	1	30	30	CD
cord-342372-2g9sq36w	191	2	mg	mg	NNP
cord-342372-2g9sq36w	191	3	/	/	SYM
cord-342372-2g9sq36w	191	4	kg	kg	NNP
cord-342372-2g9sq36w	191	5	daily	daily	RB
cord-342372-2g9sq36w	191	6	for	for	IN
cord-342372-2g9sq36w	191	7	1	1	CD
cord-342372-2g9sq36w	191	8	-	-	SYM
cord-342372-2g9sq36w	191	9	3	3	CD
cord-342372-2g9sq36w	191	10	days	day	NNS
cord-342372-2g9sq36w	191	11	[	[	-LRB-
cord-342372-2g9sq36w	191	12	6••	6••	NN
cord-342372-2g9sq36w	191	13	]	]	-RRB-
cord-342372-2g9sq36w	191	14	.	.	.
cord-342372-2g9sq36w	192	1	Further	further	JJ
cord-342372-2g9sq36w	192	2	research	research	NN
cord-342372-2g9sq36w	192	3	into	into	IN
cord-342372-2g9sq36w	192	4	the	the	DT
cord-342372-2g9sq36w	192	5	use	use	NN
cord-342372-2g9sq36w	192	6	of	of	IN
cord-342372-2g9sq36w	192	7	corticosteroids	corticosteroid	NNS
cord-342372-2g9sq36w	192	8	in	in	IN
cord-342372-2g9sq36w	192	9	the	the	DT
cord-342372-2g9sq36w	192	10	primary	primary	JJ
cord-342372-2g9sq36w	192	11	treatment	treatment	NN
cord-342372-2g9sq36w	192	12	of	of	IN
cord-342372-2g9sq36w	192	13	KD	KD	NNP
cord-342372-2g9sq36w	192	14	remains	remain	VBZ
cord-342372-2g9sq36w	192	15	ongoing	ongoing	JJ
cord-342372-2g9sq36w	192	16	.	.	.
cord-342372-2g9sq36w	193	1	In	in	IN
cord-342372-2g9sq36w	193	2	2007	2007	CD
cord-342372-2g9sq36w	193	3	,	,	,
cord-342372-2g9sq36w	193	4	a	a	DT
cord-342372-2g9sq36w	193	5	randomized	randomized	JJ
cord-342372-2g9sq36w	193	6	controlled	control	VBN
cord-342372-2g9sq36w	193	7	trial	trial	NN
cord-342372-2g9sq36w	193	8	by	by	IN
cord-342372-2g9sq36w	193	9	Newburger	Newburger	NNP
cord-342372-2g9sq36w	193	10	et	et	NNP
cord-342372-2g9sq36w	193	11	al	al	NNP
cord-342372-2g9sq36w	193	12	.	.	NNP
cord-342372-2g9sq36w	193	13	showed	show	VBD
cord-342372-2g9sq36w	193	14	that	that	IN
cord-342372-2g9sq36w	193	15	the	the	DT
cord-342372-2g9sq36w	193	16	addition	addition	NN
cord-342372-2g9sq36w	193	17	of	of	IN
cord-342372-2g9sq36w	193	18	one	one	CD
cord-342372-2g9sq36w	193	19	dose	dose	NN
cord-342372-2g9sq36w	193	20	of	of	IN
cord-342372-2g9sq36w	193	21	IVMP	IVMP	NNP
cord-342372-2g9sq36w	193	22	therapy	therapy	NN
cord-342372-2g9sq36w	193	23	to	to	IN
cord-342372-2g9sq36w	193	24	initial	initial	JJ
cord-342372-2g9sq36w	193	25	IVIG	IVIG	NNP
cord-342372-2g9sq36w	193	26	infusion	infusion	NN
cord-342372-2g9sq36w	193	27	did	do	VBD
cord-342372-2g9sq36w	193	28	not	not	RB
cord-342372-2g9sq36w	193	29	reduce	reduce	VB
cord-342372-2g9sq36w	193	30	the	the	DT
cord-342372-2g9sq36w	193	31	prevalence	prevalence	NN
cord-342372-2g9sq36w	193	32	of	of	IN
cord-342372-2g9sq36w	193	33	coronary	coronary	JJ
cord-342372-2g9sq36w	193	34	artery	artery	NN
cord-342372-2g9sq36w	193	35	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	193	36	or	or	CC
cord-342372-2g9sq36w	193	37	total	total	JJ
cord-342372-2g9sq36w	193	38	length	length	NN
cord-342372-2g9sq36w	193	39	of	of	IN
cord-342372-2g9sq36w	193	40	hospital	hospital	NN
cord-342372-2g9sq36w	193	41	stay	stay	NN
cord-342372-2g9sq36w	193	42	[	[	-LRB-
cord-342372-2g9sq36w	193	43	40	40	CD
cord-342372-2g9sq36w	193	44	]	]	-RRB-
cord-342372-2g9sq36w	193	45	.	.	.
cord-342372-2g9sq36w	194	1	In	in	IN
cord-342372-2g9sq36w	194	2	Japan	Japan	NNP
cord-342372-2g9sq36w	194	3	,	,	,
cord-342372-2g9sq36w	194	4	the	the	DT
cord-342372-2g9sq36w	194	5	study	study	NN
cord-342372-2g9sq36w	194	6	on	on	IN
cord-342372-2g9sq36w	194	7	the	the	DT
cord-342372-2g9sq36w	194	8	efficacy	efficacy	NN
cord-342372-2g9sq36w	194	9	of	of	IN
cord-342372-2g9sq36w	194	10	IVIG	IVIG	NNP
cord-342372-2g9sq36w	194	11	and	and	CC
cord-342372-2g9sq36w	194	12	steroids	steroid	NNS
cord-342372-2g9sq36w	194	13	in	in	IN
cord-342372-2g9sq36w	194	14	patients	patient	NNS
cord-342372-2g9sq36w	194	15	with	with	IN
cord-342372-2g9sq36w	194	16	severe	severe	JJ
cord-342372-2g9sq36w	194	17	presentation	presentation	NN
cord-342372-2g9sq36w	194	18	of	of	IN
cord-342372-2g9sq36w	194	19	KD	KD	NNP
cord-342372-2g9sq36w	194	20	(	(	-LRB-
cord-342372-2g9sq36w	194	21	RAISE	raise	VB
cord-342372-2g9sq36w	194	22	study	study	NN
cord-342372-2g9sq36w	194	23	)	)	-RRB-
cord-342372-2g9sq36w	194	24	,	,	,
cord-342372-2g9sq36w	194	25	a	a	DT
cord-342372-2g9sq36w	194	26	multicenter	multicenter	NN
cord-342372-2g9sq36w	194	27	,	,	,
cord-342372-2g9sq36w	194	28	prospective	prospective	JJ
cord-342372-2g9sq36w	194	29	,	,	,
cord-342372-2g9sq36w	194	30	randomized	randomized	JJ
cord-342372-2g9sq36w	194	31	,	,	,
cord-342372-2g9sq36w	194	32	open	open	JJ
cord-342372-2g9sq36w	194	33	-	-	HYPH
cord-342372-2g9sq36w	194	34	label	label	NN
cord-342372-2g9sq36w	194	35	,	,	,
cord-342372-2g9sq36w	194	36	blinded	blind	VBN
cord-342372-2g9sq36w	194	37	-	-	HYPH
cord-342372-2g9sq36w	194	38	endpoints	endpoint	NNS
cord-342372-2g9sq36w	194	39	trial	trial	NN
cord-342372-2g9sq36w	194	40	,	,	,
cord-342372-2g9sq36w	194	41	showed	show	VBD
cord-342372-2g9sq36w	194	42	combination	combination	NN
cord-342372-2g9sq36w	194	43	treatment	treatment	NN
cord-342372-2g9sq36w	194	44	with	with	IN
cord-342372-2g9sq36w	194	45	IVIG	IVIG	NNP
cord-342372-2g9sq36w	194	46	and	and	CC
cord-342372-2g9sq36w	194	47	prednisolone	prednisolone	NN
cord-342372-2g9sq36w	194	48	had	have	VBD
cord-342372-2g9sq36w	194	49	significant	significant	JJ
cord-342372-2g9sq36w	194	50	advantages	advantage	NNS
cord-342372-2g9sq36w	194	51	over	over	IN
cord-342372-2g9sq36w	194	52	IVIG	IVIG	NNP
cord-342372-2g9sq36w	194	53	alone	alone	RB
cord-342372-2g9sq36w	194	54	in	in	IN
cord-342372-2g9sq36w	194	55	the	the	DT
cord-342372-2g9sq36w	194	56	prevention	prevention	NN
cord-342372-2g9sq36w	194	57	of	of	IN
cord-342372-2g9sq36w	194	58	coronary	coronary	JJ
cord-342372-2g9sq36w	194	59	artery	artery	NN
cord-342372-2g9sq36w	194	60	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	194	61	with	with	IN
cord-342372-2g9sq36w	194	62	rapid	rapid	JJ
cord-342372-2g9sq36w	194	63	defervescence	defervescence	NN
cord-342372-2g9sq36w	194	64	of	of	IN
cord-342372-2g9sq36w	194	65	fever	fever	NN
cord-342372-2g9sq36w	194	66	and	and	CC
cord-342372-2g9sq36w	194	67	normalization	normalization	NN
cord-342372-2g9sq36w	194	68	of	of	IN
cord-342372-2g9sq36w	194	69	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	194	70	markers	marker	NNS
cord-342372-2g9sq36w	194	71	[	[	-LRB-
cord-342372-2g9sq36w	194	72	41•	41•	CD
cord-342372-2g9sq36w	194	73	]	]	-RRB-
cord-342372-2g9sq36w	194	74	.	.	.
cord-342372-2g9sq36w	195	1	Severe	severe	JJ
cord-342372-2g9sq36w	195	2	KD	KD	NNP
cord-342372-2g9sq36w	195	3	was	be	VBD
cord-342372-2g9sq36w	195	4	determined	determine	VBN
cord-342372-2g9sq36w	195	5	through	through	IN
cord-342372-2g9sq36w	195	6	a	a	DT
cord-342372-2g9sq36w	195	7	risk	risk	NN
cord-342372-2g9sq36w	195	8	score	score	NN
cord-342372-2g9sq36w	195	9	evaluation	evaluation	NN
cord-342372-2g9sq36w	195	10	of	of	IN
cord-342372-2g9sq36w	195	11	five	five	CD
cord-342372-2g9sq36w	195	12	points	point	NNS
cord-342372-2g9sq36w	195	13	or	or	CC
cord-342372-2g9sq36w	195	14	higher	high	JJR
cord-342372-2g9sq36w	195	15	per	per	IN
cord-342372-2g9sq36w	195	16	Kobayashi	Kobayashi	NNP
cord-342372-2g9sq36w	195	17	risk	risk	NN
cord-342372-2g9sq36w	195	18	score	score	NN
cord-342372-2g9sq36w	195	19	scale	scale	NN
cord-342372-2g9sq36w	195	20	,	,	,
cord-342372-2g9sq36w	195	21	which	which	WDT
cord-342372-2g9sq36w	195	22	predicts	predict	VBZ
cord-342372-2g9sq36w	195	23	a	a	DT
cord-342372-2g9sq36w	195	24	>	>	SYM
cord-342372-2g9sq36w	195	25	30	30	CD
cord-342372-2g9sq36w	195	26	%	%	NN
cord-342372-2g9sq36w	195	27	probably	probably	RB
cord-342372-2g9sq36w	195	28	of	of	IN
cord-342372-2g9sq36w	195	29	nonresponsiveness	nonresponsiveness	NN
cord-342372-2g9sq36w	195	30	to	to	IN
cord-342372-2g9sq36w	195	31	initial	initial	JJ
cord-342372-2g9sq36w	195	32	IVIG	IVIG	NNP
cord-342372-2g9sq36w	195	33	treatment	treatment	NN
cord-342372-2g9sq36w	195	34	(	(	-LRB-
cord-342372-2g9sq36w	195	35	Table	table	NN
cord-342372-2g9sq36w	195	36	2	2	CD
cord-342372-2g9sq36w	195	37	)	)	-RRB-
cord-342372-2g9sq36w	195	38	[	[	-LRB-
cord-342372-2g9sq36w	195	39	42	42	CD
cord-342372-2g9sq36w	195	40	]	]	-RRB-
cord-342372-2g9sq36w	195	41	.	.	.
cord-342372-2g9sq36w	196	1	There	there	EX
cord-342372-2g9sq36w	196	2	were	be	VBD
cord-342372-2g9sq36w	196	3	significant	significant	JJ
cord-342372-2g9sq36w	196	4	differences	difference	NNS
cord-342372-2g9sq36w	196	5	in	in	IN
cord-342372-2g9sq36w	196	6	corticosteroid	corticosteroid	NN
cord-342372-2g9sq36w	196	7	regimen	regimen	NN
cord-342372-2g9sq36w	196	8	between	between	IN
cord-342372-2g9sq36w	196	9	the	the	DT
cord-342372-2g9sq36w	196	10	two	two	CD
cord-342372-2g9sq36w	196	11	trials	trial	NNS
cord-342372-2g9sq36w	196	12	.	.	.
cord-342372-2g9sq36w	197	1	The	the	DT
cord-342372-2g9sq36w	197	2	median	median	JJ
cord-342372-2g9sq36w	197	3	start	start	NN
cord-342372-2g9sq36w	197	4	time	time	NN
cord-342372-2g9sq36w	197	5	of	of	IN
cord-342372-2g9sq36w	197	6	therapy	therapy	NN
cord-342372-2g9sq36w	197	7	in	in	IN
cord-342372-2g9sq36w	197	8	the	the	DT
cord-342372-2g9sq36w	197	9	RAISE	raise	JJ
cord-342372-2g9sq36w	197	10	study	study	NN
cord-342372-2g9sq36w	197	11	was	be	VBD
cord-342372-2g9sq36w	197	12	2	2	CD
cord-342372-2g9sq36w	197	13	days	day	NNS
cord-342372-2g9sq36w	197	14	earlier	early	RBR
cord-342372-2g9sq36w	197	15	than	than	IN
cord-342372-2g9sq36w	197	16	in	in	IN
cord-342372-2g9sq36w	197	17	the	the	DT
cord-342372-2g9sq36w	197	18	trial	trial	NN
cord-342372-2g9sq36w	197	19	by	by	IN
cord-342372-2g9sq36w	197	20	Newburger	Newburger	NNP
cord-342372-2g9sq36w	197	21	et	et	NNP
cord-342372-2g9sq36w	197	22	al	al	NNP
cord-342372-2g9sq36w	197	23	.	.	.
cord-342372-2g9sq36w	198	1	Additionally	additionally	RB
cord-342372-2g9sq36w	198	2	,	,	,
cord-342372-2g9sq36w	198	3	the	the	DT
cord-342372-2g9sq36w	198	4	steroid	steroid	NN
cord-342372-2g9sq36w	198	5	dosage	dosage	NN
cord-342372-2g9sq36w	198	6	of	of	IN
cord-342372-2g9sq36w	198	7	the	the	DT
cord-342372-2g9sq36w	198	8	RAISE	raise	JJ
cord-342372-2g9sq36w	198	9	study	study	NN
cord-342372-2g9sq36w	198	10	was	be	VBD
cord-342372-2g9sq36w	198	11	IV	IV	NNP
cord-342372-2g9sq36w	198	12	prednisone	prednisone	NNP
cord-342372-2g9sq36w	198	13	2	2	CD
cord-342372-2g9sq36w	198	14	mg	mg	NNP
cord-342372-2g9sq36w	198	15	/	/	SYM
cord-342372-2g9sq36w	198	16	kg	kg	NNS
cord-342372-2g9sq36w	198	17	divided	divide	VBD
cord-342372-2g9sq36w	198	18	three	three	CD
cord-342372-2g9sq36w	198	19	times	time	NNS
cord-342372-2g9sq36w	198	20	a	a	DT
cord-342372-2g9sq36w	198	21	day	day	NN
cord-342372-2g9sq36w	198	22	over	over	IN
cord-342372-2g9sq36w	198	23	5	5	CD
cord-342372-2g9sq36w	198	24	days	day	NNS
cord-342372-2g9sq36w	198	25	followed	follow	VBN
cord-342372-2g9sq36w	198	26	by	by	IN
cord-342372-2g9sq36w	198	27	titration	titration	NN
cord-342372-2g9sq36w	198	28	to	to	IN
cord-342372-2g9sq36w	198	29	oral	oral	JJ
cord-342372-2g9sq36w	198	30	prednisolone	prednisolone	NN
cord-342372-2g9sq36w	198	31	dosed	dose	VBN
cord-342372-2g9sq36w	198	32	at	at	IN
cord-342372-2g9sq36w	198	33	2	2	CD
cord-342372-2g9sq36w	198	34	mg	mg	NNP
cord-342372-2g9sq36w	198	35	/	/	SYM
cord-342372-2g9sq36w	198	36	kg	kg	NNP
cord-342372-2g9sq36w	198	37	/	/	SYM
cord-342372-2g9sq36w	198	38	day	day	NN
cord-342372-2g9sq36w	198	39	until	until	IN
cord-342372-2g9sq36w	198	40	resolution	resolution	NN
cord-342372-2g9sq36w	198	41	of	of	IN
cord-342372-2g9sq36w	198	42	fever	fever	NN
cord-342372-2g9sq36w	198	43	and	and	CC
cord-342372-2g9sq36w	198	44	improvement	improvement	NN
cord-342372-2g9sq36w	198	45	in	in	IN
cord-342372-2g9sq36w	198	46	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	198	47	markers	marker	NNS
cord-342372-2g9sq36w	198	48	.	.	.
cord-342372-2g9sq36w	199	1	The	the	DT
cord-342372-2g9sq36w	199	2	median	median	JJ
cord-342372-2g9sq36w	199	3	duration	duration	NN
cord-342372-2g9sq36w	199	4	of	of	IN
cord-342372-2g9sq36w	199	5	steroid	steroid	NN
cord-342372-2g9sq36w	199	6	therapy	therapy	NN
cord-342372-2g9sq36w	199	7	in	in	IN
cord-342372-2g9sq36w	199	8	the	the	DT
cord-342372-2g9sq36w	199	9	RAISE	raise	JJ
cord-342372-2g9sq36w	199	10	study	study	NN
cord-342372-2g9sq36w	199	11	was	be	VBD
cord-342372-2g9sq36w	199	12	21	21	CD
cord-342372-2g9sq36w	199	13	days	day	NNS
cord-342372-2g9sq36w	199	14	.	.	.
cord-342372-2g9sq36w	200	1	This	this	DT
cord-342372-2g9sq36w	200	2	is	be	VBZ
cord-342372-2g9sq36w	200	3	a	a	DT
cord-342372-2g9sq36w	200	4	significant	significant	JJ
cord-342372-2g9sq36w	200	5	increase	increase	NN
cord-342372-2g9sq36w	200	6	in	in	IN
cord-342372-2g9sq36w	200	7	total	total	JJ
cord-342372-2g9sq36w	200	8	steroid	steroid	NN
cord-342372-2g9sq36w	200	9	dose	dose	NN
cord-342372-2g9sq36w	200	10	as	as	IN
cord-342372-2g9sq36w	200	11	compared	compare	VBN
cord-342372-2g9sq36w	200	12	to	to	IN
cord-342372-2g9sq36w	200	13	the	the	DT
cord-342372-2g9sq36w	200	14	single	single	JJ
cord-342372-2g9sq36w	200	15	dose	dose	NN
cord-342372-2g9sq36w	200	16	of	of	IN
cord-342372-2g9sq36w	200	17	30	30	CD
cord-342372-2g9sq36w	200	18	mg	mg	NNP
cord-342372-2g9sq36w	200	19	/	/	SYM
cord-342372-2g9sq36w	200	20	kg	kg	NNP
cord-342372-2g9sq36w	200	21	methylprednisolone	methylprednisolone	NN
cord-342372-2g9sq36w	200	22	in	in	IN
cord-342372-2g9sq36w	200	23	the	the	DT
cord-342372-2g9sq36w	200	24	Newburger	Newburger	NNP
cord-342372-2g9sq36w	200	25	study	study	NN
cord-342372-2g9sq36w	200	26	.	.	.
cord-342372-2g9sq36w	201	1	The	the	DT
cord-342372-2g9sq36w	201	2	earlier	early	JJR
cord-342372-2g9sq36w	201	3	initiation	initiation	NN
cord-342372-2g9sq36w	201	4	of	of	IN
cord-342372-2g9sq36w	201	5	IVIG	IVIG	NNP
cord-342372-2g9sq36w	201	6	and	and	CC
cord-342372-2g9sq36w	201	7	corticosteroid	corticosteroid	NN
cord-342372-2g9sq36w	201	8	therapy	therapy	NN
cord-342372-2g9sq36w	201	9	with	with	IN
cord-342372-2g9sq36w	201	10	subsequent	subsequent	JJ
cord-342372-2g9sq36w	201	11	increased	increase	VBN
cord-342372-2g9sq36w	201	12	steroid	steroid	NN
cord-342372-2g9sq36w	201	13	treatment	treatment	NN
cord-342372-2g9sq36w	201	14	duration	duration	NN
cord-342372-2g9sq36w	201	15	was	be	VBD
cord-342372-2g9sq36w	201	16	associated	associate	VBN
cord-342372-2g9sq36w	201	17	with	with	IN
cord-342372-2g9sq36w	201	18	significantly	significantly	RB
cord-342372-2g9sq36w	201	19	lower	low	JJR
cord-342372-2g9sq36w	201	20	rates	rate	NNS
cord-342372-2g9sq36w	201	21	of	of	IN
cord-342372-2g9sq36w	201	22	coronary	coronary	JJ
cord-342372-2g9sq36w	201	23	artery	artery	NN
cord-342372-2g9sq36w	201	24	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	201	25	in	in	IN
cord-342372-2g9sq36w	201	26	the	the	DT
cord-342372-2g9sq36w	201	27	RAISE	raise	JJ
cord-342372-2g9sq36w	201	28	study	study	NN
cord-342372-2g9sq36w	201	29	.	.	.
cord-342372-2g9sq36w	202	1	This	this	DT
cord-342372-2g9sq36w	202	2	may	may	MD
cord-342372-2g9sq36w	202	3	be	be	VB
cord-342372-2g9sq36w	202	4	a	a	DT
cord-342372-2g9sq36w	202	5	result	result	NN
cord-342372-2g9sq36w	202	6	of	of	IN
cord-342372-2g9sq36w	202	7	early	early	JJ
cord-342372-2g9sq36w	202	8	suppression	suppression	NN
cord-342372-2g9sq36w	202	9	of	of	IN
cord-342372-2g9sq36w	202	10	vasculitis	vasculitis	NN
cord-342372-2g9sq36w	202	11	that	that	WDT
cord-342372-2g9sq36w	202	12	precedes	precede	VBZ
cord-342372-2g9sq36w	202	13	vascular	vascular	JJ
cord-342372-2g9sq36w	202	14	remodeling	remodeling	NN
cord-342372-2g9sq36w	202	15	due	due	IN
cord-342372-2g9sq36w	202	16	to	to	IN
cord-342372-2g9sq36w	202	17	early	early	JJ
cord-342372-2g9sq36w	202	18	initiation	initiation	NN
cord-342372-2g9sq36w	202	19	of	of	IN
cord-342372-2g9sq36w	202	20	corticosteroid	corticosteroid	NN
cord-342372-2g9sq36w	202	21	therapy	therapy	NN
cord-342372-2g9sq36w	202	22	.	.	.
cord-342372-2g9sq36w	203	1	The	the	DT
cord-342372-2g9sq36w	203	2	addition	addition	NN
cord-342372-2g9sq36w	203	3	of	of	IN
cord-342372-2g9sq36w	203	4	corticosteroid	corticosteroid	NN
cord-342372-2g9sq36w	203	5	therapy	therapy	NN
cord-342372-2g9sq36w	203	6	to	to	IN
cord-342372-2g9sq36w	203	7	the	the	DT
cord-342372-2g9sq36w	203	8	initial	initial	JJ
cord-342372-2g9sq36w	203	9	treatment	treatment	NN
cord-342372-2g9sq36w	203	10	regimen	regimen	NN
cord-342372-2g9sq36w	203	11	of	of	IN
cord-342372-2g9sq36w	203	12	KD	KD	NNP
cord-342372-2g9sq36w	203	13	is	be	VBZ
cord-342372-2g9sq36w	203	14	not	not	RB
cord-342372-2g9sq36w	203	15	the	the	DT
cord-342372-2g9sq36w	203	16	standard	standard	NN
cord-342372-2g9sq36w	203	17	of	of	IN
cord-342372-2g9sq36w	203	18	care	care	NN
cord-342372-2g9sq36w	203	19	at	at	IN
cord-342372-2g9sq36w	203	20	this	this	DT
cord-342372-2g9sq36w	203	21	time	time	NN
cord-342372-2g9sq36w	203	22	.	.	.
cord-342372-2g9sq36w	204	1	Infliximab	Infliximab	NNP
cord-342372-2g9sq36w	204	2	(	(	-LRB-
cord-342372-2g9sq36w	204	3	Remicaide	Remicaide	NNP
cord-342372-2g9sq36w	204	4	)	)	-RRB-
cord-342372-2g9sq36w	204	5	,	,	,
cord-342372-2g9sq36w	204	6	a	a	DT
cord-342372-2g9sq36w	204	7	human	human	JJ
cord-342372-2g9sq36w	204	8	monoclonal	monoclonal	JJ
cord-342372-2g9sq36w	204	9	antibody	antibody	NN
cord-342372-2g9sq36w	204	10	against	against	IN
cord-342372-2g9sq36w	204	11	tumor	tumor	NN
cord-342372-2g9sq36w	204	12	necrosis	necrosis	NN
cord-342372-2g9sq36w	204	13	factor	factor	NN
cord-342372-2g9sq36w	204	14	(	(	-LRB-
cord-342372-2g9sq36w	204	15	TNF)-α	TNF)-α	NNP
cord-342372-2g9sq36w	204	16	,	,	,
cord-342372-2g9sq36w	204	17	can	can	MD
cord-342372-2g9sq36w	204	18	be	be	VB
cord-342372-2g9sq36w	204	19	used	use	VBN
cord-342372-2g9sq36w	204	20	in	in	IN
cord-342372-2g9sq36w	204	21	the	the	DT
cord-342372-2g9sq36w	204	22	treatment	treatment	NN
cord-342372-2g9sq36w	204	23	of	of	IN
cord-342372-2g9sq36w	204	24	refractory	refractory	JJ
cord-342372-2g9sq36w	204	25	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	204	26	disease	disease	NN
cord-342372-2g9sq36w	204	27	.	.	.
cord-342372-2g9sq36w	205	1	During	during	IN
cord-342372-2g9sq36w	205	2	the	the	DT
cord-342372-2g9sq36w	205	3	acute	acute	JJ
cord-342372-2g9sq36w	205	4	phase	phase	NN
cord-342372-2g9sq36w	205	5	of	of	IN
cord-342372-2g9sq36w	205	6	KD	KD	NNP
cord-342372-2g9sq36w	205	7	,	,	,
cord-342372-2g9sq36w	205	8	TNF	TNF	NNP
cord-342372-2g9sq36w	205	9	-	-	HYPH
cord-342372-2g9sq36w	205	10	α	α	NNP
cord-342372-2g9sq36w	205	11	is	be	VBZ
cord-342372-2g9sq36w	205	12	markedly	markedly	RB
cord-342372-2g9sq36w	205	13	elevated	elevated	JJ
cord-342372-2g9sq36w	205	14	and	and	CC
cord-342372-2g9sq36w	205	15	degree	degree	NN
cord-342372-2g9sq36w	205	16	of	of	IN
cord-342372-2g9sq36w	205	17	elevation	elevation	NN
cord-342372-2g9sq36w	205	18	has	have	VBZ
cord-342372-2g9sq36w	205	19	been	be	VBN
cord-342372-2g9sq36w	205	20	correlated	correlate	VBN
cord-342372-2g9sq36w	205	21	to	to	IN
cord-342372-2g9sq36w	205	22	the	the	DT
cord-342372-2g9sq36w	205	23	development	development	NN
cord-342372-2g9sq36w	205	24	of	of	IN
cord-342372-2g9sq36w	205	25	coronary	coronary	JJ
cord-342372-2g9sq36w	205	26	artery	artery	NN
cord-342372-2g9sq36w	205	27	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	205	28	[	[	-LRB-
cord-342372-2g9sq36w	205	29	43	43	CD
cord-342372-2g9sq36w	205	30	]	]	-RRB-
cord-342372-2g9sq36w	205	31	.	.	.
cord-342372-2g9sq36w	206	1	The	the	DT
cord-342372-2g9sq36w	206	2	most	most	RBS
cord-342372-2g9sq36w	206	3	commonly	commonly	RB
cord-342372-2g9sq36w	206	4	used	use	VBN
cord-342372-2g9sq36w	206	5	regimen	regimen	NN
cord-342372-2g9sq36w	206	6	is	be	VBZ
cord-342372-2g9sq36w	206	7	one	one	CD
cord-342372-2g9sq36w	206	8	infliximab	infliximab	VBN
cord-342372-2g9sq36w	206	9	infusion	infusion	NN
cord-342372-2g9sq36w	206	10	dosed	dose	VBN
cord-342372-2g9sq36w	206	11	at	at	IN
cord-342372-2g9sq36w	206	12	5	5	CD
cord-342372-2g9sq36w	206	13	mg	mg	NNP
cord-342372-2g9sq36w	206	14	/	/	SYM
cord-342372-2g9sq36w	206	15	kg	kg	NN
cord-342372-2g9sq36w	206	16	.	.	.
cord-342372-2g9sq36w	207	1	Two	two	CD
cord-342372-2g9sq36w	207	2	retrospective	retrospective	JJ
cord-342372-2g9sq36w	207	3	reviews	review	NNS
cord-342372-2g9sq36w	207	4	of	of	IN
cord-342372-2g9sq36w	207	5	patients	patient	NNS
cord-342372-2g9sq36w	207	6	with	with	IN
cord-342372-2g9sq36w	207	7	refractory	refractory	JJ
cord-342372-2g9sq36w	207	8	KD	KD	NNP
cord-342372-2g9sq36w	207	9	treated	treat	VBN
cord-342372-2g9sq36w	207	10	with	with	IN
cord-342372-2g9sq36w	207	11	infliximab	infliximab	NNP
cord-342372-2g9sq36w	207	12	showed	show	VBD
cord-342372-2g9sq36w	207	13	complete	complete	JJ
cord-342372-2g9sq36w	207	14	resolution	resolution	NN
cord-342372-2g9sq36w	207	15	of	of	IN
cord-342372-2g9sq36w	207	16	symptoms	symptom	NNS
cord-342372-2g9sq36w	207	17	in	in	IN
cord-342372-2g9sq36w	207	18	majority	majority	NN
cord-342372-2g9sq36w	207	19	of	of	IN
cord-342372-2g9sq36w	207	20	patients	patient	NNS
cord-342372-2g9sq36w	207	21	with	with	IN
cord-342372-2g9sq36w	207	22	refractory	refractory	JJ
cord-342372-2g9sq36w	207	23	KD	KD	NNP
cord-342372-2g9sq36w	207	24	following	follow	VBG
cord-342372-2g9sq36w	207	25	administration	administration	NN
cord-342372-2g9sq36w	207	26	of	of	IN
cord-342372-2g9sq36w	207	27	infliximab	infliximab	NNP
cord-342372-2g9sq36w	207	28	[	[	-LRB-
cord-342372-2g9sq36w	207	29	44	44	CD
cord-342372-2g9sq36w	207	30	,	,	,
cord-342372-2g9sq36w	207	31	45	45	CD
cord-342372-2g9sq36w	207	32	]	]	-RRB-
cord-342372-2g9sq36w	207	33	.	.	.
cord-342372-2g9sq36w	208	1	Additionally	additionally	RB
cord-342372-2g9sq36w	208	2	,	,	,
cord-342372-2g9sq36w	208	3	a	a	DT
cord-342372-2g9sq36w	208	4	recent	recent	JJ
cord-342372-2g9sq36w	208	5	pilot	pilot	NN
cord-342372-2g9sq36w	208	6	study	study	NN
cord-342372-2g9sq36w	208	7	randomized	randomize	VBD
cord-342372-2g9sq36w	208	8	43	43	CD
cord-342372-2g9sq36w	208	9	patients	patient	NNS
cord-342372-2g9sq36w	208	10	with	with	IN
cord-342372-2g9sq36w	208	11	KD	KD	NNP
cord-342372-2g9sq36w	208	12	refractory	refractory	JJ
cord-342372-2g9sq36w	208	13	to	to	IN
cord-342372-2g9sq36w	208	14	initial	initial	JJ
cord-342372-2g9sq36w	208	15	IVIG	IVIG	NNP
cord-342372-2g9sq36w	208	16	infusion	infusion	NN
cord-342372-2g9sq36w	208	17	to	to	TO
cord-342372-2g9sq36w	208	18	receive	receive	VB
cord-342372-2g9sq36w	208	19	either	either	DT
cord-342372-2g9sq36w	208	20	repeat	repeat	VB
cord-342372-2g9sq36w	208	21	IVIG	IVIG	NNP
cord-342372-2g9sq36w	208	22	(	(	-LRB-
cord-342372-2g9sq36w	208	23	2	2	CD
cord-342372-2g9sq36w	208	24	gm	gm	NNP
cord-342372-2g9sq36w	208	25	/	/	SYM
cord-342372-2g9sq36w	208	26	kg	kg	NNP
cord-342372-2g9sq36w	208	27	)	)	-RRB-
cord-342372-2g9sq36w	208	28	or	or	CC
cord-342372-2g9sq36w	208	29	infliximab	infliximab	NNP
cord-342372-2g9sq36w	208	30	(	(	-LRB-
cord-342372-2g9sq36w	208	31	5	5	CD
cord-342372-2g9sq36w	208	32	mg	mg	NNP
cord-342372-2g9sq36w	208	33	/	/	SYM
cord-342372-2g9sq36w	208	34	kg	kg	NNP
cord-342372-2g9sq36w	208	35	)	)	-RRB-
cord-342372-2g9sq36w	208	36	.	.	.
cord-342372-2g9sq36w	209	1	Treatment	treatment	NN
cord-342372-2g9sq36w	209	2	with	with	IN
cord-342372-2g9sq36w	209	3	infliximab	infliximab	NNP
cord-342372-2g9sq36w	209	4	was	be	VBD
cord-342372-2g9sq36w	209	5	associated	associate	VBN
cord-342372-2g9sq36w	209	6	with	with	IN
cord-342372-2g9sq36w	209	7	shortened	shorten	VBN
cord-342372-2g9sq36w	209	8	duration	duration	NN
cord-342372-2g9sq36w	209	9	of	of	IN
cord-342372-2g9sq36w	209	10	fever	fever	NN
cord-342372-2g9sq36w	209	11	and	and	CC
cord-342372-2g9sq36w	209	12	lengths	length	NNS
cord-342372-2g9sq36w	209	13	of	of	IN
cord-342372-2g9sq36w	209	14	hospitalization	hospitalization	NN
cord-342372-2g9sq36w	209	15	and	and	CC
cord-342372-2g9sq36w	209	16	possible	possible	JJ
cord-342372-2g9sq36w	209	17	reduction	reduction	NN
cord-342372-2g9sq36w	209	18	in	in	IN
cord-342372-2g9sq36w	209	19	the	the	DT
cord-342372-2g9sq36w	209	20	need	need	NN
cord-342372-2g9sq36w	209	21	for	for	IN
cord-342372-2g9sq36w	209	22	retreatment	retreatment	NN
cord-342372-2g9sq36w	209	23	[	[	-LRB-
cord-342372-2g9sq36w	209	24	46•	46•	CD
cord-342372-2g9sq36w	209	25	]	]	-RRB-
cord-342372-2g9sq36w	209	26	.	.	.
cord-342372-2g9sq36w	210	1	The	the	DT
cord-342372-2g9sq36w	210	2	effects	effect	NNS
cord-342372-2g9sq36w	210	3	of	of	IN
cord-342372-2g9sq36w	210	4	infliximab	infliximab	NN
cord-342372-2g9sq36w	210	5	on	on	IN
cord-342372-2g9sq36w	210	6	the	the	DT
cord-342372-2g9sq36w	210	7	development	development	NN
cord-342372-2g9sq36w	210	8	of	of	IN
cord-342372-2g9sq36w	210	9	coronary	coronary	JJ
cord-342372-2g9sq36w	210	10	artery	artery	NN
cord-342372-2g9sq36w	210	11	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	210	12	in	in	IN
cord-342372-2g9sq36w	210	13	KD	KD	NNP
cord-342372-2g9sq36w	210	14	remain	remain	VBP
cord-342372-2g9sq36w	210	15	unclear	unclear	JJ
cord-342372-2g9sq36w	210	16	.	.	.
cord-342372-2g9sq36w	211	1	This	this	DT
cord-342372-2g9sq36w	211	2	study	study	NN
cord-342372-2g9sq36w	211	3	did	do	VBD
cord-342372-2g9sq36w	211	4	not	not	RB
cord-342372-2g9sq36w	211	5	show	show	VB
cord-342372-2g9sq36w	211	6	reduction	reduction	NN
cord-342372-2g9sq36w	211	7	in	in	IN
cord-342372-2g9sq36w	211	8	the	the	DT
cord-342372-2g9sq36w	211	9	development	development	NN
cord-342372-2g9sq36w	211	10	of	of	IN
cord-342372-2g9sq36w	211	11	coronary	coronary	JJ
cord-342372-2g9sq36w	211	12	artery	artery	NN
cord-342372-2g9sq36w	211	13	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	211	14	.	.	.
cord-342372-2g9sq36w	212	1	However	however	RB
cord-342372-2g9sq36w	212	2	,	,	,
cord-342372-2g9sq36w	212	3	regression	regression	NN
cord-342372-2g9sq36w	212	4	in	in	IN
cord-342372-2g9sq36w	212	5	both	both	CC
cord-342372-2g9sq36w	212	6	the	the	DT
cord-342372-2g9sq36w	212	7	progression	progression	NN
cord-342372-2g9sq36w	212	8	of	of	IN
cord-342372-2g9sq36w	212	9	coronary	coronary	JJ
cord-342372-2g9sq36w	212	10	artery	artery	NN
cord-342372-2g9sq36w	212	11	dilation	dilation	NN
cord-342372-2g9sq36w	212	12	/	/	SYM
cord-342372-2g9sq36w	212	13	formation	formation	NN
cord-342372-2g9sq36w	212	14	[	[	-LRB-
cord-342372-2g9sq36w	212	15	44	44	CD
cord-342372-2g9sq36w	212	16	]	]	-RRB-
cord-342372-2g9sq36w	212	17	and	and	CC
cord-342372-2g9sq36w	212	18	the	the	DT
cord-342372-2g9sq36w	212	19	resolution	resolution	NN
cord-342372-2g9sq36w	212	20	of	of	IN
cord-342372-2g9sq36w	212	21	dilated	dilated	JJ
cord-342372-2g9sq36w	212	22	coronary	coronary	JJ
cord-342372-2g9sq36w	212	23	arteries	artery	NNS
cord-342372-2g9sq36w	212	24	[	[	-LRB-
cord-342372-2g9sq36w	212	25	45	45	CD
cord-342372-2g9sq36w	212	26	]	]	-RRB-
cord-342372-2g9sq36w	212	27	following	follow	VBG
cord-342372-2g9sq36w	212	28	infliximab	infliximab	JJ
cord-342372-2g9sq36w	212	29	infusion	infusion	NN
cord-342372-2g9sq36w	212	30	have	have	VBP
cord-342372-2g9sq36w	212	31	been	be	VBN
cord-342372-2g9sq36w	212	32	reported	report	VBN
cord-342372-2g9sq36w	212	33	.	.	.
cord-342372-2g9sq36w	213	1	Therefore	therefore	RB
cord-342372-2g9sq36w	213	2	,	,	,
cord-342372-2g9sq36w	213	3	infliximab	infliximab	NNP
cord-342372-2g9sq36w	213	4	may	may	MD
cord-342372-2g9sq36w	213	5	inhibit	inhibit	VB
cord-342372-2g9sq36w	213	6	progression	progression	NN
cord-342372-2g9sq36w	213	7	of	of	IN
cord-342372-2g9sq36w	213	8	coronary	coronary	JJ
cord-342372-2g9sq36w	213	9	artery	artery	NN
cord-342372-2g9sq36w	213	10	dilation	dilation	NN
cord-342372-2g9sq36w	213	11	and	and	CC
cord-342372-2g9sq36w	213	12	injury	injury	NN
cord-342372-2g9sq36w	213	13	rather	rather	RB
cord-342372-2g9sq36w	213	14	than	than	IN
cord-342372-2g9sq36w	213	15	prevent	prevent	VB
cord-342372-2g9sq36w	213	16	the	the	DT
cord-342372-2g9sq36w	213	17	formation	formation	NN
cord-342372-2g9sq36w	213	18	of	of	IN
cord-342372-2g9sq36w	213	19	coronary	coronary	JJ
cord-342372-2g9sq36w	213	20	artery	artery	NN
cord-342372-2g9sq36w	213	21	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	213	22	[	[	-LRB-
cord-342372-2g9sq36w	213	23	46•	46•	CD
cord-342372-2g9sq36w	213	24	]	]	-RRB-
cord-342372-2g9sq36w	213	25	.	.	.
cord-342372-2g9sq36w	214	1	In	in	IN
cord-342372-2g9sq36w	214	2	a	a	DT
cord-342372-2g9sq36w	214	3	phase	phase	NN
cord-342372-2g9sq36w	214	4	3	3	CD
cord-342372-2g9sq36w	214	5	randomized	randomized	JJ
cord-342372-2g9sq36w	214	6	,	,	,
cord-342372-2g9sq36w	214	7	double	double	JJ
cord-342372-2g9sq36w	214	8	-	-	HYPH
cord-342372-2g9sq36w	214	9	blind	blind	JJ
cord-342372-2g9sq36w	214	10	placebo	placebo	NN
cord-342372-2g9sq36w	214	11	-	-	HYPH
cord-342372-2g9sq36w	214	12	controlled	control	VBN
cord-342372-2g9sq36w	214	13	trial	trial	NN
cord-342372-2g9sq36w	214	14	,	,	,
cord-342372-2g9sq36w	214	15	the	the	DT
cord-342372-2g9sq36w	214	16	addition	addition	NN
cord-342372-2g9sq36w	214	17	of	of	IN
cord-342372-2g9sq36w	214	18	infliximab	infliximab	NNP
cord-342372-2g9sq36w	214	19	did	do	VBD
cord-342372-2g9sq36w	214	20	not	not	RB
cord-342372-2g9sq36w	214	21	reduce	reduce	VB
cord-342372-2g9sq36w	214	22	treatment	treatment	NN
cord-342372-2g9sq36w	214	23	resistance	resistance	NN
cord-342372-2g9sq36w	214	24	of	of	IN
cord-342372-2g9sq36w	214	25	initial	initial	JJ
cord-342372-2g9sq36w	214	26	therapy	therapy	NN
cord-342372-2g9sq36w	214	27	but	but	CC
cord-342372-2g9sq36w	214	28	did	do	VBD
cord-342372-2g9sq36w	214	29	shorten	shorten	VB
cord-342372-2g9sq36w	214	30	fever	fever	NN
cord-342372-2g9sq36w	214	31	duration	duration	NN
cord-342372-2g9sq36w	214	32	,	,	,
cord-342372-2g9sq36w	214	33	time	time	NN
cord-342372-2g9sq36w	214	34	to	to	IN
cord-342372-2g9sq36w	214	35	normalization	normalization	NN
cord-342372-2g9sq36w	214	36	of	of	IN
cord-342372-2g9sq36w	214	37	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	214	38	markers	marker	NNS
cord-342372-2g9sq36w	214	39	(	(	-LRB-
cord-342372-2g9sq36w	214	40	CRP	CRP	NNP
cord-342372-2g9sq36w	214	41	,	,	,
cord-342372-2g9sq36w	214	42	ESR	ESR	NNP
cord-342372-2g9sq36w	214	43	)	)	-RRB-
cord-342372-2g9sq36w	214	44	,	,	,
cord-342372-2g9sq36w	214	45	and	and	CC
cord-342372-2g9sq36w	214	46	had	have	VBD
cord-342372-2g9sq36w	214	47	a	a	DT
cord-342372-2g9sq36w	214	48	larger	large	JJR
cord-342372-2g9sq36w	214	49	decrease	decrease	NN
cord-342372-2g9sq36w	214	50	in	in	IN
cord-342372-2g9sq36w	214	51	the	the	DT
cord-342372-2g9sq36w	214	52	Z	z	NN
cord-342372-2g9sq36w	214	53	score	score	NN
cord-342372-2g9sq36w	214	54	of	of	IN
cord-342372-2g9sq36w	214	55	the	the	DT
cord-342372-2g9sq36w	214	56	left	left	JJ
cord-342372-2g9sq36w	214	57	anterior	anterior	JJ
cord-342372-2g9sq36w	214	58	descending	descend	VBG
cord-342372-2g9sq36w	214	59	coronary	coronary	JJ
cord-342372-2g9sq36w	214	60	artery	artery	NN
cord-342372-2g9sq36w	214	61	[	[	-LRB-
cord-342372-2g9sq36w	214	62	47•	47•	CD
cord-342372-2g9sq36w	214	63	]	]	-RRB-
cord-342372-2g9sq36w	214	64	.	.	.
cord-342372-2g9sq36w	215	1	Currently	currently	RB
cord-342372-2g9sq36w	215	2	,	,	,
cord-342372-2g9sq36w	215	3	there	there	EX
cord-342372-2g9sq36w	215	4	is	be	VBZ
cord-342372-2g9sq36w	215	5	no	no	DT
cord-342372-2g9sq36w	215	6	indication	indication	NN
cord-342372-2g9sq36w	215	7	for	for	IN
cord-342372-2g9sq36w	215	8	the	the	DT
cord-342372-2g9sq36w	215	9	addition	addition	NN
cord-342372-2g9sq36w	215	10	of	of	IN
cord-342372-2g9sq36w	215	11	infliximab	infliximab	NNP
cord-342372-2g9sq36w	215	12	to	to	IN
cord-342372-2g9sq36w	215	13	the	the	DT
cord-342372-2g9sq36w	215	14	initial	initial	JJ
cord-342372-2g9sq36w	215	15	treatment	treatment	NN
cord-342372-2g9sq36w	215	16	regimen	regimen	NN
cord-342372-2g9sq36w	215	17	of	of	IN
cord-342372-2g9sq36w	215	18	uncomplicated	uncomplicated	JJ
cord-342372-2g9sq36w	215	19	KD	KD	NNP
cord-342372-2g9sq36w	215	20	.	.	.
cord-342372-2g9sq36w	216	1	Cyclosporin	Cyclosporin	NNP
cord-342372-2g9sq36w	216	2	A	a	DT
cord-342372-2g9sq36w	216	3	(	(	-LRB-
cord-342372-2g9sq36w	216	4	CsA	csa	NN
cord-342372-2g9sq36w	216	5	)	)	-RRB-
cord-342372-2g9sq36w	216	6	is	be	VBZ
cord-342372-2g9sq36w	216	7	a	a	DT
cord-342372-2g9sq36w	216	8	calcineurin	calcineurin	JJ
cord-342372-2g9sq36w	216	9	inhibitor	inhibitor	NN
cord-342372-2g9sq36w	216	10	,	,	,
cord-342372-2g9sq36w	216	11	which	which	WDT
cord-342372-2g9sq36w	216	12	targets	target	VBZ
cord-342372-2g9sq36w	216	13	the	the	DT
cord-342372-2g9sq36w	216	14	Ca	Ca	NNP
cord-342372-2g9sq36w	216	15	2	2	CD
cord-342372-2g9sq36w	216	16	+	+	SYM
cord-342372-2g9sq36w	216	17	/NFAT	/NFAT	NFP
cord-342372-2g9sq36w	216	18	signaling	signal	VBG
cord-342372-2g9sq36w	216	19	pathway	pathway	NN
cord-342372-2g9sq36w	216	20	.	.	.
cord-342372-2g9sq36w	217	1	This	this	DT
cord-342372-2g9sq36w	217	2	pathway	pathway	NN
cord-342372-2g9sq36w	217	3	is	be	VBZ
cord-342372-2g9sq36w	217	4	associated	associate	VBN
cord-342372-2g9sq36w	217	5	with	with	IN
cord-342372-2g9sq36w	217	6	immune	immune	JJ
cord-342372-2g9sq36w	217	7	hyper	hyper	NN
cord-342372-2g9sq36w	217	8	-	-	NN
cord-342372-2g9sq36w	217	9	reactivity	reactivity	NN
cord-342372-2g9sq36w	217	10	.	.	.
cord-342372-2g9sq36w	218	1	Unresponsiveness	unresponsiveness	NN
cord-342372-2g9sq36w	218	2	to	to	IN
cord-342372-2g9sq36w	218	3	IVIG	IVIG	NNP
cord-342372-2g9sq36w	218	4	therapy	therapy	NN
cord-342372-2g9sq36w	218	5	and	and	CC
cord-342372-2g9sq36w	218	6	coronary	coronary	JJ
cord-342372-2g9sq36w	218	7	artery	artery	NN
cord-342372-2g9sq36w	218	8	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	218	9	in	in	IN
cord-342372-2g9sq36w	218	10	KD	KD	NNP
cord-342372-2g9sq36w	218	11	patients	patient	NNS
cord-342372-2g9sq36w	218	12	have	have	VBP
cord-342372-2g9sq36w	218	13	been	be	VBN
cord-342372-2g9sq36w	218	14	associated	associate	VBN
cord-342372-2g9sq36w	218	15	with	with	IN
cord-342372-2g9sq36w	218	16	single	single	JJ
cord-342372-2g9sq36w	218	17	nucleotide	nucleotide	JJ
cord-342372-2g9sq36w	218	18	polymorphisms	polymorphism	NNS
cord-342372-2g9sq36w	218	19	of	of	IN
cord-342372-2g9sq36w	218	20	genes	gene	NNS
cord-342372-2g9sq36w	218	21	(	(	-LRB-
cord-342372-2g9sq36w	218	22	ITPKC	ITPKC	NNP
cord-342372-2g9sq36w	218	23	,	,	,
cord-342372-2g9sq36w	218	24	CASP3	CASP3	NNP
cord-342372-2g9sq36w	218	25	)	)	-RRB-
cord-342372-2g9sq36w	218	26	which	which	WDT
cord-342372-2g9sq36w	218	27	downregulate	downregulate	VBP
cord-342372-2g9sq36w	218	28	the	the	DT
cord-342372-2g9sq36w	218	29	Ca	Ca	NNP
cord-342372-2g9sq36w	218	30	2	2	CD
cord-342372-2g9sq36w	219	1	+	+	CC
cord-342372-2g9sq36w	219	2	/NFAT	/nfat	NN
cord-342372-2g9sq36w	219	3	signaling	signal	VBG
cord-342372-2g9sq36w	219	4	pathway	pathway	NN
cord-342372-2g9sq36w	219	5	.	.	.
cord-342372-2g9sq36w	220	1	Therefore	therefore	RB
cord-342372-2g9sq36w	220	2	,	,	,
cord-342372-2g9sq36w	220	3	inhibition	inhibition	NN
cord-342372-2g9sq36w	220	4	of	of	IN
cord-342372-2g9sq36w	220	5	the	the	DT
cord-342372-2g9sq36w	221	1	Ca	Ca	NNP
cord-342372-2g9sq36w	221	2	Ca	Ca	NNP
cord-342372-2g9sq36w	221	3	2	2	CD
cord-342372-2g9sq36w	221	4	+	+	CC
cord-342372-2g9sq36w	221	5	/NFAT	/nfat	NN
cord-342372-2g9sq36w	221	6	signaling	signal	VBG
cord-342372-2g9sq36w	221	7	pathway	pathway	NN
cord-342372-2g9sq36w	221	8	through	through	IN
cord-342372-2g9sq36w	221	9	CsA	CsA	NNP
cord-342372-2g9sq36w	221	10	may	may	MD
cord-342372-2g9sq36w	221	11	be	be	VB
cord-342372-2g9sq36w	221	12	considered	consider	VBN
cord-342372-2g9sq36w	221	13	in	in	IN
cord-342372-2g9sq36w	221	14	patients	patient	NNS
cord-342372-2g9sq36w	221	15	with	with	IN
cord-342372-2g9sq36w	221	16	refractory	refractory	JJ
cord-342372-2g9sq36w	221	17	KD	KD	NNP
cord-342372-2g9sq36w	221	18	.	.	.
cord-342372-2g9sq36w	222	1	In	in	IN
cord-342372-2g9sq36w	222	2	a	a	DT
cord-342372-2g9sq36w	222	3	retrospective	retrospective	JJ
cord-342372-2g9sq36w	222	4	review	review	NN
cord-342372-2g9sq36w	222	5	of	of	IN
cord-342372-2g9sq36w	222	6	19	19	CD
cord-342372-2g9sq36w	222	7	patients	patient	NNS
cord-342372-2g9sq36w	222	8	with	with	IN
cord-342372-2g9sq36w	222	9	refractory	refractory	JJ
cord-342372-2g9sq36w	222	10	KD	KD	NNP
cord-342372-2g9sq36w	222	11	treated	treat	VBN
cord-342372-2g9sq36w	222	12	with	with	IN
cord-342372-2g9sq36w	222	13	CsA	CsA	NNP
cord-342372-2g9sq36w	222	14	,	,	,
cord-342372-2g9sq36w	222	15	dosed	dose	VBN
cord-342372-2g9sq36w	222	16	at	at	IN
cord-342372-2g9sq36w	222	17	4	4	CD
cord-342372-2g9sq36w	222	18	mg	mg	NNP
cord-342372-2g9sq36w	222	19	/	/	SYM
cord-342372-2g9sq36w	222	20	kg	kg	NNP
cord-342372-2g9sq36w	222	21	/	/	SYM
cord-342372-2g9sq36w	222	22	day	day	NN
cord-342372-2g9sq36w	222	23	for	for	IN
cord-342372-2g9sq36w	222	24	14	14	CD
cord-342372-2g9sq36w	222	25	days	day	NNS
cord-342372-2g9sq36w	222	26	,	,	,
cord-342372-2g9sq36w	222	27	14/19	14/19	CD
cord-342372-2g9sq36w	222	28	patients	patient	NNS
cord-342372-2g9sq36w	222	29	became	become	VBD
cord-342372-2g9sq36w	222	30	afebrile	afebrile	JJ
cord-342372-2g9sq36w	222	31	within	within	IN
cord-342372-2g9sq36w	222	32	5	5	CD
cord-342372-2g9sq36w	222	33	days	day	NNS
cord-342372-2g9sq36w	222	34	.	.	.
cord-342372-2g9sq36w	223	1	In	in	IN
cord-342372-2g9sq36w	223	2	these	these	DT
cord-342372-2g9sq36w	223	3	patients	patient	NNS
cord-342372-2g9sq36w	223	4	,	,	,
cord-342372-2g9sq36w	223	5	significantly	significantly	RB
cord-342372-2g9sq36w	223	6	lower	low	JJR
cord-342372-2g9sq36w	223	7	serum	serum	NN
cord-342372-2g9sq36w	223	8	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	223	9	cytokines	cytokine	NNS
cord-342372-2g9sq36w	223	10	were	be	VBD
cord-342372-2g9sq36w	223	11	found	find	VBN
cord-342372-2g9sq36w	223	12	[	[	-LRB-
cord-342372-2g9sq36w	223	13	48	48	CD
cord-342372-2g9sq36w	223	14	]	]	-RRB-
cord-342372-2g9sq36w	223	15	.	.	.
cord-342372-2g9sq36w	224	1	A	a	DT
cord-342372-2g9sq36w	224	2	phase	phase	NN
cord-342372-2g9sq36w	224	3	III	iii	CD
cord-342372-2g9sq36w	224	4	multicenter	multicenter	NN
cord-342372-2g9sq36w	224	5	,	,	,
cord-342372-2g9sq36w	224	6	randomized	randomized	JJ
cord-342372-2g9sq36w	224	7	,	,	,
cord-342372-2g9sq36w	224	8	open	open	JJ
cord-342372-2g9sq36w	224	9	-	-	HYPH
cord-342372-2g9sq36w	224	10	label	label	NN
cord-342372-2g9sq36w	224	11	,	,	,
cord-342372-2g9sq36w	224	12	blinded	blinded	JJ
cord-342372-2g9sq36w	224	13	-	-	HYPH
cord-342372-2g9sq36w	224	14	end	end	NN
cord-342372-2g9sq36w	224	15	point	point	NN
cord-342372-2g9sq36w	224	16	trial	trial	NN
cord-342372-2g9sq36w	224	17	to	to	TO
cord-342372-2g9sq36w	224	18	evaluate	evaluate	VB
cord-342372-2g9sq36w	224	19	the	the	DT
cord-342372-2g9sq36w	224	20	efficacy	efficacy	NN
cord-342372-2g9sq36w	224	21	and	and	CC
cord-342372-2g9sq36w	224	22	safety	safety	NN
cord-342372-2g9sq36w	224	23	of	of	IN
cord-342372-2g9sq36w	224	24	immunoglobulin	immunoglobulin	NN
cord-342372-2g9sq36w	224	25	plus	plus	CC
cord-342372-2g9sq36w	224	26	cyclosporin	cyclosporin	NN
cord-342372-2g9sq36w	224	27	A	a	NN
cord-342372-2g9sq36w	224	28	in	in	IN
cord-342372-2g9sq36w	224	29	patients	patient	NNS
cord-342372-2g9sq36w	224	30	with	with	IN
cord-342372-2g9sq36w	224	31	severe	severe	JJ
cord-342372-2g9sq36w	224	32	KD	KD	NNP
cord-342372-2g9sq36w	224	33	(	(	-LRB-
cord-342372-2g9sq36w	224	34	KAICA	KAICA	NNP
cord-342372-2g9sq36w	224	35	trial	trial	NN
cord-342372-2g9sq36w	224	36	)	)	-RRB-
cord-342372-2g9sq36w	224	37	is	be	VBZ
cord-342372-2g9sq36w	224	38	currently	currently	RB
cord-342372-2g9sq36w	224	39	ongoing	ongoing	JJ
cord-342372-2g9sq36w	224	40	in	in	IN
cord-342372-2g9sq36w	224	41	Japan	Japan	NNP
cord-342372-2g9sq36w	224	42	.	.	.
cord-342372-2g9sq36w	225	1	The	the	DT
cord-342372-2g9sq36w	225	2	trial	trial	NN
cord-342372-2g9sq36w	225	3	aims	aim	VBZ
cord-342372-2g9sq36w	225	4	to	to	TO
cord-342372-2g9sq36w	225	5	compare	compare	VB
cord-342372-2g9sq36w	225	6	IVIG	IVIG	NNP
cord-342372-2g9sq36w	225	7	with	with	IN
cord-342372-2g9sq36w	225	8	concurrent	concurrent	JJ
cord-342372-2g9sq36w	225	9	CsA	csa	NN
cord-342372-2g9sq36w	225	10	therapy	therapy	NN
cord-342372-2g9sq36w	225	11	to	to	IN
cord-342372-2g9sq36w	225	12	IVIG	IVIG	NNP
cord-342372-2g9sq36w	225	13	therapy	therapy	NN
cord-342372-2g9sq36w	225	14	alone	alone	RB
cord-342372-2g9sq36w	225	15	in	in	IN
cord-342372-2g9sq36w	225	16	patients	patient	NNS
cord-342372-2g9sq36w	225	17	with	with	IN
cord-342372-2g9sq36w	225	18	severe	severe	JJ
cord-342372-2g9sq36w	225	19	KD	KD	NNP
cord-342372-2g9sq36w	225	20	defined	define	VBN
cord-342372-2g9sq36w	225	21	as	as	IN
cord-342372-2g9sq36w	225	22	a	a	DT
cord-342372-2g9sq36w	225	23	Kobayashi	Kobayashi	NNP
cord-342372-2g9sq36w	225	24	risk	risk	NN
cord-342372-2g9sq36w	225	25	score	score	NN
cord-342372-2g9sq36w	225	26	scale	scale	NN
cord-342372-2g9sq36w	225	27	>	>	XX
cord-342372-2g9sq36w	225	28	5	5	CD
cord-342372-2g9sq36w	225	29	.	.	.
cord-342372-2g9sq36w	226	1	The	the	DT
cord-342372-2g9sq36w	226	2	primary	primary	JJ
cord-342372-2g9sq36w	226	3	endpoint	endpoint	NN
cord-342372-2g9sq36w	226	4	is	be	VBZ
cord-342372-2g9sq36w	226	5	the	the	DT
cord-342372-2g9sq36w	226	6	frequency	frequency	NN
cord-342372-2g9sq36w	226	7	of	of	IN
cord-342372-2g9sq36w	226	8	coronary	coronary	JJ
cord-342372-2g9sq36w	226	9	artery	artery	NN
cord-342372-2g9sq36w	226	10	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	226	11	at	at	IN
cord-342372-2g9sq36w	226	12	12	12	CD
cord-342372-2g9sq36w	226	13	week	week	NN
cord-342372-2g9sq36w	226	14	follow	follow	VB
cord-342372-2g9sq36w	226	15	up	up	RP
cord-342372-2g9sq36w	226	16	[	[	-LRB-
cord-342372-2g9sq36w	226	17	49•	49•	CD
cord-342372-2g9sq36w	226	18	]	]	-RRB-
cord-342372-2g9sq36w	226	19	.	.	.
cord-342372-2g9sq36w	227	1	The	the	DT
cord-342372-2g9sq36w	227	2	dose	dose	NN
cord-342372-2g9sq36w	227	3	of	of	IN
cord-342372-2g9sq36w	227	4	CsA	csa	NN
cord-342372-2g9sq36w	227	5	in	in	IN
cord-342372-2g9sq36w	227	6	the	the	DT
cord-342372-2g9sq36w	227	7	KAICA	KAICA	NNP
cord-342372-2g9sq36w	227	8	trial	trial	NN
cord-342372-2g9sq36w	227	9	is	be	VBZ
cord-342372-2g9sq36w	227	10	5	5	CD
cord-342372-2g9sq36w	227	11	mg	mg	NNP
cord-342372-2g9sq36w	227	12	/	/	SYM
cord-342372-2g9sq36w	227	13	kg	kg	NNP
cord-342372-2g9sq36w	227	14	/	/	SYM
cord-342372-2g9sq36w	227	15	day	day	NN
cord-342372-2g9sq36w	227	16	with	with	IN
cord-342372-2g9sq36w	227	17	a	a	DT
cord-342372-2g9sq36w	227	18	target	target	NN
cord-342372-2g9sq36w	227	19	blood	blood	NN
cord-342372-2g9sq36w	227	20	concentration	concentration	NN
cord-342372-2g9sq36w	227	21	level	level	NN
cord-342372-2g9sq36w	227	22	of	of	IN
cord-342372-2g9sq36w	227	23	60	60	CD
cord-342372-2g9sq36w	227	24	-	-	SYM
cord-342372-2g9sq36w	227	25	200	200	CD
cord-342372-2g9sq36w	227	26	ng	ng	NN
cord-342372-2g9sq36w	227	27	/	/	SYM
cord-342372-2g9sq36w	227	28	mL	ml	NN
cord-342372-2g9sq36w	227	29	for	for	IN
cord-342372-2g9sq36w	227	30	a	a	DT
cord-342372-2g9sq36w	227	31	total	total	NN
cord-342372-2g9sq36w	227	32	of	of	IN
cord-342372-2g9sq36w	227	33	5	5	CD
cord-342372-2g9sq36w	227	34	days	day	NNS
cord-342372-2g9sq36w	227	35	.	.	.
cord-342372-2g9sq36w	228	1	Prevention	prevention	NN
cord-342372-2g9sq36w	228	2	of	of	IN
cord-342372-2g9sq36w	228	3	thrombosis	thrombosis	NN
cord-342372-2g9sq36w	228	4	in	in	IN
cord-342372-2g9sq36w	228	5	patients	patient	NNS
cord-342372-2g9sq36w	228	6	with	with	IN
cord-342372-2g9sq36w	228	7	KD	KD	NNP
cord-342372-2g9sq36w	228	8	varies	vary	VBZ
cord-342372-2g9sq36w	228	9	with	with	IN
cord-342372-2g9sq36w	228	10	the	the	DT
cord-342372-2g9sq36w	228	11	extent	extent	NN
cord-342372-2g9sq36w	228	12	of	of	IN
cord-342372-2g9sq36w	228	13	the	the	DT
cord-342372-2g9sq36w	228	14	coronary	coronary	JJ
cord-342372-2g9sq36w	228	15	artery	artery	NN
cord-342372-2g9sq36w	228	16	abnormality	abnormality	NN
cord-342372-2g9sq36w	228	17	present	present	JJ
cord-342372-2g9sq36w	228	18	in	in	IN
cord-342372-2g9sq36w	228	19	the	the	DT
cord-342372-2g9sq36w	228	20	patient	patient	NN
cord-342372-2g9sq36w	228	21	.	.	.
cord-342372-2g9sq36w	229	1	Low	low	JJ
cord-342372-2g9sq36w	229	2	-	-	HYPH
cord-342372-2g9sq36w	229	3	dose	dose	NN
cord-342372-2g9sq36w	229	4	ASA	ASA	NNP
cord-342372-2g9sq36w	229	5	is	be	VBZ
cord-342372-2g9sq36w	229	6	appropriate	appropriate	JJ
cord-342372-2g9sq36w	229	7	for	for	IN
cord-342372-2g9sq36w	229	8	asymptomatic	asymptomatic	JJ
cord-342372-2g9sq36w	229	9	patients	patient	NNS
cord-342372-2g9sq36w	229	10	with	with	IN
cord-342372-2g9sq36w	229	11	mild	mild	JJ
cord-342372-2g9sq36w	229	12	to	to	IN
cord-342372-2g9sq36w	229	13	stable	stable	JJ
cord-342372-2g9sq36w	229	14	disease	disease	NN
cord-342372-2g9sq36w	229	15	.	.	.
cord-342372-2g9sq36w	230	1	However	however	RB
cord-342372-2g9sq36w	230	2	,	,	,
cord-342372-2g9sq36w	230	3	as	as	IN
cord-342372-2g9sq36w	230	4	the	the	DT
cord-342372-2g9sq36w	230	5	severity	severity	NN
cord-342372-2g9sq36w	230	6	of	of	IN
cord-342372-2g9sq36w	230	7	coronary	coronary	JJ
cord-342372-2g9sq36w	230	8	artery	artery	NN
cord-342372-2g9sq36w	230	9	enlargement	enlargement	NN
cord-342372-2g9sq36w	230	10	increase	increase	NN
cord-342372-2g9sq36w	230	11	,	,	,
cord-342372-2g9sq36w	230	12	the	the	DT
cord-342372-2g9sq36w	230	13	combination	combination	NN
cord-342372-2g9sq36w	230	14	of	of	IN
cord-342372-2g9sq36w	230	15	ASA	ASA	NNP
cord-342372-2g9sq36w	230	16	with	with	IN
cord-342372-2g9sq36w	230	17	other	other	JJ
cord-342372-2g9sq36w	230	18	antiplatelet	antiplatelet	NN
cord-342372-2g9sq36w	230	19	agents	agent	NNS
cord-342372-2g9sq36w	230	20	such	such	JJ
cord-342372-2g9sq36w	230	21	as	as	IN
cord-342372-2g9sq36w	230	22	clopidogrel	clopidogrel	NNP
cord-342372-2g9sq36w	230	23	is	be	VBZ
cord-342372-2g9sq36w	230	24	warranted	warrant	VBN
cord-342372-2g9sq36w	230	25	.	.	.
cord-342372-2g9sq36w	231	1	Additional	additional	JJ
cord-342372-2g9sq36w	231	2	anticoagulation	anticoagulation	NN
cord-342372-2g9sq36w	231	3	is	be	VBZ
cord-342372-2g9sq36w	231	4	necessary	necessary	JJ
cord-342372-2g9sq36w	231	5	with	with	IN
cord-342372-2g9sq36w	231	6	further	further	JJ
cord-342372-2g9sq36w	231	7	coronary	coronary	JJ
cord-342372-2g9sq36w	231	8	aneurysm	aneurysm	NN
cord-342372-2g9sq36w	231	9	expansion	expansion	NN
cord-342372-2g9sq36w	231	10	.	.	.
cord-342372-2g9sq36w	232	1	Frequently	frequently	RB
cord-342372-2g9sq36w	232	2	,	,	,
cord-342372-2g9sq36w	232	3	warfarin	warfarin	NNP
cord-342372-2g9sq36w	232	4	is	be	VBZ
cord-342372-2g9sq36w	232	5	added	add	VBN
cord-342372-2g9sq36w	232	6	to	to	TO
cord-342372-2g9sq36w	232	7	lowdose	lowdose	VB
cord-342372-2g9sq36w	232	8	aspirin	aspirin	NN
cord-342372-2g9sq36w	232	9	for	for	IN
cord-342372-2g9sq36w	232	10	patients	patient	NNS
cord-342372-2g9sq36w	232	11	with	with	IN
cord-342372-2g9sq36w	232	12	giant	giant	JJ
cord-342372-2g9sq36w	232	13	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	232	14	.	.	.
cord-342372-2g9sq36w	233	1	Low	low	JJ
cord-342372-2g9sq36w	233	2	molecular	molecular	JJ
cord-342372-2g9sq36w	233	3	weight	weight	NN
cord-342372-2g9sq36w	233	4	heparin	heparin	NN
cord-342372-2g9sq36w	233	5	has	have	VBZ
cord-342372-2g9sq36w	233	6	also	also	RB
cord-342372-2g9sq36w	233	7	been	be	VBN
cord-342372-2g9sq36w	233	8	used	use	VBN
cord-342372-2g9sq36w	233	9	in	in	IN
cord-342372-2g9sq36w	233	10	place	place	NN
cord-342372-2g9sq36w	233	11	of	of	IN
cord-342372-2g9sq36w	233	12	warfarin	warfarin	NN
cord-342372-2g9sq36w	233	13	by	by	IN
cord-342372-2g9sq36w	233	14	some	some	DT
cord-342372-2g9sq36w	233	15	physicians	physician	NNS
cord-342372-2g9sq36w	233	16	.	.	.
cord-342372-2g9sq36w	234	1	The	the	DT
cord-342372-2g9sq36w	234	2	efficacy	efficacy	NN
cord-342372-2g9sq36w	234	3	of	of	IN
cord-342372-2g9sq36w	234	4	other	other	JJ
cord-342372-2g9sq36w	234	5	anti	anti	JJ
cord-342372-2g9sq36w	234	6	-	-	JJ
cord-342372-2g9sq36w	234	7	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	234	8	agents	agent	NNS
cord-342372-2g9sq36w	234	9	in	in	IN
cord-342372-2g9sq36w	234	10	the	the	DT
cord-342372-2g9sq36w	234	11	treatment	treatment	NN
cord-342372-2g9sq36w	234	12	of	of	IN
cord-342372-2g9sq36w	234	13	KD	KD	NNP
cord-342372-2g9sq36w	234	14	is	be	VBZ
cord-342372-2g9sq36w	234	15	currently	currently	RB
cord-342372-2g9sq36w	234	16	being	be	VBG
cord-342372-2g9sq36w	234	17	investigated	investigate	VBN
cord-342372-2g9sq36w	234	18	.	.	.
cord-342372-2g9sq36w	235	1	Of	of	IN
cord-342372-2g9sq36w	235	2	particular	particular	JJ
cord-342372-2g9sq36w	235	3	interest	interest	NN
cord-342372-2g9sq36w	235	4	is	be	VBZ
cord-342372-2g9sq36w	235	5	the	the	DT
cord-342372-2g9sq36w	235	6	efficacy	efficacy	NN
cord-342372-2g9sq36w	235	7	of	of	IN
cord-342372-2g9sq36w	235	8	these	these	DT
cord-342372-2g9sq36w	235	9	new	new	JJ
cord-342372-2g9sq36w	235	10	agents	agent	NNS
cord-342372-2g9sq36w	235	11	in	in	IN
cord-342372-2g9sq36w	235	12	the	the	DT
cord-342372-2g9sq36w	235	13	KD	KD	NNP
cord-342372-2g9sq36w	235	14	complicated	complicate	VBN
cord-342372-2g9sq36w	235	15	by	by	IN
cord-342372-2g9sq36w	235	16	coronary	coronary	JJ
cord-342372-2g9sq36w	235	17	artery	artery	NN
cord-342372-2g9sq36w	235	18	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	235	19	.	.	.
cord-342372-2g9sq36w	236	1	The	the	DT
cord-342372-2g9sq36w	236	2	current	current	JJ
cord-342372-2g9sq36w	236	3	treatment	treatment	NN
cord-342372-2g9sq36w	236	4	regimen	regimen	NN
cord-342372-2g9sq36w	236	5	of	of	IN
cord-342372-2g9sq36w	236	6	IVIG	IVIG	NNP
cord-342372-2g9sq36w	236	7	and	and	CC
cord-342372-2g9sq36w	236	8	aspirin	aspirin	NN
cord-342372-2g9sq36w	236	9	is	be	VBZ
cord-342372-2g9sq36w	236	10	well	well	RB
cord-342372-2g9sq36w	236	11	documented	document	VBN
cord-342372-2g9sq36w	236	12	to	to	TO
cord-342372-2g9sq36w	236	13	reduce	reduce	VB
cord-342372-2g9sq36w	236	14	the	the	DT
cord-342372-2g9sq36w	236	15	incidence	incidence	NN
cord-342372-2g9sq36w	236	16	of	of	IN
cord-342372-2g9sq36w	236	17	coronary	coronary	JJ
cord-342372-2g9sq36w	236	18	artery	artery	NN
cord-342372-2g9sq36w	236	19	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	236	20	in	in	IN
cord-342372-2g9sq36w	236	21	KD	KD	NNP
cord-342372-2g9sq36w	236	22	,	,	,
cord-342372-2g9sq36w	236	23	but	but	CC
cord-342372-2g9sq36w	236	24	effective	effective	JJ
cord-342372-2g9sq36w	236	25	agents	agent	NNS
cord-342372-2g9sq36w	236	26	in	in	IN
cord-342372-2g9sq36w	236	27	the	the	DT
cord-342372-2g9sq36w	236	28	prevention	prevention	NN
cord-342372-2g9sq36w	236	29	of	of	IN
cord-342372-2g9sq36w	236	30	progression	progression	NN
cord-342372-2g9sq36w	236	31	of	of	IN
cord-342372-2g9sq36w	236	32	coronary	coronary	JJ
cord-342372-2g9sq36w	236	33	artery	artery	NN
cord-342372-2g9sq36w	236	34	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	236	35	are	be	VBP
cord-342372-2g9sq36w	236	36	currently	currently	RB
cord-342372-2g9sq36w	236	37	under	under	IN
cord-342372-2g9sq36w	236	38	investigation	investigation	NN
cord-342372-2g9sq36w	236	39	.	.	.
cord-342372-2g9sq36w	237	1	The	the	DT
cord-342372-2g9sq36w	237	2	IL-1	IL-1	NNP
cord-342372-2g9sq36w	237	3	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	237	4	pathway	pathway	NN
cord-342372-2g9sq36w	237	5	is	be	VBZ
cord-342372-2g9sq36w	237	6	upregulated	upregulate	VBN
cord-342372-2g9sq36w	237	7	in	in	IN
cord-342372-2g9sq36w	237	8	KD	KD	NNP
cord-342372-2g9sq36w	237	9	and	and	CC
cord-342372-2g9sq36w	237	10	involved	involve	VBN
cord-342372-2g9sq36w	237	11	in	in	IN
cord-342372-2g9sq36w	237	12	coronary	coronary	JJ
cord-342372-2g9sq36w	237	13	artery	artery	NN
cord-342372-2g9sq36w	237	14	inflammation	inflammation	NN
cord-342372-2g9sq36w	237	15	.	.	.
cord-342372-2g9sq36w	238	1	Blockade	blockade	NN
cord-342372-2g9sq36w	238	2	of	of	IN
cord-342372-2g9sq36w	238	3	this	this	DT
cord-342372-2g9sq36w	238	4	pathway	pathway	NN
cord-342372-2g9sq36w	238	5	in	in	IN
cord-342372-2g9sq36w	238	6	mouse	mouse	NN
cord-342372-2g9sq36w	238	7	model	model	NN
cord-342372-2g9sq36w	238	8	of	of	IN
cord-342372-2g9sq36w	238	9	KD	KD	NNP
cord-342372-2g9sq36w	238	10	has	have	VBZ
cord-342372-2g9sq36w	238	11	been	be	VBN
cord-342372-2g9sq36w	238	12	shown	show	VBN
cord-342372-2g9sq36w	238	13	to	to	TO
cord-342372-2g9sq36w	238	14	prevent	prevent	VB
cord-342372-2g9sq36w	238	15	the	the	DT
cord-342372-2g9sq36w	238	16	development	development	NN
cord-342372-2g9sq36w	238	17	of	of	IN
cord-342372-2g9sq36w	238	18	coronary	coronary	JJ
cord-342372-2g9sq36w	238	19	artery	artery	NN
cord-342372-2g9sq36w	238	20	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	238	21	[	[	-LRB-
cord-342372-2g9sq36w	238	22	50	50	CD
cord-342372-2g9sq36w	238	23	]	]	-RRB-
cord-342372-2g9sq36w	238	24	.	.	.
cord-342372-2g9sq36w	239	1	Anakinra	Anakinra	NNP
cord-342372-2g9sq36w	239	2	is	be	VBZ
cord-342372-2g9sq36w	239	3	an	an	DT
cord-342372-2g9sq36w	239	4	IL-1	IL-1	NNP
cord-342372-2g9sq36w	239	5	receptor	receptor	NN
cord-342372-2g9sq36w	239	6	antagonist	antagonist	NN
cord-342372-2g9sq36w	239	7	which	which	WDT
cord-342372-2g9sq36w	239	8	has	have	VBZ
cord-342372-2g9sq36w	239	9	be	be	VB
cord-342372-2g9sq36w	239	10	used	use	VBN
cord-342372-2g9sq36w	239	11	in	in	IN
cord-342372-2g9sq36w	239	12	rare	rare	JJ
cord-342372-2g9sq36w	239	13	cases	case	NNS
cord-342372-2g9sq36w	239	14	of	of	IN
cord-342372-2g9sq36w	239	15	refractory	refractory	JJ
cord-342372-2g9sq36w	239	16	KD	KD	NNP
cord-342372-2g9sq36w	239	17	[	[	-LRB-
cord-342372-2g9sq36w	239	18	51	51	CD
cord-342372-2g9sq36w	239	19	,	,	,
cord-342372-2g9sq36w	239	20	52	52	CD
cord-342372-2g9sq36w	239	21	]	]	-RRB-
cord-342372-2g9sq36w	239	22	.	.	.
cord-342372-2g9sq36w	240	1	The	the	DT
cord-342372-2g9sq36w	240	2	ANAKID	ANAKID	NNP
cord-342372-2g9sq36w	240	3	trial	trial	NN
cord-342372-2g9sq36w	240	4	,	,	,
cord-342372-2g9sq36w	240	5	phase	phase	NN
cord-342372-2g9sq36w	240	6	I	I	NNP
cord-342372-2g9sq36w	240	7	/	/	SYM
cord-342372-2g9sq36w	240	8	IIa	IIa	NNP
cord-342372-2g9sq36w	240	9	trial	trial	NN
cord-342372-2g9sq36w	240	10	of	of	IN
cord-342372-2g9sq36w	240	11	anakinra	anakinra	NNP
cord-342372-2g9sq36w	240	12	in	in	IN
cord-342372-2g9sq36w	240	13	KD	KD	NNP
cord-342372-2g9sq36w	240	14	patients	patient	NNS
cord-342372-2g9sq36w	240	15	with	with	IN
cord-342372-2g9sq36w	240	16	coronary	coronary	JJ
cord-342372-2g9sq36w	240	17	artery	artery	NN
cord-342372-2g9sq36w	240	18	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	240	19	,	,	,
cord-342372-2g9sq36w	240	20	is	be	VBZ
cord-342372-2g9sq36w	240	21	ongoing	ongoing	JJ
cord-342372-2g9sq36w	240	22	in	in	IN
cord-342372-2g9sq36w	240	23	the	the	DT
cord-342372-2g9sq36w	240	24	USA	USA	NNP
cord-342372-2g9sq36w	240	25	.	.	.
cord-342372-2g9sq36w	241	1	Subjects	subject	NNS
cord-342372-2g9sq36w	241	2	will	will	MD
cord-342372-2g9sq36w	241	3	receive	receive	VB
cord-342372-2g9sq36w	241	4	a	a	DT
cord-342372-2g9sq36w	241	5	2	2	CD
cord-342372-2g9sq36w	241	6	-	-	HYPH
cord-342372-2g9sq36w	241	7	6-week	6-week	CD
cord-342372-2g9sq36w	241	8	course	course	NN
cord-342372-2g9sq36w	241	9	of	of	IN
cord-342372-2g9sq36w	241	10	daily	daily	JJ
cord-342372-2g9sq36w	241	11	anakinra	anakinra	NNP
cord-342372-2g9sq36w	241	12	injections	injection	NNS
cord-342372-2g9sq36w	241	13	.	.	.
cord-342372-2g9sq36w	242	1	The	the	DT
cord-342372-2g9sq36w	242	2	study	study	NN
cord-342372-2g9sq36w	242	3	aims	aim	VBZ
cord-342372-2g9sq36w	242	4	to	to	TO
cord-342372-2g9sq36w	242	5	evaluate	evaluate	VB
cord-342372-2g9sq36w	242	6	the	the	DT
cord-342372-2g9sq36w	242	7	safety	safety	NN
cord-342372-2g9sq36w	242	8	and	and	CC
cord-342372-2g9sq36w	242	9	tolerability	tolerability	NN
cord-342372-2g9sq36w	242	10	of	of	IN
cord-342372-2g9sq36w	242	11	anakinra	anakinra	NNP
cord-342372-2g9sq36w	242	12	to	to	TO
cord-342372-2g9sq36w	242	13	prevent	prevent	VB
cord-342372-2g9sq36w	242	14	/	/	SYM
cord-342372-2g9sq36w	242	15	attenuate	attenuate	VB
cord-342372-2g9sq36w	242	16	coronary	coronary	JJ
cord-342372-2g9sq36w	242	17	artery	artery	NN
cord-342372-2g9sq36w	242	18	damage	damage	NN
cord-342372-2g9sq36w	242	19	in	in	IN
cord-342372-2g9sq36w	242	20	patients	patient	NNS
cord-342372-2g9sq36w	242	21	with	with	IN
cord-342372-2g9sq36w	242	22	KD	KD	NNP
cord-342372-2g9sq36w	242	23	[	[	-LRB-
cord-342372-2g9sq36w	242	24	53•	53•	CD
cord-342372-2g9sq36w	242	25	]	]	-RRB-
cord-342372-2g9sq36w	242	26	.	.	.
cord-342372-2g9sq36w	243	1	The	the	DT
cord-342372-2g9sq36w	243	2	KAWAKINRA	KAWAKINRA	NNP
cord-342372-2g9sq36w	243	3	trial	trial	NN
cord-342372-2g9sq36w	243	4	,	,	,
cord-342372-2g9sq36w	243	5	a	a	DT
cord-342372-2g9sq36w	243	6	phase	phase	NN
cord-342372-2g9sq36w	243	7	IIa	IIa	NNP
cord-342372-2g9sq36w	243	8	multicenter	multicenter	JJ
cord-342372-2g9sq36w	243	9	trial	trial	NN
cord-342372-2g9sq36w	243	10	of	of	IN
cord-342372-2g9sq36w	243	11	anakinra	anakinra	NNP
cord-342372-2g9sq36w	243	12	in	in	IN
cord-342372-2g9sq36w	243	13	KD	KD	NNP
cord-342372-2g9sq36w	243	14	patients	patient	NNS
cord-342372-2g9sq36w	243	15	who	who	WP
cord-342372-2g9sq36w	243	16	fail	fail	VBP
cord-342372-2g9sq36w	243	17	to	to	TO
cord-342372-2g9sq36w	243	18	respond	respond	VB
cord-342372-2g9sq36w	243	19	to	to	IN
cord-342372-2g9sq36w	243	20	initial	initial	JJ
cord-342372-2g9sq36w	243	21	IVIG	IVIG	NNP
cord-342372-2g9sq36w	243	22	therapy	therapy	NN
cord-342372-2g9sq36w	243	23	(	(	-LRB-
cord-342372-2g9sq36w	243	24	persistent	persistent	JJ
cord-342372-2g9sq36w	243	25	fever	fever	NN
cord-342372-2g9sq36w	243	26	up	up	IN
cord-342372-2g9sq36w	243	27	to	to	IN
cord-342372-2g9sq36w	243	28	48	48	CD
cord-342372-2g9sq36w	243	29	h	h	NN
cord-342372-2g9sq36w	243	30	after	after	IN
cord-342372-2g9sq36w	243	31	infusion	infusion	NN
cord-342372-2g9sq36w	243	32	)	)	-RRB-
cord-342372-2g9sq36w	243	33	,	,	,
cord-342372-2g9sq36w	243	34	is	be	VBZ
cord-342372-2g9sq36w	243	35	currently	currently	RB
cord-342372-2g9sq36w	243	36	enrolling	enrol	VBG
cord-342372-2g9sq36w	243	37	in	in	IN
cord-342372-2g9sq36w	243	38	Europe	Europe	NNP
cord-342372-2g9sq36w	243	39	(	(	-LRB-
cord-342372-2g9sq36w	243	40	Clinicaltrials.gov	Clinicaltrials.gov	NNP
cord-342372-2g9sq36w	243	41	NCT02390596	NCT02390596	NNP
cord-342372-2g9sq36w	243	42	)	)	-RRB-
cord-342372-2g9sq36w	243	43	.	.	.
cord-342372-2g9sq36w	244	1	In	in	IN
cord-342372-2g9sq36w	244	2	addition	addition	NN
cord-342372-2g9sq36w	244	3	to	to	IN
cord-342372-2g9sq36w	244	4	their	-PRON-	PRP$
cord-342372-2g9sq36w	244	5	well	well	RB
cord-342372-2g9sq36w	244	6	-	-	HYPH
cord-342372-2g9sq36w	244	7	documented	document	VBN
cord-342372-2g9sq36w	244	8	cholesterol	cholesterol	NN
cord-342372-2g9sq36w	244	9	lowering	lower	VBG
cord-342372-2g9sq36w	244	10	effects	effect	NNS
cord-342372-2g9sq36w	244	11	,	,	,
cord-342372-2g9sq36w	244	12	statins	statin	NNS
cord-342372-2g9sq36w	244	13	likely	likely	RB
cord-342372-2g9sq36w	244	14	have	have	VBP
cord-342372-2g9sq36w	244	15	anti	anti	JJ
cord-342372-2g9sq36w	244	16	-	-	JJ
cord-342372-2g9sq36w	244	17	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	244	18	and	and	CC
cord-342372-2g9sq36w	244	19	anti	anti	JJ
cord-342372-2g9sq36w	244	20	-	-	JJ
cord-342372-2g9sq36w	244	21	oxidant	oxidant	JJ
cord-342372-2g9sq36w	244	22	effects	effect	NNS
cord-342372-2g9sq36w	244	23	.	.	.
cord-342372-2g9sq36w	245	1	Statins	statin	NNS
cord-342372-2g9sq36w	245	2	have	have	VBP
cord-342372-2g9sq36w	245	3	been	be	VBN
cord-342372-2g9sq36w	245	4	associated	associate	VBN
cord-342372-2g9sq36w	245	5	with	with	IN
cord-342372-2g9sq36w	245	6	reduction	reduction	NN
cord-342372-2g9sq36w	245	7	in	in	IN
cord-342372-2g9sq36w	245	8	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	245	9	markers	marker	NNS
cord-342372-2g9sq36w	245	10	such	such	JJ
cord-342372-2g9sq36w	245	11	as	as	IN
cord-342372-2g9sq36w	245	12	CRP	CRP	NNP
cord-342372-2g9sq36w	245	13	[	[	-LRB-
cord-342372-2g9sq36w	245	14	54	54	CD
cord-342372-2g9sq36w	245	15	]	]	-RRB-
cord-342372-2g9sq36w	245	16	.	.	.
cord-342372-2g9sq36w	246	1	The	the	DT
cord-342372-2g9sq36w	246	2	Cholesterol	cholesterol	NN
cord-342372-2g9sq36w	246	3	and	and	CC
cord-342372-2g9sq36w	246	4	Recurrent	recurrent	JJ
cord-342372-2g9sq36w	246	5	Events	event	NNS
cord-342372-2g9sq36w	246	6	(	(	-LRB-
cord-342372-2g9sq36w	246	7	CARE	care	NN
cord-342372-2g9sq36w	246	8	)	)	-RRB-
cord-342372-2g9sq36w	246	9	trial	trial	NN
cord-342372-2g9sq36w	246	10	found	find	VBD
cord-342372-2g9sq36w	246	11	a	a	DT
cord-342372-2g9sq36w	246	12	higher	high	JJR
cord-342372-2g9sq36w	246	13	risk	risk	NN
cord-342372-2g9sq36w	246	14	of	of	IN
cord-342372-2g9sq36w	246	15	recurrent	recurrent	JJ
cord-342372-2g9sq36w	246	16	myocardial	myocardial	JJ
cord-342372-2g9sq36w	246	17	infarction	infarction	NN
cord-342372-2g9sq36w	246	18	in	in	IN
cord-342372-2g9sq36w	246	19	patients	patient	NNS
cord-342372-2g9sq36w	246	20	with	with	IN
cord-342372-2g9sq36w	246	21	normal	normal	JJ
cord-342372-2g9sq36w	246	22	cholesterol	cholesterol	NN
cord-342372-2g9sq36w	246	23	levels	level	NNS
cord-342372-2g9sq36w	246	24	who	who	WP
cord-342372-2g9sq36w	246	25	received	receive	VBD
cord-342372-2g9sq36w	246	26	placebo	placebo	NN
cord-342372-2g9sq36w	246	27	rather	rather	RB
cord-342372-2g9sq36w	246	28	than	than	IN
cord-342372-2g9sq36w	246	29	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	246	30	[	[	-LRB-
cord-342372-2g9sq36w	246	31	55	55	CD
cord-342372-2g9sq36w	246	32	]	]	-RRB-
cord-342372-2g9sq36w	246	33	.	.	.
cord-342372-2g9sq36w	247	1	The	the	DT
cord-342372-2g9sq36w	247	2	anti	anti	JJ
cord-342372-2g9sq36w	247	3	-	-	JJ
cord-342372-2g9sq36w	247	4	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	247	5	,	,	,
cord-342372-2g9sq36w	247	6	anti	anti	JJ
cord-342372-2g9sq36w	247	7	-	-	JJ
cord-342372-2g9sq36w	247	8	oxidant	oxidant	JJ
cord-342372-2g9sq36w	247	9	,	,	,
cord-342372-2g9sq36w	247	10	and	and	CC
cord-342372-2g9sq36w	247	11	endothelial	endothelial	JJ
cord-342372-2g9sq36w	247	12	healing	healing	NN
cord-342372-2g9sq36w	247	13	properties	property	NNS
cord-342372-2g9sq36w	247	14	of	of	IN
cord-342372-2g9sq36w	247	15	statins	statin	NNS
cord-342372-2g9sq36w	247	16	have	have	VBP
cord-342372-2g9sq36w	247	17	been	be	VBN
cord-342372-2g9sq36w	247	18	postulated	postulate	VBN
cord-342372-2g9sq36w	247	19	to	to	TO
cord-342372-2g9sq36w	247	20	be	be	VB
cord-342372-2g9sq36w	247	21	beneficial	beneficial	JJ
cord-342372-2g9sq36w	247	22	in	in	IN
cord-342372-2g9sq36w	247	23	blocking	block	VBG
cord-342372-2g9sq36w	247	24	the	the	DT
cord-342372-2g9sq36w	247	25	progression	progression	NN
cord-342372-2g9sq36w	247	26	of	of	IN
cord-342372-2g9sq36w	247	27	coronary	coronary	JJ
cord-342372-2g9sq36w	247	28	artery	artery	NN
cord-342372-2g9sq36w	247	29	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	247	30	in	in	IN
cord-342372-2g9sq36w	247	31	KD	KD	NNP
cord-342372-2g9sq36w	247	32	[	[	-LRB-
cord-342372-2g9sq36w	247	33	56•	56•	CD
cord-342372-2g9sq36w	247	34	]	]	-RRB-
cord-342372-2g9sq36w	247	35	.	.	.
cord-342372-2g9sq36w	248	1	Use	use	NN
cord-342372-2g9sq36w	248	2	of	of	IN
cord-342372-2g9sq36w	248	3	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	248	4	in	in	IN
cord-342372-2g9sq36w	248	5	a	a	DT
cord-342372-2g9sq36w	248	6	40-year	40-year	JJ
cord-342372-2g9sq36w	248	7	-	-	HYPH
cord-342372-2g9sq36w	248	8	old	old	JJ
cord-342372-2g9sq36w	248	9	patient	patient	NN
cord-342372-2g9sq36w	248	10	with	with	IN
cord-342372-2g9sq36w	248	11	history	history	NN
cord-342372-2g9sq36w	248	12	of	of	IN
cord-342372-2g9sq36w	248	13	KD	KD	NNP
cord-342372-2g9sq36w	248	14	and	and	CC
cord-342372-2g9sq36w	248	15	giant	giant	JJ
cord-342372-2g9sq36w	248	16	left	leave	VBD
cord-342372-2g9sq36w	248	17	coronary	coronary	JJ
cord-342372-2g9sq36w	248	18	artery	artery	NN
cord-342372-2g9sq36w	248	19	aneurysm	aneurysm	NN
cord-342372-2g9sq36w	248	20	has	have	VBZ
cord-342372-2g9sq36w	248	21	been	be	VBN
cord-342372-2g9sq36w	248	22	shown	show	VBN
cord-342372-2g9sq36w	248	23	to	to	TO
cord-342372-2g9sq36w	248	24	have	have	VB
cord-342372-2g9sq36w	248	25	reduction	reduction	NN
cord-342372-2g9sq36w	248	26	in	in	IN
cord-342372-2g9sq36w	248	27	coronary	coronary	JJ
cord-342372-2g9sq36w	248	28	artery	artery	NN
cord-342372-2g9sq36w	248	29	inflammation	inflammation	NN
cord-342372-2g9sq36w	248	30	[	[	-LRB-
cord-342372-2g9sq36w	248	31	57•	57•	NNP
cord-342372-2g9sq36w	248	32	]	]	-RRB-
cord-342372-2g9sq36w	248	33	.	.	.
cord-342372-2g9sq36w	249	1	Additionally	additionally	RB
cord-342372-2g9sq36w	249	2	,	,	,
cord-342372-2g9sq36w	249	3	treatment	treatment	NN
cord-342372-2g9sq36w	249	4	of	of	IN
cord-342372-2g9sq36w	249	5	13	13	CD
cord-342372-2g9sq36w	249	6	children	child	NNS
cord-342372-2g9sq36w	249	7	with	with	IN
cord-342372-2g9sq36w	249	8	KD	KD	NNP
cord-342372-2g9sq36w	249	9	complicated	complicate	VBN
cord-342372-2g9sq36w	249	10	by	by	IN
cord-342372-2g9sq36w	249	11	medium	medium	NN
cord-342372-2g9sq36w	249	12	to	to	IN
cord-342372-2g9sq36w	249	13	giant	giant	JJ
cord-342372-2g9sq36w	249	14	coronary	coronary	JJ
cord-342372-2g9sq36w	249	15	artery	artery	NN
cord-342372-2g9sq36w	249	16	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	249	17	with	with	IN
cord-342372-2g9sq36w	249	18	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	249	19	resulted	result	VBD
cord-342372-2g9sq36w	249	20	in	in	IN
cord-342372-2g9sq36w	249	21	improvement	improvement	NN
cord-342372-2g9sq36w	249	22	in	in	IN
cord-342372-2g9sq36w	249	23	endothelial	endothelial	JJ
cord-342372-2g9sq36w	249	24	function	function	NN
cord-342372-2g9sq36w	249	25	measured	measure	VBN
cord-342372-2g9sq36w	249	26	by	by	IN
cord-342372-2g9sq36w	249	27	flow	flow	NN
cord-342372-2g9sq36w	249	28	-	-	HYPH
cord-342372-2g9sq36w	249	29	mediated	mediate	VBN
cord-342372-2g9sq36w	249	30	dilation	dilation	NN
cord-342372-2g9sq36w	249	31	and	and	CC
cord-342372-2g9sq36w	249	32	reduction	reduction	NN
cord-342372-2g9sq36w	249	33	in	in	IN
cord-342372-2g9sq36w	249	34	CRP	crp	NN
cord-342372-2g9sq36w	249	35	[	[	-LRB-
cord-342372-2g9sq36w	249	36	58•	58•	CD
cord-342372-2g9sq36w	249	37	]	]	-RRB-
cord-342372-2g9sq36w	249	38	.	.	.
cord-342372-2g9sq36w	250	1	Currently	currently	RB
cord-342372-2g9sq36w	250	2	,	,	,
cord-342372-2g9sq36w	250	3	there	there	EX
cord-342372-2g9sq36w	250	4	is	be	VBZ
cord-342372-2g9sq36w	250	5	a	a	DT
cord-342372-2g9sq36w	250	6	phase	phase	NN
cord-342372-2g9sq36w	250	7	I	-PRON-	PRP
cord-342372-2g9sq36w	250	8	/	/	SYM
cord-342372-2g9sq36w	250	9	IIa	IIa	NNP
cord-342372-2g9sq36w	250	10	dose	dose	NN
cord-342372-2g9sq36w	250	11	escalation	escalation	NN
cord-342372-2g9sq36w	250	12	study	study	NN
cord-342372-2g9sq36w	250	13	of	of	IN
cord-342372-2g9sq36w	250	14	atorvastatin	atorvastatin	NNP
cord-342372-2g9sq36w	250	15	to	to	TO
cord-342372-2g9sq36w	250	16	determine	determine	VB
cord-342372-2g9sq36w	250	17	its	-PRON-	PRP$
cord-342372-2g9sq36w	250	18	safety	safety	NN
cord-342372-2g9sq36w	250	19	,	,	,
cord-342372-2g9sq36w	250	20	pharamacokinetics	pharamacokinetic	NNS
cord-342372-2g9sq36w	250	21	,	,	,
cord-342372-2g9sq36w	250	22	and	and	CC
cord-342372-2g9sq36w	250	23	activity	activity	NN
cord-342372-2g9sq36w	250	24	in	in	IN
cord-342372-2g9sq36w	250	25	children	child	NNS
cord-342372-2g9sq36w	250	26	with	with	IN
cord-342372-2g9sq36w	250	27	acute	acute	JJ
cord-342372-2g9sq36w	250	28	KD	KD	NNP
cord-342372-2g9sq36w	250	29	and	and	CC
cord-342372-2g9sq36w	250	30	coronary	coronary	JJ
cord-342372-2g9sq36w	250	31	artery	artery	NN
cord-342372-2g9sq36w	250	32	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	251	1	(	(	-LRB-
cord-342372-2g9sq36w	251	2	Clinicaltrials.gov	Clinicaltrials.gov	NNP
cord-342372-2g9sq36w	251	3	NCT01431105	NCT01431105	NNP
cord-342372-2g9sq36w	251	4	)	)	-RRB-
cord-342372-2g9sq36w	251	5	.	.	.
cord-342372-2g9sq36w	252	1	The	the	DT
cord-342372-2g9sq36w	252	2	diagnosis	diagnosis	NN
cord-342372-2g9sq36w	252	3	and	and	CC
cord-342372-2g9sq36w	252	4	initial	initial	JJ
cord-342372-2g9sq36w	252	5	treatment	treatment	NN
cord-342372-2g9sq36w	252	6	of	of	IN
cord-342372-2g9sq36w	252	7	KD	KD	NNP
cord-342372-2g9sq36w	252	8	with	with	IN
cord-342372-2g9sq36w	252	9	IVIG	IVIG	NNP
cord-342372-2g9sq36w	252	10	and	and	CC
cord-342372-2g9sq36w	252	11	aspirin	aspirin	NN
cord-342372-2g9sq36w	252	12	remains	remain	VBZ
cord-342372-2g9sq36w	252	13	unchanged	unchanged	JJ
cord-342372-2g9sq36w	252	14	from	from	IN
cord-342372-2g9sq36w	252	15	the	the	DT
cord-342372-2g9sq36w	252	16	2004	2004	CD
cord-342372-2g9sq36w	252	17	American	American	NNP
cord-342372-2g9sq36w	252	18	Heart	Heart	NNP
cord-342372-2g9sq36w	252	19	Association	Association	NNP
cord-342372-2g9sq36w	252	20	(	(	-LRB-
cord-342372-2g9sq36w	252	21	AHA	AHA	NNP
cord-342372-2g9sq36w	252	22	)	)	-RRB-
cord-342372-2g9sq36w	252	23	treatment	treatment	NN
cord-342372-2g9sq36w	252	24	guidelines	guideline	NNS
cord-342372-2g9sq36w	252	25	.	.	.
cord-342372-2g9sq36w	253	1	However	however	RB
cord-342372-2g9sq36w	253	2	,	,	,
cord-342372-2g9sq36w	253	3	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	253	4	challenges	challenge	NNS
cord-342372-2g9sq36w	253	5	exist	exist	VBP
cord-342372-2g9sq36w	253	6	,	,	,
cord-342372-2g9sq36w	253	7	particularly	particularly	RB
cord-342372-2g9sq36w	253	8	in	in	IN
cord-342372-2g9sq36w	253	9	the	the	DT
cord-342372-2g9sq36w	253	10	presentation	presentation	NN
cord-342372-2g9sq36w	253	11	of	of	IN
cord-342372-2g9sq36w	253	12	incomplete	incomplete	JJ
cord-342372-2g9sq36w	253	13	KD	KD	NNP
cord-342372-2g9sq36w	253	14	,	,	,
cord-342372-2g9sq36w	253	15	due	due	JJ
cord-342372-2g9sq36w	253	16	to	to	TO
cord-342372-2g9sq36w	253	17	overlap	overlap	VB
cord-342372-2g9sq36w	253	18	of	of	IN
cord-342372-2g9sq36w	253	19	clinical	clinical	JJ
cord-342372-2g9sq36w	253	20	features	feature	NNS
cord-342372-2g9sq36w	253	21	of	of	IN
cord-342372-2g9sq36w	253	22	KD	KD	NNP
cord-342372-2g9sq36w	253	23	with	with	IN
cord-342372-2g9sq36w	253	24	other	other	JJ
cord-342372-2g9sq36w	253	25	common	common	JJ
cord-342372-2g9sq36w	253	26	pediatric	pediatric	JJ
cord-342372-2g9sq36w	253	27	illnesses	illness	NNS
cord-342372-2g9sq36w	253	28	.	.	.
cord-342372-2g9sq36w	254	1	Prompt	prompt	JJ
cord-342372-2g9sq36w	254	2	treatment	treatment	NN
cord-342372-2g9sq36w	254	3	with	with	IN
cord-342372-2g9sq36w	254	4	IVIG	IVIG	NNP
cord-342372-2g9sq36w	254	5	and	and	CC
cord-342372-2g9sq36w	254	6	aspirin	aspirin	NN
cord-342372-2g9sq36w	254	7	remains	remain	VBZ
cord-342372-2g9sq36w	254	8	the	the	DT
cord-342372-2g9sq36w	254	9	mainstay	mainstay	NN
cord-342372-2g9sq36w	254	10	of	of	IN
cord-342372-2g9sq36w	254	11	treatment	treatment	NN
cord-342372-2g9sq36w	254	12	.	.	.
cord-342372-2g9sq36w	255	1	Treatment	treatment	NN
cord-342372-2g9sq36w	255	2	options	option	NNS
cord-342372-2g9sq36w	255	3	Human	Human	NNP
cord-342372-2g9sq36w	255	4	and	and	CC
cord-342372-2g9sq36w	255	5	Animal	Animal	NNP
cord-342372-2g9sq36w	255	6	Rights	Rights	NNPS
cord-342372-2g9sq36w	255	7	and	and	CC
cord-342372-2g9sq36w	255	8	Informed	Informed	NNP
cord-342372-2g9sq36w	255	9	Consent	Consent	NNP
cord-342372-2g9sq36w	256	1	This	this	DT
cord-342372-2g9sq36w	256	2	article	article	NN
cord-342372-2g9sq36w	256	3	does	do	VBZ
cord-342372-2g9sq36w	256	4	not	not	RB
cord-342372-2g9sq36w	256	5	contain	contain	VB
cord-342372-2g9sq36w	256	6	any	any	DT
cord-342372-2g9sq36w	256	7	studies	study	NNS
cord-342372-2g9sq36w	256	8	with	with	IN
cord-342372-2g9sq36w	256	9	human	human	JJ
cord-342372-2g9sq36w	256	10	or	or	CC
cord-342372-2g9sq36w	256	11	animal	animal	NN
cord-342372-2g9sq36w	256	12	subjects	subject	NNS
cord-342372-2g9sq36w	256	13	performed	perform	VBN
cord-342372-2g9sq36w	256	14	by	by	IN
cord-342372-2g9sq36w	256	15	the	the	DT
cord-342372-2g9sq36w	256	16	author	author	NN
cord-342372-2g9sq36w	256	17	.	.	.
cord-342372-2g9sq36w	257	1	A	a	DT
cord-342372-2g9sq36w	257	2	new	new	JJ
cord-342372-2g9sq36w	257	3	infantile	infantile	JJ
cord-342372-2g9sq36w	257	4	acute	acute	JJ
cord-342372-2g9sq36w	257	5	febrile	febrile	JJ
cord-342372-2g9sq36w	257	6	mucocutaneous	mucocutaneous	JJ
cord-342372-2g9sq36w	257	7	lymph	lymph	NN
cord-342372-2g9sq36w	257	8	node	node	NN
cord-342372-2g9sq36w	257	9	syndrome	syndrome	NN
cord-342372-2g9sq36w	257	10	(	(	-LRB-
cord-342372-2g9sq36w	257	11	MLNS	MLNS	NNP
cord-342372-2g9sq36w	257	12	)	)	-RRB-
cord-342372-2g9sq36w	257	13	prevailing	prevail	VBG
cord-342372-2g9sq36w	257	14	in	in	IN
cord-342372-2g9sq36w	257	15	Japan	Japan	NNP
cord-342372-2g9sq36w	257	16	Long	long	JJ
cord-342372-2g9sq36w	257	17	-	-	HYPH
cord-342372-2g9sq36w	257	18	term	term	NN
cord-342372-2g9sq36w	257	19	consequences	consequence	NNS
cord-342372-2g9sq36w	257	20	of	of	IN
cord-342372-2g9sq36w	257	21	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	257	22	disease	disease	NN
cord-342372-2g9sq36w	257	23	.	.	.
cord-342372-2g9sq36w	258	1	A	a	DT
cord-342372-2g9sq36w	258	2	10-to	10-to	CD
cord-342372-2g9sq36w	258	3	21-year	21-year	JJ
cord-342372-2g9sq36w	258	4	follow	follow	NN
cord-342372-2g9sq36w	258	5	-	-	HYPH
cord-342372-2g9sq36w	258	6	up	up	NN
cord-342372-2g9sq36w	258	7	study	study	NN
cord-342372-2g9sq36w	258	8	of	of	IN
cord-342372-2g9sq36w	258	9	594	594	CD
cord-342372-2g9sq36w	258	10	patients	patient	NNS
cord-342372-2g9sq36w	258	11	Nationwide	nationwide	JJ
cord-342372-2g9sq36w	258	12	survey	survey	NN
cord-342372-2g9sq36w	258	13	of	of	IN
cord-342372-2g9sq36w	258	14	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	258	15	disease	disease	NN
cord-342372-2g9sq36w	258	16	and	and	CC
cord-342372-2g9sq36w	258	17	acute	acute	JJ
cord-342372-2g9sq36w	258	18	rheumatic	rheumatic	JJ
cord-342372-2g9sq36w	258	19	fever	fever	NN
cord-342372-2g9sq36w	259	1	The	the	DT
cord-342372-2g9sq36w	259	2	treatment	treatment	NN
cord-342372-2g9sq36w	259	3	of	of	IN
cord-342372-2g9sq36w	259	4	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	259	5	syndrome	syndrome	NN
cord-342372-2g9sq36w	259	6	with	with	IN
cord-342372-2g9sq36w	259	7	intravenous	intravenous	JJ
cord-342372-2g9sq36w	259	8	gamma	gamma	NN
cord-342372-2g9sq36w	259	9	globulin	globulin	NN
cord-342372-2g9sq36w	260	1	This	this	DT
cord-342372-2g9sq36w	260	2	report	report	NN
cord-342372-2g9sq36w	260	3	provides	provide	VBZ
cord-342372-2g9sq36w	260	4	the	the	DT
cord-342372-2g9sq36w	260	5	most	most	RBS
cord-342372-2g9sq36w	260	6	recent	recent	JJ
cord-342372-2g9sq36w	260	7	epidemiological	epidemiological	JJ
cord-342372-2g9sq36w	260	8	data	datum	NNS
cord-342372-2g9sq36w	260	9	which	which	WDT
cord-342372-2g9sq36w	260	10	postulates	postulate	VBZ
cord-342372-2g9sq36w	260	11	the	the	DT
cord-342372-2g9sq36w	260	12	source	source	NN
cord-342372-2g9sq36w	260	13	of	of	IN
cord-342372-2g9sq36w	260	14	the	the	DT
cord-342372-2g9sq36w	260	15	etiologic	etiologic	JJ
cord-342372-2g9sq36w	260	16	agent	agent	NN
cord-342372-2g9sq36w	260	17	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	260	18	disease	disease	NN
cord-342372-2g9sq36w	260	19	Diagnosis	Diagnosis	NNP
cord-342372-2g9sq36w	260	20	,	,	,
cord-342372-2g9sq36w	260	21	treatment	treatment	NN
cord-342372-2g9sq36w	260	22	,	,	,
cord-342372-2g9sq36w	260	23	and	and	CC
cord-342372-2g9sq36w	260	24	long	long	JJ
cord-342372-2g9sq36w	260	25	-	-	HYPH
cord-342372-2g9sq36w	260	26	term	term	NN
cord-342372-2g9sq36w	260	27	management	management	NN
cord-342372-2g9sq36w	260	28	of	of	IN
cord-342372-2g9sq36w	260	29	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	260	30	disease	disease	NN
cord-342372-2g9sq36w	260	31	:	:	:
cord-342372-2g9sq36w	260	32	a	a	DT
cord-342372-2g9sq36w	260	33	statement	statement	NN
cord-342372-2g9sq36w	260	34	for	for	IN
cord-342372-2g9sq36w	260	35	health	health	NN
cord-342372-2g9sq36w	260	36	professionals	professional	NNS
cord-342372-2g9sq36w	260	37	from	from	IN
cord-342372-2g9sq36w	260	38	the	the	DT
cord-342372-2g9sq36w	260	39	Committee	Committee	NNP
cord-342372-2g9sq36w	260	40	on	on	IN
cord-342372-2g9sq36w	260	41	Rheumatic	Rheumatic	NNP
cord-342372-2g9sq36w	260	42	Fever	Fever	NNP
cord-342372-2g9sq36w	260	43	,	,	,
cord-342372-2g9sq36w	260	44	Endocarditis	Endocarditis	NNP
cord-342372-2g9sq36w	260	45	,	,	,
cord-342372-2g9sq36w	260	46	and	and	CC
cord-342372-2g9sq36w	260	47	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	260	48	Disease	Disease	NNP
cord-342372-2g9sq36w	260	49	,	,	,
cord-342372-2g9sq36w	260	50	Council	Council	NNP
cord-342372-2g9sq36w	260	51	on	on	IN
cord-342372-2g9sq36w	260	52	Cardiovascular	Cardiovascular	NNP
cord-342372-2g9sq36w	260	53	Disease	Disease	NNP
cord-342372-2g9sq36w	260	54	in	in	IN
cord-342372-2g9sq36w	260	55	the	the	DT
cord-342372-2g9sq36w	260	56	Young	Young	NNP
cord-342372-2g9sq36w	261	1	This	this	DT
cord-342372-2g9sq36w	261	2	report	report	NN
cord-342372-2g9sq36w	261	3	provides	provide	VBZ
cord-342372-2g9sq36w	261	4	a	a	DT
cord-342372-2g9sq36w	261	5	current	current	JJ
cord-342372-2g9sq36w	261	6	and	and	CC
cord-342372-2g9sq36w	261	7	comprehensive	comprehensive	JJ
cord-342372-2g9sq36w	261	8	summary	summary	NN
cord-342372-2g9sq36w	261	9	of	of	IN
cord-342372-2g9sq36w	261	10	the	the	DT
cord-342372-2g9sq36w	261	11	current	current	JJ
cord-342372-2g9sq36w	261	12	global	global	JJ
cord-342372-2g9sq36w	261	13	epidemiology	epidemiology	NN
cord-342372-2g9sq36w	261	14	of	of	IN
cord-342372-2g9sq36w	261	15	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	16	disease	disease	NN
cord-342372-2g9sq36w	261	17	Epidemiology	epidemiology	NN
cord-342372-2g9sq36w	261	18	of	of	IN
cord-342372-2g9sq36w	261	19	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	20	disease	disease	NN
cord-342372-2g9sq36w	261	21	in	in	IN
cord-342372-2g9sq36w	261	22	Asia	Asia	NNP
cord-342372-2g9sq36w	261	23	,	,	,
cord-342372-2g9sq36w	261	24	Europe	Europe	NNP
cord-342372-2g9sq36w	261	25	,	,	,
cord-342372-2g9sq36w	261	26	and	and	CC
cord-342372-2g9sq36w	261	27	the	the	DT
cord-342372-2g9sq36w	261	28	United	United	NNP
cord-342372-2g9sq36w	261	29	States	States	NNP
cord-342372-2g9sq36w	261	30	Racial	Racial	NNP
cord-342372-2g9sq36w	261	31	/	/	SYM
cord-342372-2g9sq36w	261	32	ethnic	ethnic	JJ
cord-342372-2g9sq36w	261	33	differences	difference	NNS
cord-342372-2g9sq36w	261	34	in	in	IN
cord-342372-2g9sq36w	261	35	the	the	DT
cord-342372-2g9sq36w	261	36	incidence	incidence	NN
cord-342372-2g9sq36w	261	37	of	of	IN
cord-342372-2g9sq36w	261	38	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	39	syndrome	syndrome	NN
cord-342372-2g9sq36w	261	40	among	among	IN
cord-342372-2g9sq36w	261	41	children	child	NNS
cord-342372-2g9sq36w	261	42	in	in	IN
cord-342372-2g9sq36w	261	43	Hawaii	Hawaii	NNP
cord-342372-2g9sq36w	261	44	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	45	disease	disease	NN
cord-342372-2g9sq36w	261	46	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	47	disease	disease	NN
cord-342372-2g9sq36w	261	48	:	:	:
cord-342372-2g9sq36w	261	49	novel	novel	JJ
cord-342372-2g9sq36w	261	50	insights	insight	NNS
cord-342372-2g9sq36w	261	51	into	into	IN
cord-342372-2g9sq36w	261	52	etiology	etiology	NN
cord-342372-2g9sq36w	261	53	and	and	CC
cord-342372-2g9sq36w	261	54	genetic	genetic	JJ
cord-342372-2g9sq36w	261	55	susceptibility	susceptibility	NN
cord-342372-2g9sq36w	261	56	Update	update	NN
cord-342372-2g9sq36w	261	57	on	on	IN
cord-342372-2g9sq36w	261	58	etio	etio	NNP
cord-342372-2g9sq36w	261	59	and	and	CC
cord-342372-2g9sq36w	261	60	immunopathogenesis	immunopathogenesis	NNP
cord-342372-2g9sq36w	261	61	of	of	IN
cord-342372-2g9sq36w	261	62	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	63	disease	disease	NN
cord-342372-2g9sq36w	261	64	Update	update	NN
cord-342372-2g9sq36w	261	65	on	on	IN
cord-342372-2g9sq36w	261	66	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	261	67	disease	disease	NN
cord-342372-2g9sq36w	261	68	:	:	:
cord-342372-2g9sq36w	261	69	epidemiology	epidemiology	NN
cord-342372-2g9sq36w	261	70	,	,	,
cord-342372-2g9sq36w	261	71	aetiology	aetiology	NN
cord-342372-2g9sq36w	261	72	and	and	CC
cord-342372-2g9sq36w	261	73	pathogenesis	pathogenesis	NN
cord-342372-2g9sq36w	262	1	Three	three	CD
cord-342372-2g9sq36w	262	2	linked	link	VBN
cord-342372-2g9sq36w	262	3	vasculopathic	vasculopathic	JJ
cord-342372-2g9sq36w	262	4	processes	process	NNS
cord-342372-2g9sq36w	262	5	characterize	characterize	VBP
cord-342372-2g9sq36w	262	6	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	262	7	disease	disease	NN
cord-342372-2g9sq36w	262	8	:	:	:
cord-342372-2g9sq36w	262	9	a	a	DT
cord-342372-2g9sq36w	262	10	light	light	NN
cord-342372-2g9sq36w	262	11	and	and	CC
cord-342372-2g9sq36w	262	12	transmission	transmission	NN
cord-342372-2g9sq36w	262	13	electron	electron	NN
cord-342372-2g9sq36w	262	14	microscopic	microscopic	JJ
cord-342372-2g9sq36w	262	15	study	study	NN
cord-342372-2g9sq36w	262	16	Active	active	JJ
cord-342372-2g9sq36w	262	17	remodeling	remodeling	NN
cord-342372-2g9sq36w	262	18	of	of	IN
cord-342372-2g9sq36w	262	19	the	the	DT
cord-342372-2g9sq36w	262	20	coronary	coronary	JJ
cord-342372-2g9sq36w	262	21	arterial	arterial	JJ
cord-342372-2g9sq36w	262	22	lesions	lesion	NNS
cord-342372-2g9sq36w	262	23	in	in	IN
cord-342372-2g9sq36w	262	24	the	the	DT
cord-342372-2g9sq36w	262	25	late	late	JJ
cord-342372-2g9sq36w	262	26	phase	phase	NN
cord-342372-2g9sq36w	262	27	of	of	IN
cord-342372-2g9sq36w	262	28	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	262	29	disease	disease	NN
cord-342372-2g9sq36w	262	30	:	:	:
cord-342372-2g9sq36w	262	31	immunohistochemical	immunohistochemical	JJ
cord-342372-2g9sq36w	262	32	study	study	NN
cord-342372-2g9sq36w	262	33	Regression	regression	NN
cord-342372-2g9sq36w	262	34	of	of	IN
cord-342372-2g9sq36w	262	35	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	262	36	in	in	IN
cord-342372-2g9sq36w	262	37	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	262	38	disease	disease	NN
cord-342372-2g9sq36w	262	39	:	:	:
cord-342372-2g9sq36w	262	40	a	a	DT
cord-342372-2g9sq36w	262	41	pathological	pathological	JJ
cord-342372-2g9sq36w	262	42	study	study	NN
cord-342372-2g9sq36w	262	43	Regression	regression	NN
cord-342372-2g9sq36w	262	44	of	of	IN
cord-342372-2g9sq36w	262	45	coronary	coronary	JJ
cord-342372-2g9sq36w	262	46	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	262	47	in	in	IN
cord-342372-2g9sq36w	262	48	patients	patient	NNS
cord-342372-2g9sq36w	262	49	with	with	IN
cord-342372-2g9sq36w	262	50	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	262	51	syndrome	syndrome	NN
cord-342372-2g9sq36w	263	1	This	this	DT
cord-342372-2g9sq36w	263	2	retrospective	retrospective	JJ
cord-342372-2g9sq36w	263	3	review	review	NN
cord-342372-2g9sq36w	263	4	compares	compare	VBZ
cord-342372-2g9sq36w	263	5	the	the	DT
cord-342372-2g9sq36w	263	6	main	main	JJ
cord-342372-2g9sq36w	263	7	clinical	clinical	JJ
cord-342372-2g9sq36w	263	8	presentation	presentation	NN
cord-342372-2g9sq36w	263	9	,	,	,
cord-342372-2g9sq36w	263	10	echocardiogram	echocardiogram	NN
cord-342372-2g9sq36w	263	11	and	and	CC
cord-342372-2g9sq36w	263	12	laboratory	laboratory	NN
cord-342372-2g9sq36w	263	13	findings	finding	NNS
cord-342372-2g9sq36w	263	14	as	as	RB
cord-342372-2g9sq36w	263	15	well	well	RB
cord-342372-2g9sq36w	263	16	as	as	IN
cord-342372-2g9sq36w	263	17	treatment	treatment	NN
cord-342372-2g9sq36w	263	18	options	option	NNS
cord-342372-2g9sq36w	263	19	of	of	IN
cord-342372-2g9sq36w	263	20	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	263	21	shock	shock	NN
cord-342372-2g9sq36w	263	22	syndrome	syndrome	NN
cord-342372-2g9sq36w	263	23	which	which	WDT
cord-342372-2g9sq36w	263	24	is	be	VBZ
cord-342372-2g9sq36w	263	25	a	a	DT
cord-342372-2g9sq36w	263	26	rare	rare	JJ
cord-342372-2g9sq36w	263	27	presentation	presentation	NN
cord-342372-2g9sq36w	263	28	of	of	IN
cord-342372-2g9sq36w	263	29	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	263	30	disease	disease	NN
cord-342372-2g9sq36w	263	31	Adenovirus	Adenovirus	NNP
cord-342372-2g9sq36w	263	32	infections	infection	NNS
cord-342372-2g9sq36w	263	33	in	in	IN
cord-342372-2g9sq36w	263	34	young	young	JJ
cord-342372-2g9sq36w	263	35	children	child	NNS
cord-342372-2g9sq36w	263	36	Epidemiology	epidemiology	NN
cord-342372-2g9sq36w	263	37	of	of	IN
cord-342372-2g9sq36w	263	38	viral	viral	JJ
cord-342372-2g9sq36w	263	39	respiratory	respiratory	JJ
cord-342372-2g9sq36w	263	40	tract	tract	NN
cord-342372-2g9sq36w	263	41	infections	infection	NNS
cord-342372-2g9sq36w	263	42	in	in	IN
cord-342372-2g9sq36w	263	43	a	a	DT
cord-342372-2g9sq36w	263	44	prospective	prospective	JJ
cord-342372-2g9sq36w	263	45	cohort	cohort	NN
cord-342372-2g9sq36w	263	46	of	of	IN
cord-342372-2g9sq36w	263	47	infants	infant	NNS
cord-342372-2g9sq36w	263	48	and	and	CC
cord-342372-2g9sq36w	263	49	toddlers	toddler	NNS
cord-342372-2g9sq36w	263	50	attending	attend	VBG
cord-342372-2g9sq36w	263	51	daycare	daycare	NN
cord-342372-2g9sq36w	264	1	This	this	DT
cord-342372-2g9sq36w	264	2	report	report	NN
cord-342372-2g9sq36w	264	3	provides	provide	VBZ
cord-342372-2g9sq36w	264	4	a	a	DT
cord-342372-2g9sq36w	264	5	summary	summary	NN
cord-342372-2g9sq36w	264	6	of	of	IN
cord-342372-2g9sq36w	264	7	the	the	DT
cord-342372-2g9sq36w	264	8	clinical	clinical	JJ
cord-342372-2g9sq36w	264	9	and	and	CC
cord-342372-2g9sq36w	264	10	microbiological	microbiological	JJ
cord-342372-2g9sq36w	264	11	characteristics	characteristic	NNS
cord-342372-2g9sq36w	264	12	which	which	WDT
cord-342372-2g9sq36w	264	13	may	may	MD
cord-342372-2g9sq36w	264	14	aid	aid	VB
cord-342372-2g9sq36w	264	15	in	in	IN
cord-342372-2g9sq36w	264	16	the	the	DT
cord-342372-2g9sq36w	264	17	differentiation	differentiation	NN
cord-342372-2g9sq36w	264	18	of	of	IN
cord-342372-2g9sq36w	264	19	incidental	incidental	JJ
cord-342372-2g9sq36w	264	20	adenovirus	adenovirus	NN
cord-342372-2g9sq36w	264	21	detection	detection	NN
cord-342372-2g9sq36w	265	1	This	this	DT
cord-342372-2g9sq36w	265	2	retrospective	retrospective	JJ
cord-342372-2g9sq36w	265	3	review	review	NN
cord-342372-2g9sq36w	265	4	identifies	identify	VBZ
cord-342372-2g9sq36w	265	5	characteristics	characteristic	NNS
cord-342372-2g9sq36w	265	6	differentiating	differentiate	VBG
cord-342372-2g9sq36w	265	7	the	the	DT
cord-342372-2g9sq36w	265	8	node	node	NN
cord-342372-2g9sq36w	265	9	-	-	HYPH
cord-342372-2g9sq36w	265	10	first	first	JJ
cord-342372-2g9sq36w	265	11	presentation	presentation	NN
cord-342372-2g9sq36w	265	12	of	of	IN
cord-342372-2g9sq36w	265	13	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	265	14	disease	disease	NN
cord-342372-2g9sq36w	265	15	from	from	IN
cord-342372-2g9sq36w	265	16	bacterial	bacterial	JJ
cord-342372-2g9sq36w	265	17	cervical	cervical	JJ
cord-342372-2g9sq36w	265	18	lymphadenitis	lymphadenitis	NN
cord-342372-2g9sq36w	265	19	and	and	CC
cord-342372-2g9sq36w	265	20	typical	typical	JJ
cord-342372-2g9sq36w	265	21	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	265	22	disease	disease	NN
cord-342372-2g9sq36w	265	23	to	to	TO
cord-342372-2g9sq36w	265	24	aid	aid	VB
cord-342372-2g9sq36w	265	25	the	the	DT
cord-342372-2g9sq36w	265	26	recognization	recognization	NN
cord-342372-2g9sq36w	265	27	and	and	CC
cord-342372-2g9sq36w	265	28	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	265	29	disease	disease	NN
cord-342372-2g9sq36w	265	30	mimicking	mimic	VBG
cord-342372-2g9sq36w	265	31	retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	265	32	abscess	abscess	NN
cord-342372-2g9sq36w	265	33	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	265	34	disease	disease	NN
cord-342372-2g9sq36w	265	35	resembling	resemble	VBG
cord-342372-2g9sq36w	265	36	a	a	DT
cord-342372-2g9sq36w	265	37	retropharyngeal	retropharyngeal	NN
cord-342372-2g9sq36w	265	38	abscess	abscess	NN
cord-342372-2g9sq36w	265	39	-	-	HYPH
cord-342372-2g9sq36w	265	40	case	case	NN
cord-342372-2g9sq36w	265	41	report	report	NN
cord-342372-2g9sq36w	265	42	and	and	CC
cord-342372-2g9sq36w	265	43	literature	literature	NN
cord-342372-2g9sq36w	265	44	review	review	NN
cord-342372-2g9sq36w	266	1	This	this	DT
cord-342372-2g9sq36w	266	2	retrospective	retrospective	JJ
cord-342372-2g9sq36w	266	3	casecontrol	casecontrol	NNP
cord-342372-2g9sq36w	266	4	study	study	NN
cord-342372-2g9sq36w	266	5	identifies	identify	VBZ
cord-342372-2g9sq36w	266	6	the	the	DT
cord-342372-2g9sq36w	266	7	clinical	clinical	JJ
cord-342372-2g9sq36w	266	8	manifestations	manifestation	NNS
cord-342372-2g9sq36w	266	9	as	as	RB
cord-342372-2g9sq36w	266	10	well	well	RB
cord-342372-2g9sq36w	266	11	as	as	IN
cord-342372-2g9sq36w	266	12	radiographic	radiographic	JJ
cord-342372-2g9sq36w	266	13	findings	finding	NNS
cord-342372-2g9sq36w	266	14	to	to	TO
cord-342372-2g9sq36w	266	15	aid	aid	VB
cord-342372-2g9sq36w	266	16	in	in	IN
cord-342372-2g9sq36w	266	17	the	the	DT
cord-342372-2g9sq36w	266	18	differentiation	differentiation	NN
cord-342372-2g9sq36w	266	19	of	of	IN
cord-342372-2g9sq36w	266	20	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	266	21	disease	disease	NN
cord-342372-2g9sq36w	266	22	with	with	IN
cord-342372-2g9sq36w	266	23	retropharygeal	retropharygeal	NN
cord-342372-2g9sq36w	266	24	edema	edema	NN
cord-342372-2g9sq36w	266	25	to	to	IN
cord-342372-2g9sq36w	266	26	those	those	DT
cord-342372-2g9sq36w	266	27	with	with	IN
cord-342372-2g9sq36w	266	28	retropharyngeal	retropharyngeal	JJ
cord-342372-2g9sq36w	266	29	abscess	abscess	NN
cord-342372-2g9sq36w	266	30	Incomplete	Incomplete	NNP
cord-342372-2g9sq36w	266	31	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	266	32	disease	disease	NN
cord-342372-2g9sq36w	266	33	followed	follow	VBN
cord-342372-2g9sq36w	266	34	by	by	IN
cord-342372-2g9sq36w	266	35	systemic	systemic	JJ
cord-342372-2g9sq36w	266	36	onset	onset	NN
cord-342372-2g9sq36w	266	37	juvenile	juvenile	JJ
cord-342372-2g9sq36w	266	38	idiopathic	idiopathic	JJ
cord-342372-2g9sq36w	266	39	arthritis	arthritis	NN
cord-342372-2g9sq36w	266	40	-	-	,
cord-342372-2g9sq36w	266	41	the	the	DT
cord-342372-2g9sq36w	266	42	diagnostic	diagnostic	JJ
cord-342372-2g9sq36w	266	43	dilemma	dilemma	NN
cord-342372-2g9sq36w	266	44	Systemic	systemic	JJ
cord-342372-2g9sq36w	266	45	onset	onset	NN
cord-342372-2g9sq36w	266	46	juvenile	juvenile	JJ
cord-342372-2g9sq36w	266	47	idiopathic	idiopathic	JJ
cord-342372-2g9sq36w	266	48	arthritis	arthritis	NN
cord-342372-2g9sq36w	266	49	with	with	IN
cord-342372-2g9sq36w	266	50	macrophage	macrophage	NN
cord-342372-2g9sq36w	266	51	activation	activation	NN
cord-342372-2g9sq36w	266	52	syndrome	syndrome	NN
cord-342372-2g9sq36w	266	53	misdiagnosed	misdiagnose	VBN
cord-342372-2g9sq36w	266	54	as	as	IN
cord-342372-2g9sq36w	266	55	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	266	56	disease	disease	NN
cord-342372-2g9sq36w	266	57	:	:	:
cord-342372-2g9sq36w	266	58	case	case	NN
cord-342372-2g9sq36w	266	59	report	report	NN
cord-342372-2g9sq36w	266	60	and	and	CC
cord-342372-2g9sq36w	266	61	literature	literature	NN
cord-342372-2g9sq36w	266	62	review	review	NN
cord-342372-2g9sq36w	267	1	This	this	DT
cord-342372-2g9sq36w	267	2	retrospective	retrospective	JJ
cord-342372-2g9sq36w	267	3	review	review	NN
cord-342372-2g9sq36w	267	4	identifies	identify	VBZ
cord-342372-2g9sq36w	267	5	characteristics	characteristic	NNS
cord-342372-2g9sq36w	267	6	differentiating	differentiate	VBG
cord-342372-2g9sq36w	267	7	Toxic	toxic	JJ
cord-342372-2g9sq36w	267	8	Shock	Shock	NNP
cord-342372-2g9sq36w	267	9	Syndrome	Syndrome	NNP
cord-342372-2g9sq36w	267	10	with	with	IN
cord-342372-2g9sq36w	267	11	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	267	12	disease	disease	NN
cord-342372-2g9sq36w	267	13	shock	shock	NN
cord-342372-2g9sq36w	267	14	syndrome	syndrome	NN
cord-342372-2g9sq36w	267	15	to	to	TO
cord-342372-2g9sq36w	267	16	aid	aid	VB
cord-342372-2g9sq36w	267	17	in	in	IN
cord-342372-2g9sq36w	267	18	recognization	recognization	NN
cord-342372-2g9sq36w	267	19	and	and	CC
cord-342372-2g9sq36w	267	20	treatment	treatment	NN
cord-342372-2g9sq36w	267	21	of	of	IN
cord-342372-2g9sq36w	267	22	this	this	DT
cord-342372-2g9sq36w	267	23	rare	rare	JJ
cord-342372-2g9sq36w	267	24	presentation	presentation	NN
cord-342372-2g9sq36w	267	25	of	of	IN
cord-342372-2g9sq36w	267	26	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	267	27	disease	disease	NN
cord-342372-2g9sq36w	267	28	Recognition	Recognition	NNP
cord-342372-2g9sq36w	267	29	of	of	IN
cord-342372-2g9sq36w	267	30	a	a	DT
cord-342372-2g9sq36w	267	31	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	267	32	disease	disease	NN
cord-342372-2g9sq36w	267	33	shock	shock	NN
cord-342372-2g9sq36w	267	34	syndrome	syndrome	NN
cord-342372-2g9sq36w	267	35	Tricuspid	Tricuspid	NNP
cord-342372-2g9sq36w	267	36	and	and	CC
cord-342372-2g9sq36w	267	37	mitral	mitral	JJ
cord-342372-2g9sq36w	267	38	regurgitation	regurgitation	NN
cord-342372-2g9sq36w	267	39	detected	detect	VBN
cord-342372-2g9sq36w	267	40	by	by	IN
cord-342372-2g9sq36w	267	41	color	color	NN
cord-342372-2g9sq36w	267	42	flow	flow	NN
cord-342372-2g9sq36w	267	43	Doppler	Doppler	NNP
cord-342372-2g9sq36w	267	44	in	in	IN
cord-342372-2g9sq36w	267	45	the	the	DT
cord-342372-2g9sq36w	267	46	acute	acute	JJ
cord-342372-2g9sq36w	267	47	phase	phase	NN
cord-342372-2g9sq36w	267	48	of	of	IN
cord-342372-2g9sq36w	267	49	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	267	50	disease	disease	NN
cord-342372-2g9sq36w	267	51	Clinical	clinical	JJ
cord-342372-2g9sq36w	267	52	manifestations	manifestation	NNS
cord-342372-2g9sq36w	267	53	associated	associate	VBN
cord-342372-2g9sq36w	267	54	with	with	IN
cord-342372-2g9sq36w	267	55	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	267	56	disease	disease	NN
cord-342372-2g9sq36w	267	57	shock	shock	NN
cord-342372-2g9sq36w	267	58	syndrome	syndrome	NN
cord-342372-2g9sq36w	267	59	in	in	IN
cord-342372-2g9sq36w	267	60	Mexican	mexican	JJ
cord-342372-2g9sq36w	267	61	children	child	NNS
cord-342372-2g9sq36w	268	1	The	the	DT
cord-342372-2g9sq36w	268	2	prevention	prevention	NN
cord-342372-2g9sq36w	268	3	of	of	IN
cord-342372-2g9sq36w	268	4	coronary	coronary	JJ
cord-342372-2g9sq36w	268	5	artery	artery	NN
cord-342372-2g9sq36w	268	6	aneurysm	aneurysm	NN
cord-342372-2g9sq36w	268	7	in	in	IN
cord-342372-2g9sq36w	268	8	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	268	9	disease	disease	NN
cord-342372-2g9sq36w	268	10	:	:	:
cord-342372-2g9sq36w	268	11	a	a	DT
cord-342372-2g9sq36w	268	12	meta	meta	NN
cord-342372-2g9sq36w	268	13	-	-	HYPH
cord-342372-2g9sq36w	268	14	analysis	analysis	NN
cord-342372-2g9sq36w	268	15	on	on	IN
cord-342372-2g9sq36w	268	16	the	the	DT
cord-342372-2g9sq36w	268	17	efficacy	efficacy	NN
cord-342372-2g9sq36w	268	18	of	of	IN
cord-342372-2g9sq36w	268	19	aspirin	aspirin	NN
cord-342372-2g9sq36w	268	20	and	and	CC
cord-342372-2g9sq36w	268	21	immunoglobulin	immunoglobulin	NN
cord-342372-2g9sq36w	268	22	treatment	treatment	NN
cord-342372-2g9sq36w	268	23	High	high	JJ
cord-342372-2g9sq36w	268	24	-	-	HYPH
cord-342372-2g9sq36w	268	25	dose	dose	NN
cord-342372-2g9sq36w	268	26	intravenous	intravenous	JJ
cord-342372-2g9sq36w	268	27	gammaglobulin	gammaglobulin	NN
cord-342372-2g9sq36w	268	28	for	for	IN
cord-342372-2g9sq36w	268	29	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	268	30	disease	disease	NN
cord-342372-2g9sq36w	268	31	Economic	economic	JJ
cord-342372-2g9sq36w	268	32	evaluation	evaluation	NN
cord-342372-2g9sq36w	268	33	of	of	IN
cord-342372-2g9sq36w	268	34	intravenous	intravenous	JJ
cord-342372-2g9sq36w	268	35	immune	immune	JJ
cord-342372-2g9sq36w	268	36	globulin	globulin	NN
cord-342372-2g9sq36w	268	37	therapy	therapy	NN
cord-342372-2g9sq36w	268	38	for	for	IN
cord-342372-2g9sq36w	268	39	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	268	40	syndrome	syndrome	NN
cord-342372-2g9sq36w	269	1	Early	early	JJ
cord-342372-2g9sq36w	269	2	intravenous	intravenous	JJ
cord-342372-2g9sq36w	269	3	gamma	gamma	NN
cord-342372-2g9sq36w	269	4	-	-	HYPH
cord-342372-2g9sq36w	269	5	globulin	globulin	NN
cord-342372-2g9sq36w	269	6	treatment	treatment	NN
cord-342372-2g9sq36w	269	7	for	for	IN
cord-342372-2g9sq36w	269	8	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	269	9	disease	disease	NN
cord-342372-2g9sq36w	269	10	:	:	:
cord-342372-2g9sq36w	269	11	the	the	DT
cord-342372-2g9sq36w	269	12	nationwide	nationwide	JJ
cord-342372-2g9sq36w	269	13	surveys	survey	NNS
cord-342372-2g9sq36w	269	14	in	in	IN
cord-342372-2g9sq36w	269	15	Japan	Japan	NNP
cord-342372-2g9sq36w	269	16	Cyclooxygenase	Cyclooxygenase	NNP
cord-342372-2g9sq36w	269	17	inhibitors	inhibitor	NNS
cord-342372-2g9sq36w	269	18	and	and	CC
cord-342372-2g9sq36w	269	19	the	the	DT
cord-342372-2g9sq36w	269	20	antiplatelet	antiplatelet	JJ
cord-342372-2g9sq36w	269	21	effects	effect	NNS
cord-342372-2g9sq36w	269	22	of	of	IN
cord-342372-2g9sq36w	269	23	aspirin	aspirin	NN
cord-342372-2g9sq36w	269	24	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	269	25	disease	disease	NN
cord-342372-2g9sq36w	269	26	with	with	IN
cord-342372-2g9sq36w	269	27	Reye	Reye	NNP
cord-342372-2g9sq36w	269	28	syndrome	syndrome	NN
cord-342372-2g9sq36w	269	29	:	:	:
cord-342372-2g9sq36w	269	30	report	report	NN
cord-342372-2g9sq36w	269	31	of	of	IN
cord-342372-2g9sq36w	269	32	one	one	CD
cord-342372-2g9sq36w	269	33	case	case	NN
cord-342372-2g9sq36w	269	34	Intravenous	intravenous	JJ
cord-342372-2g9sq36w	269	35	gamma	gamma	NN
cord-342372-2g9sq36w	269	36	-	-	HYPH
cord-342372-2g9sq36w	269	37	globulin	globulin	NN
cord-342372-2g9sq36w	269	38	treatment	treatment	NN
cord-342372-2g9sq36w	269	39	and	and	CC
cord-342372-2g9sq36w	269	40	retreatment	retreatment	NN
cord-342372-2g9sq36w	269	41	in	in	IN
cord-342372-2g9sq36w	269	42	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	269	43	disease	disease	NN
cord-342372-2g9sq36w	269	44	.	.	.
cord-342372-2g9sq36w	270	1	US	US	NNP
cord-342372-2g9sq36w	270	2	/	/	SYM
cord-342372-2g9sq36w	270	3	Canadian	canadian	JJ
cord-342372-2g9sq36w	270	4	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	270	5	Syndrome	Syndrome	NNP
cord-342372-2g9sq36w	270	6	Study	Study	NNP
cord-342372-2g9sq36w	270	7	Group	Group	NNP
cord-342372-2g9sq36w	270	8	Re	re	NN
cord-342372-2g9sq36w	270	9	-	-	NN
cord-342372-2g9sq36w	270	10	treatment	treatment	NN
cord-342372-2g9sq36w	270	11	for	for	IN
cord-342372-2g9sq36w	270	12	immune	immune	JJ
cord-342372-2g9sq36w	270	13	globulin	globulin	NN
cord-342372-2g9sq36w	270	14	-	-	HYPH
cord-342372-2g9sq36w	270	15	resistant	resistant	JJ
cord-342372-2g9sq36w	270	16	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	270	17	disease	disease	NN
cord-342372-2g9sq36w	270	18	:	:	:
cord-342372-2g9sq36w	270	19	a	a	DT
cord-342372-2g9sq36w	270	20	comparative	comparative	JJ
cord-342372-2g9sq36w	270	21	study	study	NN
cord-342372-2g9sq36w	270	22	of	of	IN
cord-342372-2g9sq36w	270	23	additional	additional	JJ
cord-342372-2g9sq36w	270	24	immune	immune	JJ
cord-342372-2g9sq36w	270	25	globulin	globulin	NN
cord-342372-2g9sq36w	270	26	and	and	CC
cord-342372-2g9sq36w	270	27	steroid	steroid	NN
cord-342372-2g9sq36w	270	28	pulse	pulse	NN
cord-342372-2g9sq36w	270	29	therapy	therapy	NN
cord-342372-2g9sq36w	270	30	Randomized	randomized	JJ
cord-342372-2g9sq36w	270	31	trial	trial	NN
cord-342372-2g9sq36w	270	32	of	of	IN
cord-342372-2g9sq36w	270	33	pulsed	pulse	VBN
cord-342372-2g9sq36w	270	34	corticosteroid	corticosteroid	NN
cord-342372-2g9sq36w	270	35	therapy	therapy	NN
cord-342372-2g9sq36w	270	36	for	for	IN
cord-342372-2g9sq36w	270	37	primary	primary	JJ
cord-342372-2g9sq36w	270	38	treatment	treatment	NN
cord-342372-2g9sq36w	270	39	of	of	IN
cord-342372-2g9sq36w	270	40	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	270	41	disease	disease	NN
cord-342372-2g9sq36w	271	1	This	this	DT
cord-342372-2g9sq36w	271	2	multicenter	multicenter	NN
cord-342372-2g9sq36w	271	3	,	,	,
cord-342372-2g9sq36w	271	4	prospective	prospective	JJ
cord-342372-2g9sq36w	271	5	,	,	,
cord-342372-2g9sq36w	271	6	randomized	randomized	JJ
cord-342372-2g9sq36w	271	7	,	,	,
cord-342372-2g9sq36w	271	8	open	open	JJ
cord-342372-2g9sq36w	271	9	-	-	HYPH
cord-342372-2g9sq36w	271	10	label	label	NN
cord-342372-2g9sq36w	271	11	,	,	,
cord-342372-2g9sq36w	271	12	blinded	blind	VBN
cord-342372-2g9sq36w	271	13	-	-	HYPH
cord-342372-2g9sq36w	271	14	endpoints	endpoint	NNS
cord-342372-2g9sq36w	271	15	trial	trial	NN
cord-342372-2g9sq36w	271	16	,	,	,
cord-342372-2g9sq36w	271	17	showed	show	VBD
cord-342372-2g9sq36w	271	18	combination	combination	NN
cord-342372-2g9sq36w	271	19	treatment	treatment	NN
cord-342372-2g9sq36w	271	20	with	with	IN
cord-342372-2g9sq36w	271	21	IVIG	IVIG	NNP
cord-342372-2g9sq36w	271	22	and	and	CC
cord-342372-2g9sq36w	271	23	prednisolone	prednisolone	NN
cord-342372-2g9sq36w	271	24	had	have	VBD
cord-342372-2g9sq36w	271	25	significant	significant	JJ
cord-342372-2g9sq36w	271	26	advantages	advantage	NNS
cord-342372-2g9sq36w	271	27	over	over	IN
cord-342372-2g9sq36w	271	28	IVIG	IVIG	NNP
cord-342372-2g9sq36w	271	29	alone	alone	RB
cord-342372-2g9sq36w	271	30	in	in	IN
cord-342372-2g9sq36w	271	31	the	the	DT
cord-342372-2g9sq36w	271	32	prevention	prevention	NN
cord-342372-2g9sq36w	271	33	of	of	IN
cord-342372-2g9sq36w	271	34	coronary	coronary	JJ
cord-342372-2g9sq36w	271	35	artery	artery	NN
cord-342372-2g9sq36w	271	36	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	271	37	,	,	,
cord-342372-2g9sq36w	271	38	rapid	rapid	JJ
cord-342372-2g9sq36w	271	39	defervescence	defervescence	NN
cord-342372-2g9sq36w	271	40	of	of	IN
cord-342372-2g9sq36w	271	41	fever	fever	NN
cord-342372-2g9sq36w	271	42	and	and	CC
cord-342372-2g9sq36w	271	43	normalization	normalization	NN
cord-342372-2g9sq36w	271	44	of	of	IN
cord-342372-2g9sq36w	271	45	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	271	46	markers	marker	NNS
cord-342372-2g9sq36w	271	47	Prediction	Prediction	NNP
cord-342372-2g9sq36w	271	48	of	of	IN
cord-342372-2g9sq36w	271	49	intravenous	intravenous	JJ
cord-342372-2g9sq36w	271	50	immunoglobulin	immunoglobulin	NN
cord-342372-2g9sq36w	271	51	unresponsiveness	unresponsiveness	NN
cord-342372-2g9sq36w	271	52	in	in	IN
cord-342372-2g9sq36w	271	53	patients	patient	NNS
cord-342372-2g9sq36w	271	54	with	with	IN
cord-342372-2g9sq36w	271	55	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	271	56	disease	disease	NN
cord-342372-2g9sq36w	271	57	Serum	serum	NN
cord-342372-2g9sq36w	271	58	levels	level	NNS
cord-342372-2g9sq36w	271	59	of	of	IN
cord-342372-2g9sq36w	271	60	tumor	tumor	NN
cord-342372-2g9sq36w	271	61	necrosis	necrosis	NN
cord-342372-2g9sq36w	271	62	factor	factor	NN
cord-342372-2g9sq36w	271	63	,	,	,
cord-342372-2g9sq36w	271	64	interleukin	interleukin	NN
cord-342372-2g9sq36w	271	65	2	2	CD
cord-342372-2g9sq36w	271	66	receptor	receptor	NN
cord-342372-2g9sq36w	271	67	,	,	,
cord-342372-2g9sq36w	271	68	and	and	CC
cord-342372-2g9sq36w	271	69	interferon	interferon	NN
cord-342372-2g9sq36w	271	70	-	-	HYPH
cord-342372-2g9sq36w	271	71	gamma	gamma	NN
cord-342372-2g9sq36w	271	72	in	in	IN
cord-342372-2g9sq36w	271	73	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	271	74	disease	disease	NN
cord-342372-2g9sq36w	271	75	involved	involve	VBD
cord-342372-2g9sq36w	271	76	coronary	coronary	JJ
cord-342372-2g9sq36w	271	77	-	-	HYPH
cord-342372-2g9sq36w	271	78	artery	artery	NN
cord-342372-2g9sq36w	271	79	lesions	lesion	NNS
cord-342372-2g9sq36w	272	1	Infliximab	infliximab	JJ
cord-342372-2g9sq36w	272	2	treatment	treatment	NN
cord-342372-2g9sq36w	272	3	for	for	IN
cord-342372-2g9sq36w	272	4	refractory	refractory	JJ
cord-342372-2g9sq36w	272	5	kawasaki	kawasaki	NNP
cord-342372-2g9sq36w	272	6	disease	disease	NN
cord-342372-2g9sq36w	272	7	in	in	IN
cord-342372-2g9sq36w	272	8	korean	korean	JJ
cord-342372-2g9sq36w	272	9	children	child	NNS
cord-342372-2g9sq36w	273	1	Infliximab	infliximab	JJ
cord-342372-2g9sq36w	273	2	treatment	treatment	NN
cord-342372-2g9sq36w	273	3	for	for	IN
cord-342372-2g9sq36w	273	4	refractory	refractory	JJ
cord-342372-2g9sq36w	273	5	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	273	6	syndrome	syndrome	NN
cord-342372-2g9sq36w	273	7	Treatment	Treatment	NNP
cord-342372-2g9sq36w	273	8	with	with	IN
cord-342372-2g9sq36w	273	9	infliximab	infliximab	NNP
cord-342372-2g9sq36w	273	10	in	in	IN
cord-342372-2g9sq36w	273	11	patients	patient	NNS
cord-342372-2g9sq36w	273	12	with	with	IN
cord-342372-2g9sq36w	273	13	refractory	refractory	JJ
cord-342372-2g9sq36w	273	14	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	273	15	disease	disease	NN
cord-342372-2g9sq36w	273	16	was	be	VBD
cord-342372-2g9sq36w	273	17	associated	associate	VBN
cord-342372-2g9sq36w	273	18	with	with	IN
cord-342372-2g9sq36w	273	19	shorter	short	JJR
cord-342372-2g9sq36w	273	20	duration	duration	NN
cord-342372-2g9sq36w	273	21	of	of	IN
cord-342372-2g9sq36w	273	22	fever	fever	NN
cord-342372-2g9sq36w	273	23	and	and	CC
cord-342372-2g9sq36w	273	24	hospitalization	hospitalization	NN
cord-342372-2g9sq36w	273	25	when	when	WRB
cord-342372-2g9sq36w	273	26	compared	compare	VBN
cord-342372-2g9sq36w	273	27	to	to	IN
cord-342372-2g9sq36w	273	28	second	second	JJ
cord-342372-2g9sq36w	273	29	dose	dose	NN
cord-342372-2g9sq36w	273	30	of	of	IN
cord-342372-2g9sq36w	273	31	IVIG	IVIG	NNP
cord-342372-2g9sq36w	273	32	in	in	IN
cord-342372-2g9sq36w	273	33	this	this	DT
cord-342372-2g9sq36w	273	34	randomized	randomized	JJ
cord-342372-2g9sq36w	273	35	This	this	DT
cord-342372-2g9sq36w	273	36	phase	phase	NN
cord-342372-2g9sq36w	273	37	3	3	CD
cord-342372-2g9sq36w	273	38	randomized	randomized	JJ
cord-342372-2g9sq36w	273	39	,	,	,
cord-342372-2g9sq36w	273	40	double	double	JJ
cord-342372-2g9sq36w	273	41	-	-	HYPH
cord-342372-2g9sq36w	273	42	blind	blind	JJ
cord-342372-2g9sq36w	273	43	placebo	placebo	NN
cord-342372-2g9sq36w	273	44	-	-	HYPH
cord-342372-2g9sq36w	273	45	controlled	control	VBN
cord-342372-2g9sq36w	273	46	trial	trial	NN
cord-342372-2g9sq36w	273	47	revealed	reveal	VBD
cord-342372-2g9sq36w	273	48	that	that	IN
cord-342372-2g9sq36w	273	49	the	the	DT
cord-342372-2g9sq36w	273	50	addition	addition	NN
cord-342372-2g9sq36w	273	51	of	of	IN
cord-342372-2g9sq36w	273	52	infliximab	infliximab	NNP
cord-342372-2g9sq36w	273	53	to	to	IN
cord-342372-2g9sq36w	273	54	the	the	DT
cord-342372-2g9sq36w	273	55	initial	initial	JJ
cord-342372-2g9sq36w	273	56	treatment	treatment	NN
cord-342372-2g9sq36w	273	57	regimen	regimen	NN
cord-342372-2g9sq36w	273	58	of	of	IN
cord-342372-2g9sq36w	273	59	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	273	60	disease	disease	NN
cord-342372-2g9sq36w	273	61	did	do	VBD
cord-342372-2g9sq36w	273	62	not	not	RB
cord-342372-2g9sq36w	273	63	reduce	reduce	VB
cord-342372-2g9sq36w	273	64	the	the	DT
cord-342372-2g9sq36w	273	65	incidence	incidence	NN
cord-342372-2g9sq36w	273	66	of	of	IN
cord-342372-2g9sq36w	273	67	refractory	refractory	JJ
cord-342372-2g9sq36w	273	68	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	273	69	disease	disease	NN
cord-342372-2g9sq36w	273	70	Inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	273	71	cytokine	cytokine	NN
cord-342372-2g9sq36w	273	72	profiles	profile	NNS
cord-342372-2g9sq36w	273	73	during	during	IN
cord-342372-2g9sq36w	273	74	Cyclosporin	Cyclosporin	NNP
cord-342372-2g9sq36w	273	75	treatment	treatment	NN
cord-342372-2g9sq36w	273	76	for	for	IN
cord-342372-2g9sq36w	273	77	immunoglobulin	immunoglobulin	NN
cord-342372-2g9sq36w	273	78	-	-	HYPH
cord-342372-2g9sq36w	273	79	resistant	resistant	JJ
cord-342372-2g9sq36w	273	80	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	273	81	disease	disease	NN
cord-342372-2g9sq36w	273	82	Study	study	NN
cord-342372-2g9sq36w	273	83	protocol	protocol	NN
cord-342372-2g9sq36w	273	84	for	for	IN
cord-342372-2g9sq36w	273	85	a	a	DT
cord-342372-2g9sq36w	273	86	phase	phase	NN
cord-342372-2g9sq36w	273	87	III	III	NNP
cord-342372-2g9sq36w	273	88	multicentre	multicentre	NNP
cord-342372-2g9sq36w	273	89	,	,	,
cord-342372-2g9sq36w	273	90	randomised	randomised	JJ
cord-342372-2g9sq36w	273	91	,	,	,
cord-342372-2g9sq36w	273	92	open	open	JJ
cord-342372-2g9sq36w	273	93	-	-	HYPH
cord-342372-2g9sq36w	273	94	label	label	NN
cord-342372-2g9sq36w	273	95	,	,	,
cord-342372-2g9sq36w	273	96	blinded	blinded	JJ
cord-342372-2g9sq36w	273	97	-	-	HYPH
cord-342372-2g9sq36w	273	98	end	end	NN
cord-342372-2g9sq36w	273	99	point	point	NN
cord-342372-2g9sq36w	273	100	trial	trial	NN
cord-342372-2g9sq36w	273	101	to	to	TO
cord-342372-2g9sq36w	273	102	evaluate	evaluate	VB
cord-342372-2g9sq36w	273	103	the	the	DT
cord-342372-2g9sq36w	273	104	efficacy	efficacy	NN
cord-342372-2g9sq36w	273	105	and	and	CC
cord-342372-2g9sq36w	273	106	safety	safety	NN
cord-342372-2g9sq36w	273	107	of	of	IN
cord-342372-2g9sq36w	273	108	immunoglobulin	immunoglobulin	NN
cord-342372-2g9sq36w	273	109	plus	plus	CC
cord-342372-2g9sq36w	273	110	cyclosporin	cyclosporin	NN
cord-342372-2g9sq36w	273	111	A	a	NN
cord-342372-2g9sq36w	273	112	in	in	IN
cord-342372-2g9sq36w	273	113	patients	patient	NNS
cord-342372-2g9sq36w	273	114	with	with	IN
cord-342372-2g9sq36w	273	115	severe	severe	JJ
cord-342372-2g9sq36w	273	116	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	273	117	disease	disease	NN
cord-342372-2g9sq36w	273	118	(	(	-LRB-
cord-342372-2g9sq36w	273	119	KAICA	KAICA	NNP
cord-342372-2g9sq36w	273	120	Trial	Trial	NNP
cord-342372-2g9sq36w	273	121	)	)	-RRB-
cord-342372-2g9sq36w	274	1	Interleukin-1beta	interleukin-1beta	NN
cord-342372-2g9sq36w	274	2	is	be	VBZ
cord-342372-2g9sq36w	274	3	crucial	crucial	JJ
cord-342372-2g9sq36w	274	4	for	for	IN
cord-342372-2g9sq36w	274	5	the	the	DT
cord-342372-2g9sq36w	274	6	induction	induction	NN
cord-342372-2g9sq36w	274	7	of	of	IN
cord-342372-2g9sq36w	274	8	coronary	coronary	JJ
cord-342372-2g9sq36w	274	9	artery	artery	NN
cord-342372-2g9sq36w	274	10	inflammation	inflammation	NN
cord-342372-2g9sq36w	274	11	in	in	IN
cord-342372-2g9sq36w	274	12	a	a	DT
cord-342372-2g9sq36w	274	13	mouse	mouse	NN
cord-342372-2g9sq36w	274	14	model	model	NN
cord-342372-2g9sq36w	274	15	of	of	IN
cord-342372-2g9sq36w	274	16	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	274	17	disease	disease	NN
cord-342372-2g9sq36w	274	18	Adjunctive	Adjunctive	NNP
cord-342372-2g9sq36w	274	19	therapies	therapy	NNS
cord-342372-2g9sq36w	274	20	for	for	IN
cord-342372-2g9sq36w	274	21	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	274	22	disease	disease	NN
cord-342372-2g9sq36w	274	23	High	High	NNP
cord-342372-2g9sq36w	274	24	dose	dose	NN
cord-342372-2g9sq36w	274	25	Anakinra	Anakinra	NNP
cord-342372-2g9sq36w	274	26	for	for	IN
cord-342372-2g9sq36w	274	27	treatment	treatment	NN
cord-342372-2g9sq36w	274	28	of	of	IN
cord-342372-2g9sq36w	274	29	severe	severe	JJ
cord-342372-2g9sq36w	274	30	neonatal	neonatal	JJ
cord-342372-2g9sq36w	274	31	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	274	32	disease	disease	NN
cord-342372-2g9sq36w	274	33	:	:	:
cord-342372-2g9sq36w	274	34	a	a	DT
cord-342372-2g9sq36w	274	35	case	case	NN
cord-342372-2g9sq36w	274	36	report	report	NN
cord-342372-2g9sq36w	274	37	This	this	DT
cord-342372-2g9sq36w	274	38	phase	phase	NN
cord-342372-2g9sq36w	274	39	I	-PRON-	PRP
cord-342372-2g9sq36w	274	40	/	/	SYM
cord-342372-2g9sq36w	274	41	IIa	IIa	NNP
cord-342372-2g9sq36w	274	42	trial	trial	NN
cord-342372-2g9sq36w	274	43	of	of	IN
cord-342372-2g9sq36w	274	44	anakinra	anakinra	NNP
cord-342372-2g9sq36w	274	45	in	in	IN
cord-342372-2g9sq36w	274	46	children	child	NNS
cord-342372-2g9sq36w	274	47	with	with	IN
cord-342372-2g9sq36w	274	48	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	274	49	disease	disease	NN
cord-342372-2g9sq36w	274	50	and	and	CC
cord-342372-2g9sq36w	274	51	coronary	coronary	JJ
cord-342372-2g9sq36w	274	52	artery	artery	NN
cord-342372-2g9sq36w	274	53	abnormalities	abnormality	NNS
cord-342372-2g9sq36w	274	54	aims	aim	VBZ
cord-342372-2g9sq36w	274	55	to	to	TO
cord-342372-2g9sq36w	274	56	evaluate	evaluate	VB
cord-342372-2g9sq36w	274	57	the	the	DT
cord-342372-2g9sq36w	274	58	saftety	saftety	NN
cord-342372-2g9sq36w	274	59	and	and	CC
cord-342372-2g9sq36w	274	60	tolerability	tolerability	NN
cord-342372-2g9sq36w	274	61	of	of	IN
cord-342372-2g9sq36w	274	62	2	2	CD
cord-342372-2g9sq36w	274	63	-	-	SYM
cord-342372-2g9sq36w	274	64	6	6	CD
cord-342372-2g9sq36w	274	65	week	week	NN
cord-342372-2g9sq36w	274	66	course	course	NN
cord-342372-2g9sq36w	274	67	of	of	IN
cord-342372-2g9sq36w	274	68	daily	daily	JJ
cord-342372-2g9sq36w	274	69	anakinra	anakinra	NNP
cord-342372-2g9sq36w	274	70	injection	injection	NN
cord-342372-2g9sq36w	274	71	to	to	TO
cord-342372-2g9sq36w	274	72	to	to	TO
cord-342372-2g9sq36w	274	73	prevent	prevent	VB
cord-342372-2g9sq36w	274	74	or	or	CC
cord-342372-2g9sq36w	274	75	attenuate	attenuate	VB
cord-342372-2g9sq36w	274	76	coronary	coronary	JJ
cord-342372-2g9sq36w	274	77	artery	artery	NN
cord-342372-2g9sq36w	274	78	damage	damage	NN
cord-342372-2g9sq36w	274	79	associated	associate	VBN
cord-342372-2g9sq36w	274	80	with	with	IN
cord-342372-2g9sq36w	274	81	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	274	82	disease	disease	NN
cord-342372-2g9sq36w	274	83	Long	long	JJ
cord-342372-2g9sq36w	274	84	-	-	HYPH
cord-342372-2g9sq36w	274	85	term	term	NN
cord-342372-2g9sq36w	274	86	effects	effect	NNS
cord-342372-2g9sq36w	274	87	of	of	IN
cord-342372-2g9sq36w	274	88	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	274	89	on	on	IN
cord-342372-2g9sq36w	274	90	plasma	plasma	NN
cord-342372-2g9sq36w	274	91	concentration	concentration	NN
cord-342372-2g9sq36w	274	92	of	of	IN
cord-342372-2g9sq36w	274	93	C	C	NNP
cord-342372-2g9sq36w	274	94	-	-	HYPH
cord-342372-2g9sq36w	274	95	reactive	reactive	JJ
cord-342372-2g9sq36w	274	96	protein	protein	NN
cord-342372-2g9sq36w	274	97	.	.	.
cord-342372-2g9sq36w	275	1	The	the	DT
cord-342372-2g9sq36w	275	2	Cholesterol	cholesterol	NN
cord-342372-2g9sq36w	275	3	and	and	CC
cord-342372-2g9sq36w	275	4	Recurrent	recurrent	JJ
cord-342372-2g9sq36w	275	5	Events	event	NNS
cord-342372-2g9sq36w	275	6	(	(	-LRB-
cord-342372-2g9sq36w	275	7	CARE	care	NN
cord-342372-2g9sq36w	275	8	)	)	-RRB-
cord-342372-2g9sq36w	276	1	Investigators	investigator	NNS
cord-342372-2g9sq36w	276	2	Inflammation	inflammation	NN
cord-342372-2g9sq36w	276	3	,	,	,
cord-342372-2g9sq36w	276	4	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	276	5	,	,	,
cord-342372-2g9sq36w	276	6	and	and	CC
cord-342372-2g9sq36w	276	7	the	the	DT
cord-342372-2g9sq36w	276	8	risk	risk	NN
cord-342372-2g9sq36w	276	9	of	of	IN
cord-342372-2g9sq36w	276	10	coronary	coronary	JJ
cord-342372-2g9sq36w	276	11	events	event	NNS
cord-342372-2g9sq36w	276	12	after	after	IN
cord-342372-2g9sq36w	276	13	myocardial	myocardial	JJ
cord-342372-2g9sq36w	276	14	infarction	infarction	NN
cord-342372-2g9sq36w	276	15	in	in	IN
cord-342372-2g9sq36w	276	16	patients	patient	NNS
cord-342372-2g9sq36w	276	17	with	with	IN
cord-342372-2g9sq36w	276	18	average	average	JJ
cord-342372-2g9sq36w	276	19	cholesterol	cholesterol	NN
cord-342372-2g9sq36w	276	20	levels	level	NNS
cord-342372-2g9sq36w	276	21	.	.	.
cord-342372-2g9sq36w	277	1	Cholesterol	cholesterol	NN
cord-342372-2g9sq36w	277	2	and	and	CC
cord-342372-2g9sq36w	277	3	Recurrent	recurrent	JJ
cord-342372-2g9sq36w	277	4	Events	event	NNS
cord-342372-2g9sq36w	277	5	(	(	-LRB-
cord-342372-2g9sq36w	277	6	CARE	care	NN
cord-342372-2g9sq36w	277	7	)	)	-RRB-
cord-342372-2g9sq36w	278	1	Investigators	investigator	NNS
cord-342372-2g9sq36w	279	1	This	this	DT
cord-342372-2g9sq36w	279	2	editorial	editorial	JJ
cord-342372-2g9sq36w	279	3	review	review	NN
cord-342372-2g9sq36w	279	4	of	of	IN
cord-342372-2g9sq36w	279	5	the	the	DT
cord-342372-2g9sq36w	279	6	role	role	NN
cord-342372-2g9sq36w	279	7	of	of	IN
cord-342372-2g9sq36w	279	8	statins	statin	NNS
cord-342372-2g9sq36w	279	9	in	in	IN
cord-342372-2g9sq36w	279	10	non	non	JJ
cord-342372-2g9sq36w	279	11	-	-	JJ
cord-342372-2g9sq36w	279	12	atherosclerotic	atherosclerotic	JJ
cord-342372-2g9sq36w	279	13	,	,	,
cord-342372-2g9sq36w	279	14	acute	acute	JJ
cord-342372-2g9sq36w	279	15	and	and	CC
cord-342372-2g9sq36w	279	16	chronic	chronic	JJ
cord-342372-2g9sq36w	279	17	vasculitides	vasculitide	NNS
cord-342372-2g9sq36w	279	18	due	due	IN
cord-342372-2g9sq36w	279	19	to	to	IN
cord-342372-2g9sq36w	279	20	their	-PRON-	PRP$
cord-342372-2g9sq36w	279	21	anti	anti	JJ
cord-342372-2g9sq36w	279	22	-	-	JJ
cord-342372-2g9sq36w	279	23	inflammatory	inflammatory	JJ
cord-342372-2g9sq36w	279	24	,	,	,
cord-342372-2g9sq36w	279	25	anti	anti	JJ
cord-342372-2g9sq36w	279	26	-	-	JJ
cord-342372-2g9sq36w	279	27	oxidant	oxidant	JJ
cord-342372-2g9sq36w	279	28	,	,	,
cord-342372-2g9sq36w	279	29	and	and	CC
cord-342372-2g9sq36w	279	30	endothelial	endothelial	JJ
cord-342372-2g9sq36w	279	31	repairing	repair	VBG
cord-342372-2g9sq36w	279	32	properties	property	NNS
cord-342372-2g9sq36w	279	33	provides	provide	VBZ
cord-342372-2g9sq36w	279	34	an	an	DT
cord-342372-2g9sq36w	279	35	concise	concise	JJ
cord-342372-2g9sq36w	279	36	review	review	NN
cord-342372-2g9sq36w	279	37	of	of	IN
cord-342372-2g9sq36w	279	38	the	the	DT
cord-342372-2g9sq36w	279	39	use	use	NN
cord-342372-2g9sq36w	279	40	of	of	IN
cord-342372-2g9sq36w	279	41	statins	statin	NNS
cord-342372-2g9sq36w	279	42	in	in	IN
cord-342372-2g9sq36w	279	43	the	the	DT
cord-342372-2g9sq36w	279	44	treatment	treatment	NN
cord-342372-2g9sq36w	279	45	of	of	IN
cord-342372-2g9sq36w	279	46	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	279	47	disease	disease	NN
cord-342372-2g9sq36w	280	1	This	this	DT
cord-342372-2g9sq36w	280	2	case	case	NN
cord-342372-2g9sq36w	280	3	report	report	NN
cord-342372-2g9sq36w	280	4	documents	document	VBZ
cord-342372-2g9sq36w	280	5	the	the	DT
cord-342372-2g9sq36w	280	6	use	use	NN
cord-342372-2g9sq36w	280	7	of	of	IN
cord-342372-2g9sq36w	280	8	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	280	9	in	in	IN
cord-342372-2g9sq36w	280	10	a	a	DT
cord-342372-2g9sq36w	280	11	42	42	CD
cord-342372-2g9sq36w	280	12	year	year	NN
cord-342372-2g9sq36w	280	13	old	old	JJ
cord-342372-2g9sq36w	280	14	pt	pt	NN
cord-342372-2g9sq36w	280	15	with	with	IN
cord-342372-2g9sq36w	280	16	history	history	NN
cord-342372-2g9sq36w	280	17	of	of	IN
cord-342372-2g9sq36w	280	18	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	280	19	disease	disease	NN
cord-342372-2g9sq36w	280	20	complicated	complicate	VBN
cord-342372-2g9sq36w	280	21	by	by	IN
cord-342372-2g9sq36w	280	22	giant	giant	JJ
cord-342372-2g9sq36w	280	23	left	leave	VBN
cord-342372-2g9sq36w	280	24	coronary	coronary	JJ
cord-342372-2g9sq36w	280	25	artery	artery	NN
cord-342372-2g9sq36w	280	26	aneurysm	aneurysm	NN
cord-342372-2g9sq36w	280	27	which	which	WDT
cord-342372-2g9sq36w	280	28	resulted	result	VBD
cord-342372-2g9sq36w	280	29	in	in	IN
cord-342372-2g9sq36w	280	30	reduction	reduction	NN
cord-342372-2g9sq36w	280	31	in	in	IN
cord-342372-2g9sq36w	280	32	coronary	coronary	JJ
cord-342372-2g9sq36w	280	33	artery	artery	NN
cord-342372-2g9sq36w	280	34	inflammation	inflammation	NN
cord-342372-2g9sq36w	280	35	Effect	effect	NN
cord-342372-2g9sq36w	280	36	of	of	IN
cord-342372-2g9sq36w	280	37	pravastatin	pravastatin	NN
cord-342372-2g9sq36w	280	38	on	on	IN
cord-342372-2g9sq36w	280	39	endothelial	endothelial	JJ
cord-342372-2g9sq36w	280	40	dysfunction	dysfunction	NN
cord-342372-2g9sq36w	280	41	in	in	IN
cord-342372-2g9sq36w	280	42	children	child	NNS
cord-342372-2g9sq36w	280	43	with	with	IN
cord-342372-2g9sq36w	280	44	medium	medium	NN
cord-342372-2g9sq36w	280	45	to	to	IN
cord-342372-2g9sq36w	280	46	giant	giant	JJ
cord-342372-2g9sq36w	280	47	coronary	coronary	JJ
cord-342372-2g9sq36w	280	48	aneurysms	aneurysm	NNS
cord-342372-2g9sq36w	280	49	due	due	JJ
cord-342372-2g9sq36w	280	50	to	to	IN
cord-342372-2g9sq36w	280	51	Kawasaki	Kawasaki	NNP
cord-342372-2g9sq36w	280	52	disease	disease	NN